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Over the last several decades, there has been a remarkable growth in the number of fluorescence 
imaging techniques for studying biological systems. Fluorescent small molecules, in particular, 
have significant advantages in optical imaging and analytical sensing due to their small size, high 
sensitivity, and fast response time. Functional fluorescent probes, such as photoactivatable 
fluorophores, can also provide dynamic information concerning the localization and quantity of 
biomolecules in living cells. Although numerous fluorescent probes are known, within the context 
of biological systems, “ideal” fluorescent probes are still in high demand, as properties such as cell 
permeability or cytotoxicity are often difficult to predict on the basis of rational design and 
theoretical calculations. Hence, there is still a need for simple fluorogenic scaffolds, which allow 
the rational design of molecules with predictable photophysical properties and are amenable to 
concise synthesis for high-throughput combinatorial screening. My work in the Chenoweth and 
Petersson Lab has focused on developing functional fluorescent probes based on modular scaffolds 
that exhibit advances over classic and contemporary dyes. In undertaking this work, three 
functional fluorescent scaffolds have been explored: (1) a quinoline-based highly tunable dye, (2) 
a diazaxanthilidene-based photoconvertible probe, and (3) an acridone-based fluorescent unnatural 
amino acid (UAA). Each fluorescent scaffold is rationally designed, efficiently synthesized, and 
utilized in live cell imaging experiments to demonstrate utility. 
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Chapter 1 
 
Introduction to Fluorescent Small Molecules 
 
 2 
1.1    Introduction  
 
Chemical biology is a rapidly-growing field that utilizes chemical strategies to decipher 
and manipulate natural biology.1-4 The interdisciplinary research between chemistry and biology 
has generated cutting-edge technologies to probe biological systems, innovated diagnostic 
platforms to improve human health, and allowed synthetic biology to benefit human needs. These 
advances often rely on fluorescence-based imaging techniques that can detect, visualize, and 
characterize morphological and dynamic phenomena of biology at the molecular level in multi-
dimensional fashions.2-3 Therefore, fluorescent probes have become indispensable tools for the 
field of molecular biology and medicine.5 Owing to their high sensitivity and rapid response, 
fluorescent probes offer diverse benefits in visualizing spatiotemporal changes of biological 
systems.3, 6 Though there are many fluorescent probes, including genetically engineered fluorescent 
proteins7 and quantum dots,8 this thesis is focused on fluorescent small molecules.  Small molecule 
fluorophores present a highly attractive space for organic chemists as they hold several key 
advantages such as small size, ease of use, and chemical tunability.1, 9 
1.2    Brief history and significance   
 
The first well-defined small molecule fluorescent compound was the antimalarial drug 
quinine sulfate (Figure 1.1). The fluorescence of quinine was first discovered by Fredrick W. 
Herschel in 1845 when he noticed the visible emission from an aqueous quinine solution (tonic 
water).10 Later, in 1852, British scientist Sir George G. Stokes explained that this phenomenon of 
emission was due to absorption of light by quinine and coined the term ‘fluorescence.’11 However, 
fluorescent compounds did not receive much attention until the development of the fluorimeter and 
fluorescence microscopy in the 1950s.12 Since then, fluorophores have been widely used in 
bioanalytical techniques to stain tissues and bacteria, spurring many discoveries of other organic 
dyes. In the early 1990s, Roger Y. Tsien and others achieved the cloning of green fluorescent 
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protein (GFP) to use as a fluorescent probe in bioscience.7, 13 Tsien, as well as Osamu Shimomura 
and Martin Chalfie,14 then won the Nobel Prize in Chemistry in 2008 for the discovery and 
development of GFP.15 The extant collection of fluorescent probes has exponentially developed in 
conjunction with development of imaging instruments (Figure 1.1). In 2014, the Nobel Prize for 
Chemistry was awarded to William E. Moerner, Eric Betzig, and Stefan Hell for the development 
of super-resolved fluorescence microscopy, which overcomes the diffraction limit of conventional 
light microscopy.16 The advent of these imaging techniques foreshadowed the significance in the 
synthesis of novel or improved fluorogenic probes. Now these synthetic fluorogenic probes are 
found in a vast majority of biological experiments, demonstrating diagnostic or even clinical utility. 
 
Figure 1.1 Number of publications with “fluorescent dye” (source: Scifinder) and related key 
developments in fluorescent probe and imaging technologies. 
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Note. “fluorescent dye” was searched by ‘research topic’ in Scifinder. The number of publications 
per every 10 years is shown in the chart to illustrate the growth of research interest in fluorescent 
dyes (left). Structure of currently FDA-approved synthetic dyes (right).   
Fluorescent small molecules have ubiquitous utility in diverse experiments, including 
cellular staining, detection of specific bioanalytes, and tracking biomolecules of interest. These 
synthetic fluorophores are generally modified as fluorescent tags that possess an affinity to the 
target molecule either by chemical (e.g., biorthogonal click chemistry)17 or biological (e.g., self-
labeling protein tag)18-20 means (Figure 1.2).1, 4 The target molecules can be as small as inorganic 
bio-analytes (e.g., calcium, iron, copper), nucleic acids (e.g., DNA, RNA), sugars, or lipids, and as 
big as macromolecules, such as proteins. A fluorescent probe commonly consists of a fluorophore, 
linker, and recognition motif (tag), which can be the site of covalent attachment to the target. The 
small size of synthetic fluorophore probes provides many benefits over fluorescent proteins, 
including minimal perturbation on the native functions of the target and high flexibility in 
molecular design and application. Beyond biological imaging, fluorescent materials enable many 
useful technologies, such as high-throughput screening, genome sequencing, and activity-based 
protein profiling (ABPP).21 Figure 1.3 presents a schematic representation of ABPP using a 
fluorogenic compound for high-throughput proteomic studies. 
 5 
 
Figure 1.2 Types of fluorescent tags. Chemical labeling via click chemistry or maleimide-cystein 
biorthogonal conjugation. Biological labeling involves engineering cell line or protein of interest 
with HaloTag or SNAP tag. 
 
 
 
Figure 1.3 Activity based protein profiling (ABPP). Activity based probe (ABP) is added to cells 
and covalently linked to target protein via photo-crosslinking. Fluorescent probe is then added to 
click to the protein conjugated with ABP. Fluorescence is used as the signal to detect the target 
protein. 
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Successful development of a fluorescent small molecule for biological imaging can be 
achieved through a combination of the following methods: 1) efficient synthetic skills, 2) high 
throughput in vitro and in silico analytical methods, 3) sufficient imaging instrumentation for in 
cellulo and in vivo studies, and 4) background knowledge in a biological system. The first key step 
is efficient chemical synthesis because all probe properties, including photophysical characteristics 
of the small molecule, can be tailored by chemical structure. In particular, employing advances in 
chemical synthesis and high-throughput analysis is essential for the discovery of ‘functional’ 
fluorophores. A ‘functional’ fluorophore changes fluorescence in response to some external stimuli 
such as interaction with the target biomolecules, reactive chemical species, enzymatic activity, light, 
or environmental changes (Figure 1.4).22-25 Such probes allow sophisticated bioassays and real-
time imaging of biological systems. With recent revolutionary advances in imaging techniques, 
these functional fluorophores allow multi-color imaging and super-resolution microscopy.  
 
 
 
 
 
 
 7 
 
Figure 1.4 General types of functional probes. A) Cellular stains with specific localization, B) 
environmental indicator that activates fluorescence upon reacting with substrates (e.g., protonation, 
intracellular metals), C) indicator for enzymatic catalysis (e.g., esterase cleaving off ester tag in 
fluorophore), and D) biorthogonal tag (e.g., azide-alkyne 1,3-dipolar cycloaddition, 
oxime/hydrazine formation from aldehyde/ketones, tetrazine ligation, and photo-crosslinking) 
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1.3    Overview of Fluorescence  
 
Over several decades myriad different fluorophores has been developed with various 
photophysical and chemical properties.26-27 The photophysical characteristics of fluorophores 
include the absorption maximum (λabs), the emission maximum (λem), the extinction coefficient at 
λmax (ε), and the fluorescence quantum yield (Φ). The process of fluorescence is described in the 
Jabłoński diagram (Figure 1.5A-B).28 Upon absorption of light, a molecule initially reaches a 
singlet excited state (S1, S2, etc.). Typically, an excited molecule will then rapidly lose energy due 
to solvent reorganization around the distorted dipole moment of the excited state and relax to the 
first singlet excited state (S1). From this excited state, a molecule relaxes back to the ground state 
(S0) and emits a photon in a process known as fluorescence or emission (λem). In short, fluorescence 
is an emission of a photon by relaxation of excited state electrons following absorption of external 
light. The difference between λabs and λem is termed the “Stokes shift” in homage to Sir George 
Stokes (Figure 1.5C). Due to the energy loss stemming from relaxation to S1 and solvent 
reorganization, the emission wavelength is generally longer than the absorption maximum. 
However, λmax > λem can occur upon multiphoton excitation where two or more photons are 
simultaneously absorbed to yield the singlet excited state. Alternatively, intersystem crossing (ISC) 
to and from the triplet state (T1) can occur when the excited electron is no longer paired 
(parallel/same spin) with the ground state electron. This causes the excited molecule to relax and 
emit a photon through either radiative (phosphorescence) or nonradiative (quenched) means. 
Phosphorescent processes usually have significantly longer lifetimes and longer emission 
wavelengths than fluorescent ones. In general, ISC can be commonly found in heavy-atom 
containing fluorophores (e.g., those containing iodine or bromine) or fluorophores in the presence 
of paramagnetic species in solution. 
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Figure 1.5 A) Jabłoński diagram, B) the time scale of each process in order of fastest to slowest, 
and C) fluorescence spectra with schematic view of Stokes shift (e.g., coumarin29). Absorption 
maximum (λabs) and emission maximum (λem)  
 
The sequence of events leading to fluorescence emission is consistent and thus allows one 
to analyze fluorescent properties in terms of structural motifs. The fluorescence lifetime (τ) is the 
average time between excitation and emission and allows the quantification of competing rates of 
fluorescence and nonradiative processes. This delay also enables fluorescence 
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anisotropy/polarization measurements.  The extinction coefficient, or molar absorptivity, measures 
the capacity of a dye to absorb photons. The quantum yield (Φ) measures the efficiency of the 
fluorescence process by taking the ratio of the number of photons emitted to the number of photons 
absorbed. Taking these values into account, the relative brightness of fluorophores can be 
determined by multiplying the extinction coefficient and quantum yield (ε x Φ). Another important 
property is photostability or photobleaching, which demonstrates the robustness of dye under the 
subjected light source. Lastly, chemical characteristics of fluorophores include environmental 
sensitivities based on the pH or polarity of solvents, aggregation inducive properties, solubility, 
and cell permeability.30 
Combining classical strategies for the synthesis of fluorophores with recent advances in 
synthetic methods has allowed the vast growth of small molecule fluorescent probe development.  
A plethora of small molecule fluorophores has been synthesized, structurally tailored and applied 
for specific biological experiments with desired properties. However, the vast number of 
fluorophores are generated from a modest set of “core” scaffolds as reported in several reviews by 
Nagano, Raines and Lavis.1, 9, 27, 31 The structures of common fluorogenic cores used in current 
biological research are shown in Figure 1.6. Each scaffold has been derivatized into dyes with 
improved photophysical and chemical properties; the utility and popularity of each fluorogenic core 
is analyzed by the number of publications based on the Scifinder database (Figure 1.7). 
Unsurprisingly, fluorescein was the most ubiquitous core as it is an FDA approved dye that was 
discovered in 1871. Interestingly, quinoline was the least studied core despite the fact that it was 
the first well-defined fluorophore.  Studying the dye family based on each core allows us to 
understand the distinct structure-photophysical properties of each scaffold and to generate 
roadmaps for future probes (Table 1.1). For instance, boron dipyrromethene (BODIPY) dyes 
generally have high brightness but suffer from self-quenching, due to a small Stokes shift. On the 
other hand, coumarins and quinolines usually have large Stokes shift, but generally exhibit blue-
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shifted absorption wavelength relative to that of fluoresceins or rhodamines. Modification of these 
cores has generated numerous synthetic dyes with versatile utilities; however, only a small number 
of them are compatible with in vivo studies and, in fact, only two (e.g., fluorescein sodium and 
indocyananine green) are FDA-approved contrast agents for optical imaging for human health 
studies (Figure 1.1).32 This statistic demonstrates that there is still high demand for “ideal” in vivo 
or live cell probes that are non-cytotoxic, red-shifted, substantially bright, and highly selective to 
the target of interest. The major bottleneck in ideal probe development, especially for in vivo 
imaging, is that some properties (e.g., high selectivity, sensitivity, photostability and non-
cytotoxicity) under physiological conditions cannot be rationally designed or computationally 
predicted from first principles. One of the formidable challenges for in vivo imaging is the 
requirement of highly red-shifted spectra. Longer excitation wavelengths are needed to penetrate 
deeper into tissue and to avoid eliciting cellular autofluorescence (>750 nm excitation) and photon 
scattering for high-resolution or two-photon imaging (>1400 nm excitation). Additionally, the 
necessary instrumentation to readily analyze these red-shifted probes, such as infrared lamps, are 
also not widely available.  
 Addressing both predictable and unpredictable properties of small molecule probes, we 
will discuss how dye chemistry has been developed by two main approaches: a rational design 
approach and a combinatorial approach. Here, we survey the development of fluorophores over the 
past 20 years and highlight the exemplary use of sophisticated, custom-made probes. 
Understanding the chemistry that underlies the fluorophore design and synthesis is essential to 
inspire the design and creation of new, high-precision tools.   
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Figure 1.6 List of core fluorescent scaffolds listed in order of increasing absorption values. R 
groups indicate site for common functionalization. 
 
 
 
 
Figure 1.7 Number of publications for each fluorescent core scaffold (source: Scifinder) 
 
Note. The number of publications for each fluorescent core was searched by ‘research topic’ as 
listed in the table (left). A pie-chart is shown to represent the most developed scaffold and the least 
developed scaffolds (right).  
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Table 1.1 Table of general photophysical and chemical properties of each fluorescent core 
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1.4    Rational Design of Fluorophore  
 
Each step in the fluorescence process can be modulated by organic synthesis. To accelerate 
rational and efficient probe development, many efforts to understand the mechanism of each 
fluorescence process by computational chemistry have been made in recent years. Here, we detail 
the collection of fluorophores and highlight both general strategies and unique approaches that are 
employed to control fluorescence through rational design.  Three general guidelines are considered 
for the design of new dyes at the present time.  First, absorption and emission spectra of a 
fluorophore can be modulated by attaching electronically diverse groups to the fluorescent core.  
Second, the brightness of the fluorophore can be modulated by employing photoinduced electron 
transfer (PeT) and controlling bond rotation. Lastly, fluorescence readout can be modulated by 
utilizing interchromophore Förster resonance energy transfer (FRET)33 or PeT. Each modulation 
will be further discussed below.  
First, in general, a donor-p-acceptor moiety is the key structural framework to give 
fluorescence to small organic compounds (Figure 1.8).34-35 Within the core fluorophore, changes 
in the electronics of the donor-p-acceptor dye can cause changes in fluorescence.36-37  An increase 
in the “push−pull” effect of electronics in dyes, whose excitation involves intramolecular charge 
transfer (ICT), results in a bathochromic (red) shift in their UV−vis absorption and emission spectra.  
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Figure 1.8 Donor-p-acceptor moiety of fluorescent small molecule 
 
Additionally, expanding the π-conjugated network by appendages such as methylene 
moieties or aromatic substituents leads to a bathochromic shift and typically to an enhanced molar 
extinction coefficient (Figure 1.9).32, 38 Nagano and Lavis showed a series of fluorescein and 
rhodamine derivatives with fine-tuned absorption and emission spectra by changing substituents.39-
41 Moreover, absorption and emission of cyanine dyes can be red-shifted by extending the 
methylene bridge or modifying heterocycles with stronger electronic donating and accepting groups. 
Alteration of substituents can also contribute to improving quantum yield or water solubility of 
synthetic dyes,42 which will be explained in a later section (Figure 1.14).43-44 Briefly, Lavis et al. 
reported that azetidinyl substitutions in place of dimethylamino groups in rhodamine derivatives 
greatly enhance the quantum efficiency. Likewise, Waggoner and Schnermann et. al. dramatically 
improved the quantum yield of cyanine dyes by conformationally restraining the trimethine or 
pentamethine bridge (compound C559, compound C670).45-46 Through installation of fused 6-
membred rings to the polymethine bridge, the major deactivation pathway, excited-state trans-to-
cis polyene rotation, is blocked. Hence, the photon output is maximized by reducing the energy 
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loss.45 To overcome lipophilicity and water insolubility of synthetic dyes due to the planar structure 
of fused rings, sulfonate or carboxylic groups can be installed (compound C820). 
 
 
Figure 1.9 Structure-photophysical relationship chart of visible and near IR dyes. 
 
The addition of substituents to a fluorophore framework shifts not only the UV−vis 
absorption but also the emission spectra. The main challenges in developing detailed strategies to 
modulate fluorescence is that multiple factors change upon a single modification.  Because 
substitution affects both the absorption and emission spectra, the Stokes shift generally remains 
unchanged. To modulate the Stokes shift, it has been suggested that a large structural change (e.g., 
the rotation of a molecular structure) upon its excitation leads to increased geometrical relaxation 
resulting in a large Stokes shift (Figure 1.10).47 Such molecular structure perturbations can be 
 17 
quantified by taking the root-mean-square (RMS) of the cumulative atomic displacements in 
comparison to the ground-state molecular structure. This geometry relaxation-induced change in 
Stokes shift can be found in biphenyl, 9-tert-butylanthracene, stilbene derivatives, heptamethine 
cyanine dyes, and BODIPY dyes (Figure 1.10).48-50 
 
 
Figure 1.10 Choice of rotating substituent on Stokes shift (△l) 
 
Second, we can modulate the brightness (or quantum yield) of small molecule dyes through 
PeT or the tailoring of bond rotations. Figure 1.11 presents a schematic representation of these 
different modes of modulation and corresponding examples of fluorogenic compounds.51-52 Nagano 
and coworkers have divided the fluorophore into acceptor and donor parts: the xanthene moiety is 
the source of fluorescence, and the benzene moiety acts as an intensity switch.53-54 The benzene 
moiety can be either a PeT donor or acceptor depending on the highest occupied molecular orbital 
(HOMO)-lowest unoccupied molecular orbital (LUMO) level relative to that of the xanthene 
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moiety. Figure 1.11A shows that the PeT-based molecular switch can be tuned by installing steric 
groups in the benzene moiety. Although the fluorescein derivative with the unsubstituted benzene 
ring is weakly fluorescent, those with substituted benzene rings are highly fluorescent. This 
demonstrates that the steric groups at R1 reduce the PeT quenching in fluorescence by keeping the 
benzene moiety orthogonal to the fluorophore.51 Figure 1.11B shows that the molecular switch can 
also be modulated by introducing electronic substituents by changing the HOMO-LUMO level.  
 
 
Figure 1.11 A) Steric and B) electronic effect to modulate PeT in fluorescein scaffold. Adapted 
with permission from ref 51. Copyright (2005) American Chemical Society. 
 
This concept was successfully applied to BODIPY as well (Figure 1.12).55 Figure 1.12 
shows the change in electronic properties of substituents upon structural modification leads to either 
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suppression or restoration of fluorescence.  The most straightforward method for structural 
modification is to install a protecting group onto the dye to suppress fluorescence, which can later 
be deprotected by external stimuli to restore fluorescence. Such protecting groups can be light-
sensitive photocages, enzyme-cleavable linkers, or other covalent bonds that can be cleaved upon 
exposure to chemical stimuli. Initially suppressed fluorescence can be restored by an enzyme-
catalyzed reaction, photolysis, or another covalent bond cleavage. Expanding this chemical concept, 
zinc sensing and enzymatic or photoactivable probes have been developed (Figure 1.13). 
 
 
Figure 1.12 Development of PeT-based sensors in BODIPY scaffold. Chemical stimuli (nitric 
oxide) to change the structure of benzene moiety or light to remove photocleavable protecting 
group (PG) 
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Figure 1.13 Examples of PeT based turn-on probes.56  
 
Another general method to modulate brightness or quantum yield of fluorophores is by 
restricting bond rotation. Lavis and coworkers have shown that installing azetidine in place of a 
dimethylamino donor greatly enhances the brightness by restricting the rotation barrier and 
eliminating quenching through twisted intramolecular charge transfer (Figure 1.14).44 The 
azetidinyl moiety has also been shown to tune the ring opening-closing equilibrium of rhodamine 
dyes (Figure 1.14B). Electron-withdrawing groups on the azetidine force the molecule to adopt a 
“closed” lactone form, which is nonfluorescent, while electron donating groups favor the “open,” 
highly fluorescent, form of rhodamine.  Moreover, acetylation of the phenolic oxygens of 
fluorescein diacetate forces the molecule to adopt a nonfluorescent “closed” lactone form. The 
“open” form fluorescein can be generated upon hydrolysis of the acetate. Precise control of the 
open–closed equilibrium in fluorescein or rhodamine provides a rational design to modulate 
brightness of biological probes.44 Lastly, restricting the rotation of the dimethylamino group in a 
coumarin photocage has also been shown to improve the efficiency of photocleavage (Figure 
1.14C).  
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Figure 1.14 Effect of restricting the bond rotation of dialkyl amine by installing restricted 
azetidine. 
 
A third approach to modulate fluorescence is to use Förster resonance energy transfer 
(FRET) or interchromophore PeT.  FRET requires energy transfer from the excited state of one 
“donor” dye to another “acceptor” dye (Figure 1.15).57 Generally, two structurally distinct dyes are 
assigned as a FRET-pair, where the FRET efficiency is related to the overlapping regions of the 
emission spectrum from the donor fluorophore and the absorption spectrum of the acceptor dye 
(Figure 1.16). Homo-FRET can also occur between two dyes with the same structure if there is a 
small Stokes shift.  Such an energy transfer mechanism can be useful for versatile applications: for 
instance, BODIPY dyes, which show small Stokes shifts of < 20 nm, can be utilized as homo-FRET 
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probe. For example, a phospholipase substrate containing two BODIPY dyes in close proximity 
will have low fluorescence because homo-FRET between the two BODIPYs increases the 
probability of non-radiative processes occurring. Upon phospholipase-catalyzed hydrolysis of the 
ester bond in between two BODIPYs, fluorescence will increase as they get farther apart.  
 
  
 
 
Figure 1.15 General scheme for FRET  
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Figure 1.16 Examples for FRET-based sensors and the process in a Jabłoński diagram. 
 
Collectively, these disparate modes of modulation enable the construction of fluorogenic 
molecules from almost any fluorophore scaffold. Examples of probes utilizing these processes are 
shown above. Many dyes have been used as examples to demonstrate that the substituent positional 
effect affords considerable impact on the UV−Vis absorption spectra, the molar extinction 
coefficients, and the Stokes shifts of fluorophores. To this end, time-dependent density functional 
theory (DFT/TD-DFT) calculations, the empirical harmonic oscillator-stabilization-energy (HOSE) 
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model, and bond length-alternation (BLA) analysis are employed to reveal the relevant structure-
property relationship of organic dyes at the molecular level. Three-dimensional consideration of 
the molecular structure is critical to develop rational guidelines on designing fluorophores.  
 
1.5    Photo-modulatable Fluorescent Dyes  
 
Previous sections discussed several methods to modulate photophysical properties of 
fluorophores with rationally designed chemical modifications. The utility of these probes can be 
further extended by developing them into photo-activatable fluorescent dyes, a group of activatable 
fluorophores that can be triggered by light.  Photoactivatable dyes are compatible with many of the 
recently developed super-resolution microscopy techniques such as stochastic optical 
reconstruction microscopy (STORM) and (fluorescence) photoactivated localization microscopy 
((F)PALM).58 These dyes are generally grouped into three categories: photoactivatable, 
photoconvertible, and photoswitchable fluorescent dyes.  Photoactivatable probes switch “on” from 
a weak fluorescent state to a strong fluorescent state upon illumination. In contrast to 
photoactivatable probes, photoconvertible probes are initially “on” but able to change their 
fluorescent emission spectrum by irradiation with light. While photoactivatable and 
photoconvertible probes undergo irreversible conversion, photoswitchable probes can switch “on 
and off” in reversible manner. This phenomenon of reversible switching between fluorescent to 
dark states, without photo-bleaching, is called photochromism.  
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Figure 1.17 Examples of photoactivatable, photoswitchable, and photoconvertible fluorescent 
dyes 
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A variety of photoactivatable fluorescent probes have been previously reported (Figure 
1.17). Photoactivation can occur by azide decomposition (PA1), a “photo-click” reaction (PA2), 
and by uncaging photolabile protecting group (PA3). Photoswitching can be achieved by light-
activated, reversible thiol or phosphine addition to the polymethine chain of Cy5 (PS1), or by the 
generation of a long-lived reduced non-fluorescent radical in a rhodamine dye (PS2). 
Photoconvertible dyes (PC1,PC2) can be developed by incorporating stilbene photocyclization and 
oxidation reactions.59-60 Whereas PC1 and PC2 undergo irreversible photocyclization, compounds 
incorporating an ethene bridge with 2,5-substituted thiophene groups (RP1) display reversible 
fluorescence switching upon photo-isomerization (Figure 1.18).61 Alternatively, a 
photoconvertible effect can also be achieved by using light as a source to cleave the linker between 
two FRET pairs (Figure 1.16). 
 
 
Figure 1.18 Reversible photocyclization. The conrototory photocyclization reaction can proceed 
only from antiparallel conformation (RP1).  
 
1.6    Combinatorial Strategies for Fluorophore  
Previous sections discussed versatile methods to modulate each step of the fluorescence 
process of a dye. The rational design approach successfully improved intrinsic photophysical or 
chemical properties of the dyes in a test tube (or in vitro), but the actual behaviors of dyes in a 
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physiological setting are often unpredictable.31, 62 Especially, fluorophores with desired biological 
properties such as cell-permeability, non-cytotoxicity, selective localization in cell, or high 
sensitivity to a specific target can be extremely difficult to predict by computational models or 
guided rational design. Designing probes for in cellulo or in vivo use/experiments is a whole new 
challenge due to the intricate and dynamic nature biological systems.32, 38 The probes should be 
highly cell-permeable, biocompatible, and display a high fluorescence signal without any non-
specific interactions from non-target cellular apparatuses. Additionally, the probe itself should be 
minimally perturbative to the native cellular environment to allow visualization of intracellular 
architectures and dynamics of target biomolecule without any biased or false signals. Therefore, 
probing specific intracellular systems with a small fluorescent molecule is not a simple process of 
design and synthesis.  This section will highlight the advances in design strategies for fluorescent 
probes through a combinatorial approach that can be divided into target-oriented fluorescent sensor 
discovery and a diversity-oriented fluorescent sensor discovery (Figure 1.19).  
 
Figure 1.19 Workflow for target-oriented fluorescent sensor discovery and diversity-oriented 
fluorescent sensor discovery.62  
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The combinatorial chemistry approach has sped up the probe discovery process with 
efficient syntheses of large numbers of fluorescent libraries. Due to structural flexibility and 
technical simplicity, tunable fluorescent scaffolds were easily utilized to generate diversity oriented 
fluorescent libraries (DOFLs).62 With DOFLs, a series of cell-permeable and highly selective 
probes were successfully discovered and helped to revolutionize the fluorophore field. In general, 
DOFLs are synthesized by versatile palladium-catalyzed reactions such as the Buchwald–Hartwig 
and Suzuki-Miyaura cross couplings. Pd chemistry is the most promising and efficient approach to 
attach different chemical substituents to the fluorescent core to fine-tune their photophysical 
properties (Figure 1.20).63  
 
 
Figure 1.20 Synthesis of diversity-oriented fluorescent library with coumarin fluorescent core. 
 
Generated libraries of fluorescent dyes can be efficiently analyzed in a high-throughput 
manner to discover highly selective probes for in vivo and live cells (Figure 1.21).  Furthermore, 
libraries of fluorescent compounds can be utilized for structure–activity relationship (SAR) studies. 
The SAR studies to understand the effect of subtle changes to the chemical and optical properties 
of the fluorophore will provide additional insights for rational design.  
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Figure 1.21 Probes developed by diversity-oriented probe discovery strategies 
 
1.7    Conspectus  
 
Overall, developing new fluorophore scaffolds remains a very challenging task.64 The development 
of new fluorophores is still largely based on trial-and-error or by serendipitous discovery. Moreover, 
the often-used dyes in biochemical research are still limited to a few fluorogenic core families 
shown in Figure 1.6. The new dye families require more extensive studies to obtain appreciable 
biocompatibility, photophysical understanding, and controllable photochemistry for in cellulo or in 
vivo studies.  To address this, novel (or underexplored) fluorogenic scaffolds with tunable sites are 
desirable as they can allow both rational and combinatorial approaches. A rationally designed 
fluorogenic core with tunable substituents can modulate photophysical properties and install 
functional groups with minimal perturbation. The tunable fluorescent core can also be used to 
generate DOFLs for high-throughput analysis and combinatorial strategies, where the associated 
molecular origins of these structure−property relationships will provide a judicious strategy to 
design a next generation of fluorophores with improved optoelectronic properties.  
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The work presented in this thesis is focused on the rational design and facile synthesis of 
novel or underexplored fluorescent small molecules for live biological studies. Three types of 
fluorophores are explored: quinoline-based probes (Chapter 2-4), diazaxanthilidene-based probes 
(Ch 5-6) and acridone-based fluorescent unnatural amino acids (Ch7). The probes are targeted to 
study a challenging biological system, a-Synuclein (aS). aS is a protein implicated in Parkinson 
disease that aggregates into toxic species; however, there is still no optimal tool to understand the 
mechanism of protein (mis)folding and aggregation. In Chapter 2, a quinoline-based fluorescent 
probe with four tunable domains is presented with optimized synthetic protocols requiring only two 
to three steps to make a fluorescent library that will allow combinatorial studies. This chapter 
demonstrates that dimethylamino quinoline (DMAQ), can be synthesized in an efficient manner, is 
cell permeable, noncytotoxic, and displays unprecedented pH dependent dual emissive properties. 
Chapter 3 builds on synthetic methods in Chapter 2 to generate clickable DMAQ derivatives 
targeted to the studies of aS. This chapter demonstrates that clickable DMAQ exhibits turn-on 
fluorescence upon click conjugation, pH sensitivity, and various environmental sensitivities that 
are not observed in other conventional dyes.  Chapter 4 shows many different synthetic routes that 
are optimized for generation of DMAQ libraries in the future. The effect of p system extension as 
well as photoconvertability of DMAQ dyes are currently under investigation. Chapter 5 details the 
rational design of a clickable and photoconvertiable diazaxanthilidene-based dye (CPX). The utility 
of CPX was demonstrated by labeling to aS and showing tracking experiments under highly precise 
temporal and spatial resolution, providing a new class of tracking small molecule probe. In Chapter 
6, an isomer of diazaxanthilidene was studied and applied for both fixed and live tissue staining as 
well as in vivo studies. The compounds discovered in Chapter 6 were found to possess highly 
favorable cellular properties: subcellular organelle-specificity, brightness, and high non-
cytotoxicity. Chapter 7 details the structural modification of an acridonyl alanine dye, highlighting 
the effect of substituents on the photophysical properties. Developed amino-acridonyl alanine (Aad) 
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showed red-shifted absorption and emission to provide a better FRET pair with methoxy coumarin. 
An ongoing effort to incorporate Aad through unnatural amino acid mutagenesis and its potential 
use as a chemical reporter are shown by other group members. Overall, this thesis demonstrates the 
combination of rational and combinatorial approach to discover fluorogenic probes in biology.  
 
 
Figure 1.22 Scope of this thesis 
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1. Chapter 2 
 
Rational Design and Facile Synthesis of a Highly Tunable Quinoline-
based Fluorescent Small Molecule Scaffold for Live Cell Imaging 
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Abstract 
 
Small-molecule fluorescent probes are powerful tools for chemical biology; however, 
despite the large number of probes available, there is still a need for a simple fluorogenic scaffold 
that allows the rational design of molecules with predictable photophysical properties and is 
amenable to concise synthesis for high throughput screening. Here, we introduce a highly modular 
quinoline-based probe containing three strategic domains that can be easily engineered and 
optimized for various applications. Such domains are allotted for 1) compound polarization, 2) 
tuning of photophysical properties, and 3) structural diversity. We successfully synthesized our 
probes in two steps from commercially available starting materials in overall yields of up to 95%. 
Facile probe synthesis was permitted by regioselective, palladium-catalyzed cross-coupling, which 
enables combinatorial development of structurally diverse quinoline-based fluorophores. We have 
further applied our probes to live-cell imaging, utilizing their unique two stage fluorescence 
response to intracellular pH. These studies provide a full demonstration of our strategy in rational 
design and streamlined probe discovery to reveal the diverse potential of quinoline-based 
fluorescent compounds. 
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2.1    Introduction 
 
 Fluorescence-based technologies have emerged as indispensable tools for both in vitro and 
in vivo biomedical studies, making them an essential facet of chemical biology.1-3  Fluorescent small 
molecules, in particular, have significant advantages over protein-based probes in optical imaging 
and analytical sensing due to their small, noninvasive size, high sensitivity, and fast response time.2-
3 Because they have ubiquitous applications as cellular stains, environmental sensors, or 
biomolecular labels, a plethora of fluorescent probes have been developed over the past decades.3 
Although numerous fluorescent probes are known, the vast majority of these probes are developed 
through structural modification of a diminutive set of classical “core” dyes such as coumarin, 
fluorescein, BODIPY, or cyanine.3 This underscores the importance of intrinsic modularity of the 
“core” fluorophores in the elaboration and modification of dyes, but also reveals the limited number 
of available “core” scaffolds.3-4 Moreover, within the context of biological systems, “ideal” 
fluorescent probes are still in high demand, as properties such as cell permeability, cytotoxicity, 
selectivity/sensitivity, and dynamic range in the cellular environment are often difficult to predict 
based on rational design and theoretical calculations.5  
 Addressing these limitations, combinatorial approaches to the discovery of fluorescent 
probes have emerged as exciting alternatives for the exploration and optimization of fluorophores.6-
7 As a result of successful implementation of combinatorial chemistry techniques – including major 
improvements in high-throughput screening and imaging methods – on fluorescent scaffolds, many 
rare and surprising probes such as tricarbocyanine-based photostable near-infrared (NIR) dyes8 or 
rosamine-based in vivo glutathione probes9 were developed.7  Yet, challenges still exist for both 
library design and the ease of synthetic methods, stressing the necessity of new tunable scaffolds 
that can be easily diversified.6 
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 Among many synthetic scaffolds, quinoline is a highly attractive structure for its relative 
synthetic versatility.4 Quinoline, being an important construction motif, is widely observed in 
natural products, drug discovery, as well as advanced functional materials.4, 10-12 Moreover, 
quinoline is the core structure of quinine, a first well-defined small molecule fluorophore,3, 13 and 
has been investigated as an intriguing molecular probe because the nitrogen can be used as the site 
for monitoring the interactions with target molecules through changes in fluorescence.4, 14-15 
However, despite considerable efforts to develop novel synthetic scaffolds containing heterocyclic 
rings, quinoline has been under-explored as a fluorescent probe largely due to synthetic difficulties. 
 
 
Figure 2.1 (A) Modularity of dimethylamino quinoline (DMAQ) dyes consisting of a polarization 
domain and two tuning domains (B) Two-step synthesis of 2,4-disubstituted quinoline derivatives 
(15 monoarylated, 9 bisarylated DMAQ) 
 
 
 Here, we introduce a small, yet highly tunable quinoline-based “core” scaffold that is 
compatible with the generation of libraries of fluorescent molecules in two steps (Figure 2.1). Our 
scaffold includes three strategic domains that can be easily functionalized and optimized to present 
potential advances over classic and contemporary dyes. Multi-well plate analysis of the resulting 
chemical libraries allowed us to identify useful photophysical features in an efficient manner, and 
our observations can serve as a guideline for next generation library design based on rational 
structure/photophysical relationships. We have further demonstrated the utility of one derivative 
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with particularly unusual pH-sensitivity in multi-color live-cell imaging. We call this scaffold 
dimethylamino quinoline or DMAQ. 
 
2.2    Results and Discussion 
2.2.1. Rational Design of DMAQ Scaffold    
In general, a simple and short synthetic route to generate a large number of target molecules 
is favored.16-17 However, most commonly used dyes require several steps for derivatization, 
resulting in low overall yields because they lack easy tunability or late-stage modification sites.6 
To achieve the desired step economy in obtaining dyes of interest, a highly efficient synthetic route 
to obtain a key precursor and its derivatives was investigated. Therefore, we designed our scaffold 
to contain three strategic domains: one for polarization and two tunable domains for structural 
diversity and/or late-stage chemical modification (Figure 2.1A). Polarization of the fluorophore is 
achieved by the electron-donating dimethylamino group at the 7-position of quinoline, which can 
push electron density into the core of DMAQ. The 2- and 4-positions of DMAQ are allotted for 
tuning domains, where electronically and structurally diverse chemical moieties can be installed to 
either push or pull the electron density. These substitutions were envisioned to orchestrate a 
versatile “push-pull” system of the fluorescent scaffold (Figure 2.1A). Generated molecules with 
a D(donor)-π-A(acceptor) system are anticipated to display varied photophysical (e.g., fluorescence, 
quantum yield, solvatochromism, Stokes shifts, etc.) and chemical properties (e.g., solubility, ion 
binding, acidity/basicity, etc.).  
 
 To accelerate the utilization of our scaffold, a synthetic route for rapid assembly of the 
DMAQ core was studied. Not surprisingly, over the past decades, several condensation and cascade 
reactions to access medicinally valuable multi-substituted quinolines efficiently have been reported 
with various mechanisms and conditions, including: Conard-Limpach-Knorr18-19, Skraub-Doebner-
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Von Miller20-22, Friedlaender23-24, halogen25 or copper26 mediated.4, 27-28However, many traditional 
condensation methods suffer from low yields, harsh reaction conditions, and operational 
complications, or require specialized starting materials or catalysts.4, 28 In this work, we report a 
significantly improved two-step synthesis of quinoline-based dyes from commercially available 
starting materials which provides good to excellent yields. The initial DMAQ library was generated 
by (1) a one-pot two-step cyclocondensation and chlorination procedure to afford key precursor 3, 
and (2) a regioselective Suzuki-Miyaura cross-coupling reaction at the 2-position (C-2) of DMAQ 
(Figure 2.1B). The second DMAQ library was achieved via a sequential cross-coupling reaction at 
C-2 and then at the 4-position (C-4). 
 
2.2.2. Synthesis of the 2,4-Dichloroquinoline Core.    
 The synthesis of the key precursor of the DMAQ probe, 2,4-dichloro-N,N-
dimethylquinolin-7-amine 3, was first attempted following previous reports, which involved two 
purification steps such as filtration or recrystallization, and harsh conditions such as extremely high 
temperatures, up to 270 ˚C.29-30 Adapting the reported conditions, 3-(dimethylamino) aniline 1 was 
first cyclocondensed with neat diethyl malonate to form 7-(dimethylamino)-4-hydroxyquinolin-
2(1H)-one 2. After filtration of solids, 2 was chlorinated using neat phosphorus oxychloride 
(POCl3) under reflux conditions to afford dichloroquinoline 3. The previously reported yield for 
compound 3 was estimated to be 54% (Figure S 2.2);29-30however, we found that these conditions 
resulted in only 26 % yield on the gram scale (Table 2.1, entry 1), which is similar to the 25% yield 
of 2,4-dibromo-N,N-dimehtylquinolin-7-amine in a recent report (Figure S 2.2).30 
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Table 2.1 Conditions for Synthesis of Key Precursor 3 
 
 
All reactions in the table above were performed on the same scale (8.8 mmol) and monitored by 
thin layer chromatography (TLC) analysis for formation of 2. aReported yield was obtained after 
intermediate 2 was isolated. DPE is diphenyl ether. 
 
 The poor reproducibility and low yield that we observed was presumed to be due to 
heterogeneity during the cyclocondensation reaction. Moreover, the poor solubility of 
hydroxyquinolone 2 made column purification difficult and further affected the yield in the 
following halogenation reaction. We envisioned that an appropriate solvent with a high boiling 
point would keep 2 in solution and ensure that the reaction mixture remained homogeneous. 
Gratifyingly, we found that diphenyl ether (DPE), which has a boiling point of 258 ˚C, not only 
keeps the reaction mixture in a homogeneous state, but also is inert to both cyclocondensation and 
halogenation reaction conditions, allowing an one-pot two-step synthesis of 2 in an excellent yield 
on gram scale. Complete formation of 2 was monitored via thin layer chromatography (TLC) 
analysis (Figure S 2.3B), which was then followed by addition of POCl3 to obtain 3 in 96% overall 
yield (Table 2.1, entry 2). The yield dropped to 72% when the chlorination reaction was performed 
after intermediate 2 was isolated by solid filtration (Table 2.1, entry 3). Cyclocondensation 
reactions were also attempted in milder conditions such as lower temperature (190 ˚C or 160 ˚C) or 
entry solvent T (˚C) time (h) POCl3 (equiv.) yield (%)
1 none 180 - 270 5 6 < 26
2 DPE 160 - 200 15 10 96
3 DPE 160 - 200 15 10 72a
4 DPE 160 - 190 >20 10 80
5 DPE 160 >24 3 75
N
H
N O
OH
NH2N NN Cl
Cl
Cyclocondensation Overall Yield (%)Chlorination
1 2 3
1) Diethyl Malonate 
(1.1 equiv)
T (˚C), time (h)
Solvent
POCl3 
(X equiv)
105 ˚C, 1-2 h
2)
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fewer equivalents of POCl3. Those conditions successfully afforded 2, but resulted in lower 
conversion and longer reaction times than that entry 2 conditions (Table 2.1, Entry 4-5). Thus, our 
one-pot, optimized conditions efficiently produce poly-halogenated quinoline 3, a core subunit that 
can be utilized in transition-metal-catalyzed cross coupling reactions to generate fluorogenic probes 
as well as medicinally valuable bio-active compounds.31  
 
2.2.3. Synthesis of Monoarylated DMAQ via Regioselective Cross-Coupling Reaction  
 Palladium-catalyzed cross-coupling reactions of halogenated heteroarenes have played a 
pivotal role in the synthesis of important biological targets or their key precursors.32  We were 
interested in identifying a general catalyst system capable of C-2 selective arylation of 
dichloroquinoline 3, which would give us the flexibility for structure-photophysical property 
relationship studies of fluorophores. However, with heteroarenes bearing identical halogens, high 
selectivity is difficult to achieve as the final regioselectivity is determined by multiple factors 
including steric effects, electronic effects, and the presence of directing groups in the reactants.32 
Although many conditions have been investigated to achieve C-2 selective functionalization of 2,4-
dichloroquinoline or 2,4-dichloropyridine, there was no reported condition for 3 , which includes 
an electron donating substituent at the 7-position.32-33 Unlike 2,4-dichloroquinoline, which 
possesses only one highly electrophilic position at C-2, 3 contains the dimethylamino group that 
could reduce the electrophilicity of C-2 and weaken selectivity. Additionally, the C-2 selectivity of 
the pyridine moiety seems to be highly dependent on the choice of ligand or the presence of 
additives such as LiCl, which could alter the selectivity to C-4. 32-33 Finally, consideration must be 
given to avoid bis-arylated products, as we would like to keep C-4 as an additional site for late-
stage structural diversification or functionalization. In an effort to achieve highly regioselective and 
broadly compatible catalyst condition for electronically diverse aryl boronic acids, we screened 
several factors: electronically distinct boronic acids, ligands, bases, solvents, and temperature. With 
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the support of the Penn/Merck High Throughput Experimentation center, a general and efficient 
condition for C-2 selective Suzuki Miyaura cross-coupling of 3 was investigated.  
 
 Screening was conducted with 5 mol % palladium acetate [Pd(OAc)2], 5 mol % (bidentate) 
or 10 mol % (monodentate) of eight different ligands, two different bases, cesium carbonate 
(Cs2CO3) or potassium carbonate (K2CO3) (3.0 equiv), and three different phenylboronic acids (1.1 
equiv). We chose 4-(dimethylamino)phenyl-, phenyl-, and 4-(cyano)phenylboronic acids as three 
representative electron-rich, -neutral, and -deficient substrates, respectively. Eight ligands were 
chosen based on the previous report that showed high C-2 selectivity for dichloropyridine.16 Using 
0.6 mg (2.5 µmol) of dichloroquinoline 3 per reaction, a total of 96 conditions were screened 
(Figure S 2.4).  Not surprisingly, mixtures of mono-coupling products (4, 4’), bis-coupling product 
(5), dechlorinated byproduct, and hydrolyzed byproducts were observed from these reactions 
(Tables S 2.1-2.4 and Figures S 2.5-2.7). As summarized in Table 2, the ligands exert a profound 
effect on the regioselectivity of the coupling as well as optimal reactivity to minimize bis product.32 
Unlike previously reported conditions for C-2 selective Suzuki-Miyaura cross coupling of 
dichloropyridine using 1,1′-ferrocenediyl-bis(diphenylphosphine) (DPPF), it was observed that, in 
general, triphenylphosphine (PPh3) and 1,3-bis(diphenylphosphino)propane (DPPP) highly favored 
coupling at C-2 over C-4 (Table 2.2, entries 1, 2, 5, 6, 9, and 10, while 1,1’-bis(di-
isopropylphosphino)ferrocene (DIPPF) and tricyclohexylphosphine (PCy3) gave a low yield for 4 
(Table 2.2, entries 3, 4, 7, 8, 11, and 12) due to poor C-2 selectivity or a high yield of 5. 
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Table 2.2 Selected results of regioselective cross-coupling reactions with three boronic acids  
 
Four selected catalyst conditions are shown for each boronic acid: triphenylphosphine (PPh3), 1,3-
bis(diphenylphosphino)propane (DPPP), 1,1’-bis(di-isopropylphosphino)ferrocene (DIPPF), 
tricyclohexylphosphine (PCy3). The highlighted condition is the best condition for the 
corresponding boronic acid. The final solvent consists of 4:1 solvent/water. Percent composition 
of products was determined by chromatographic peak integration normalized with an internal 
standard.  
 
 Nonetheless, our desired 4 was the major product in most screened conditions, presumably 
due to the intrinsic reactivity of C=N bond and the effect of the quinoline nitrogen coordinating to 
the Pd catalyst, confirming that the order of the relative ease of oxidative addition for 2,4-
dichlorquinoline is C-2 > C-4.32,33-34 After additional temperature screening at 60 ˚C, 70˚C, and 80 
˚C, we established that performing the reaction with 5 mol % of bis(triphenylphosphine) palladium 
chloride [Pd(PPh3)2Cl2] and 3 equiv of K2CO3 in 4:1 tetrahydrofuran (THF)/water at 65 ˚C for 5 to 
48 h afforded products in the highest yield with excellent C-2 regioselectivity for a broad scope of 
boronic acids. A range of arylboronic acids, spanning electron donating to withdrawing para-
NN Cl
Cl
NN Ar
Cl
Pd(OAc)2 (5 mol %)
ligand (1.0 or 2.0 equiv)
Ar-B(OH)2 (1.1 equiv)
base (3.0 equiv)
solvent (0.1 M)
70 ˚C, 18 h
NN Cl
Ar
NN Ar
Ar
3 4 4’ 5
entry Ar-B(OH)2 ligand solvent base 4 (%) 4’ (%) 5 (%) 3 (%)
1 PPh3 THF K2CO3 75 0 0 14
2 DPPP Dioxane Cs2CO3 76 2 3 12
3 DIPPF THF K2CO3 57 13 6 15
4 PCy3 Dioxane Cs2CO3 29 35 8 22
5 PPh3 THF K2CO3 75 6 10 0
6 DPPP Dioxane Cs2CO3 90 8 1 0
7 DIPPF THF K2CO3 60 5 16 17
8 PCy3 Dioxane Cs2CO3 36 3 38 22
9 PPh3 THF K2CO3 78 9 1 3
10 DPPP Dioxane Cs2CO3 59 4 17 17
11 DIPPF THF K2CO3 38 5 22 16
12 PCy3 Dioxane Cs2CO3 44 4 43 8
N
N
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substituted phenylboronic acids, sterically hindered arylboronic acids, and heteroaryl boronic acids, 
was subjected to the optimized reaction condition (Scheme 2.1). 
 All of the electron-rich (4b), electron-neutral (4c-d), and electron poor (4e-f) 
phenylboronic acids afforded excellent isolated yields (>91%) of C-2 arylated products. Of 
sterically hindered phenylboronic acids, the presence of a methoxy functional group at the ortho- 
and para-position resulted in 92% (4g) and 94% (4i) yields, respectively, while at the meta-position 
a slightly lower isolated yield of 83% (4h) was observed. Though phenyl-substituted 4a resulted in 
relatively low yield35 (39%), the high yield for para-methoxyphenyl-substituted 4i demonstrates 
that a protected phenol can be utilized for the synthesis of 4a.  To assess additional steric effects, 
2,4-difluorophenylboronic acid and 9-anthraceneboronic acid were subjected to reaction with 3. 
Although 4j was afforded in 87% yield, only a 20% yield was observed for 4k, it was still the major 
arylated product. The low yield of 4k is most likely due to protodeboronation of the anthracene 
boronic acid, as significant amounts of anthracene product were observed (Figure S 2.8).36  
Furthermore, we examined C-2 arylation with heterocycles, 2-thienyl-and 3-thienylboronic acid, to 
afford 4m and 4n in 85% and 97% yields, respectively.  The cross-coupling condition tolerated a 
variety of para-substituted functional groups, such as hydroxyl, methoxy, cyano, dimethylamino, 
and fluoro as well as a Boc-protected primary amine. Fluorine and primary amines are particularly 
important functional groups as fluorine is a frequently used substituent in both medicinal chemistry 
and organic material design,37 and a primary amine is a convenient site for conjugation for 
biological studies. Interestingly, electron-withdrawing arylboronic acids reacted much more rapidly 
with starting material 3 than electron-donating boronic acids. The overall scope of the study showed 
the robustness and generality of the reaction condition to electronic differences, steric hindrance, 
and varied functional groups with high yields and excellent regioselectivity. This enabled the rapid 
construction of diverse arrays of monoaryl- or heteroarylquinolines.  
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Scheme 2.1 Aryl/Heteroaryl Boronic Acid Substrate 
 
 
 
All reactions performed on 0.18 mmol scale. Reported yields are isolated yields. 
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Figure 2.2 Structure-photophysical property relationship of DMAQ. A) A range of C-2 aryl 
substitution with emission maximum under 405 nm excitation is shown. The compound order is 
4b, 4a, 4n, 4i, 4c, 4d, 4m, 4l, 4g, 4h, 4j, 4e, 4f, 4k, and 4l’ from left to right. Stock solutions of 4a-
4n were made in DMSO (5 mM) and 4l’ in water with 0.1% TFA (5 mM). The image was taken 
using a handheld UV lamp (365 nm). B) Correlation between emission wavelength and Hammett 
constant (σp) of R1 substituents in monoaryl DMAQ. (R2 =0.79) 
 
2.2.4. Effect of the C-2 Substituents on Photophysical Properties of DMAQ.  
 Having accomplished the facile synthesis of a DMAQ library, we then turned our attention 
to studying the photophysical properties generated by variations in the push-pull system of DMAQ. 
Upon initial visual inspection, more electron withdrawing (hetero)aryl substitution on C-2 of 
DMAQ showed more red-shifted emission in DMSO, indicating the formation of a D-p-A system 
(Figure 2.2A). To provide a guideline for rational selection of substituents for future DMAQ 
derivatives, we analyzed 4b, 4a, 4i, 4c, 4d, 4e, and 4f in terms of the Hammett substituent constant 
for the para functional group on the C-2 phenyl ring (Figure 2.2B).38 Electronegativity and 
emission wavelength showed a positive correlation, as expected.  This analysis is further supported 
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by HOMO-LUMO calculations that show a movement of electron density from the C-7 
dimethylamino group to the C-2 aryl group upon excitation from S0 to S1 (see full discussion in 
Supporting Information, Table S 2.7-2.8 and Figure S 2.21-2.26). 
2.2.5. Photophysical Properties of Monoaryl DMAQ  
 Strategies in fluorescent probe development consider not only the design and synthesis of 
fluorescent libraries, but also the evaluation and validation of the probes in a high-throughput 
manner. Thus, to obtain more quantitative information on the properties of our DMAQ library, we 
designed a multi-well assay amenable to assessing spectral properties such as fluorescence intensity 
and emission wavelength for each compound in the library (Figure 2.3).  
 
Figure 2.3 Plate reader analysis of photophysical properties of monoaryl DMAQ. Each compound 
(3,4a-4n) was prepared as a 5 mM stock solution in dimethyl sulfoxide (DMSO) except for 4l’ in 
water. Each well contains 1% DMSO in solution with a final 50 µM dye concentration. For polarity 
screening (left panel), toluene, basic alumina filtered dichloromethane (DCM), 0.1% trifluoroacetic 
acid in DCM (DCM+TFA), dimethylformamide (DMF), DMSO, and ethanol (EtOH) were used as 
solvents. For pH screening (right panel), 10 mM buffer solutions were prepared; pH 2 (hydrochloric 
acid), pH 4 (citric acid/phosphate buffer), pH 6.9 (citric acid/phosphate buffer), pH 7.3 (phosphate 
buffer), pH 10 (carbonate buffer), and pH 11 (sodium hydroxide). Emission spectra were measured 
at lex of 405 nm regardless of their optimal max absorption, and the image was taken under 
handheld UV lamp (365 nm).         
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 The emission spectrum of each compound was measured under excitation at 405 nm, a 
common wavelength laser used in confocal microscopes for biological studies. Since the 
dimethylamino group and quinoline nitrogen in the DMAQ derivatives were expected to induce 
solvatochromism and pH sensitivity, six organic solvents with varying properties were chosen: 
nonpolar aprotic (toluene, DCM), nonpolar protic/acidic (DCM+TFA), polar aprotic (DMF, 
DMSO), and polar protic (EtOH). In addition, six different buffered aqueous solutions spanning 
pH 2 to pH 11 were used for screening. While our parent compound, 3, showed no significant 
environmental sensitivity, the rest (4a-4n) of the 2,4-substituted quinoline dyes showed solvent-
dependent photophysical properties, confirming the design principle of tunability (spectra selected 
to illustrate certain observations are shown in Figure 2.3, complete sets of emission spectra for all 
dyes are shown in Figures S 2.9-2.10). Furthermore, this tunability was generally predictable, with 
electron withdrawing para-substituted phenyl rings at the 2-position red-shifting the emission (e.g., 
4f) as one would expect for the designed push-pull system.  
 Selected DMAQs with para-substituded aryl rings (4b,4c,4e,4f,4i,4l), (hetero)aryl rings 
(4m), and parent core DMAQ 3 showed emission spanning 453 nm to 516 nm in basic alumina 
filtered DCM (Figure 2.3B). Under nonpolar protic/acidic conditions (DCM+TFA), all compounds 
4a-4n showed a significant bathochromic emission shift in comparison to emission in basic 
alumina-filtered DCM (Figure 2.3A). While 3 had a minimal bathochromic shift of 3 nm, 
(hetero)arylated DMAQs (4b,4c,4e,4f,4i,4l,4m) showed an 84 to 96 nm shift in the presence of 
0.1% TFA. These results indicate the general pH sensitivity of the quinoline “core” scaffold. 
Moreover, many dyes showed a sensitivity to solvent polarity as well as pH. 4k, in particular, was 
highly solvatochromic, with an emission spanning 480 to 586 nm in various organic solvents 
(Figure 2.3C). This can be a very valubale property in which the dye could be used to sense its 
local environment on a protein surface or in a cellular compartment. Boc deprotection of 4l gave 
4l’ with significantly increased water solubility and enhanced brightness (Figure 2.3D). 
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 Dyes with explicitly pH-sensitive functional groups were also investigated, where the 
emission of phenol-functionalized 4a red-shifted in acidic environments, with an apparent pKa in 
the 4-6.9 range (Figure 2.3E). The pH range for fluorescence changes can be tuned through 
electronic effects; fluorine functionalized 4d exhibited a 118 nm red-shift in emission on going 
from pH 4 to pH 2 (Figure 2.3G), while the emission of ortho-methoxy functionalized 4g red-
shifted 100 nm on going from pH 7 to pH 4 (Figure 2.3H). The fluorescence of dimethylamino-
substituted 4b showed an interesting three stage change with pH, where it was quenched at acidic 
pHs, and had two emission peaks at 480 and 600 nm at pH 7, with the second peak growing more 
prominent at basic pHs (Figure 2.3F). Taken together, these data show the importance of the C-2 
position in tuning the spectral peroperties of DMAQ dyes.  The monoaryl DMAQ derivatives can 
easily be functionalized at C-4 for conjugation to other molecules or for further derivatization.   
 
2.2.6. Synthesis of Bisaryl DMAQ via Sequential Cross-Coupling Reaction  
The ability to regioselectively cross-couple aryl groups at the C-2 position of 3 provided 
us with the opportunity to tune the properties of our dyes further by substitution at the C-4 position. 
In screening conditions for sequential cross-coupling, we found that once the 2-arylated product 
was formed using our optimized regioselective cross coupling conditions, a second arylation cross-
coupling reaction could be performed without additional Pd by addition of an excess of a second 
boronic acid and increasing the temperature to 85 ˚C (Figure 2.4A). Using three boronic acids used 
in Table 2.2, we investigated the efficiency of sequential cross coupling. To run sequential coupling 
reactions at 85 ˚C, dioxane was used instead of THF. Gratifyingly, we found that all reaction 
sequences gave good to excellent yields (HPLC yields shown in Figures S 2.11-2.13). 
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Figure 2.4 Sequential cross-coupling for bisaryl DMAQ dyes. A) Reaction scheme for sequential 
cross coupling. B-D) Emission spectra of 5a-5i in DMSO upon 405 nm excitation. They are 
categorized under same R1 where B) R1= N(CH3)2, C) R1= H, and D) R1= CN. Reported yield is 
isolated yield. 
 
2.2.7. Effects of the C-4 Substituents on Photophysical Properties of DMA.  
 The nine compound doubly-substituted DMAQ library was used to study the effect of the 
C-4 domain on DMAQ photophysical properties. Generally, electron-withdrawing groups on the 
on C-4 phenyl ring red-shifted the emission of the corresponding parent DMAQ 4b, 4c, or 4f.  5c 
was particularly strongly affected by para-cyanophenyl modification at C-4, resulting in a highly 
red shifted emission maximum of 593 nm compared to 482 nm for 4b (Figure 2.4B).  Conversely, 
the emission maximum of 4f (576 nm) was strongly blue-shifted to 483 nm by addition of an 
electron donating amino group on C-4 to give 5g (Figure 2.4D). Interestingly, 5c and 5g both had 
 53 
the same set of substitutions, but in opposite positions, giving very different properties: 5c exhibited 
highly red-shifted emission while 5g was highly blue-shifted. This phenomenon implies that 
excitation involves the flow of electrons from the C-2 substituent to the C-4 substituent, so that 
matching this with appropriate electron donating (C-2) and electron withdrawing (C-4) groups 
lowers the energy for this transition and red-shifts the absorption (Table S 2.5) and emission. 
 
2.2.8. Photophysical Property of Bisaryl DMAQ 
 5a-i were subjected to pH-dependent fluorescence spectral analysis by screening their emission in 
pH 2, 4, 6.9, 7.3, 10, and 11 as shown in Figure 3 for 4a – 4n (Figure S 2.14).  5a, 5b, 5d, 5e, and 
5f exhibited pH dependent dual emissive properties, where emission red-shifted up to 170 nm in 
solutions of pH 2 and/or pH 4 under single excitation at 405 nm.  5g and 5i showed pH dependent 
intensity changes; 5g had 20-fold higher emission at 525 nm in pH 11 buffer than pH 2 buffer.  
Lastly, 5c had quenched emission in buffers at or below pH 4, while 5h had quenched emission at 
pH 2 (Figure S 2.18-2.19) under excitation at 405 nm. 
 
2.2.9. Live Cell Imaging of DMAQ dyes  
 The DMAQ compounds (4a-4n, 5a-5i) were all subjected to live HeLa cell imaging 
(Figure S 2.15). All of them, except for 4f, were cell permeable and were suitable for live cell 
imaging. Yet it should be noted that modifying 4f to 5g-5i enabled good cell permeability, validating 
the benefit of tunable scaffold. Selected dyes were subjected to cytotoxicity assays (Table S 2.6). 
Among them, an application of pH sensitive dye 5a in live cells was chosen as a proof-of-concept 
to illustrate the value of DMAQs. 5a demonstrated superior properties over many commercial pH 
sensitive probes (Figure 2.5). In a neutral to basic environment (pH >7), a broad absorption band 
with lex at 308 nm and 412 nm (green dotted line) and lem at 469 nm (green solid line) of 5a were 
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observed (Figure 2.5A). However, at a pH of 4 or lower, absorbance and emission shifted to l ex at 
474 nm (red dotted line) and lem at 637 nm (red solid line), respectively.  Having a bathochromic 
shift of 168 nm in emission from basic to acidic environment produced a large Stokes shift and 
gave 5a an unusual pH-dependent dual-emission characteristic. These properties allowed 5a to stain 
two different locations based in live HeLa cells. Green staining (Figure 2.5C) obtained by exciting 
at 405 nm and collecting the emission at 475±25 nm (Figure 2.5C) identified a subset of probe 
molecules presumably sequestered in neutral or basic compartments. Red staining was produced 
by exciting at 488 nm with the emission filter set at 650±25 nm (Figure 2.5D) and indicated a 
substantial fraction of the dye in a presumably acidic environment. A merged image did not show 
any yellow regions, indicating that 5a can orthogonally image two regions that differ in local 
environment (Figure 2.5F). This is in contrast to many pH-sensitive dyes which are based on a 
change in fluorescence quenching. For instance, the commercial dye, cell-permeant ratiometric pH 
indicator Seminaphthorhodafluor (SNARF) exhibits a pH-dependent emission shift from acidic to 
basic conditions. This pH dependence allows the ratio of the fluorescence intensity from the dye at 
two emission wavelengths – typically 580 nm and 640 nm – to be widely used for quantitative 
determination of pH. However, SNARF derivatives are only sensitive to pH changes near 7 and 
have a relatively small (60 nm) emission shift with changes in pH. Moreover, the published 
syntheses of SNARF variants are challenging (2-7 of steps and <18% yield).39-41 These limitations 
are addressed by 5a, which exhibits a 170 nm pH-dependent emission shift, and other DMAQ 
derivatives, all of which are easily synthesized, with a tunable pH sensor range that can be seen in 
(Figure S 2.14). 
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Figure 2.5 Fluorescence spectrum and live HeLa cell imaging after 3 h incubation of 5a. A) 
Normalized UV absorption spectra and emission spectra excited by 405 nm are shown in pH 7 and 
pH 2 buffer. 405 nm and 488 nm lasers for microscopy excitation are shown by arrows. B) 
Differential interference contrast (DIC) image of Hela cells after 3 h incubation of 5a C) lex = 405 
nm, lem = 425-475 nm D) lex = 488 nm, lem = 650-700 nm E-G) Merged images of green (lex = 
405 nm, lem = 425-475 nm) and red (lex = 488 nm, lem = 625-675 nm) in E), red (lex = 488 nm, 
lem = 650-700 nm) in F), and red (lex = 488 nm, lem = 700-750 nm) in G).  
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2.3    Conclusions 
  In conclusion, our work demonstrates a synthetic advance to develop the under-
explored quinoline as a fluorescent scaffold “core” that allows both rational and combinatorial 
approaches to create novel dyes. Our method has also served to simplify the synthesis of 
medicinally important substituted quinoline analogues. The power of the rationally designed 
DMAQ “core” scaffold in the discovery of new DMAQ dyes has been validated, although by no 
means fully explored. There is an exciting and immediate opportunity for the exploration and 
optimization of DMAQ probes for a wide range of applications. For instance, these DMAQ 
fluorophores exhibit solid state fluorescence in amorphous and/or crystalline solids, which have 
potential for application in organic materials (Figure S 2.20). Combining a rationally designed 
tunable scaffold with high throughput analysis, we show more than 20 different 2,4-disubstituted 
DMAQ derivatives with a range of emission spectra spanning the visible region as well as 
interesting chemical properties. With this library, we were able to further understand the structure-
photophysical relationship and intrinsic properties of the DMAQ scaffold. Emission of DMAQ 
could be rationally tuned by C-2 substituents and DMAQ dyes generally exhibited a large Stokes 
shift. Our study of 2,4-diarylated DMAQs revealed a probable photophysical mechanism for 
electron flow from the C-2 substituent to the C-4 substituent, which can be explored in subsequent 
theoretical and experimental investigations.  Building off of our results with 5c, further 
accentuating the electron donation of the C-2 position and electron withdrawal of the C-4 position 
could generate very small near IR dyes. Studies of the cellular localization of 5a and other dyes 
presented here will allow the microscopy community to take advantage of their unique properties. 
Based on these promising initial investigations, we expect to develop DMAQ as a multi-functional 
probe that can serve as both drug and sensor to answer challenging questions in complex biological 
processes. We envision that highly tunable and optimizable fluorescent probes can function in 
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convenient, continuous assays, thereby providing useful tools for studying biological events in 
cellular environments. 
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2.6    Experimental Section 
2.6.1. General Information. 
Materials. All commercial reagents and solvents were used as received. trans-
dichlorobis(triphenylphosphine)palladium(II) was purchased from Strem Chemicals, Inc. 
(Newburyport, MA). 4-(Boc-aminomethyl)benzeneboronic acid was purchased from Alfa Aesar 
(Haverhill, MA). 2-methoxyphenylboronic acid, 3-methoxypehnylboronic acid, 4-
methoxyphenylboronic acid, and 2,4-difluorophenylboronic acid were purchased from Acros 
(Waltham, MA). Phenylboronic acid was purchased from Fluka (Muskegon, Michigan). All other 
reagents and solvents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise 
specified. Flash column chromatography was performed using Silicycle silica gel (40-63 µm (230-
400 mesh), 60 Å irregular pore diameter). Thin-layer chromatography was performed on TLC 
Silica gel 60G F254 plate from Millipore Sigma. Reagents were purchased at the highest commercial 
quality and used without further purification, unless otherwise stated. Dulbecco’s Modified Eagle 
Medium (DMEM) was purchased from Invitrogen (Carlsbad, CA). Fetal bovine serum (FBS) was 
purchased from Gibco, Life Technologies (Gaithersburg, MD). Penicillin/streptomycin were 
purchased from Corning Cellgro (Corning, NY).  
 
Instruments. Accurate mass measurement analyses were conducted on either a Waters GCT 
Premier, time-of-flight, GCMS with electron ionization (EI), or an LCT Premier XE, time-of-flight, 
LCMS with electrospray ionization (ESI).  The signals were measured against an internal lock mass 
reference of perfluorotributylamine (PFTBA) for EI-GCMS, and leucine enkephalin for ESI-
LCMS. Waters software calibrates and reports by use of neutral atom mass. The mass of an electron 
is not included.  High-resolution mass spectra were obtained by Joomyung Vicky Jun and Dr. 
Charles Ross III at the University of Pennsylvania’s Mass Spectrometry Service Center on a 
Micromass AutoSpec electrospray/chemical ionization spectrometer. X-ray diffraction data 
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obtained and solved by Dr. Patrick Carroll at the University of Pennsylvania.  UV-Vis absorption 
spectra were acquired on a Hewlett-Packard 8452A diode array spectrophotometer (currently 
Agilent Technologies; Santa Clara, CA, USA) using quartz cells with a 1 cm cell path length (Starna 
Cells, Inc 120ul UV cells) or disposable UV cuvettes.  Fluorescence spectra were acquired on a 
Tecan M1000 plate reader (Mannedorf, Switzerland). Nuclear magnetic resonance (NMR) spectra 
were obtained on a Bruker UNI-500 and AVII-500B instrument and are calibrated using deuterated 
solvent (CD2Cl2 at 53.84 ppm 13C NMR. The following abbreviations were used to explain 
multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad).  High-
performance liquid chromatography (HPLC) chromatograms were recorded and compounds 4l’, 
5b, and 5d were purified on an Agilent Technology 1260 infinity II equipped with a Gemini NX 
5μm C18 110A; 250 x 21.2 mm LC column. Analytical HPLC studies were done with a JASCO-
FC-2088-30 HPLC equipped with a Phenomenex Luna Omega 5μm PS C18(2) 100A; 250 x 4.60 
mm column using aqueous (H2O + 0.1% CF3CO2H) and organic (CH3CN) phases. Purification 
conditions via combiflash Teledyne ISCO were also recorded. Melting points were determined on 
a Thomas-Hoover "UNI-MELT" capillary melting point apparatus and are uncorrected. The 
infrared (IR) spectra were obtained with Perkin Elmer Spectrum Two FT-IR by dissolving a small 
amount of compound in dichloromethane to mount the sample. For certain experiments, anhydrous 
solvents are obtained from Meyer Solvent Dispensing System (Laguna Beach, CA). 
 
Cell Culture and Imaging. HeLa cells were maintained in a humidified incubator at 37 °C in 5% 
CO2. HeLa cells were cultured in DMEM supplemented with 10% fetal bovine serum (Gibco, Life 
Technologies) and penicillin and streptomycin (Corning Cellgro). For live cell imaging, cells were 
plated in glass-bottom 35-mm dishes (MatTEK) 48 h before experiments. 48 h after plating, 2 μL 
of compound (stock solution 5 mM) was added to 2 mL of media. Cells were incubated for 2-5 h 
with compounds at 37 °C, followed by washing with fresh media 2 times. During imaging, cells 
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were maintained in DMEM without phenol red, supplemented with 10% FBS. A Leica TCS SP8 
confocal microscope equipped with a 40x and 63x/1.4 NA oil immersion objective lens was used. 
Compounds 4a-4n were excited at 405 nm and emission was observed in various wavelength filter 
sets with a consistent range of 50 nm. Compounds 5a-5i were excited at both 405 nm and 488 nm 
and emissions were observed in various wavelength filter sets with a consistent range of 50 nm. 
Images were processed using Fiji ImageJ. 
2.6.2. Experimental Procedure for Key Precursor 3 
 
 
Figure S 2.1 Synthesis of 2,4-dichloro-N,N-dimethylquinolin-7-amine 3  
 
Optimized Gram Scale Synthesis of Compound 3 (This Work) 
N,N-Dimethyl-1,3-phenylenediamine dihydrochloride (5.70 g, 270 mmole, 1.0 equiv) purchased 
from Acros OrganicsTM was dissolved in 100 mL of water and neutralized with neat K2CO3 until 
pH 9-10 was reached. The aqueous mixture was then extracted with EtOAc three times and washed 
with brine. Organic layers were combined, dried over Na2SO4 and concentrated in vacuo to give a 
brownish oil (3.63 g).  In a 20 mL or 40 mL scintillation vial, free-based N,N-dimethyl-1,3-
phenylenediamine (1) was added (1.20 g, 8.81 mmol, 1.0 equiv) to diphenylether (2.0 mL). Diethyl 
malonate (1.55 g, 9.69 mmol, 1.1 equiv) was added to the reaction vial, and capped tightly with 
Green Open Top SURE-Link™ Polypropylene Cap (Chemglass Life Sciences CG-4904-05) to 
allow self-condensation. The reaction vial, and the reaction mixture was vigorously stirred and 
heated at 160 °C for 3 h until the solution turned orange (Figure S 2.3A). The reaction was then 
heated to 200 °C for approximately 12 h until TLC indicated the complete formation of 7-
N
H
N O
OH
NH2N NN Cl
Cl
1 2 3
1) Diethyl Malonate 
(1.1 equiv)
190 oC, 3 h
Ph2O
2) POCl3 
(10 equiv)
105 oC, 1-2 h
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(dimethylamino)-4-hydroxyquinolin-2(1H)-one 2 (Rf=0.34 in 10% MeOH in DCM, or Figure S 
2.3B). The reaction vial turned brown and cooled to room temperature. Without any wash or 
purification, phosphorus oxychloride (13.5 g, 88.1 mmol, 10.0 equiv) was added to the reaction 
vial. The reaction mixture was stirred and refluxed at 105 °C (external temperature of silicon oil 
bath) for 3 h. The reaction was cooled to 0 °C over the course of 30 min, and ice deionized water 
was slowly added to the reaction mixture to quench excess phosphorus oxychloride. The resulting 
mixture was poured into a larger Erlenmeyer flask and neutralized with neat K2CO3. Then the 
mixture was poured into a separatory funnel and extracted with EtOAc 3 times. Finally, the organic 
layer was washed with brine, dried with Na2SO4, and concentrated in vacuo. Residual diphenylether 
was filtered out by silica column with 100% hexane, as it is the most non-polar component (Ph2O= 
1.14D). The crude mixture was purified by flash column chromatography (0% to 30% EtOAc in 
Hexane) to yield the yellow crystalline compound (2.03 g, 95.6% yield).  
Reproducibility of Previously Reported Synthesis of Compound 3 
 
 
 
Figure S 2.2 Previously reported synthetic conditions for 2,4-dihaloquinoline.1-3   
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Method 1. The synthesis of 2,4-dihydroxy-7-(dimethylamino)quinolone (2) was adapted from Nasr 
and Eisenhart.1,2 Diethylmalonate (0.72 mL, 1.1 equiv)  was added to the round-bottom flask 
containing the N,N-dimethyl-m-phenylenediamine (1) (0.58 g, 4.26 mmol, 1.0 equiv). A Dean-
Stark apparatus was fitted to the flask to distill off ethanol, and the mixture was refluxed in an oil 
bath at 180 ˚C for 3 h. The reaction mixture was then heated on a heating mantle at 270 ˚C for 2 h. 
After the reaction and upon cooling, solids were left behind in the reaction flask. The resulting solid 
was cooled and washed with acetone, giving a crude mixture containing 4-hydroxyquinolone (641 
mg, 74% crude yield).  Chlorination of crude 4-hydroxyquinolone (2) was accomplished by 
addition of phosphorus oxychloride (1.71 mL, 18.4 mmol, 6.0 equiv) to 641 mg of 2 (3.06 mmol, 
1.0 equiv). The reaction was refluxed for 2 h and then cooled to 0 ˚C. Ice water was then slowly 
added, and the reaction mixture was transferred to larger flask and neutralized with K2CO3. The 
mixture was poured into a separatory funnel and extracted with EtOAc three times followed by 
brine wash. The organic layer was dried over Na2SO4 and concentrated under reduced pressure in 
a water bath. The crude product was purified by column chromatography (100 % DCM) to yield 
the title compound (640 mg, 81% yield). Overall yield was 62.3 % but was not reproducible. 
Moreover, at larger scale (1-2g of 1), the reaction yield dropped down to less than 26 %. In general, 
a lack of reproducibility was observed, which is attributed to the nature of heterogeneity of the 
reaction mixture. Hence, variations of yields are evidently reported in the literature.S1-S3  
 
Method 2. Adapting the one-pot two-step synthesis of substituted 2,4-dichloroquinoline,S3 malonic 
acid (420 mg, 4.04 mmol, 1.1 equiv) was dissolved in phosphorus oxychloride (3.5 ml, 37.5 mmol, 
10 equiv) in a round bottom flask. The reaction mixture was heated at 50 oC for 30 min, 150 ˚C for 
2 h, and then cooled down to 0 ˚C in the ice bath.  In a separate vial, N,N-dimethyl-m-
phenylenediamine (500 mg, 3.67 mmol, 1.0 equiv) was dissolved in dry toluene from the Meyer 
Solvent Dispensing System (3 mL) and added dropwise via syringe pump (1 mL per 10 min) to the 
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reaction mixture in the ice bath. The reaction was heated at 150 ˚C for additional 2 h. The reaction 
mixture was cooled, poured onto ice with vigorous stirring, neutralized with sodium carbonate, 
filtered, dried and purified by column chromatography (100 % DCM) to afford the desired 
substituted 2,4-dichloroquinoline 3 (203 mg, 23 % yield).  
 
 
Figure S 2.3 A) Formation of 4-hydroxyquinolone 2 based on color of the solution B) Indication 
of the product formation of 2 via TLC in 1:1 Hexane: EtOAc C) Product from identical scale 
reaction under previously reported condition3 (left) and from our work (right) 
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Characterization Data of 2,4-dichloro-N,N-dimethylquinolin-7-amine (Compound 3) 
 
    
 
Physical State: yellow needle crystal, blue emissive under 365 nm UV lamp, m. p. =108-110 °C1 
TLC: Rf = 0.47 (20% EtOAc in Hexanes). 
1H NMR (500 MHz, CDCl3): δ 7.67 (d, J = 9.3 Hz, 1H), 6.92 (s, 1H), 6.87 (dd, J = 9.3, 2.6 Hz, 
1H), 6.76 (d, J = 2.5 Hz, 1H), 2.92 (s, 6H). 
13C NMR (126 MHz, CDCl3): δ 151.73, 149.75, 149.54, 143.31, 124.40, 116.54, 116.05, 105.45, 
and 39.90 
HRMS (ESI-TOF): calc’d for C11H11Cl2N2 [M+H]+ 241.0299; found 241.0309. 
IR (neat): 1623.18, 1573.16, 1546.81, 1502.41, 1446.51, 1416.61, 1361.15, 1312.18, 1270.84, 
1231.87, 1195.14, 1157.87, 1087.42, 1056.86, 964.79, 893.15, 843.1, 816.4, 801.57, 719.72 cm-1 
NN Cl
Cl
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2.6.3. High-Throughput Experimentation (HTE) Screenings for Pd-catalyzed Regioselective Cross-
Coupling Reaction.  
 
Screening Set Up:   
  
Ligands:          XantPhos, DPPP, DPPF, DPEPhos, DIPPF, PPh3, and PCy3  
             R-BINAP was not soluble in THF so stock solution was diluted;   
Solvents:                   THF, Dioxane;  [Final Concentration] = 0.1M 
Base:                         K2CO3, Cs2CO3 ; [Stock Solution] = 1.2 M  
Boronic Acid:           4-(dimethylamino)phenylboronic acid, 4-cyanophenylboronic acid,  
                                  phenylboronic acid;   
 
 
General Procedure:   
Experiments were set up inside a glovebox under a nitrogen atmosphere. Solvents were all degassed 
and stored in the glovebox. A 96-well aluminum block containing 250 μL glass vials was first 
predosed with Pd(OAc)2 (0.125 μmol, 5 mol %) and the phosphine ligands (0.25 μmol for 
monodentate ligands and 0.125 μmol for bidentate ligands) in THF. The solvent was dried 
overnight and a parylene stir bar was then added to each reaction vial. Dichloroquinoline 3 (2.5 
μmol, 1.0 equiv) and the boronic acid (2.75 μmol, 1.1 equiv) were dosed into each reaction vial as 
a solution in of two different solvent (25 μL of THF or dioxane). Base (0.75 μmol, 3.0 equiv) in 
H2O (6.25 μL) was added to give a final concentration of 0.1M. The 96-well plate was then sealed 
and stirred for 18 h at 70 oC.   
 
Work up:   
Upon opening the plate to air, 250 μL of a solution of biphenyl (used as internal standard to measure 
HPLC yields) in acetonitrile (0.001 mol/L) was added to each vial. The plate was covered again, 
and the vials stirred for 10 min. to ensure good homogenization. Into a separate 96-well LC block 
was added 700 μL of acetonitrile, followed by 25 μL of the diluted reaction mixtures. The LC block 
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was then sealed with a silicon-rubber storage mat and mounted on an automated UP-LCMS 
instrument for analysis. 
Screening Results:  
 
 
 
Figure S 2.4 Possible product distribution from Suzuki cross-coupling reaction of 3 
 
Notes:   
 
- Prod A refers to compound 4, Prod B refers to compound 4’, and Prod Bis refers to 5 
(Table 2). 
 
- HPLC yield of each product is calculated based on the area of corresponding HPLC 
chromatogram peak divided by the area of internal standard  
(100 % = area of Prod A + Prod B + Prod Bis + OH + deCl + 3).  
 
- Prod A/B quantitatively demonstrate regioselectivity of the reaction condition (Prod A / 
Prod B).  
 
- Conversion (%) of the reaction was calculated as 100 (%) - percent yield of 3 (%).  
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Table S 2.1 Product distribution based on HPLC yield of 4-cyanophenylboronic acid 
 
 
 
 
Figure S 2.5 Crude UP-LCMS chromatogram of Conditions 9 and 28 (4-Cyanophenylboronic 
Acid)  
Condition ligand solvent base Prod A/IS Prod B/IS Prod Bis/IS SM/ IS deCl/ IS OH/ IS Prod A/B Conv. (%)
1 XantPhos Dioxane Cs2CO3 58.4 3.9 34.2 1.0 1.2 1.4 15.0 99.0
2 XantPhos THF Cs2CO3 53.6 6.6 14.7 14.7 1.2 9.2 8.1 85.3
3 XantPhos Dioxane K2CO3 58.2 3.4 36.9 0.7 0.0 0.7 16.9 99.3
4 XantPhos THF K2CO3 54.4 6.7 15.0 15.0 0.6 8.3 8.1 85.0
5 R-BINAP Dioxane Cs2CO3 61.3 4.4 32.4 1.1 0.0 0.8 13.9 98.9
6 R-BINAP THF Cs2CO3 63.6 5.9 12.2 12.2 2.1 3.9 10.7 87.8
7 R-BINAP Dioxane K2CO3 45.9 4.3 23.4 23.4 1.6 1.4 10.7 76.6
8 R-BINAP THF K2CO3 51.1 5.6 12.7 22.2 2.6 5.8 9.0 77.8
9 DPPP Dioxane Cs2CO3 59.0 4.1 17.3 17.3 1.5 0.9 14.5 82.7
10 DPPP THF Cs2CO3 68.1 9.1 7.5 7.5 1.6 6.1 7.5 92.5
11 DPPP Dioxane K2CO3 68.8 4.7 19.4 4.4 1.6 0.9 14.5 95.6
12 DPPP THF K2CO3 55.4 6.4 6.9 29.4 0.0 1.9 8.7 70.6
13 DPPF Dioxane Cs2CO3 64.1 3.5 27.6 0.7 1.7 2.4 18.4 99.3
14 DPPF THF Cs2CO3 57.4 14.0 21.3 6.5 0.0 0.9 4.1 93.5
15 DPPF Dioxane K2CO3 68.0 5.2 24.9 0.9 0.0 1.0 13.1 99.1
16 DPPF THF K2CO3 59.3 11.2 13.3 13.3 0.0 2.9 5.3 86.7
17 DPEPhos Dioxane Cs2CO3 67.1 4.1 25.6 1.9 0.0 1.3 16.3 98.1
18 DPEPhos THF Cs2CO3 63.8 6.9 19.5 9.0 0.0 0.8 9.2 91.0
19 DPEPhos Dioxane K2CO3 47.5 3.1 24.4 24.4 0.0 0.7 15.5 75.6
20 DPEPhos THF K2CO3 49.1 11.0 25.6 12.4 1.0 0.8 4.5 87.6
21 DIPPF Dioxane Cs2CO3 48.8 2.5 41.0 4.7 2.3 0.8 19.3 95.3
22 DIPPF THF Cs2CO3 57.9 4.2 22.4 11.5 1.9 2.0 13.7 88.5
23 DIPPF Dioxane K2CO3 49.5 2.7 37.7 6.1 3.0 1.0 18.4 93.9
24 DIPPF THF K2CO3 37.7 5.2 22.1 16.1 4.6 14.2 7.2 83.9
25 PPh3 Dioxane Cs2CO3 67.1 7.2 22.6 1.1 0.0 1.9 9.3 98.9
26 PPh3 THF Cs2CO3 68.0 13.3 7.1 10.4 0.0 1.3 5.1 89.6
27 PPh3 Dioxane K2CO3 54.9 7.1 18.2 18.2 0.0 1.6 7.7 81.8
28 PPh3 THF K2CO3 78.4 8.7 1.2 3.3 0.0 8.4 9.0 96.7
29 PCy3 Dioxane Cs2CO3 44.3 3.5 43.4 7.7 0.0 1.1 12.7 92.3
30 PCy3 THF Cs2CO3 45.0 4.0 28.9 20.7 0.0 1.3 11.3 79.3
31 PCy3 Dioxane K2CO3 44.7 3.6 40.6 10.0 0.0 1.1 12.4 90.0
32 PCy3 THF K2CO3 48.3 4.5 24.8 21.5 0.0 0.9 10.8 78.5
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Table S 2.2 Product distribution based on HPLC yield of phenylboronic acid 
  
 
 
 
Figure S 2.6 Crude UP-LCMS chromatogram of Conditions 29 and 9 (Phenylboronic Acid) 
  
Condition ligand solvent base Prod A/IS Prod B/IS Prod Bis/IS SM/ IS deCl/ IS OH/ IS Prod A/B Conv. (%)
1 XantPhos Dioxane Cs2CO3 85.9 6.3 6.2 0.0 0.0 1.5 13.6 100.0
2 XantPhos THF Cs2CO3 84.1 6.0 8.3 0.0 0.0 1.6 13.9 100.0
3 XantPhos Dioxane K2CO3 86.0 6.1 0.8 5.9 0.0 1.3 14.1 94.1
4 XantPhos THF K2CO3 83.5 5.9 9.1 0.0 0.0 1.5 14.2 100.0
5 R-BINAP Dioxane Cs2CO3 74.2 5.3 11.1 7.6 0.8 1.1 14.1 92.4
6 R-BINAP THF Cs2CO3 61.7 4.8 14.1 18.4 0.0 1.0 12.8 81.6
7 R-BINAP Dioxane K2CO3 79.4 6.0 6.0 7.6 0.0 1.1 13.2 92.4
8 R-BINAP THF K2CO3 73.9 5.9 7.4 11.7 0.0 1.1 12.6 88.3
9 DPPP Dioxane Cs2CO3 90.2 7.8 1.2 0.0 0.0 0.7 11.5 100.0
10 DPPP THF Cs2CO3 84.0 7.4 1.4 6.4 0.0 0.9 11.4 93.6
11 DPPP Dioxane K2CO3 80.6 6.6 3.6 6.6 0.0 2.6 12.2 93.4
12 DPPP THF K2CO3 69.6 5.9 4.8 18.8 0.0 0.9 11.8 81.2
13 DPPF Dioxane Cs2CO3 75.7 5.6 4.9 11.0 0.8 2.1 13.6 89.0
14 DPPF THF Cs2CO3 86.0 6.2 4.3 1.1 0.0 2.4 13.9 98.9
15 DPPF Dioxane K2CO3 83.0 5.9 1.1 6.5 0.9 2.6 14.0 93.5
16 DPPF THF K2CO3 86.0 6.1 0.7 4.4 0.0 2.7 14.0 95.6
17 DPEPhos Dioxane Cs2CO3 73.6 5.8 7.3 12.1 0.0 1.1 12.6 87.9
18 DPEPhos THF Cs2CO3 79.4 5.8 5.0 6.9 0.0 2.8 13.7 93.1
19 DPEPhos Dioxane K2CO3 74.8 5.9 6.6 11.7 0.0 1.0 12.6 88.3
20 DPEPhos THF K2CO3 78.1 6.0 4.2 8.1 0.8 2.7 13.0 91.9
21 DIPPF Dioxane Cs2CO3 55.2 4.4 18.6 19.2 1.6 0.9 12.5 80.8
22 DIPPF THF Cs2CO3 64.5 4.7 15.8 13.1 1.1 0.8 13.7 86.9
23 DIPPF Dioxane K2CO3 55.6 4.1 20.8 16.8 1.8 0.8 13.5 83.2
24 DIPPF THF K2CO3 60.1 4.6 16.1 17.3 1.1 0.8 13.0 82.7
25 PPh3 Dioxane Cs2CO3 79.8 6.1 0.8 10.3 0.0 3.0 13.0 89.7
26 PPh3 THF Cs2CO3 76.8 5.9 0.9 12.7 0.0 3.7 13.0 87.3
27 PPh3 Dioxane K2CO3 80.6 6.1 1.4 7.8 0.9 3.2 13.2 92.2
28 PPh3 THF K2CO3 75.3 6.5 9.9 0.0 1.2 7.2 11.7 100.0
29 PCy3 Dioxane Cs2CO3 35.9 3.3 38.0 21.9 0.0 0.9 11.0 78.1
30 PCy3 THF Cs2CO3 41.0 3.7 34.3 18.9 0.0 2.1 11.1 81.1
31 PCy3 Dioxane K2CO3 39.1 3.8 33.7 22.2 0.0 1.3 10.3 77.8
32 PCy3 THF K2CO3 43.6 4.2 29.1 22.4 0.0 0.8 10.4 77.6
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Table S 2.3 Product distribution based on HPLC yield of 4-(dimethylamino)phenylboronic acid 
 
 
 
 
Figure S 2.7 Crude UP-LCMS chromatogram of Condition 32 and 25 (4-dimethylamino) 
phenylboronic acid  
Condition ligand solvent base Prod A/IS Prod B/IS Prod C/IS Prod Bis/IS SM/ IS deCl/ IS OH/ IS Prod A/B Conv. (%)
1 XantPhos Dioxane Cs2CO3 83.4 0.0 5.7 5.3 3.2 1.4 1.1 complete 96.8
2 XantPhos THF Cs2CO3 78.3 3.7 6.6 4.7 3.7 1.6 1.2 21.0 96.3
3 XantPhos Dioxane K2CO3 78.8 3.9 1.1 4.5 5.4 2.9 3.4 20.0 94.6
4 XantPhos THF K2CO3 77.0 3.4 6.7 6.9 3.4 1.5 1.1 22.5 96.6
5 R-BINAP Dioxane Cs2CO3 73.9 5.8 5.5 7.6 5.8 0.0 1.4 12.6 94.2
6 R-BINAP THF Cs2CO3 61.7 9.5 5.1 4.0 16.2 0.0 3.5 6.5 83.8
7 R-BINAP Dioxane K2CO3 70.6 6.9 5.4 8.0 7.5 0.0 1.6 10.2 92.5
8 R-BINAP THF K2CO3 70.8 6.7 4.4 4.6 11.1 0.0 2.5 10.6 88.9
9 DPPP Dioxane Cs2CO3 76.4 2.0 5.6 2.5 11.6 0.0 2.0 38.5 88.4
10 DPPP THF Cs2CO3 78.9 1.1 6.3 11.0 1.1 0.7 1.0 74.8 98.9
11 DPPP Dioxane K2CO3 87.4 1.1 5.9 3.8 1.1 0.0 0.8 81.6 98.9
12 DPPP THF K2CO3 78.9 0.8 5.6 0.0 12.2 0.0 2.5 94.7 87.8
13 DPPF Dioxane Cs2CO3 81.0 1.8 5.4 2.2 7.7 0.0 1.9 45.3 92.3
14 DPPF THF Cs2CO3 77.6 2.6 7.8 7.0 2.6 1.7 0.7 29.9 97.4
15 DPPF Dioxane K2CO3 80.3 1.5 5.1 2.5 6.9 1.8 1.8 54.6 93.1
16 DPPF THF K2CO3 86.4 0.8 5.6 1.9 4.0 0.0 1.4 113.3 96.0
17 DPEPhos Dioxane Cs2CO3 67.4 7.5 5.1 3.3 14.0 0.0 2.7 9.0 86.0
18 DPEPhos THF Cs2CO3 73.3 5.7 5.1 2.7 10.7 0.0 2.4 12.9 89.3
19 DPEPhos Dioxane K2CO3 70.7 7.0 5.1 4.2 11.0 0.0 2.0 10.1 89.0
20 DPEPhos THF K2CO3 77.3 3.2 6.9 7.9 2.5 0.0 2.2 24.0 97.5
21 DIPPF Dioxane Cs2CO3 50.3 16.1 4.1 7.1 17.6 0.0 4.7 3.1 82.4
22 DIPPF THF Cs2CO3 60.2 13.2 4.2 7.6 11.1 0.0 3.7 4.6 88.9
23 DIPPF Dioxane K2CO3 52.7 16.8 3.5 11.0 12.4 0.0 3.6 3.1 87.6
24 DIPPF THF K2CO3 56.6 13.5 4.2 6.3 15.1 0.0 4.3 4.2 84.9
25 PPh3 Dioxane Cs2CO3 87.7 0.0 6.6 0.0 4.3 0.0 1.4 complete 95.7
26 PPh3 THF Cs2CO3 81.3 0.0 9.5 0.0 7.1 0.0 2.1 complete 92.9
27 PPh3 Dioxane K2CO3 79.2 0.6 5.6 0.0 12.5 0.0 2.1 124.0 87.5
28 PPh3 THF K2CO3 74.9 0.0 8.7 0.0 13.9 0.0 2.5 complete 86.1
29 PCy3 Dioxane Cs2CO3 28.8 34.8 2.4 7.8 21.7 0.0 4.5 0.8 78.3
30 PCy3 THF Cs2CO3 34.5 29.2 2.9 7.0 22.0 0.0 4.4 1.2 78.0
31 PCy3 Dioxane K2CO3 40.0 29.4 3.4 11.0 13.5 0.0 2.7 1.4 86.5
32 PCy3 THF K2CO3 39.1 25.6 3.4 6.2 21.7 0.0 3.9 1.5 78.3
 
 
 
 
 
 
 
 
 
 
 
                                
 
 
    
  
  
  
  
  
  
  
    
Condition 32 (Ph-NMe2) 
Condition 25 (Ph-NMe2) 
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 Table S 2.4 General Conditions with Average HPLC Yield and Standard Deviation.  
 
 
 
Top three general conditions 9, 25, and 28 with high average yields with small standard deviations 
are highlighted. Condition 28 (pink highlight) was chosen as final general condition for scope study. 
condition ligand solvent base PhNMe2 Ph PhCN avg std 
1 XantPhos Dioxane Cs2CO3 83.4 79.8 58.4 73.9 13.5 
2 XantPhos THF Cs2CO3 78.3 76.5 53.6 69.5 13.8 
3 XantPhos Dioxane K2CO3 78.8 84.9 57.8 73.9 14.2 
4 XantPhos THF K2CO3 77.0 75.5 54.4 69.0 12.7 
5 R-BINAP Dioxane Cs2CO3 72.9 74.2 60.8 69.3 7.4 
6 R-BINAP THF Cs2CO3 59.7 61.1 63.6 61.4 2.0 
7 R-BINAP Dioxane K2CO3 69.5 78.6 45.9 64.6 16.9 
8 R-BINAP THF K2CO3 69.1 73.1 51.1 64.4 11.7 
9 DPPP Dioxane Cs2CO3 74.9 88.6 59.0 74.2 14.8 
10 DPPP THF Cs2CO3 78.9 83.3 68.1 76.8 7.8 
11 DPPP Dioxane K2CO3 86.7 78.6 68.8 78.0 9.0 
12 DPPP THF K2CO3 77.0 68.9 54.4 66.8 11.4 
13 DPPF Dioxane Cs2CO3 79.4 75.7 64.1 73.1 8.0 
14 DPPF THF Cs2CO3 77.6 83.9 56.9 72.8 14.1 
15 DPPF Dioxane K2CO3 80.3 83.0 67.4 76.9 8.4 
16 DPPF THF K2CO3 85.1 83.7 57.6 75.5 15.5 
17 DPEPhos Dioxane Cs2CO3 65.7 72.9 66.2 68.3 4.0 
18 DPEPhos THF Cs2CO3 71.6 77.3 63.3 70.7 7.0 
19 DPEPhos Dioxane K2CO3 69.3 74.0 47.2 63.5 14.3 
20 DPEPhos THF K2CO3 75.6 78.1 49.1 67.6 16.1 
21 DIPPF Dioxane Cs2CO3 48.1 55.2 48.8 50.7 4.0 
22 DIPPF THF Cs2CO3 58.1 64.5 57.9 60.2 3.8 
23 DIPPF Dioxane K2CO3 50.9 55.6 49.5 52.0 3.2 
24 DIPPF THF K2CO3 54.2 60.1 37.7 50.7 11.6 
25 PPh3 Dioxane Cs2CO3 86.5 79.1 65.9 77.1 10.4 
26 PPh3 THF Cs2CO3 79.6 74.1 67.2 73.6 6.2 
27 PPh3 Dioxane K2CO3 77.5 80.6 54.1 70.7 14.5 
28 PPh3 THF K2CO3 73.1 68.6 72.3 71.3 2.4 
29 PCy3 Dioxane Cs2CO3 27.5 35.6 43.9 35.7 8.2 
30 PCy3 THF Cs2CO3 33.1 40.1 44.4 39.2 5.7 
31 PCy3 Dioxane K2CO3 39.0 38.6 44.3 40.6 3.2 
32 PCy3 THF K2CO3 37.6 43.2 47.8 42.9 5.1 
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2.6.4. General Procedure A and Characterization Data for Monoarylated Quinolines. 
 
General Procedure A.  Experiments were set up inside a glovebox under a nitrogen atmosphere. 
Tetrahydrofuran (THF) and dioxane were obtained from Meyer solvent system, and water was 
degassed prior to use in the glovebox. A stock solution of 2,4-dichloro-N,N-dimethylquinolin-7-
amine (3) was prepared by dissolving 696 mg (2.88 mmol) in 1.6 ml of THF in the glovebox. To a 
4.0 mL scintillation vial, 100 µL (43.5 mg, 0.18 mmol, 1 equiv) of compound 3 from the stock 
solution was added. PdCl2(PPh3)2 (6.3 mg, 0.009 mmol, 0.05 equiv), and boronic acid (0.198 mmol, 
1.1 equiv) were added and dissolved in a total 1443.4 µL of THF.  K2CO3 (74.8 mg, 0.541 mmol, 
3.0 equiv) dissolved in 360.8 mL of H2O was added to the vial, which was capped in the glovebox. 
Under nitrogen, the mixture was stirred for 5 to 48 h at 65 ˚C. Upon completion of the reaction, 30 
mL of EtOAc and water were added to the reaction mixture. The organic layer was extracted, dried 
with anhydrous Na2SO4, concentrated in vacuo. The desired product was purified by column 
chromatography or using the ISCO system.  Standard ISCO condition: 0 to 100% EtOAc in Hexane 
over 10 min.  
 
Characterization Data Notes. 
Image Interpretation: The left vial has the corresponding compound in DMSO (5mM) and right 
the vial has dry compound. The photo with the dark background is taken under a handheld UV 
lamp. Solid state emission can vary depending on packing of residual solvent molecules.  
 
 
Note. IR spectra and Analytical HPLC data are omitted. Please refer to the published supporting 
information. 
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4-(4-chloro-7-(dimethylamino)quinolin-2-yl)phenol (4a):  Following the General Procedure A 
with 4-hydroxyphenylboronic acid (27 mg, 0.20 mmol, 1.1 equiv, purchased from Aldrich) at 65 °C 
for 48 h afforded 21 mg (39 % isolated yield) of the title compound after purification by the standard 
ISCO method. The desired product was eluted with 50-70% ethyl acetate. 
 
Physical Property: dark orange brownish solid, m. p. = 200-205 °C 
TLC: Rf = 0.13 (20% EtOAc in Hexanes). 
1H NMR (500 MHz, Acetone-d6) δ 8.19 – 8.16 (m, 2H), 7.98 (d, J = 9.2 Hz, 1H), 7.77 (s, 1H), 7.33 
(dd, J = 9.2, 2.6 Hz, 1H), 7.17 (d, J = 2.6 Hz, 1H), 7.00 – 6.97 (m, 2H), 3.15 (s, 6H). 
13C NMR (126 MHz, Acetone-d6) δ 157.57, 152.99, 151.81, 142.69, 131.04, 129.66, 128.21, 
124.97, 117.56, 117.33, 116.33, 114.53, 107.60, and 40.42. 
HRMS (ESI-TOF): calc’d for C17H16ClN2O+  [M+H]+ 299.0951; found 299.0942. 
IR (neat): 2925.83, 1709.77, 1609.94, 1571.48, 1506.11, 1448.61, 1418.73, 1371.68, 1336.1, 
1253.13, 1213.51, 1171.68, 961.9, 896.22, 835.5, 730.08, 680.88, 541.4, 515.82 cm-1  
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4-chloro-2-(4-(dimethylamino)phenyl)-N,N-dimethylquinolin-7-amine (4b): Following 
General Procedure A with 4-(dimethylamino)phenylboronic acid (33 mg, 0.20 mmol, 1.1 equiv, 
purchased from Aldrich) at 65 °C for 36 h afforded 57 mg (97 % isolated yield) of the title 
compound after purification by column chromatography (1:1 dichloromethane:EtOAc).  
  
Physical Property: dark orange/brown solid, m. p. = 188-191 °C 
TLC: Rf = 0.26 (20% EtOAc in Hexanes). 
1H NMR (500 MHz, CD2Cl2): δ 8.08 – 8.04 (m, 2H), 7.99 (d, J = 9.2 Hz, 1H), 7.63 (s, 1H), 7.18 
(dd, J = 9.2, 2.6 Hz, 1H), 7.15 (d, J = 2.6 Hz, 1H), 6.85 – 6.80 (m, 2H), 3.14 (s, 6H), 3.06 (s,6H). 
13C NMR (126 MHz, CD2Cl2): δ 157.64, 152.31, 151.96, 151.41, 142.35, 128.50, 126.73, 124.74, 
117.20, 116.02, 114.30, 112.32, 107.18, 40.64, and 40.47. 
HRMS (ESI-TOF): calc’d for C19H21ClN3+  [M+H]+ 326.1424; found 326.1410. 
IR (neat): 2919.68, 1628.9, 1600.98, 1571.45, 1525.2, 1497.78, 1445.42, 1414.33, 1381.95, 
1331.15, 1299.53, 1262.73, 1203.59, 1174.01, 1067.49, 988.14, 945.63, 816.77, 765.55, 512.43 
cm-1  
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4-chloro-N,N-dimethyl-2-phenylquinolin-7-amine (4c): Following the General Procedure A 
with phenylboronic acid (33 mg, 0.20 mmol, 1.1 equiv, purchased from Aldrich) at 65 °C for 36 h 
afforded 47 mg (93 % isolated yield) of the title compound after purification by column 
chromatography (8:1:1 Hex:DCM:EtOAc). With standard ISCO conditions, the desired product 
eluted at 30-38% EtOAc. 
 
Physical Property: red film (DCM dry) or yellow solid, m. p. = 98-101 °C 
TLC: Rf =0.45 (20% EtOAc in Hexanes). 
1H NMR (500 MHz, CD2Cl2): δ 8.16 (dt, J = 9.1, 2.5 Hz, 2H), 8.02 (d, J = 9.3 Hz, 1H), 7.63 (s, 
1H), 7.57 – 7.49 (m, 3H), 7.48 – 7.44 (m, 1H), 7.23 (dd, J = 9.3, 2.6 Hz, 1H), 3.16 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ156.52, 152.77, 149.46, 144.39, 137.46, 130.46, 129.18, 128.07, 
125.02, 117.87, 117.38, 115.01, 105.18, and 40.56. 
HRMS (ESI-TOF): calc’d for C17H16ClN2+  [M+H]+ 283.1002; found 283.1011. 
IR (neat): 1612.97, 1585.94, 1568.61, 1540.52, 1510.74, 1494.95, 1453.87, 1438.05, 1416.41, 
1370.2, 1318.58, 1261.58, 1212.32, 1149.46, 960.88, 847.78, ,809.48, 772.67, 740.48, 692.67 
 cm-1  
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4-chloro-2-(4-fluorophenyl)-N,N-dimethylquinolin-7-amine (4d): Following the General 
Procedure A with 4-fluorophenylboronic acid (28 mg, 0.20 mmol, 1.1 equiv, purchased from 
Aldrich) at 65 °C for 12 h afforded 49 mg (91 % isolated yield) of the title compound after 
purification by the ISCO standard purification method. The desired product eluted at 25-30% 
EtOAc.  
 
Physical Property: yellow solid, m. p. = 149-151 °C 
TLC: Rf = 0.5 (20% EtOAc in Hexanes) / 0.27 (40% Hexanes in CH2Cl2) 
1H NMR (500 MHz, CD2Cl2): δ 8.18 – 8.11 (m, 2H), 8.02 (d, J = 9.2 Hz, 1H), 7.62 (s, 1H), 7.26 – 
7.18 (m, 3H), 7.17 (d, J = 2.7 Hz, 1H), 3.14 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 164.21 (d, 1JFC = 248.3 Hz, 1C), 156.40, 152.39, 151.30, 142.92, 
135.74 (d, 4JFC = 3.3 Hz, 1C), 129.55 (d, 3JFC = 8.7 Hz, 1C), 124.80, 117.63, 117.03, 115.93 (d, 
2JFC  = 21.5 Hz, 1C), 114.72, 107.17, and 40.56.  
HRMS (ESI-TOF): calc’d for C17H15ClFN2+  [M+H]+ 301.0908; found 301.0895. 
IR (neat): 2922.12, 2812.66, 1627.87, 1615.19, 1574.61, 1543.95, 1504.04, 1426.26, 1371.56, 
1326.18, 1214.47, 1156.52, 1063.88, 961.69, 896.99, 834.65, 810.82, 725.67, 535.29, 510 cm-1 
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4-chloro-N,N-dimethyl-2-(4-(trifluoromethyl)phenyl)quinolin-7-amine (4e): Following the 
General Procedure A with 4-(trifluoromethyl)phenylboronic acid (38 mg, 0.20 mmol, 1.1 equiv, 
purchased from Aldrich) at 65 °C for 48 h afforded 61 mg (96 % isolated yield) of the title 
compound after purification by the standard ISCO purification. The desired product eluted at 24-
28% EtOAc.  
 
Physical Property: red solid, m. p. = 108-110 °C 
TLC: Rf = 0.54 (20% EtOAc in Hexanes). 
 1H NMR (500 MHz, CD2Cl2): δ 8.32 (d, J = 8.1 Hz, 2H), 8.09 (d, J = 9.5 Hz, 1H), 7.82 (d, J = 8.1 
Hz, 2H), 7.66 (s, 1H), 7.33 (dd, J = 9.4, 2.7 Hz, 1H), 3.20 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 155.91, 152.49, 151.39, 143.16, 142.98, 131.10, 128.00, 126.05, 
126.02, 125.99, 124.87, 118.04, 117.58, 115.02, 107.19, and 40.57.  
HRMS (ESI-TOF): calc’d for C18H15ClF3N2+  [M+H]+ 351.0876; found 351.0867. 
IR (neat): 1616.11, 1587.85, 1567.08, 1543.04, 1505.05, 1442.89, 1426.76, 1373.48, 1316.55, 
1263.72, 1214.98, 1160.71, 120.27, 1082.47, 1068.77, 1015.16, 835.19, 811.67, 733.19, 677.4 cm-
1 
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4-(4-chloro-7-(dimethylamino)quinolin-2-yl)benzonitrile (4f) Following the General Procedure 
A with 4-cyanophenylboronic acid (29 mg, 0.20 mmol, 1.1 equiv, purchased from Aldrich) at 65 °C 
for 5 h afforded  55 mg (99 % isolated yield) of the title compound after purification by column 
chromatography (1:1 DCM : EtOAc). Using the ISCO standard method, the desired compound 
eluted at 30-38% EtOAc.   
 
Physical Property: yellow solid, m. p. = 225-230 °C 
TLC: Rf = 0.38 (20% EtOAc in Hexanes). 
1H NMR (500 MHz, CDCl3): δ 8.24 – 8.16 (m, 2H), 8.04 (d, J = 9.3 Hz, 1H), 7.81 – 7.74 (m, 2H), 
7.61 (s, 1H), 7.24 (dd, J = 9.3, 2.6 Hz, 1H), 7.18 (d, J = 2.5 Hz, 1H), 3.15 (s, 6H). 
13C NMR (126 MHz, CDCl3): δ 155.38, 152.16, 151.10, 143.52, 143.24, 132.66, 128.06, 124.83, 
118.93, 118.02, 117.50, 114.93, 112.88, 107.04, 40.50.  
HRMS (ESI-TOF): calc’d for C18H15ClN3+ [M+H]+ 308.0955 found 308.0954. 
IR (neat): 3035.08, 2924.56, 2228.48, 1626.96, 1578.11, 1559.22, 1508.5, 1444.88, 1425.84, 
1381.99, 1333.5, 1319.39, 1256.73, 1214.19, 1159.71, 960.16, 895.49, 836.37, 732.04, 545.79  
cm-1  
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4-chloro-2-(2-methoxyphenyl)-N,N-dimethylquinolin-7-amine (4g): Following the General 
Procedure A with 2-methoxyphenylboronic acid (30.1 mg, 0.198 mmol, 1.1 equiv, purchased from 
Aldrich) at 65 °C for 48 h afforded 52 mg (92 % isolated yield) of the title compound after 
purification by column chromatography (6:1 hexanes:EtOAc). Using the standard ISCO method, 
the desired compound eluted at 18-22% EtOAc. 
 
Physical Property: orange solid, bright yellow solid state fluorescence, m. p. = 136-140 °C 
TLC: Rf = 0.26 (20% EtOAc in Hexanes) 
1H NMR (500 MHz, CD2Cl2): δ 8.05 (d, J = 9.3 Hz, 1H), 7.84 (dd, J = 7.6, 1.8 Hz, 1H), 7.72 (s, 
1H), 7.45 – 7.40 (m, 1H), 7.27 (dd, J = 9.2, 2.6 Hz, 1H), 7.20 (d, J = 2.7 Hz, 1H), 7.12 – 7.05 (m, 
2H), 3.90 (s, 3H), 3.14 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 157.72, 157.20, 152.12, 151.24, 141.18, 131.63, 130.76, 129.40, 
124.69, 121.21, 119.60, 117.56, 116.98, 111.87, 107.42, 56.01, 40.63. 
HRMS (ESI-TOF): calc’d for C18H18ClN2O+  [M+H]+ 312.1108; found 313.1129. 
IR (neat): 2924.16, 2853.79, 1624.92, 1601.61, 1566.72 ,1541.9, 1503.3, 1463.66, 1416.88, 
1380.43, 1321.25, 1290.55, 1264.42, 1240.85, 1210.53, 1156.86, 1036.02, 818.61, 787.81, 723.88 
cm-1 
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4-chloro-2-(3-methoxyphenyl)-N,N-dimethylquinolin-7-amine (4h): Following the General 
Procedure A 3-methoxyphenylboronic acid (30 mg, 0.20 mmol, 1.1 equiv) purchased from Aldrich) 
at 65 °C  for 48 h afforded 47mg (83 % isolated yield) of the title compound after purification by 
column chromatography (12:1 hexanes:EtOAc).  
 
Physical Property: red film, orange-yellowish fluorescence film 
TLC: Rf = 0.39 (20% EtOAc in Hexanes) 
 1H NMR (500 MHz, CD2Cl2): δ 8.02 (d, J = 9.3 Hz, 1H), 7.77 (dd, J = 2.6, 1.7 Hz, 1H), 7.67 (ddd, 
J = 7.6, 1.7, 0.9 Hz, 1H), 7.63 (s, 1H), 7.45 – 7.39 (m, 2H), 7.24 (dd, J = 9.3, 2.6 Hz, 1H), 7.03 
(ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 3.94 (s, 3H), 3.15 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 160.50, 156.52, 152.67, 149.82, 144.00, 139.35, 130.12, 124.96, 
120.22, 117.91, 117.33, 116.37, 115.11, 113.02, 108.41, 105.60, 101.86, 55.86, and 40.55. 
HRMS (ESI-TOF): calc’d for C18H18ClN2O +  [M+H]+ 313.1108; found 313.1094. 
IR (neat): 2929.2, 1626.04, 1600.41, 1583.21, 1566.04, 1540.05, 1503.19, 1418.79, 1379.86, 
1329.61, 1262.03, 1213.36,  1159.04, 1127.57, 1076.3, 1019.51, 895.83, 848.88, 755.93, 
729.99 cm-1  
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4-chloro-2-(4-methoxyphenyl)-N,N-dimethylquinolin-7-amine (4i): Following the General 
Procedure A with 4-methoxyphenylboronic acid (30 mg, 0.20 mmol, 1.1 equiv, purchased from 
Aldrich) at 65 °C for 15 h afforded 53 mg (94 % isolated yield) of the title compound after 
purification by column chromatography (10:1 hexanes:EtOAc).  
 
Physical Property: orange solid, orange fluorescence, m. p. = 112-115 °C 
TLC: Rf = 0.34 (20% EtOAc in Hexanes) 
1H NMR (500 MHz, CD2Cl2): δ 8.11 (dd, J = 9.4, 2.6 Hz, 2H), 8.02 (d, J = 9.2 Hz, 1H), 7.64 (s, 
1H), 7.22 (dd, J = 9.3, 2.6 Hz, 1H), 7.17 (d, J = 2.6 Hz, 1H), 7.07 – 7.01 (m, 2H), 3.89 (s, 3H), 3.15 
(s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 161.40, 157.15, 152.35, 151.35, 142.66, 131.95, 128.96, 124.77, 
117.45, 116.61, 114.62, 114.44, 107.21, 55.76, and 40.60. 
HRMS (ESI-TOF): calc’d for C18H18ClN2O + [M+H]+ 313.1108; found 313.1101. 
IR (neat): 2932.43, 1607.24, 1586.09, 1573.95, 1505.24, 1452.87, 1427.54, 1403.59, 1370.15, 
1306.73, 1282.65, 1250.42, 1212.87, 1173.31, 1150.83, 1030.84, 961.64, 831.47, 810.17, 678.88 
cm-1 
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4-chloro-2-(2,4-difluorophenyl)-N,N-dimethylquinolin-7-amine (4j): Following the General 
Procedure A with 2,4-difluorophenylboronic acid (31 mg, 0.20 mmol, 1.1 equiv, purchased from 
Aldrich) at 65 °C for 12 h afforded 50 mg (87 % isolated yield) of the title compound after 
purification by the standard ISCO purification method. The desired product eluted at 16-20% 
EtOAc. 
 
Physical Property: yellow solid, m. p. = 168-172 °C 
TLC: Rf = 0.5 (20% EtOAc in Hexanes) 
1H NMR (500 MHz, CD2Cl2): δ 8.16 (td, J = 8.8, 6.6 Hz, 1H), 8.08 – 8.02 (m, 1H), 7.62 (d, J = 2.3 
Hz, 1H), 7.33 – 7.25 (m, 2H), 7.08 (dddd, J = 8.8, 7.9, 2.6, 1.0 Hz, 1H), 6.99 (ddd, J = 11.3, 8.9, 
2.5 Hz, 1H), 3.16 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 165.15-163.05 (dd, 1JCF  = 11.7, 253.7 Hz, 1C), 162.30-160.19 
(dd, 5JCF  = 12.1, 251.3 Hz, 1C), 152.57, 152.45, 150.25, 143.27, 133.19-133.07 (dd, 2JCF  = 4.3, 
9.7 Hz, 1C), 124.95, 118.04-117.87 (t, 3JCF  = 10.4 Hz, 1C), 117.69, 112.42-112.22 (dd, 4JCF  = 3.5, 
21.3 Hz, 1C), 105.86, 104.99-104.57 (t, 6JCF  = 26.4 Hz, 1C), and 40.56. 
HRMS (ESI-TOF): calc’d for C17H14ClF2N2+ [M+H]+ 319.0814; found 319.0823. 
IR (neat): 2925.79, 2428.79, 1626.26, 1567.77, 1542.89, 1506.89, 1445.47, 1423.95, 1382.07, 
1332.82, 1296.95, 1267.03, 1214.5, 1159.09, 1109.9, 968.97, 892.25, 849.06, 815.15, 726.48 cm-1 
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2-(anthracen-9-yl)-4-chloro-N,N-dimethylquinolin-7-amine (4k): Following the General 
Procedure A with 4-(dimethylamino)phenylboronic acid (44 mg, 0.20 mmol, 1.1 equiv, purchased 
from Aldrich) at 65 °C for 48 h afforded 14 mg (20 % isolated yield) of the title compound after 
purification by column chromatography (16:1 hexanes:EtOAc).  
Physical Property: dark orange solid, m. p. = 225-228 °C 
TLC: Rf = 0.34 (20% EtOAc in Hexanes) 
1H NMR (500 MHz, CD2Cl2): δ 8.60 (s, 1H), 8.22 (d, J = 9.3 Hz, 1H), 8.11 (d, J = 8.5 Hz, 2H), 
7.69 – 7.60 (m, 2H), 7.50 (dd, J = 8.2, 6.8 Hz, 2H), 7.42 – 7.37 (m, 4H), 7.24 (d, J = 2.5 Hz, 1H), 
3.16 (d, J = 0.9 Hz, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 159.06, 152.49, 151.60, 142.41, 135.48, 131.79, 130.21, 128.85, 
127.94, 126.38, 126.34, 125.64, 125.00, 120.68, 117.73, 117.53, 107.39, 40.60. 
HRMS (ESI-TOF): calc’d for C25H20ClN2+  [M+H]+ 383.1315; found 383.1332. 
IR (neat) :1615.06, 1567.15, 1509.93, 1442.78, 1418.13, 1371.86, 1359.41, 1323.58, 1289.47, 
1264.03, 1214.32, 1184.65, 1170, 1155.69, 1136.64, 1119.75, 888.99, 813.62, 731.66, 699.56cm-1 
 
Figure S 2.8 Crude run on ISCO is shown to show presence of decomposed deborylated 
anthracene boronic acid, starting material (3), and the desired product (4k) from left to  right.   
254nm
320 nm
Product (4k)Starting
Material
(3)
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tert-butyl (4-(4-chloro-7-(dimethylamino)quinolin-2-yl)benzyl)carbamate (4l): Following the 
General Procedure A with 4-(Boc-aminomethyl)benzeneboronic acid (50 mg, 0.20 mmol, 1.1 equiv, 
purchased from Aldrich) at 65 °C  for 48 h afforded 62 mg (84 % isolated yield) of the title 
compound after purification by column chromatography (4:1 hexanes:EtOAc).  
 
Physical Property: orange solid, orange solid state fluorescence m. p. = 148-151 °C 
TLC: Rf = 0.16 (20% EtOAc in Hexanes) 
1H NMR (500 MHz, CD2Cl2): δ  8.13 – 8.09 (m, 2H), 8.03 (d, J = 9.2 Hz, 1H), 7.67 (s, 1H), 7.46 
– 7.40 (m, 2H), 7.24 (dd, J = 9.2, 2.6 Hz, 1H), 7.19 (d, J = 2.7 Hz, 1H), 5.08 (s, 1H), 4.38 (d, J = 
6.1 Hz, 2H), 3.15 (s, 6H), 1.48 (s, 9H). 
13C NMR (126 MHz, CD2Cl2): δ 157.16, 156.27, 152.38, 151.32, 142.84, 141.28, 138.35, 128.10, 
127.95, 127.79, 124.80, 117.75, 117.01, 114.99, 107.22, 79.64, 44.65, 40.60, 28.55. 
HRMS (ESI-TOF): calc’d for C23H27ClN3O2+ [M+H]+ 412.1792; found 412.1778. 
IR (neat): 2976.3, 2928.4, 1698.5, 1614.81, 1584.24, 1569.14, 1505.04, 1452.08, 1426.87, 1389.77, 
1365.22, 1317.72, 1266.45, 1250.17, 1215.65, 1160.86, 851.94, 838.85, 810.51, 733.75 cm-1 
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2-(4-(aminomethyl)phenyl)-4-chloro-N,N-dimethylquinolin-7-amine (4l’): To 20 mL 
scintillation vial, 4l (7.0 mg, 0.017 mmol) was added and stirred in anhydrous dichloromethane 
(0.84 mL) at 0°C for 10 min. Anhydrous AlCl3 (11 mg, 5.0 equiv ) was slowly added and the 
reaction was stirred at room temperature overnight. Dichloromethane in crude reaction was 
removed in vacuo and dissolved in 80:20 MeCN: H2O. After filtering out insoluble residues, the 
crude reaction was purified via Agilent HPLC (10-40% MeCN in H2O over 30 min) and fractions 
eluting at 22.5-23.5% MeCN were lyophilized to give 7.1 mg (99% isolated yield) of the title 
compound in trifluoroacetic acid salt form (product mass calculated as 425.83g/mol). 
 
Physical Property: red solid, m. p. = 275-278 °C 
1H NMR (500 MHz, D2O): δ 8.14 (d, J = 9.6 Hz, 1H), 8.05 – 7.97 (m, 2H), 7.81 – 7.71 (m, 3H), 
7.46 (dd, J = 9.7, 2.5 Hz, 1H), 6.88 (d, J = 2.4 Hz, 1H), 4.37 (s, 2H), 3.20 (s, 6H). 
13C NMR (126 MHz, D2O): δ 155.31, 152.95, 150.76, 143.76, 138.03, 133.39, 131.13, 130.04, 
127.17, 121.16, 120.17, 119.26, 118.84, 116.12, 114.20, 43.85, 40.78.  
HRMS (ESI-TOF): calc’d for C18H19ClN3+  [M+H]+ 312.1268; found 312.1281. 
IR (neat): 2921.36, 2851.33, 1614.73, 1584.28, 1570.3, 1541.65, 1505.22, 1453.78, 1426.19, 
1402.8, 1369.93, 1315.92, 1263.82, 1215.67, 1181.34, 1150.23, 961.52, 838.31, 811.59, 679.8 cm-
1  
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4-chloro-N,N-dimethyl-2-(thiophen-2-yl)quinolin-7-amine (4m): Following the General 
Procedure A with 2-thienylboronic acid (25 mg, 0.20 mmol, 1.1 equiv) purchased from Aldrich) at 
65 °C  for 5 h afforded 44 mg (85 % isolated yield) of the title compound after purification by 
column chromatography (3:4 DCM:Hexanes). Using the standard ISCO purification method, the 
desired product eluted at 18-22% EtOAc.  
 
Physical Property: dark orange solid, orange solid state fluorescence, m. p. = 155-158 °C 
TLC: Rf = 0.57 (20% EtOAc in Hexanes) 
 1H NMR (500 MHz, CD2Cl2): δ 8.09 (s, 1H), 8.02 – 7.98 (m, 1H), 7.83 (dd, J = 5.1, 1.3 Hz, 1H), 
7.57 (d, J = 1.4 Hz, 1H), 7.46 (dd, J = 5.0, 3.0 Hz, 1H), 7.21 (dd, J = 9.2, 1.9 Hz, 2H), 3.14 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 153.25, 152.44, 150.86, 142.99, 142.05, 127.01, 126.76, 125.34, 
124.85, 117.63, 116.79, 115.09, 106.54, and 40.56. 
HRMS (ESI-TOF): calc’d for C15H14ClN2S +  [M+H]+ 289.0566; found 289.0562. 
IR (neat): 3567.18, 3072.69, 2919.65, 2850.28, 1678.59, 1615.14, 1579.27, 1536.71, 1506.27, 
1445.42, 1418.28, 1369.81, 1325.43, 1233.96, 1210.01, 1144.52, 1065.12, 828.42, 808.46, 717.09 
cm-1 
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4-chloro-N,N-dimethyl-2-(thiophen-3-yl)quinolin-7-amine (4n): Following the General 
Procedure A with 3-thienylboronic acid (25 mg, 0.20 mmol, 1.1 equiv, purchased from Aldrich) at 
65 °C for 12 h afforded 50 mg (97 % isolated yield) of the title compound after purification by 
column chromatography (4:6 DCM:Hexane). Using the standard ISCO purification, the desired 
product eluted at 18-22% EtOAc. 
 
Physical Property: orange solid, m. p. = 132-135 °C 
TLC: Rf = 0.47 (20% EtOAc in Hexanes) 
1H NMR (500 MHz, CD2Cl2): δ  7.98 (d, J = 9.2 Hz, 1H), 7.75 (d, J = 4.7 Hz, 1H), 7.59 (s, 1H), 
7.49 (dd, J = 5.0, 1.2 Hz, 1H), 7.20 – 7.16 (m, 2H), 7.14 (d, J = 4.2 Hz, 1H), 3.14 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 152.52, 152.38, 150.70, 144.85, 142.96, 129.10, 128.55, 126.51, 
124.92, 117.66, 116.68, 113.60, 106.21, and 40.56. 
HRMS (ESI-TOF): calc’d for C15H14ClN2S+  [M+H]+ 289.0566; found 289.0573. 
IR (neat): 3048.4, 2924.67, 1626.65, 1570.36, 1545.51, 1517.92, 1498.52, 1473.43, 1446.36, 
1419.71, 1360.77, 1319.02, 1248.87, 1211.84, 1158.15, 876.8, 845.72, 811.21, 730.51, 705.59 cm-
1 
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2.6.5. Fluorescence Spectra Analysis of Monoarylated DMAQs (4a-4n) via Plate Reader. 
Experiments were set up using two types of 96 well plates with black flat bottoms. Organic solvents 
(polarity screening) were screened on Greiner Bio-One 96 well non-treated polypropylene 
microplates, and aqueous solutions (pH screening) were screened on Greiner Bio 96 Well non-
treated polystyrene microplates. A 5 mM DMSO stock solution (4a-4n) and a 5 mM water stock 
solution (4l’) were placed in a separate plate and dosed to each well using a multichannel pipette. 
Polarity and pH screenings were done in two different sets. Regardless of their optimal maximum 
absorption, every compound was excited at 405 nm. Due to possible errors in pipetting and 
evaporation of solvents, the intensity is only treated as an estimate. For polarity screening, DCM 
and DCM+TFA columns were run separately to minimize solvent evaporation. DCM was filtered 
with basic activated alumina and DCM+TFA was made by adding 0.1% TFA v/v to alumina filtered 
DCM. 
 
Application: Tecan i-control  
Device: infinite M1000Pro  
Plate: Greiner 96 Flat Bottom Black Polypropylene or Polystyrene  
Target Temperature: 20 °C        
Shaking (Linear) Duration: 5s     
Shaking (Linear) Amplitude: 2 mm   
Shaking (Linear) Frequency: 654 rpm       
Mode: Fluorescence Top Reading   
Emission Wavelength Start: 420 nm  
Emission Wavelength End: 780 nm  
Emission Wavelength Step Size: 1 nm (pH screening) 2 nm (polarity screening)  
Excitation Wavelength: 405 nm  
Gain: 80% Manual  
Number of Flashes: 50   
Flash Frequency: 400 Hz  
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Maximum emission wavelength of each compound and its relative intensity 
 
 
 
 
 
 
Figure S 2.9 Maximum λem of 4a-4n and 3 in organic solvents of different polarity. (a) platereader 
image under handheld UV lamp (365 nm), (b) maximum emission wavelength (λem ) under 
excitation at 405 nm, and (c) relative intensity.  Darker red represents higher fluorescence intensity 
while darker blue represents lower intensity. Stock solution of 4l’ is in water, fluorescence emission 
measurements in toluene, DCM, and DCM+TFA showed minimal to no fluorescence due to 
immiscibility. Compound 4l’ stayed in the water droplet even after vigorous mixing. Compound 4c 
gave two emission peaks in DCM+TFA (0.1% TFA in DCM), possibly due to mixture of protonated 
and unprotonated compounds. 
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Compound R Toluene (nm) DCM (nm) DCM+TFA (nm) DMF (nm) DMSO (nm) EtOH (nm)
3 Cl 448 465 468 476 478 474
4a Ph-OH 448 456 546 482 486 486
4b Ph-NMe2 442 453 543 480 482 476
4c Ph 452 471 478, 598 496 500 494
4d Ph-F 456 474 567 498 502 496
4e Ph-CF3 480 495 588 528 534 524
4f Ph-CN 494 516 600 564 576 552
4g Ph-2OMe 456 474 558 496 502 498
4h Ph-3OMe 470 537 636 500 508 498
4i Ph-4OMe 452 471 552 484 492 492
4j Ph-2,4FF 472 477 552 508 516 502
4k 9-Anthracene 480 504 546 560 574 510
4l Ph-CH2-NHBoc 454 471 564 498 502 500
4l' Ph-CH2-NH2 458 - 573 510 516 510
4m 2Thienyl 470 480 576 506 514 506
4n 3Thienyl 450 474 555 490 498 496
Compound R Toluene DCM DCM+TFA DMF DMSO EtOH
3 Cl 5938 3724 3723 3014 1602 10043
4a Ph-OH 3711 162 2712 7811 6405 3846
4b Ph-NMe2 14145 446 2252 10914 8509 5296
4c Ph 2509 9 160 6463 4757 5829
4d Ph-F 3193 1283 12 10245 7527 5615
4e Ph-CF3 2905 11 12 7370 5002 5141
4f Ph-CN 1518 12 12 2167 924 1312
4g Ph-2OMe 1478 12 25 8479 5656 3789
4h Ph-3OMe 2215 550 529 3792 4912 4161
4i Ph-4OMe 2928 1384 1413 5080 5219 3408
4j Ph-2,4FF 2580 207 59 5590 5753 6349
4k 9-Anthracene 7002 9 335 857 867 4355
4l Ph-CH2-NHBoc 2321 12 12 4028 5128 3621
4l' Ph-CH2-NH2 18 11 11 2016 2659 2351
4m 2Thienyl 1262 12 12 1439 1363 1209
4n 3Thienyl 1671 12 12 3155 4450 2120
 93 
 
 
 
 
 
 
 
 
Figure S 2.10 Maximum λem of 4a-4n and 3 in aqueous solutions of varying pH (a) platereader 
image under handheld UV lamp (365 nm), (b) maximum emission wavelength (λem ) under 
excitation at 405 nm, and (c) relative intensity.  Darker red represents higher fluorescence intensity 
while darker blue represents lower intensity. Compound 4f has poor solubility in water, and thus 
showed minimal to no fluorescence. However, aggregated solids of 4f were observed to fluoresce 
in the wells. 
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Compound R pH 2 (nm) pH 4 (nm) pH 6.9 (nm) pH 7.3 (nm) pH 10 (nm) pH 11 (nm)
3 Cl 494 490 485 482 482 487
4a Ph-OH 575 573 513 512 502 497
4b Ph-NMe2 609? 563 487 483 486 483
4c Ph 583 511 486 488 484 483
4d Ph-F 590 474 475 471 477 476
4e Ph-CF3 609? 515 510 504 515 507
4f Ph-CN - - - - - -
4g Ph-2OMe 582 576 482 493 474 476
4h Ph-3OMe 588 577 500 503 503 502
4i Ph-4OMe 577 577 494 497 487 486
4j Ph-2,4FF 585 501 498 499 503 503
4k 9-Anthracene 569 503 503 495 499 500
4l Ph-CH2-NHBoc 583 498 486 490 488 488
4l' Ph-CH2-NH2 606 561 542 536 523 519
4m 2Thienyl 599 532 492 492 497 494
4n 3Thienyl 577 563 509 510 503 511
>1000 1000-800 800-600 600-400 499-200 200-100 100-50 50-0Intensity color code:
Compound R pH 2 pH 4 pH 6.9 pH 7.3 pH 10 pH 11
3 Cl 392 1029 1206 1170 1296 1094
4a Ph-OH 817 859 498 416 664 569
4b Ph-NMe2 35 24 847 885 1466 1575
4c Ph 209 391 1403 830 1589 1109
4d Ph-F 348 137 224 215 289 234
4e Ph-CF3 47 358 431 443 780 830
4f Ph-CN 8 8 8 8 10 10
4g Ph-2OMe 512 457 711 441 126 128
4h Ph-3OMe 152 130 271 234 386 546
4i Ph-4OMe 753 606 379 318 613 712
4j Ph-2,4FF 193 87 106 110 137 115
4k 9-Anthracene 166 239 280 276 326 347
4l Ph-CH2-NHBoc 236 149 462 494 694 815
4l' Ph-CH2-NH2 56 155 840 1119 1393 1434
4m 2Thienyl 56 109 136 140 196 210
4n 3Thienyl 409 348 329 328 408 317
(c) Intensity
(b) Emission(a)
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General Procedure B for Sequential Cross-Coupling (Bisarylated DMAQ). 
 
General Procedure B 
Experiments were set up inside a glovebox under a nitrogen atmosphere. Solvents were obtained 
from the solvent system, degassed and kept in the glove box. A stock solution of 2,4-dichloro-N,N-
dimethylquinolin-7-amine (3) was prepared by dissolving 200 mg (0.83 mmol) in 1.0 mL of 
dioxane in the glovebox. To a 4 mL scintillation vial, 100 µL (20 mg, 0.083 mmol, 1 equiv) of 
compound 3 from the stock solution was added. PdCl2(PPh3) (2.9 mg, 0.004 mmol, 0.05 equiv), 
and the first boronic acid (0.087 mmol, 1.05 equiv) were added and dissolved in total 663.6 µL of 
dioxane.  K2CO3 (34.4 mg, 0.249 mmol, 3.0 equiv) dissolved in 165.9 mL H2O was added to the 
vial, which was capped in the glovebox. Under nitrogen, the mixture was stirred for 24 hr at 65˚C 
under nitrogen gas. Upon completion of the first coupling, the reaction vial was cooled down to rt 
and second boronic acid (0.249 mmol, 3.0 equiv) was added. The mixture was stirred for 24 hr at 
85˚C. Upon completion, 30 mL of EtOAc and water were added to the reaction mixture. The 
organic layer was extracted from the solution, dried with anhydrous Na2SO4, concentrated in vacuo. 
Purity was checked by JASCO analytical HPLC (30-100% MeCN over 20min) 
 
Crude UP-LCMS (Figure S11-13):  The desired product is colored based on the retention time of 
previously synthesized standard and expected m/z. Background solvent (light grey) elutes at 0.1 
min and the internal standard (biphenyl, dark grey) elutes at 1.95 min. Standard compounds were 
confirmed by column purification and NMR analysis.  
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Figure S 2.11 Crude UP-LCMS of bisarylated DMAQ with 4b core (5a-5c)  
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Figure S 2.12 Crude UP-LCMS of bisarylated DMAQ with 4c core (5d-5f)  
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Figure S 2.13 Crude UP-LCMS of bisarylated DMAQ with 4f core (5g-5i)  
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4,4'-(7-(dimethylamino)quinoline-2,4-diyl)bis(N,N-dimethylaniline) (5a): Following the 
General Procedure B with 4-(dimethylamino)phenylboronic acid (14 mg, 0.087 mmol, 1.05 equiv) 
as the first boronic acid and 4-(dimethylamino)phenylboronic acid (41mg, 0.25 mmol, 3.0 equiv) 
as the second boronic acid afforded 28 mg (83 % isolated yield) of the title compound after 
purification by column chromatography (1:1 hexanes : EtOAc).  
 
Physical Property: orange solid, m. p. = 200-205 °C 
TLC: Rf = 0.31 (100% EtOAc) 
1H NMR (500 MHz, CD2Cl2): δ  8.20 – 8.13 (m, 2H), 7.84 (d, J = 9.3 Hz, 1H), 7.48 (dd, J = 6.5, 
2.3 Hz, 4H), 7.07 (dd, J = 9.3, 2.7 Hz, 1H), 6.89 – 6.81 (m, 4H), 3.14 (s, 6H), 3.05 (d, J = 0.9 Hz, 
12H). 
13C NMR (126 MHz, CD2Cl2): δ 156.16, 151.87, 151.80, 151.07, 149.89, 130.79, 128.83, 126.99, 
126.56, 118.07, 112.42, 112.29, 106.38, 40.68, 40.61, 40.47. 
HRMS (ESI-TOF): calc’d for C27H31N4+  [M+H]+ 411.2549; found 411.2571. 
IR (neat): 2920.72, 1678.57, 1602.84, 1522.05, 1360.53, 1257.37, 1204.93, 818.68 cm-1  
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2-(4-(dimethylamino)phenyl)-N,N-dimethyl-4-phenylquinolin-7-amine (5b): Following the 
General Procedure B with 4-(dimethylamino)phenylboronic acid (14 mg, 0.087 mmol, 1.05 equiv) 
as the first boronic acid and phenylboronic acid (30 mg, 0.25 mmol, 3.0 equiv) as the second 
boronic acid afforded 26 mg (86 % isolated yield) of the title compound after purification by 
Agilent Prep HPLC chromatography (40-50% over 40min). The desired product was eluted at 42.5-
43% MeCN. The product was also crystallized in DCM. 
 
Physical Property: red solid, yellowish green crystal, m.p. = 238-240 °C 
TLC: Rf = 0.20 (25% EtOAc in Hexanes). 
1H NMR (500 MHz, CD2Cl2): δ 8.17 – 8.07 (m, 2H), 7.69 (d, J = 9.2 Hz, 1H), 7.62 – 7.47 (m, 6H), 
7.25 (d, J = 2.7 Hz, 1H), 7.07 (dd, J = 9.3, 2.7 Hz, 1H), 6.86 – 6.80 (m, 2H), 3.13 (s, 6H), 3.05 (s, 
6H). 
13C NMR (126 MHz, CD2Cl2): δ (126 MHz, CD2Cl2) δ 157.97, 152.76, 152.70, 151.97, 149.60, 
140.67, 130.90, 129.80, 129.52, 129.40, 128.75, 127.48, 118.94, 116.46, 115.98, 113.39, 113.32, 
108.65, 41.72, 41.52. 
HRMS (ESI-TOF): calc’d for C25H26N3+  [M+H]+ 368.2127; found 368.2127. 
IR (neat): 3567.17, 3044.89, 1603.34, 1443.43, 1352.85, 1208.48, 1145.41, 1047.57, 892.22, 
795.01/3332.75, 2924.88, 2854.42, 1666.52, 1602.14, 1516.83, 1446.5, 1340.35, 1262.22, 1164.64, 
1118.37, 974.01, 876.97, 843.02, 796.96, 767.55, 736.66, 702.97, 598.69 cm-1  
NN
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4-(7-(dimethylamino)-2-(4-(dimethylamino)phenyl)quinolin-4-yl)benzonitrile (5c):  
Following the General Procedure B with 4-(dimethylamino)phenylboronic acid (14 mg, 0.087 
mmol, 1.05 equiv) as the first boronic acid and 4-cyanophenylboronic acid (37 mg, 0.25 mmol, 3.0 
equiv) as the second boronic acid afforded 27 mg (84 % isolated yield) of the title compound after 
purification by ISCO (method: 10-70% EtOAc in Hexane over 10 min). The desired compound 
was eluted at 45-50% EtOAc.   
 
Physical Property: reddish orange solid, m. p. = 200-205 °C 
TLC: Rf = 0.18 (33% EtOAc in Hexanes). 
1H NMR (500 MHz, CD2Cl2): δ  8.14 – 8.09 (m, 2H), 7.86 – 7.80 (m, 2H), 7.69 – 7.65 (m, 2H), 
7.55 (d, J = 9.3 Hz, 1H), 7.47 (s, 1H), 7.25 (d, J = 2.7 Hz, 1H), 7.07 (dd, J = 9.3, 2.7 Hz, 1H), 6.87 
– 6.80 (m, 2H), 3.13 (s, 6H), 3.05 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 157.01, 151.80, 151.75, 151.05, 146.48, 144.40, 132.63, 130.66, 
128.49, 127.42, 125.73, 119.11, 117.06, 115.75, 114.65, 112.34, 112.24, 107.69, 40.63, 40.47. 
HRMS (ESI-TOF): calc’d for C26H25N4+  [M+H]+ 393.2079; found 393.2087. 
IR (neat): 2920.17, 2228.26, 1628.8, 1,599.93 1580.21, 1526.07, 1504.84, 1444.96, 1421.97, 
1359.46, 1329.81, 1257.19, 1204.82, 1173.36, 1134.11, 980.97, 945.84, 841.47, 818.86, 730.29 
cm-1 
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4-(4-(dimethylamino)phenyl)-N,N-dimethyl-2-phenylquinolin-7-amine (5d): Following the 
General Procedure B with phenylboronic acid (11 mg, 0.087 mmol, 1.05 equiv) as the first boronic 
acid and 4-(dimethylamino)phenylboronic acid (41 mg, 0.25 mmol, 3.0 equiv) as the second 
boronic acid afforded 16 mg (51 % isolated yield) of the title compound after precipitation with 
50% MeCN/50% Water. Further purification was done by HPLC (30-65% over 20 min, retention 
time 9.5-10.5)  
 
Physical Property: dark brown solid, m. p. = 197-199 °C 
TLC: Rf = 0.37 (33% EtOAc in Hexanes). 
 1H NMR (500 MHz, CD2Cl2): δ 8.26 – 8.22 (m, 2H), 7.93 (d, J = 9.3 Hz, 1H), 7.58 – 7.48 (m, 
7H), 7.16 (dd, J = 9.4, 2.4 Hz, 1H), 6.90 – 6.87 (m, 2H), 3.18 (s, 6H), 3.07 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 152.35, 151.45, 131.01, 130.88, 130.35, 129.79, 129.13, 129.08, 
128.45, 127.61, 127.49, 118.64, 117.03, 116.54, 115.28, 112.40, 107.21, 40.61, 40.54. 
HRMS (ESI-TOF): calc’d for C25H26N3+  [M+H]+ 368.2127; found 368.2120. 
IR (neat): 2922.65, 2853.01, 1671.69, 1632.84, 1602.85, 1589.09, 1573.61, 1531.7, 1500.16, 
1466.74, 1444.73, 1424.23, 1363.64, 1329.25, 1317.42, 1256.17, 1197.64, 1181.8, 1130.46, 823.24 
cm-1 
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N,N-dimethyl-2,4-diphenylquinolin-7-amine (5e): Following the General Procedure B with 
phenylboronic acid (11 mg, 0.087 mmol, 1.05 equiv) as the first boronic acid and phenylboronic 
acid (30 mg, 0.25 mmol, 3.0 equiv) as the second boronic acid afforded 21 mg (78 % isolated yield) 
of the title compound after purification by precipitation with DCM:Hex (1:1). Under ISCO standard 
purification method, the desired product was eluted at 38-42% EtOAc.  
 
Physical Property: yellow solid (red film), m. p. = 144-147 °C 
TLC: Rf = 0.47 (33% EtOAc in Hexanes). 
 1H NMR (500 MHz, CD2Cl2): δ 8.29 – 8.24 (m, 2H), 7.80 (d, J = 9.5 Hz, 1H), 7.59 (q, J = 4.4 Hz, 
9H), 7.51 (s, 1H), 7.20 (dd, J = 9.5, 2.7 Hz, 1H), 3.21 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 157.08, 154.18, 152.44, 143.05, 136.60, 132.50, 131.88, 130.49, 
129.71, 129.66, 129.43, 129.14, 128.40, 119.11, 118.36, 115.72, 97.46, 40.48. 
HRMS (ESI-TOF): calc’d for C23H21N2+  [M+H]+ 325.1705; found 325.1705. 
IR (neat): 3054.14, 2925.52, 2854.05, 1743.65, 1628.27, 1588.09, 1573.9, 1534.03,1499.32, 
1446.5,1423.95, 1359.79, 1329.14, 1244.87, 1215.26, 1030.41, 895.9, 775.83, 761.7, 701.18 cm-1 
 
 
  
NN
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4-(7-(dimethylamino)-2-phenylquinolin-4-yl)benzonitrile (5f): Following the General 
Procedure B with phenylboronic acid (11 mg, 0.087 mmol, 1.05 equiv) as the first boronic acid and 
4-cyanophenylboronic acid (36 mg, 0.25 mmol, 3.0 equiv) as the second boronic acid afforded 17 
mg (58 % isolated yield) of the title compound after purification by standard ISCO purification 
method. The desired product was eluted at 45-50% EtOAc.  
 
Physical Property: yellow solid (red film), m. p. = 205-208 °C 
TLC: Rf = 0.42 (33% EtOAc in Hexanes). 
1H NMR (500 MHz, CD2Cl2): 8.24 – 8.16 (m, 2H), 7.90 – 7.80 (m, 2H), 7.72 – 7.67 (m, 2H), 7.61 
(d, J = 9.3 Hz, 1H), 7.57 – 7.51 (m, 3H), 7.48 (dd, J = 6.9, 1.7 Hz, 1H), 7.30 (d, J = 2.7 Hz, 1H), 
7.15 (dd, J = 9.3, 2.7 Hz, 1H), 3.15 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 157.03, 151.84, 151.09, 146.95, 144.10, 140.16, 132.70, 130.68, 
129.57, 129.07, 127.65, 125.81, 119.05, 117.60, 116.76, 115.38, 112.44, 107.82, 40.61. 
HRMS (ESI-TOF): calc’d for C24H20N3+  [M+H]+ 350.1657; found 350.1667. 
IR (neat): 3045.38, 2228.74, 1683.25, 1593.2, 1548.22, 1493.28, 1468.76, 1420.65, 1356.93, 
1235.41, 1146.19, ,1086.22, 1022.01, 844.7, 775.01, 731.97, 696.11, 610.89, 548.57 cm-1   
  
NN
CN
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4-(7-(dimethylamino)-4-(4-(dimethylamino)phenyl)quinolin-2-yl)benzonitrile (5g): Following 
the General Procedure B with 4-cyanophenylboronic acid (13 mg, 0.087 mmol, 1.05 equiv) as the 
first boronic acid and 4-(dimethyamino)phenylboronic acid (41 mg, 0.25 mmol, 3.0 equiv) as the 
second boronic acid afforded 24 mg (75 % isolated yield) of the title compound after purification 
by standard ISCO method. The desired product was eluted at 70-75% EtOAc.  
 
Physical Property: yellow solid, m. p. = 275-278 °C 
TLC: Rf = 0.34 (33% EtOAc in Hexanes) 
1H NMR (500 MHz, CD2Cl2): δ 8.34 (d, J = 8.1 Hz, 2H), 7.94 (d, J = 9.4 Hz, 1H), 7.82 (d, J = 8.1 
Hz, 2H), 7.60 – 7.53 (m, 1H), 7.51 – 7.45 (m, 3H), 7.19 (dd, J = 9.4, 2.6 Hz, 1H), 6.91 – 6.86 (m, 
2H), 3.17 (s, 6H), 3.07 (s, 6H). 
13C  NMR (126 MHz, CD2Cl2): δ 153.18, 152.36, 151.44, 142.35, 132.86, 132.76, 131.00, 128.76, 
128.18, 127.48, 125.35, 119.07, 119.01, 117.12, 115.18, 113.34, 112.41, 104.81, 40.58, 40.53. 
HRMS (ESI-TOF): calc’d for C26H25N4+ [M+H]+ 393.2079; found 393.2087. 
IR (neat): 2891.42, 2804.81, 2225.66, 1614.77, 1576.67, 1523.98, 1501.52, 1483.96, 1429, 
1401.21, 1355.78, 1316.05, 1208.72, 1185.7, 1164.73, 1125.68, 1063.75, 843.62, 820.02, 547.91 
cm-1  
  
NN
N
N
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4-(7-(dimethylamino)-4-phenylquinolin-2-yl)benzonitrile (5h): Following the General 
Procedure B with 4-cyanophenylboronic acid (13 mg, 0.087 mmol, 1.05 equiv) as the first boronic 
acid and phenylboronic acid (30 mg, 0.25 mmol, 3.0 equiv) as the second boronic acid afforded 21 
mg (72 % isolated yield) of the title ncompound after purification by ISCO (method: 0-40% EtOAc 
in Hexane over 8 min). The desired product was eluted at 28-32% EtOAc.  
 
Physical Property: red solid, m. p. = 195-198 °C 
TLC: Rf = 0.49 (33% EtOAc in Hexanes) 
 1H NMR (500 MHz, CD2Cl2): δ 8.34 – 8.29 (m, 2H), 7.81 – 7.77 (m, 2H), 7.76 (d, J = 9.2 Hz, 
1H), 7.58 – 7.51 (m, 6H), 7.27 (d, J = 2.6 Hz, 1H), 7.16 (dd, J = 9.3, 2.7 Hz, 1H), 3.14 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 154.73, 151.82, 151.13, 149.40, 144.54, 139.03, 133.20, 132.80, 
129.86, 128.92, 128.71, 128.26, 128.14, 126.60, 119.29, 118.74, 117.10, 115.44, 112.67, 107.58, 
40.57. 
HRMS (ESI-TOF): calc’d for C24H20N3+  [M+H]+ 350.1657; found 350.1678. 
IR (neat): 2226.87, 1628.15, 1617.51, 1584.21, 1534.42, 1493.73, 1445.59, 1426.44,1373.45, 
1358.71, 1326.36, 1214.53, 1190.88, 1135.94, 842.1, 820.51, 780.99, 765.21, 703.94, 547.99 cm-1 
 
  
NN
N
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4,4'-(7-(dimethylamino)quinoline-2,4-diyl)dibenzonitrile (5i): Following the General Procedure 
B with 4-cyanophenylboronic acid (13 mg, 0.087 mmol, 1.05 equiv) as first boronic acid and 4-
cyanophenylboronic acid (37 mg, 0.25 mmol, 3.0 equiv) as second boronic acid afforded 27 mg 
(88 % isolated yield) of the title compound after purification by standard ISCO method. The desired 
product was eluted at 50-55% EtOAc. 
 
Physical Property: red solid, m. p. = 196-200 °C 
TLC: Rf = 0.36 (33% EtOAc in Hexanes) 
1H NMR (500 MHz, CD2Cl2): δ 8.34 – 8.29 (m, 2H), 7.88 – 7.80 (m, 4H), 7.71 – 7.66 (m, 2H), 
7.63 (d, J = 9.3 Hz, 1H), 7.52 (d, J = 1.3 Hz, 1H), 7.28 (d, J = 2.7 Hz, 1H), 7.20 (dd, J = 9.3, 2.7 
Hz, 1H), 3.16 (s, 6H). 
13C NMR (126 MHz, CD2Cl2): δ 154.89, 152.01, 151.12, 147.45, 144.25, 143.74, 132.91, 132.79, 
130.66, 128.19, 125.93, 119.21, 118.97, 117.99, 117.53, 115.15, 112.96, 112.67, 107.55, 40.56. 
HRMS (ESI-TOF): calc’d for C25H19N4+  [M+H]+ 375.1610; found 365.1600. 
IR (neat): 3053.54, 2926.57, 2228.44, 1683.66, 1628.68, 1585.25, 1497.08, 1426.14, 1358.37, 
1324.86, 1215.78, 1136.43, 1081.22, 1018.99, 896.81, 839.76, 733.07, 699.47, 583.57, 557.15 cm-
1  
  
NN
N
CN
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2.6.6. Fluorescence Spectra Analysis of bisarylated DMAQs (5a-5i) via Plate reader  
General Procedure C 
 
Device: infinite M1000Pro / Tecan i-control    
Emission Wavelength: 420 nm-800 nm / Excitation Wavelength: 405 nm  
Maximum emission wavelength of 5a-5i and their relative intensity 
  
 
 
Figure S 2.14 5mM stock solution in DMSO was used to screen have final 50uM of dyes in each 
well (1% DMSO in aqueous buffer). Compound is labeled with corresponding number as well as 
R1 and R2, which are the substituent in 2-position and 4-position of aryl rings, respectively. A) 
Image of plate reader under handheld UV lamp (254 nm), B) maximum emission wavelength ( λem ) 
under excitation at 405 nm, and C) relative intensity. Darker red represents higher fluorescence 
intensity while darker blue represents lower intensity. 
5i
5h
5g
5f
5e
5d
5c
5b
5a
Polarity
pH
pH2  pH4   pH7  pH7  pH10  pH11
Et
O
H
D
M
SOA)
NN
R1
R2
R1-R2 pH 2 (nm) pH 4 (nm) pH 6.9 (nm) pH 7.3 (nm) pH 10 (nm) pH 11 (nm) EtOH (nm) DMSO (nm)
5a NMe2-NMe2 618 637 469 473 472 475 480 490
5b NMe2-H 610 603 472 475 478 479 488 503
5c NMe2-CN 633 703 525 526 531 527 563 597
5d H-NMe2 602 598 476 476 483 479 500 507
5e H-H 591 594 523 525 525 531 505 510
5f H-CN 613 530 527 524 525 526 545 565
5g CN-NMe2 533 536 534 536 539 526 544 486
5h CN-H 631 531 526 526 529 527 555 568
5i CN-CN 470 547 550 550 553 554 571 588
R1-R2 pH 2 (nm) pH 4 (nm) pH 6.9 (nm) pH 7.3 (nm) pH 10 (nm) pH 11 (nm) EtOH (nm) DMSO (nm)
5a NMe2-NMe2 256 323 2910 2667 3181 5205 21059 63820
5b NMe2-H 164 73 1465 1173 2727 3980 12216 19949
5c NMe2-CN 106 77 1768 1990 4004 4351 2016 1125
5d H-NMe2 676 150 1273 1318 1896 3110 2866 12568
5e H-H 2765 1889 11661 11813 25923 30805 30017 39902
5f H-CN 733 1165 9919 10888 15094 16656 8527 7072
5g CN-NMe2 111 354 980 1135 1749 2027 1457 3683
5h CN-H 104 5597 6592 8113 7863 9546 8200 8724
5i CN-CN 91 309 591 733 795 793 2896 3506
Emission
Intensity
B)
C)
>50000 50000-30000 30000-10000 10000-5000 5000-2500 2500-1000 1000-500 500-100 100-0
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Table S 2.5 UV Absorption Spectra Analysis of DMAQs 4a-4n, 5a-5i 
 
 
4l’ in water with residual trifluoroacetic acid from HPLC gave red-shifted absorption 302nm and 
470 nm.  
 
 
  UV Abs in Methanol (nm) 
3 302,390 
4a 296,390 
4b 306,400,494 
4c 290,398 
4d 290,398 
4e 290,406 
4f 298,412 
4g 298,394 
4h 298,398 
4i 298,398 
4j 290,398 
4k 288,346,364,384,462 
4l 298,398 
4l' 296,394 
4m 300,402 
4n 294,396 
5a 274,478 
5b 292,490 
5c 292,408,498 
5d 450 
5e 290,400 
5f 290,406 
5g 296,376 
5h 298,412 
5i 296,416 
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2.6.7. Live HeLa Cell Imaging of Monoarylated DMAQ (4a-4n) 
Cell imaging was done with final concentration of 5uM of dye in 0.1% DMSO in media. Each 
plate was incubated for 2-5 hrs. Excited with 405 nm laser with various emission filter set.  
 
 
 
Figure S 2.15 Live Cell imaging of monoarylated DMAQ 4a-4n 
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Selected Dual-Emissive dyes  
 
 
Figure S 2.16 pH sensitive dye 4b was irradiated with a 405 nm excitation laser A) fluorescence 
emission spectra from plate reader (Figure 3), B) bright field image, C) emission filter at 450-500 
nm, D) emission filter at 550-600 nm, and E) merged image. 
 
 
Figure S 2.17 Solvatochromic dye 4k was irradiated with a 405 nm excitation laser. A) 
fluorescence emission spectra from plate reader (Figure 3), B) bright field image, C) emission filter 
at 450-500 nm, D) emission filter at 550-600 nm, and E) merged image. 
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2.6.8. Live HeLa Cell Imaging of Bisarylated DMAQ (5a-5i) 
Top spectra are extracted from the plate reader (excitation at 405 nm). Cell imaging was done 
with a 405 nm laser. Each emission filter set is highlighted in the spectra above. 
 
 
 
Figure S 2.18 pH dependent intensity sensitive dyes 5c, 5h, 5g, and 5i 
 
 
Figure S 2.19 pH dependent dual emissive dyes 5a, 5d, 5e, 5f, and 5b 
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2.6.9. Cell Cytotoxicity 
Experiments followed the alamarBlue® Cell Viability Assay Protocol. Compounds were measured 
in quadruplicate. Positive controls were made with 0 to 1% DMSO, and negative controls were 
made by treating with hydrogen peroxide. Cells were incubated for 64 h in 0.1% DMSO in two 
different final concentration. The plate reader was used.   
Reading: excitation at 570 nm, emission at 600 nm, Top reading, 37 ˚C. 
Table S 2.6 Cell cytotoxicity of selected compounds in two different concentration 
 
 
 
 
2.6.10. Solid State Emission  
 
 
Figure S 2.20 Amorphous and Crystal Solid State of DMAQ Under Handheld UV Lamp (365 
nm) 
Compounds 5µM (%) 1µM (%) 
4a 83 86 
4b 81 84 
4k 92 93 
5a 88 112 
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2.6.11. Computational Studies  
 
Methods. All calculations were performed using the Gaussian 09S4 / WebMO program (B3LYP/6-
31G*). Geometry optimizations and energies were calculated for a series of monoaryl-DMAQ (4b, 
4a, 4i, 4c, 4d, 4e, 4f) and selected bisaryl-DMAQ (5a, 5b, 5c, 5g, 5h, 5i) compounds using density 
functional theory (DFT). The HOMO-LUMO energy gaps between the ground state (S0) and the 
first excited state (S1) of the DMAQs were calculated and are shown below. All structures are 
ground-state minima according to the analysis of their vibrational frequencies, which showed no 
negative value. 
Table S 2.7 Calculation of the Energy Gaps of Monoaryl DMAQ Based on Optimized Ground-
State Geometries. 
 
 
Table S 2.8 Calculation of the Energy Gaps of Bisaryl DMAQ Based on Optimized Ground-State 
Geometries. 
 
 
 
Compound 
Hammett 
Constant 
(σp) 
Absorbance 
Wavelength 
(nm)c 
Electronic Transition HOMO (eV) 
LUMO 
(eV) 
LUMO-
HOMO 
Δ(eV) 
5a -0.83 478 LUMO - HOMO -11.716 -9.88 1.836 
5b 0 490 LUMO - HOMO -11.717 -9.894 1.823 
5c 0.66 498 LUMO - HOMO -11.709 -9.968 1.741 
5g -0.83 376 LUMO - HOMO (ΔE1) -11.748 -10.082 1.666 
5g -0.83 376 LUMO - HOMO-1 (ΔE2) -11.823 -10.082 1.741 
5g -0.83 376 LUMO+1 - HOMO (ΔE3) -11.748 -9.457 2.291 
5g* -0.83 376 LUMO+1 - HOMO-1 (ΔE4) -11.823 -9.457 2.366 
5h 0 412 LUMO - HOMO -11.819 -10.097 1.722 
5i 0.66 416 LUMO - HOMO -11.802 -10.116 1.686 
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Computational Analysis of Monoaryl DMAQ (Table S15). 
 
 
Figure S 2.21 Correlation between HOMO-LUMO energy gap (eV) compared to experimentally 
measured UV absorption maximum (nm).  aMaximum UV absorption wavelengths above 300 nm 
were obtained in methanol (Table S5). bUV absorbance value for 4b was chosen as 400 nm since 
494 nm was a minor peak, which can be due to protonation of the compound (R2 =0.71). 
 
 
 
Figure S 2.22 Relative HOMO-LUMO energy gap (eV) of selected monoaryl DMAQ 
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Figure S 2.23 Schematic representation of contour surface of HOMO & LUMO of representative 
monoaryl DMAQ compounds. 
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2.6.12. Computational Analysis of Bisaryl DMAQ (Table S16). 
 
 
 
Figure S 2.24 Correlation between HOMO-LUMO energy gaps and experimentally measured 
UV absorption maximum in methanol (Table S5). Most red-shifted UV absorption wavelengths 
were chosen for analysis. Effects of C-4 substituents on HOMO-LUMO gap were investigated by 
grouping bisaryl DMAQs into A) correlation among derivatives of 4b and B) correlation among 
derivatives of 4f. Among four possible electronic transitions for 5g, the largest and smallest values 
are shown as 5g and 5g* in Table S16.  
 
 
 
Figure S 2.25 Possible MO energy gaps of 5g. 
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Figure S 2.26 Schematic Representation of HOMO & LUMO of Representative bisaryl DMAQ 
Compounds. 
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2.6.14. Discussion of Computational Modeling.  
The correlation between the photophysical properties of DMAQ derivatives and the 
electronic characteristics of the substituents were quantitatively analyzed to demonstrate the 
rational design of the DMAQ scaffold. It is generally accepted that the absorption wavelength (λabs) 
correlates well with the energy gap between the HOMO and LUMO determined using simple 
electronic structure calculations, but that determining the emission wavelength requires more 
complex methods due to the nature of the fluorescence process (e.g., Stokes shifts).S5-S7 With regard 
to the emission wavelength (λem) of DMAQ, we clearly demonstrated a positive linear correlation 
between λem and the Hammett constant in Figure 2 in the main text. Relative energy levels of 
HOMO and LUMO were calculated using DFT calculations (B3LYP/6-31+G*). Model compounds 
were chosen based on various functional groups at the para-position in the C-2 aryl substituent of 
DMAQ derivatives. Generally, a decrease in HOMO-LUMO gap was observed with more electron 
withdrawing substituents, which matched well with red-shifts of the UV-absorbance (Table S2.7 / 
Figure S 2.21 for monoaryl, Table S16/Figure S34 for bisaryl DMAQ). Interestingly, 4b had a 
higher HOMO-LUMO gap than derivatives with more electron withdrawing substituents (4a,4c,4d, 
and 4i). This outlier behavior can be explained by examination of the HOMO of 4b as the electrons 
are donated by the dimethylamino group on the C-2 phenyl ring rather than the C-7 dimethylamino 
group (Figure S 2.22 and S 2.23). Moreover, 4b has the HOMO energy level at -11.7 eV while rest 
have around -11.8 eV. In general, the HOMO level stays constant and the LUMO level decreases 
from -9.8 eV to -10.0 eV, lowering the HOMO-LUMO energy gap with more electron withdrawing 
substitution at C-2 aryl. Figure S36 shows a schematic representation of the HOMOs and LUMOs 
of selected bisaryl DMAQs. While most of the electron transitions in DMAQs occur through the 
core monoaryl moiety, 5g exhibited a different electronic transition. Hence, the LUMO+1 and 
HOMO-1 energy levels of 5g were also considered (Figure S 2.25). With this, correlations between 
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the HOMO-LUMO energy gap and the UV absorption of two extreme cases (5g, 5g*) were shown 
(Figure S 2.25). 
S4.   Gaussian 09, Revision D.01, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria,   
M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci,   G. A. Petersson, 
H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. 
L. Sonnenberg, M. Hada,   M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. 
Nakajima,  Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr.,  J. E. Peralta, 
F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, T. Keith, 
R. Kobayashi, J. Normand,  K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. 
Tomasi,  M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross,  V. Bakken, 
C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann,  O. Yazyev, A. J. Austin, R. 
Cammi, C. Pomelli, J. W. Ochterski,  R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. 
A. Voth,  P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels,  O. Farkas, J. B. 
Foresman, J. V. Ortiz, J. Cioslowski,  and D. J. Fox, Gaussian, Inc., Wallingford CT, 2013.  
 
S5.    Patalinghug, W. C.; Chang, M.; Solis, J. J. Chem. Educ. 2007, 84, 1945–1947. 
S6.     (a)Zollinger,H. Color Chemistry; VCH:Weinheim,Germany, 1991; (b) Bauernschmitt, R.; 
Ahlrichs, R.; Hennrich, F. H.; Kappes, M. M. J. Am. Chem. Soc. 1998, 120, 5052–5059.  
S7.       Kim, E.; Koh, M.; Lim, B.J.; Park, S.B.  J. Am. Chem. Soc. 2011, 133, 6642–6649.  
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2.7    Spectra and Supplemental Information 
2.7.1. X-ray Structure Data 
 
Figure S 2.27 ORTEP drawing of the title compound 4b with 50% thermal ellipsoids 
 
Table S 2.9 Summary of Structure Determination of Compound 4b 
 
  
 
 
NN
Cl
N
Empirical formula  C38H40Cl2N6  
Formula weight  651.66  
Temperature/K  100  
Crystal system  triclinic  
Space group  P1
_
  
a  7.2999(3)Å  
b  11.4015(4)Å  
c  19.5644(9)Å  
α  102.4030(10)°  
β  92.022(2)°  
γ  90.205(2)°  
Volume  1589.24(11)Å3  
Z  2  
dcalc  1.362 g/cm3  
μ  0.244 mm-1  
F(000)  688.0  
Crystal size, mm  0.48 × 0.35 × 0.02  
2θ range for data collection      5.904 - 55.13°  
Index ranges  -9 ≤ h ≤ 9, -14 ≤ k ≤ 13, -25 ≤ l ≤ 25  
Reflections collected  66713  
Independent reflections  7344[R(int) = 0.0335]  
Data/restraints/parameters  7344/0/423  
Goodness-of-fit on F2  1.036  
Final R indexes [I>=2σ (I)]  R1 = 0.0327, wR2 = 0.0841  
Final R indexes [all data]  R1 = 0.0384, wR2 = 0.0881  
Largest diff. peak/hole  0.34/-0.33 eÅ-3  
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Figure S 2.28 ORTEP drawing of the title compound 4c with 50% thermal ellipsoids. 
 
Table S 2.10 Summary of Structure Determination of Compound 4c 
 
 
 
 
  
NN
Cl
Cl1
N1N2
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
Cl1
N1' N2'
C1'
C2'
C3'
C4'
C5'
C6'
C7'
C8'
C9'
C10'
C11'
C12'
C13'
C14'
C15'
C16'
C17'
Empirical formula  C17H15N2Cl  
Formula weight  282.76  
Temperature/K  100  
Crystal system  monoclinic  
Space group  P21/c  
a  14.8016(6)Å  
b  3.8248(2)Å  
c  24.8987(10)Å  
β  106.0000(10)°  
Volume  1354.99(11)Å3  
Z  4  
dcalc  1.386 g/cm3  
μ  0.272 mm-1  
F(000)  592.0  
Crystal size, mm  0.45 × 0.12 × 0.02  
2θ range for data collection      5.8 - 50.76°  
Index ranges  -17 ≤ h ≤ 17, -4 ≤ k ≤ 4, -30 ≤ l ≤ 25  
Reflections collected  34694  
Independent reflections  2485[R(int) = 0.0389]  
Data/restraints/parameters  2485/336/285  
Goodness-of-fit on F2  1.117  
Final R indexes [I>=2σ (I)]  R1 = 0.0385, wR2 = 0.0982  
Final R indexes [all data]  R1 = 0.0446, wR2 = 0.1107  
Largest diff. peak/hole  0.29/-0.48 eÅ-3  
 
 122 
 
 
Figure S 2.29 ORTEP drawing of the title compound 4j with 50% thermal ellipsoids. 
Table S 2.11 Summary of Structure Determination of Compound 4j 
 
 
 
 
 
 
  
Empirical formula  C17H13ClF2N2  
Formula weight  318.74  
Temperature/K  100  
Crystal system  monoclinic  
Space group  P21/n  
a  16.2916(14)Å  
b  3.7822(3)Å  
c  22.808(2)Å  
β  96.651(3)°  
Volume  1395.9(2)Å3  
Z  4  
dcalc  1.517 g/cm3  
μ  0.293 mm-1  
F(000)  656.0  
Crystal size, mm  0.29 × 0.05 × 0.05  
2θ range for data collection      2.918 - 50.812°  
Index ranges  -19 ≤ h ≤ 19, -3 ≤ k ≤ 4, -27 ≤ l ≤ 27  
Reflections collected  8584  
Independent reflections  2539[R(int) = 0.0410]  
Data/restraints/parameters  2539/0/201  
Goodness-of-fit on F2  1.109  
Final R indexes [I>=2σ (I)]  R1 = 0.0435, wR2 = 0.1266  
Final R indexes [all data]  R1 = 0.0636, wR2 = 0.1432  
Largest diff. peak/hole  0.33/-0.29 eÅ-3  
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Figure S 2.30 ORTEP drawing of the title compound 4k with 50% thermal ellipsoids. 
 
Table S 2.12 Summary of Structure Determination of Compound 4k 
 
 
Empirical formula  C25H19ClN2  
Formula weight  382.87  
Temperature/K  100  
Crystal system  monoclinic  
Space group  P21/c  
a  15.3538(4)Å  
b  7.8662(2)Å  
c  15.3729(4)Å  
β  98.639(2)°  
Volume  1835.61(8)Å3  
Z  4  
dcalc  1.385 g/cm3  
μ  0.222 mm-1  
F(000)  800.0  
Crystal size, mm  0.38 × 0.25 × 0.15  
2θ range for data collection      5.36 - 50.892°  
Index ranges  -17 ≤ h ≤ 18, -9 ≤ k ≤ 9, -18 ≤ l ≤ 18  
Reflections collected  17086  
Independent reflections  3384[R(int) = 0.0241]  
Data/restraints/parameters  3384/0/255  
Goodness-of-fit on F2  1.036  
Final R indexes [I>=2σ (I)]  R1 = 0.0339, wR2 = 0.0891  
Final R indexes [all data]  R1 = 0.0390, wR2 = 0.0933  
Largest diff. peak/hole  0.29/-0.23 eÅ-3  
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Figure S 2.31 ORTEP drawing of the title compound 5b with 50% thermal ellipsoids. 
 
Table S 2.13 Summary of Structure Determination of Compound 5b. 
 
 
 
 
 
Empirical formula  C25H25N3  
Formula weight  367.48  
Temperature/K  173  
Crystal system  monoclinic  
Space group  P21/c  
a  15.9363(7)Å  
b  10.7056(5)Å  
c  12.5061(6)Å  
β  112.986(2)°  
Volume  1964.23(16)Å3  
Z  4  
dcalc  1.243 g/cm3  
μ  0.074 mm-1  
F(000)  784.0  
Crystal size, mm  0.23 × 0.15 × 0.07  
2θ range for data collection      6.512 - 50.826°  
Index ranges  -19 ≤ h ≤ 19, -12 ≤ k ≤ 12, -15 ≤ l ≤ 15  
Reflections collected  25815  
Independent reflections  3597[R(int) = 0.0505]  
Data/restraints/parameters  3597/0/257  
Goodness-of-fit on F2  1.044  
Final R indexes [I>=2σ (I)]  R1 = 0.0506, wR2 = 0.1140  
Final R indexes [all data]  R1 = 0.0768, wR2 = 0.1277  
Largest diff. peak/hole  0.16/-0.23 eÅ-3  
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Figure S 2.32 ORTEP drawing of the title compound 5c with 50% thermal ellipsoids 
 
Table S 2.14 Summary of Structure Determination of Compound 5c 
 
 
  
Empirical formula  C26H24N4  
Formula weight  392.49  
Temperature/K  100  
Crystal system  monoclinic  
Space group  P21/c  
a  14.4066(9)Å  
b  10.7927(7)Å  
c  13.7564(8)Å  
β  108.248(3)°  
Volume  2031.4(2)Å3  
Z  4  
dcalc  1.283 g/cm3  
μ  0.077 mm-1  
F(000)  832.0  
Crystal size, mm  0.21 × 0.19 × 0.16  
2θ range for data collection      4.808 - 55.062°  
Index ranges  -18 ≤ h ≤ 18, -14 ≤ k ≤ 14, -16 ≤ l ≤ 17  
Reflections collected  39603  
Independent reflections  4684[R(int) = 0.0332]  
Data/restraints/parameters  4684/0/275  
Goodness-of-fit on F2  1.037  
Final R indexes [I>=2σ (I)]  R1 = 0.0395, wR2 = 0.1069  
Final R indexes [all data]  R1 = 0.0483, wR2 = 0.1137  
Largest diff. peak/hole  0.34/-0.23 eÅ-3  
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Figure S 2.33 ORTEP drawing of the title compound 5g with 50% thermal ellipsoids. 
 
 
Table S 2.15 Summary of Structure Determination of Compound 5g 
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Figure S 2.34 ORTEP drawing of the title compound 5i with 50% thermal ellipsoids. 
 
Table S 2.16 Summary of Structure Determination of Compound 5i 
 
 
  
Empirical formula  C25H18N4  
Formula weight  374.43  
Temperature/K  100  
Crystal system  monoclinic  
Space group  P21/c  
a  12.1596(3)Å  
b  18.6109(5)Å  
c  8.2523(2)Å  
β  91.7830(10)°  
Volume  1866.60(8)Å3  
Z  4  
dcalc  1.332 g/cm3  
μ  0.081 mm-1  
F(000)  784.0  
Crystal size, mm  0.38 × 0.23 × 0.18  
2θ range for data collection      3.352 - 50.8°  
Index ranges  -14 ≤ h ≤ 14, -22 ≤ k ≤ 22, -9 ≤ l ≤ 9  
Reflections collected  61870  
Independent reflections  3424[R(int) = 0.0184]  
Data/restraints/parameters  3424/0/264  
Goodness-of-fit on F2  1.029  
Final R indexes [I>=2σ (I)]  R1 = 0.0320, wR2 = 0.0844  
Final R indexes [all data]  R1 = 0.0344, wR2 = 0.0871  
Largest diff. peak/hole  0.17/-0.20 eÅ-3  
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2.7.2. NMR Spectra 
Figure S 2.35 1H NMR spectrum of 3 in CDCl3 (500 MHz).  
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 Figure S 2.36 13C NMR spectrum of 3 in CDCl3 (126 MHz). 
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Figure S 2.37 1H NMR spectrum of 4a in (CD3)2CO (500 MHz).  
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Figure S 2.38 13C NMR spectrum of 4a in (CD3)2CO (126 MHz).  
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Figure S 2.39 1H NMR spectrum of 4b in CD2Cl2 (500 MHz).  
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Figure S 2.40 13C NMR spectrum of 4b in CD2Cl2 (126 MHz).  
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Figure S 2.41 1H NMR spectrum of 4c in in CD2Cl2 (500 MHz). 
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 Figure S 2.42 13C NMR spectrum of 4c in CD2Cl2 (126 MHz). 
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Figure S 2.43 1H NMR spectrum of 4d in CD2Cl2 (500 MHz). 
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Figure S 2.44  13C NMR spectrum of 4d in CD2Cl2 (126 MHz).  
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Figure S 2.45 1H NMR spectrum of 4e in CD2Cl2 (500 MHz). 
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Figure S 2.46 13C NMR spectrum of 4e in CD2Cl2 (126 MHz).  
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Figure S 2.47 1H NMR spectrum of 4f in CDCl3 (500 MHz). 
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Figure S 2.48 13C NMR spectrum of 4e in CDCl3 (126 MHz).  
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Figure S 2.49  1H NMR spectrum of 4g in CD2Cl2 (500 MHz). 
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Figure S 2.50  13C NMR spectrum of 4g in CD2Cl2 (126 MHz).  
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Figure S 2.51 1H NMR spectrum of 4h in CD2Cl2 (500 MHz). 
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Figure S 2.52  13C NMR spectrum of 4h in CD2Cl2 (126 MHz).  
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Figure S 2.53  1H NMR spectrum of 4i in CD2Cl2 (500 MHz) 
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Figure S 2.54  13C NMR spectrum of 4i in CD2Cl2 (126 MHz). 
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Figure S 2.55  1H NMR spectrum of 4j in CD2Cl2 (500 MHz). 
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 Figure S 2.56 13C NMR spectrum of 4j in CD2Cl2 (126 MHz). 
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Figure S 2.57  1H NMR spectrum of 4k in CD2Cl2 (500 MHz). 
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Figure S 2.58  13C NMR spectrum of 4k in CD2Cl2 (126 MHz).  
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Figure S 2.59  1H NMR spectrum of 4l in CD2Cl2 (500 MHz). 
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Figure S 2.60  13C NMR spectrum of 4l in CD2Cl2 (126 MHz).  
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 Figure S 2.61 1H NMR spectrum of 4l’ in D2O (500 MHz). 
-0
.5
0
.0
0
.5
1.0
1.5
2.0
2.5
3.0
3.5
4
.0
4
.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10
.0
10
.5
.0
f1	(ppm
)
6.00
2.15
1.00
1.05
3.01
2.02
1.00
3.20
4.37
4.79	D2O
6.87
6.88
7.45
7.46
7.47
7.48
7.75
7.77
7.77
7.78
8.00
8.00
8.01
8.01
8.13
8.15
NN
Cl
NH24l’
 155 
 Figure S 2.62  13C NMR spectrum of 4l’ in D2O (Cryo 126 MHz). 
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Figure S 2.63  1H NMR spectrum of 4m in CD2Cl2 (500 MHz). 
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Figure S 2.64  13C NMR spectrum of 4m in CD2Cl2 (126 MHz). 
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Figure S 2.65  1H NMR spectrum of 4n in CD2Cl2 (500 MHz). 
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Figure S 2.66  13C NMR spectrum of 4n in CD2Cl2 (126 MHz).  
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Figure S 2.67  1H NMR spectrum of 5a in CD2Cl2 (500 MHz). 
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Figure S 2.68 13C NMR spectrum of 5a in CD2Cl2 (126 MHz).  
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Figure S 2.69 1H NMR spectrum of 5b in CD2Cl2 (500 MHz).  
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Figure S 2.70 13C NMR spectrum of 5b in CD2Cl2 (126 MHz). 
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Figure S 2.71  1H NMR spectrum of 5c in CD2Cl2 (500 MHz). 
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Figure S 2.72  13C NMR spectrum of 5c in CD2Cl2 (126 MHz).  
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Figure S 2.73 1H NMR spectrum of 5d in CD2Cl2 (500 MHz). 
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Figure S 2.74  13C NMR spectrum of 5d in CD2Cl2 (126 MHz).  
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Figure S 2.75  1H NMR spectrum of 5e in CD2Cl2 (500 MHz). 
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Figure S 2.76  13C NMR spectrum of 5e in CD2Cl2 (126 MHz). 
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Figure S 2.77  1H NMR spectrum of 5f in CD2Cl2 (500 MHz).  
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Figure S 2.78  13C NMR spectrum of 5f in CD2Cl2 (126 MHz).  
1H  
 
-10
0
10
20
30
4
0
50
60
70
80
90
10
0
110
120
130
14
0
150
160
170
180
190
20
0
210
f1	(ppm
)
40.61
53.41
53.62
53.84
54.06
54.27
107.82
112.44
115.38
116.76
117.60
119.05
125.81
127.65
129.07
129.57
130.68
132.70
140.16
144.10
146.95
151.09
151.84
157.03
 172 
Figure S 2.79 NMR spectrum of 5g in CD2Cl2 (500 MHz). 
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Figure S 2.80  13C NMR spectrum of 5g in CD2Cl2 (126 MHz).  
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Figure S 2.81  1H NMR spectrum of 5h in CD2Cl2 (500 MHz).  
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Figure S 2.82  13C NMR spectrum of 5h in CD2Cl2 (126 MHz). 
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Figure S 2.83  1H NMR spectrum of 5i in CD2Cl2 (500 MHz). 
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 Figure S 2.84  13C NMR spectrum of 5i in CD2Cl2 (126 MHz). 
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2.7.3. Optimized Geometry Coordinates. 
 
 
 
 
 
 
Table S 2.17 
 
 
 
 
 
  
NN
Cl
OH4a
4a 
(OH) 
Atomic 
Number X Y Z   
Atomic 
Number X Y Z 
C 6 3.426504 -0.865082 -0.024593 C 6 -4.187363 -1.966612 -0.3828  
C 6 2.064592 -1.178636 -0.005059 H 1 -2.064488 -2.115197 -0.6818  
C 6 1.067473 -0.175637 -0.016215 C 6 -5.244138 -1.138919 0.0153  
C 6 1.454947 1.206796 -0.035208 H 1 -5.799329 0.821023 0.7396  
C 6 2.837928 1.514212 -0.036418 H 1 -4.40275 -2.985333 -0.6915  
C 6 3.790229 0.522745 -0.028115 Cl 17 0.743557 3.869473 -0.1075  
H 1 1.710055 -2.201081 0.020232 N 7 -0.236041 -0.575851 -0.0000  
C 6 0.394474 2.145007 -0.054026 N 7 4.403727 -1.847336 -0.0495  
H 1 3.150368 2.553507 -0.042231 C 6 5.798285 -1.497481 0.1814  
H 1 4.834452 0.811372 -0.025095 C 6 4.009553 -3.237817 0.11729  
C 6 -0.916377 1.73589 -0.044934 H 1 3.300789 -3.537057 -0.6635  
C 6 -1.197499 0.33699 -0.006829 H 1 4.892472 -3.873489 0.0265  
H 1 -1.712671 2.467681 -0.094527 H 1 5.966576 -1.053 1.17559  
C 6 -2.601162 -0.152869 0.008408 H 1 6.406 -2.401175 0.1053  
C 6 -3.675276 0.657593 0.408841 H 1 3.541318 -3.428171 1.0966  
C 6 -2.887165 -1.476264 -0.379497 H 1 6.162454 -0.794452 -0.5766  
C 6 -4.984769 0.175406 0.415229 O 8 -6.506116 -1.672564 -0.0057  
H 1 -3.5018 1.674919 0.746665 H 1 -7.150216 -1.009706 0.28889  
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Table S 2.18 
  
NN
Cl
N
4b
4b 
(NMe2) 
Atomic 
Number X Y Z   
Atomic 
Number X Y Z 
C 6 4.037249 -1.064313 -0.100284 H 1 -3.885501 -2.51977 0.40  
C 6 2.652209 -1.247631 -0.096755 Cl 17 1.816872 3.897149 0.15  
C 6 1.75335 -0.155413 -0.05102 N 7 0.418826 -0.430366 -0.06  
C 6 2.272392 1.181763 0.007586 N 7 4.918356 -2.133971 -0.18  
C 6 3.677647 1.356211 0.020227 C 6 6.330782 -1.935972 0.11  
C 6 4.532181 0.279791 -0.028241 C 6 4.390232 -3.486072 -0.08  
H 1 2.202455 -2.231494 -0.131953 H 1 3.650052 -3.668684 -0.87  
C 6 1.304141 2.214534 0.061917 H 1 5.205577 -4.199013 -0.22  
H 1 4.086608 2.36009 0.07297 H 1 6.506237 -1.580978 1.13  
H 1 5.599073 0.466759 -0.013071 H 1 6.853871 -2.885941 -0.0  
C 6 -0.038648 1.932321 0.051302 H 1 3.912338 -3.68632 0.88  
C 6 -0.456099 0.567257 -0.020835 H 1 6.784352 -1.219179 -0.58  
H 1 -0.758476 2.737767 0.119622 N 7 -6.000139 -0.91224 -0.10  
C 6 -1.896004 0.21319 -0.03611 C 6 -7.025793 0.11744 -0.15  
C 6 -2.912871 1.150109 -0.285946 H 1 -8.00704 -0.358939 -0.20  
C 6 -2.301468 -1.112497 0.202581 H 1 -7.007713 0.784169 0.71  
C 6 -4.257799 0.793757 -0.299025 H 1 -6.913178 0.733919 -1.05  
H 1 -2.667655 2.187266 -0.495113 C 6 -6.387734 -2.237892 0.35  
C 6 -3.638919 -1.484706 0.199813 H 1 -7.464878 -2.359199 0.22  
H 1 -1.538486 -1.857954 0.400138 H 1 -5.893282 -3.017435 -0.23  
C 6 -4.663462 -0.541519 -0.063722 H 1 -6.147164 -2.407679 1.41  
H 1 -4.991622 1.564982 -0.501397       
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Table S 2.19 
 
  
NN
Cl
4c
4c (H) Atomic Number X Y Z   
Atomic 
Number X Y Z 
C 6 3.140066 -0.682495 -0.023032 C 6 -4.36208 -2.420185 -0.413  
C 6 1.811123 -1.114213 -0.000478 H 1 -2.229008 -2.381639 -0.749  
C 6 0.730339 -0.201978 -0.014607 C 6 -5.478882 -1.701557 0.0266  
C 6 0.994761 1.209409 -0.039388 H 1 -6.177746 0.179443 0.8227  
C 6 2.345851 1.63677 -0.043608 H 1 -4.475627 -3.445383 -0.757  
C 6 3.380596 0.732157 -0.032689 H 1 -6.462569 -2.164343 0.029  
H 1 1.548092 -2.163665 0.030103 Cl 17 0.052999 3.798953 -0.119  
C 6 -0.143267 2.051386 -0.06012 N 7 -0.533167 -0.714788 0.0043  
H 1 2.566415 2.699325 -0.054039 N 7 4.200198 -1.574286 -0.045  
H 1 4.395733 1.110413 -0.033 C 6 5.557525 -1.102597 0.1922  
C 6 -1.413606 1.528204 -0.04699 C 6 3.929715 -2.994608 0.1179  
C 6 -1.569253 0.111216 -0.003722 H 1 3.247943 -3.351968 -0.662  
H 1 -2.272374 2.185547 -0.096989 H 1 4.86464 -3.550238 0.0227  
C 6 -2.928212 -0.500184 0.014718 H 1 5.679125 -0.64091 1.1852  
C 6 -4.056638 0.210301 0.458982 H 1 6.242133 -1.950145 0.1246  
C 6 -3.099942 -1.828023 -0.415 H 1 3.482493 -3.228591 1.0977  
C 6 -5.319708 -0.385195 0.466621 H 1 5.863983 -0.373795 -0.567  
H 1 -3.953775 1.226809 0.827591       
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NN
Cl
F4d
4d (F) Atomic Number X Y Z   
Atomic 
Number X Y Z 
C 6 3.41991 -0.862873 -0.018887 C 6 -4.192126 -1.96335 -0.414  
C 6 2.058168 -1.17808 0.000114 H 1 -2.067486 -2.096383 -0.740  
C 6 1.060757 -0.175938 -0.01442 C 6 -5.218348 -1.131822 0.0197  
C 6 1.445722 1.207398 -0.036608 H 1 -5.813665 0.778837 0.7993  
C 6 2.828811 1.516349 -0.037732 H 1 -4.417676 -2.972062 -0.746  
C 6 3.781573 0.525926 -0.026177 Cl 17 0.732544 3.868484 -0.116  
H 1 1.704982 -2.200912 0.028025 N 7 -0.242848 -0.57685 0.0013  
C 6 0.385525 2.145137 -0.058594 N 7 4.39781 -1.842667 -0.038  
H 1 3.140199 2.555878 -0.046132 C 6 5.793933 -1.49002 0.1793  
H 1 4.825535 0.815481 -0.023326 C 6 4.006118 -3.234744 0.1211  
C 6 -0.925856 1.734446 -0.048795 H 1 3.302556 -3.533584 -0.664  
C 6 -1.202822 0.336442 -0.007519 H 1 4.891007 -3.868006 0.0341  
H 1 -1.72369 2.4645 -0.100783 H 1 5.967288 -1.034409 1.167  
C 6 -2.60811 -0.15695 0.008571 H 1 6.40116 -2.394493 0.1106  
C 6 -3.675673 0.646541 0.444753 H 1 3.532871 -3.42851 1.0972  
C 6 -2.889282 -1.4691 -0.413171 H 1 6.153765 -0.795684 -0.589  
C 6 -4.98655 0.166286 0.454836 F 9 -6.49251 -1.607273 0.0222  
H 1 -3.492738 1.653305 0.807595       
           
 
 182 
 
 
 
 
 
 
Table S 2.20 
 
  
NN
Cl
CF34e
4e 
(CF3) 
Atomic 
Number X Y Z   
Atomic 
Number X Y  
C 6 4.28143 -1.119454 -0.009781 H 1 -1.308075 -1.682198 -0.7  
C 6 2.891736 -1.271694 -0.002429 C 6 -4.352421 -0.372632 -0.0  
C 6 2.021072 -0.158137 -0.020748 H 1 -4.669962 1.602564 0.78  
C 6 2.566671 1.17086 -0.036037 H 1 -3.71824 -2.275365 -0.8  
C 6 3.976865 1.31384 -0.027972 Cl 17 2.175974 3.897134 -0.1  
C 6 4.804766 0.217423 -0.012204 N 7 0.679111 -0.401093 -0.0  
H 1 2.420375 -2.24573 0.02022 N 7 5.136509 -2.206192 -0.0  
C 6 1.626408 2.22828 -0.060143 C 6 6.564395 -2.020557 0.  
H 1 4.409092 2.309111 -0.032311 C 6 4.582266 -3.544945 0.11  
H 1 5.87572 0.38037 -0.002456 H 1 3.863036 -3.750972 -0.6  
C 6 0.274562 1.975763 -0.057008 H 1 5.388593 -4.276226 0.03  
C 6 -0.163551 0.620873 -0.024267 H 1 6.786526 -1.577647 1.18  
H 1 -0.431325 2.795327 -0.107179 H 1 7.059143 -2.991883 0.14  
C 6 -1.618261 0.294409 -0.015759 H 1 4.072099 -3.692212 1.07  
C 6 -2.583927 1.211009 0.431797 H 1 7.007761 -1.383149 -0.5  
C 6 -2.050159 -0.968213 -0.457841 C 6 -5.807907 -0.750268 0.02  
C 6 -3.939033 0.882764 0.432747 F 9 -6.147982 -1.608205 -0.9  
H 1 -2.285204 2.184644 0.807505 F 9 -6.62588 0.327001 -0.0  
C 6 -3.401625 -1.299943 -0.464869 F 9 -6.138378 -1.369149 1.19  
 
 183 
 
 
 
 
 
 
 
 
Table S 2.21 
 
  
NN
Cl
N4f
4f (CN) Atomic Number X Y Z   
Atomic 
Number X Y Z 
C 6 3.591448 -0.981629 -0.010237 C 6 -4.054585 -1.700714 -0.4177  
C 6 2.215278 -1.229131 0.0043 H 1 -1.940635 -1.937686 -0.7443  
C 6 1.270475 -0.17799 -0.013571 C 6 -5.074905 -0.834639 0.01640  
C 6 1.723266 1.185474 -0.036041 H 1 -5.527756 1.126885 0.79924  
C 6 3.12043 1.425043 -0.03563 H 1 -4.307192 -2.70181 -0.7538  
C 6 4.021661 0.388164 -0.020494 Cl 17 1.146777 3.878064 -0.1160  
H 1 1.812423 -2.233351 0.031613 N 7 -0.051682 -0.511705 -0.0023  
C 6 0.713146 2.176157 -0.059033 N 7 4.518243 -2.006651 -0.0210  
H 1 3.483144 2.447627 -0.045587 C 6 5.934564 -1.722345 0.16622  
H 1 5.079047 0.623718 -0.016458 C 6 4.058319 -3.380105 0.1194  
C 6 -0.618498 1.832115 -0.048727 H 1 3.357916 -3.641233 -0.6830  
C 6 -0.962134 0.45063 -0.010254 H 1 4.913988 -4.05372 0.04784  
H 1 -1.378571 2.601692 -0.097861 H 1 6.145985 -1.253135 1.13973  
C 6 -2.39016 0.024277 0.005672 H 1 6.492622 -2.658688 0.11289  
C 6 -3.417547 0.878737 0.442508 H 1 3.556297 -3.555684 1.08392  
C 6 -2.732308 -1.273047 -0.416944 H 1 6.318134 -1.066242 -0.6244  
C 6 -4.745074 0.459779 0.451375 C 6 -6.441343 -1.270511 0.01897  
H 1 -3.18583 1.875212 0.805117 N 7 -7.550413 -1.624823 0.02067  
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Table S 2.22 
 
 
  
NN
Cl
O4i
4i 
(4OMe) 
Atomic 
Number X Y Z 
  
Atomic 
Number X Y  
C 6 -3.681395 -1.07285 -0.03229 C 6 4.983155 -0.515882 0.08  
C 6 -2.29638 -1.255409 -0.000801 H 1 5.346129 1.482258 0.78  
C 6 -1.398639 -0.162083 -0.014128 H 1 4.288671 -2.450168 -0.6  
C 6 -1.91638 1.176697 -0.048281 Cl 17 -1.462361 3.89424 -0.13  
C 6 -3.322238 1.351178 -0.062139 N 7 -0.063502 -0.43625 0.01  
C 6 -4.175946 0.273737 -0.051122 N 7 -4.561533 -2.144212 -0.05  
H 1 -1.846969 -2.239309 0.03727 C 6 -4.037134 -3.489224 0.12  
C 6 -0.949985 2.211689 -0.066768 C 6 -5.9808 -1.927028 0.18  
H 1 -3.731381 2.356137 -0.079819 H 1 -6.416892 -1.262346 -0.5  
H 1 -5.242918 0.460743 -0.058354 H 1 -6.501273 -2.884141 0.11  
C 6 0.393811 1.929434 -0.043243 H 1 -3.56596 -3.630195 1.11  
C 6 0.807209 0.564126 0.008962 H 1 -4.853227 -4.207596 0.02  
H 1 1.117055 2.733724 -0.090795 H 1 -6.180554 -1.499455 1.18  
C 6 2.251022 0.212251 0.039835 H 1 -3.292426 -3.721099 -0.64  
C 6 3.243254 1.128873 0.4399 O 8 6.324196 -0.767903 0.1  
C 6 2.666592 -1.07628 -0.327135 C 6 6.789715 -2.062667 -0.2  
C 6 4.586449 0.775156 0.466059 H 1 7.873499 -2.032253 -0.09  
H 1 2.969593 2.129096 0.762381 H 1 6.367686 -2.834521 0.4  
C 6 4.012378 -1.445422 -0.312337 H 1 6.548636 -2.297742 -1.2  
H 1 1.914016 -1.796523 -0.630033       
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Table S 2.23 
 
NN
N
N
5a
5a Atomic Number X Y Z   
Atomic 
Number X Y Z 
C 6 -1.1271 4.224993 -0.03093 H 1 -2.212443 7.395379 0.176594 
C 6 0.073589 3.515419 -0.077921 H 1 0.608983 6.216918 0.929479 
C 6 0.107793 2.099012 -0.056625 H 1 -3.229925 6.035855 -0.290024 
C 6 -1.115732 1.35526 0.006787 N 7 6.703698 -2.048508 -0.170614 
C 6 -2.324244 2.092739 0.103365 C 6 6.877962 -3.491761 -0.209819 
C 6 -2.338222 3.469092 0.089158 H 1 7.944554 -3.720692 -0.262919 
H 1 1.034162 4.012341 -0.1265 H 1 6.458126 -3.995853 0.677101 
C 6 -1.024232 -0.072444 0.021363 H 1 6.405301 -3.920016 -1.101268 
H 1 -3.264101 1.560356 0.210818 C 6 7.816157 -1.249148 0.318561 
H 1 -3.291767 3.976112 0.177116 H 1 8.74502 -1.804826 0.172172 
C 6 0.238555 -0.637651 0.007899 H 1 7.901239 -0.312241 -0.243434 
C 6 1.406683 0.176375 -0.049333 H 1 7.72506 -1.000501 1.389437 
H 1 0.327232 -1.718053 0.024179 C 6 -2.224124 -0.950172 0.051405 
C 6 2.764741 -0.425376 -0.075355 C 6 -2.358684 -1.964279 1.012713 
C 6 2.996342 -1.783908 -0.34785 C 6 -3.241725 -0.84961 -0.911164 
C 6 3.897301 0.369233 0.176769 C 6 -3.453623 -2.82524 1.029084 
C 6 4.278812 -2.325364 -0.369895 H 1 -1.593013 -2.076995 1.776763 
H 1 2.16711 -2.449822 -0.567739 C 6 -4.338156 -1.707702 -0.916129 
C 6 5.183581 -0.155354 0.165391 H 1 -3.162243 -0.102343 -1.696712 
H 1 3.750119 1.422409 0.391743 C 6 -4.486182 -2.713495 0.068466 
C 6 5.416561 -1.522668 -0.121639 H 1 -3.500552 -3.582921 1.80264 
H 1 4.386697 -3.380715 -0.591611 H 1 -5.077601 -1.590094 -1.699667 
H 1 6.01203 0.508752 0.383485 N 7 -5.602208 -3.54566 0.097161 
N 7 1.333231 1.502104 -0.086744 C 6 -5.583487 -4.723805 0.950444 
N 7 -1.165762 5.616267 -0.103698 H 1 -6.540178 -5.242958 0.860628 
C 6 -2.366417 6.3234 0.319276 H 1 -4.778446 -5.430299 0.685958 
C 6 0.088326 6.349646 -0.034414 H 1 -5.459833 -4.443122 2.002603 
H 1 0.765292 6.028995 -0.833462 C 6 -6.500072 -3.562563 -1.047083 
H 1 -0.112437 7.414018 -0.176895 H 1 -7.328124 -4.243753 -0.839428 
H 1 -2.616967 6.148199 1.379219 H 1 -6.928662 -2.569293 -1.222423 
     H 1 -6.003766 -3.892036 -1.975737 
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Table S 2.24 
 
  
NN
N5b
5b Atomic Number X Y Z   
Atomic 
Number X Y Z 
C 6 3.363567 -2.456653 -0.05412 H 1 2.508232 -4.94102 -0.824757 
C 6 1.970119 -2.37845 -0.089244 H 1 3.928686 -5.755712 -0.162479 
C 6 1.290085 -1.136081 -0.071092 H 1 5.613807 -3.451315 1.310484 
C 6 2.036727 0.086411 -0.01947 H 1 5.78905 -4.769697 0.129484 
C 6 3.450177 -0.011275 0.058257 H 1 2.742517 -5.009568 0.93838 
C 6 4.094015 -1.227623 0.045062 H 1 6.055179 -3.10486 -0.380748 
H 1 1.345037 -3.261511 -0.126662 N 7 -6.473408 -0.475349 -0.126938 
C 6 1.29726 1.309079 0.001763 C 6 -7.293193 0.725598 -0.159384 
H 1 4.042406 0.89414 0.14722 H 1 -8.345847 0.437683 -0.19942 
H 1 5.175073 -1.24026 0.116105 H 1 -7.141843 1.367056 0.72488 
C 6 -0.082682 1.23688 -0.0036 H 1 -7.080836 1.321995 -1.054426 
C 6 -0.748155 -0.023619 -0.057453 C 6 -7.091677 -1.706183 0.340534 
H 1 -0.655646 2.156895 0.02368 H 1 -8.172812 -1.635843 0.203395 
C 6 -2.230085 -0.111976 -0.0728 H 1 -6.741056 -2.565906 -0.241882 
C 6 -3.061519 0.991655 -0.327245 H 1 -6.889145 -1.90743 1.405889 
C 6 -2.869199 -1.340188 0.174662 C 6 1.96201 2.643178 0.035294 
C 6 -4.449314 0.88498 -0.335642 C 6 1.669597 3.555882 1.062501 
H 1 -2.632182 1.965765 -0.542333 C 6 2.856675 3.036169 -0.975181 
C 6 -4.252455 -1.463933 0.176275 C 6 2.258003 4.822944 1.083247 
H 1 -2.253124 -2.210255 0.375975 H 1 0.986131 3.261365 1.854905 
C 6 -5.089633 -0.352723 -0.091724 C 6 3.440004 4.304887 -0.95855 
H 1 -5.031423 1.775335 -0.542661 H 1 3.079132 2.349203 -1.787573 
H 1 -4.682153 -2.435958 0.389333 C 6 3.145153 5.202204 0.072336 
N 7 -0.072856 -1.166378 -0.09351 H 1 2.024187 5.512143 1.891038 
N 7 4.035117 -3.673878 -0.11915 H 1 4.121811 4.593954 -1.75469 
C 6 5.439067 -3.743625 0.261494 H 1 3.601742 6.188662 0.086269 
C 6 3.26064 -4.901812 -0.029623       
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Table S 2.25 
  
NN
N
CN
5c
5c Atomic Number X Y Z   
Atomic 
Number X Y Z 
C 6 -2.322261 3.556397 -0.043768 H 1 -0.879282 5.751488 -0.81686  
C 6 -0.991657 3.13306 -0.077477 H 1 -2.051835 6.891616 -0.14931  
C 6 -0.643066 1.761017 -0.064722 H 1 -4.276155 5.070456 1.30196  
C 6 -1.671287 0.762621 -0.019862 H 1 -4.096726 6.398831 0.13412  
C 6 -3.016117 1.208836 0.056701 H 1 -1.081924 5.876377 0.94720  
C 6 -3.336136 2.547186 0.048126 H 1 -4.762915 4.857952 -0.39909  
H 1 -0.166396 3.832819 -0.108766 N 7 6.713775 -0.800817 -0.11875  
C 6 -1.254752 -0.603601 -0.003267 C 6 7.214408 -2.166211 -0.14911  
H 1 -3.818508 0.482317 0.141768 H 1 8.305066 -2.145313 -0.19608  
H 1 -4.380204 2.827941 0.118178 H 1 6.916629 -2.746659 0.73974  
C 6 0.098983 -0.879589 -0.006659 H 1 6.856214 -2.696532 -1.0393  
C 6 1.057822 0.176552 -0.054352 C 6 7.62118 0.250776 0.31398  
H 1 0.425008 -1.91328 0.012608 H 1 8.650015 -0.092513 0.18782  
C 6 2.51432 -0.104959 -0.067657 H 1 7.497015 1.152287 -0.29713  
C 6 3.047211 -1.385151 -0.296281 H 1 7.475603 0.528914 1.37088  
C 6 3.437798 0.932888 0.155178 C 6 -2.226412 -1.732365 0.01897  
C 6 4.417901 -1.624238 -0.304438 C 6 -2.159138 -2.705691 1.03107  
H 1 2.391868 -2.229157 -0.490249 C 6 -3.198953 -1.877859 -0.98646  
C 6 4.808327 0.711875 0.156569 C 6 -3.034426 -3.788689 1.04696  
H 1 3.056402 1.932104 0.336717 H 1 -1.420105 -2.601944 1.82060  
C 6 5.344806 -0.577448 -0.08571 C 6 -4.07594 -2.95881 -0.98522  
H 1 4.762402 -2.634698 -0.490322 H 1 -3.252775 -1.146419 -1.78759  
H 1 5.465564 1.552021 0.348947 C 6 -4.001377 -3.922444 0.03608  
N 7 0.684242 1.450263 -0.085681 H 1 -2.977295 -4.529771 1.83846  
N 7 -2.668781 4.900419 -0.101448 H 1 -4.815553 -3.066141 -1.77290  
C 6 -4.017003 5.316986 0.259053 C 6 -4.906347 -5.03566 0.04495  
C 6 -1.614555 5.899489 -0.018275 N 7 -5.640962 -5.938795 0.05192  
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Table S 2.26 
  
NN
CN
N
5g
5g Atomic Number X Y Z   
Atomic 
Number X Y Z 
C 6 -0.172688 4.150071 0.111772 H 1 -2.474287 5.539933 0.670358 
C 6 -1.196696 3.20439 0.032328 H 1 -1.825286 7.060245 0.047667 
C 6 -0.928913 1.814207 0.023564 H 1 1.132361 6.350277 -1.042757 
C 6 0.42476 1.339568 0.058633 H 1 0.249592 7.477046 0.010817 
C 6 1.452608 2.315214 0.153942 H 1 -2.166714 5.718867 -1.073599 
C 6 1.174125 3.661812 0.176459 H 1 1.423241 6.367859 0.715222 
H 1 -2.240077 3.488816 -0.016813 C 6 -6.488319 -3.634502 -0.113923 
C 6 0.64003 -0.073436 0.040764 N 7 -7.444331 -4.299261 -0.12931 
H 1 2.486087 1.992708 0.226342 H 6 1.995294 -0.682153 0.054057 
H 1 2.000741 4.357758 0.256884 H 6 2.976614 -0.343846 -0.892464 
C 6 -0.478256 -0.893309 0.019883 H 6 2.32839 -1.677843 0.986821 
C 6 -1.783842 -0.336254 -0.013403 C 6 4.226261 -0.956876 -0.907019 
H 1 -0.342179 -1.969098 0.019732 H 1 2.749668 0.392941 -1.658824 
C 6 -2.991993 -1.20976 -0.048784 C 6 3.57704 -2.292946 0.994541 
C 6 -2.939455 -2.53958 -0.503134 H 1 1.597826 -1.96956 1.737668 
C 6 -4.232808 -0.697675 0.373339 C 6 4.57187 -1.940065 0.05155 
C 6 -4.080473 -3.336717 -0.529467 H 1 4.93147 -0.669133 -1.67771 
H 1 -2.005913 -2.957827 -0.865634 H 1 3.774492 -3.048117 1.745999 
C 6 -5.377676 -1.485353 0.357795 N 7 5.832153 -2.524393 0.071954 
H 1 -4.278964 0.331219 0.712619 C 6 6.060519 -3.694064 0.906942 
C 6 -5.310823 -2.816246 -0.094159 H 1 7.105633 -3.997081 0.816578 
H 1 -4.026471 -4.358924 -0.891552 H 1 5.875033 -3.464621 1.962596 
H 1 -6.327357 -1.080064 0.694023 H 1 5.425326 -4.549737 0.623495 
N 7 -2.000967 0.972019 -0.014802 C 6 6.738477 -2.301077 -1.044048 
N 7 -0.430691 5.513122 0.153926 H 1 7.685728 -2.804111 -0.839208 
C 6 0.651876 6.464325 -0.057384 H 1 6.341613 -2.684608 -1.998876 
C 6 -1.792188 5.975105 -0.06878 H 1 6.952869 -1.233132 -1.16635 
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Table S 2.27 
 
 
  
NN
CN5h
5h Atomic Number X Y Z   
Atomic 
Number X Y Z 
C 6 -2.987572 -2.380169 -0.020852 N 7 0.491989 -1.214268 0.027824 
C 6 -1.591336 -2.354204 0.013957 N 7 -3.701982 -3.567564 0.017698 
C 6 -0.869552 -1.13712 0.01594 C 6 -5.120987 -3.576485 -0.311486 
C 6 -1.568494 0.115561 -0.012581 C 6 -2.97719 -4.826478 -0.066306 
C 6 -2.985939 0.070755 -0.08962 H 1 -2.241354 -4.902777 0.742156 
C 6 -3.671323 -1.121106 -0.097646 H 1 -3.681805 -5.652857 0.046016 
H 1 -0.999801 -3.260638 0.028887 H 1 -5.321021 -3.238369 -1.341083 
C 6 -0.790244 1.311407 0.003283 H 1 -5.500384 -4.594812 -0.207341 
H 1 -3.544464 0.998595 -0.160496 H 1 -2.447303 -4.946513 -1.025484 
H 1 -4.752049 -1.094195 -0.169753 H 1 -5.692124 -2.943524 0.377109 
C 6 0.589221 1.191121 -0.001247 C 6 6.90792 -0.748185 0.049358 
C 6 1.199134 -0.09336 0.002197 N 7 8.064109 -0.885821 0.063157 
H 1 1.196958 2.087637 0.050302 C 6 -1.409301 2.666733 0.035877 
C 6 2.683015 -0.241875 0.00692 C 6 -1.094369 3.612979 -0.953524 
C 6 3.538461 0.79605 -0.403482 C 6 -2.282587 3.042528 1.071161 
C 6 3.259762 -1.456539 0.421848 C 6 -1.642166 4.897509 -0.913995 
C 6 4.921259 0.635919 -0.393596 H 1 -0.428617 3.331728 -1.765632 
H 1 3.129168 1.736815 -0.757105 C 6 -2.823399 4.329152 1.115433 
C 6 4.638754 -1.627222 0.440304 H 1 -2.520958 2.32849 1.855178 
H 1 2.602732 -2.262628 0.728667 C 6 -2.507768 5.260126 0.121337 
C 6 5.483989 -0.578673 0.032804 H 1 -1.393311 5.613391 -1.693354 
H 1 5.56872 1.444056 -0.719937 H 1 -3.48819 4.605479 1.930042 
H 1 5.070886 -2.567317 0.769836 H 1 -2.93162 6.260464 0.154735 
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Table S 2.28 
   
 
  
 
 
 
NN
CN
CN
5i
5i Atomic Number X Y Z   
Atomic 
Number X Y Z 
C 6 1.49281 3.676634 0.065924 N 7 -1.274702 1.267472 -0.015687 
C 6 0.212805 3.11733 0.012277 N 7 1.695075 5.043648 0.089667 
C 6 0.012845 1.71764 0.009239 C 6 3.036534 5.592307 -0.05533 
C 6 1.138667 0.827162 0.033351 C 6 0.554542 5.931624 -0.077835 
C 6 2.431577 1.411376 0.101892 H 1 -0.192738 5.760847 0.706606 
C 6 2.607959 2.774622 0.114403 H 1 0.891131 6.966682 0.002041 
H 1 -0.680291 3.72808 -0.022875 H 1 3.506854 5.307936 -1.00946 
C 6 0.871871 -0.574118 0.028456 H 1 2.978895 6.681406 -0.017053 
H 1 3.306212 0.771177 0.15859 H 1 0.06271 5.799494 -1.054459 
H 1 3.617547 3.16393 0.170298 H 1 3.692299 5.269392 0.762544 
C 6 -0.447694 -0.992204 0.02124 C 6 -7.024141 -1.619816 -0.060717 
C 6 -1.501778 -0.03783 -0.010316 N 7 -8.14483 -1.935423 -0.065217 
H 1 -0.668436 -2.053767 0.033965 C 6 1.958216 -1.593719 0.033682 
C 6 -2.928749 -0.468771 -0.032887 C 6 2.929584 -1.625931 -0.982596 
C 6 -3.31455 -1.749274 -0.467142 C 6 2.004097 -2.575513 1.038233 
C 6 -3.931566 0.426813 0.38152 C 6 3.91743 -2.606516 -0.998109 
C 6 -4.653333 -2.130786 -0.481318 H 1 2.896768 -0.887301 -1.77828 
H 1 -2.57144 -2.455206 -0.824171 C 6 2.991307 -3.55794 1.037166 
C 6 -5.27079 0.055541 0.377372 H 1 1.265659 -2.558106 1.834919 
H 1 -3.638712 1.419111 0.706127 C 6 3.956696 -3.57922 0.01634 
C 6 -5.643712 -1.230719 -0.054009 H 1 4.656496 -2.628527 -1.793138 
H 1 -4.937522 -3.119732 -0.827581 H 1 3.021807 -4.306579 1.822851 
H 1 -6.034608 0.753228 0.707221 C 6 4.976731 -4.588384 0.008103 
     N 7 5.804916 -5.406254 0.000982 
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2.  
 
Chapter 3 
Quinoline-based Multi Turn-ON Probe as Tunable pH Sensor for 
Biological Studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work was performed in collaboration with David M. Chenoweth, Chloe M. Jones, Rachel M. 
Lackner, and E. James Petersson at the University of Pennsylvania  
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Abstract 
Fluorescent “smart” probes across the visible spectrum have enabled sensitive and precise 
visualization of orthogonally labeled molecules in biological systems. Here we present a quinoline-
based fluorescent scaffold with substituents enabling polarization, fluorescence switching, and 
tuning of pKa to yield Multi Turn-ON azido Quinoline probes called MTOQ. Previously termed 
dimethylamino quinoline (DMAQ), MTOQ probes possess rationally designed domains that 
control the intramolecular charge transfer (ICT), photoinduced electron transfer (PeT), and 
protonation-activable resonance charge transfer (PARCT) mechanisms1 to generate desired 
photophysical properties. Utilizing the principles of PeT, ICT and PARCT, MTOQ dyes are 
minimally sized sensors that can undergo a first activation by conversion to the corresponding 
triazoles via click chemistry and a second activation based on the pH of the environment. Moreover, 
the large Stokes shifts of MTOQs may address limitations of conventional dyes due to self-
quenching and become a favorable probe for protein aggregation studies. As a proof of principle, 
we used the MTOQ probes to image synthetic vesicles with no-wash labeling as well as various 
alkyne-labeled biomolecules (e.g., a-synuclein) for aggregation studies in vitro and in cellulo. 
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3.1    Introduction 
3.1.1. Importance of Functional Fluorophore 
Fluorescent small molecule probes are essential tools in chemical biology used to decipher 
biological processes.2-7 Due to their small size, high sensitivity, fast response time and synthetic 
modularity, the vast collection of fluorescent small molecules that have been synthesized are 
utilized to visualize and understand biological systems. Many efforts are now focused on 
developing “smart” probes with functional groups activatable by external stimuli such as 
bioinorganic analytes (e.g., metals), pH or light.2, 8-9 Such probes will not visualize just one state, 
but detect the complex and dynamic nature of the cellular environment. In designing fluorescent 
sensors, the molecule generally requires at least two functional sites: a recognition site where the 
host binds to the analyte, and a fluorophore that provides a spectroscopic signal dependent on the 
interaction with the analyte.9 Detection of the analyte is translated by either electron or charge 
transfer mechanisms such as photoinduced electron transfer (PeT) or intramolecular charge transfer 
(ICT). PeT can be utilized for modulating the quantum yield of the fluorophore, and ICT can induce 
a significant emission wavelength shift or Stokes shift upon interaction with the analyte.  
 
3.1.2. Importance of pH Probe 
Among many biological analytes, pH is a vital parameter for biological studies as it is 
tightly correlated with various physiological processes including cell proliferation, metabolism, 
endocytosis, apoptosis, ion transport and homeostatsis.10 For instance, under normal physiological 
conditions, cellular regions have a distinct pH depending on their unique biological functions. 
Although the cytosolic pH value is generally 7.2-7.4, it is well known that certain organelles 
maintain special pH values, such as mitochondria and lysosomes that maintain pH values of about 
8 and 5, respectively. Disruption of normal pH homeostasis in these compartments potentially 
indicates cellular dysfunction leading to many diseases including cancer, cardiopathy and even 
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Alzheimer’s disease. Therefore, precise measurement of physiological pH values is necessary and 
critical to understanding the physiological and pathological processes.11 
 
3.1.3. Conventional Functional Probes 
To develop functional fluorophores, many collaborative efforts through rational design and 
combinatorial approaches have been conducted. As a result, numerous smart fluorogenic probes 
based on conventional fluorescent scaffolds such as fluorescein, rhodamine, coumarin and 
BODIPY were developed.5, 7, 12-13 The generated probes were used to explain the common 
mechanism behind each fluorescence process to build roadmaps to rational design probes with 
improved properties. For instance, Nagano and Lavis et al. have extensively studied fluorescein 
and rhodamine scaffolds to modulate fluorescence properties and quantum yield,12 respectively, in 
a rational manner.14-15 Additional efforts have been made to translate this modulation mechanism 
to different scaffolds such as BODIPY.16 However, the quinoline scaffold has limited rationally 
designed routes due to a lack of precedent for quinoline-based fluorescent dyes. Most importantly, 
one of the biggest challenges is that quinoline itself has built-in sensitivity to environment and thus 
often simultaneously participates in multiple photophysical mechanisms, which complicates 
rational design. Despite its complexity, it is intriguing to explore the quinoline scaffold as it can 
offer distinct properties that other conventional scaffolds do not have. For instance, fluorescein and 
rhodamine generally have high water solubility and low cytotoxicity, and BODIPY is known for 
its high brightness, but they all have relatively small Stokes shifts compared to that of quinoline.13, 
17 Quinoline dyes generally have a large Stokes shifts and environmental sensitivity that can be 
attractive to investigate to generate new functional probes.18-19  
 
 195 
3.1.4. Importance of Quinoline Dye as a Functional Probe 
Quinoline is part of an important class of heterocyclic compounds and privileged synthons 
found in natural products, drug discovery, as well as in functional materials.19-21 Much of the 
structural and mechanistic understanding of quinoline photophysical behavior comes from studies 
conducted from the perspective of drug design and materials.20 As fluorescent probes, quinolines 
have been mainly investigated as metal sensors using the quinoline nitrogen as the site for metal 
chelation or pH sensing.18, 22-23 Recently [JACS 2018 140 (30) 9486], we introduced a simple 
quinoline-based fluorescent scaffold called dimethylamino quinoline (DMAQ) that exhibits 
tunable emission by changing the electronic character of C-2 substitutions.24 We successfully 
synthesized our probes in two steps with high yield and elaborated three strategic domains allotted 
for 1) compound polarization 2) tuning of photophysical properties and 3) structural diversification 
within the DMAQ. We applied our probe for live-cell imaging and observed unique pH dependent 
dual emissive properties. To expand DMAQ as a functional probe, we deciphered the role of each 
substituent by understanding the mechanism that dictates photophysical properties and by 
rationally designing multi turn-ON functional probes with large Stokes shifts.  
In this work, we have synthesized and developed a second generation DMAQ as a multi 
turn ON probe with tunable pH sensitivity. We call this probe a Multi Turn-ON Quinoline-based 
(MTOQ) probe (Figure 3.1). MTOQ probe undergoes a first turn-ON in fluorescence from the dark 
state to bright state based-on a PeT mechanism, and a second turn-ON from one color to another 
color based-on protonation-activated resonance charge transfer (PARCT) mechanism.1, 25 
Chemically, the first turn-ON is initiated upon bioconjugation and the second turn-ON is initiated 
by protonation of the quinoline nitrogen atoms. We show that we can fine-tune the sensitivity of 
our probe by structural modification at C-2 to change the pKa of the parent probe. Generated probes 
displayed a significant shift in both absorption and emission signals upon protonation compared to 
that of previously reported sensors. With our systematically derivatized quinoline fluorophore 
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library, we show proof of principle examples to visualize intracellular pH distribution with a non-
invasive approach. Lastly, our MTOQ study offers guidelines for rational design of the next 
generation of quinoline based sensors for biomedical diagnostics, cell biology and environmental 
monitoring  
 
 
Figure 3.1 General turn-ON process and properties of multi turn-ON quinoline probe (MTOQ).  
 
3.1.5. Development of Click Turn-ON Probe  
Bioconjugation is an essential technology in chemical biology research to label target 
compounds selectively with signaling probes to enable visualization.  In particular, bio-orthogonal 
chemistry has enabled the use of many small synthetic fluorogenic probes to visualize biomolecules 
that cannot be tagged with genetically encoded fluorescent proteins.26-29 Much effort has been 
devoted to expanding the toolbox of bio-orthogonal reactions, and one of the most widely-used 
ligation methods is the azide-alkyne [3+2] cycloaddition commonly referred to the “click” 
reaction.30 The click reaction affords excellent chemoselectivity with quantitative transformation 
under mild conditions. Alkyne and azide groups are small in size and stable in various solvents and 
pH and thus can be conveniently introduced to organic compounds. They have been employed as 
a pair of orthogonal linkers for chemoselective ligations of azide- or alkyne-labeled proteins, 
nucleic acids, and lipids. Recent advances have been made to develop click turn-ON probes: 
‘inactivated’ azide-functionalized fluorogenic probes that can be ‘activated’ by either Cu(I) 
catalyzed or Cu(I)-free cycloaddition reactions with alkyne- or cyclooctyne-functionalized 
biomolecules, respectively. Such probes enable advanced imaging situations where unbound 
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probes will stay ‘inactivated.’ Inactivated probes have suppressed fluorescence due to the electron 
transfer from the azide moiety to the chromophore. Upon undergoing the click reaction, a triazole 
is formed from the azide, which can no longer donate electrons, thus ‘activating’ fluorescence of 
the underlying system. Click turn-ON probes offer significant advantages as imaging tools: not 
only does their fluorescence signal indicate successful bioconjugation to the target, but these 
compounds also allow real-time imaging of dynamic processes in cells without the need to wash 
away unbound probe.31  
 
Figure 3.2 Turn-ON probe design via photoinduced electron transfer (PeT). Fluorogenic scaffolds 
with PeT donor moiety and fluorophore 
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Building from a theoretical model developed by Nagano and co-workers, fluorogenic 
probes are rationally designed to be internally quenched via PeT in the azide- form and unquenched 
upon formation of a triazole (Figure 3.2).15, 26 Nagano, Bertozzi et al. elegantly demonstrated a 
direct correlation between the experimentally determined fluorescence quantum yield and the 
calculated energy of the highest occupied molecular orbital (EHOMO) of the PeT donor (pendant aryl 
ring) at the B3LYP/6-31G(d) level of density functional theory (DFT) calculations. In addition to 
the EHOMO calculations, oxidation potential measurements of the PeT donor moiety further validated 
the PeT quenching effect of azide-functionalized fluorogenic probes.26 These studies suggested that 
triazole formation of the PeT donor lowers the EHOMO value relative to that of the azide form, 
reducing the PeT-induced quench in fluorescence and resulting in fluorescence turn-ON (Figure 
3.2). Consistent with computational predictions, Bertozzi et al. demonstrated the expected decrease 
in the aryl EHOMO value upon triazole formation (−0.203 to −0.220 hartree) relative to that of the 
azide ( −0.196 to −0.210 hartree).26 Additionally, they observed that triazoles with increased out-
of-plane twisted structures have a higher tendency to prevent donation of electrons from the 
nitrogen lone pair into the aryl system, blocking PeT via a stereoelectronic effect.14, 26 Thus, in 
principle, an ortho-substituent of an aryl azide will force the triazole to twist further out of plane 
and enhance turn-ON efficiency.  
3.2    Results and Discussion 
3.2.1. Rational Design of Turn-ON DMAQ (PeT) 
A number of azide-functionalized turn on fluorogenic probes based on conventional 
fluorogenic scaffolds (e.g., fluorescein,26, 32 coumarin,33 or BODIPY34) have been developed. Each 
azide-functionalized fluorophore has been shown to undergo an increase in fluorescence quantum 
yield upon change in PeT donor moieties: for instance, a 3-azido 4,6-disubstituted benzene ring 
(where R = methoxy or a solubilizing zwitterionic chain) for xanthene derivatives and a 3-azido 
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group for coumarin (Figure 3.3).26 These studies established a platform for the rational design of 
fluorogenic azide probes with spectral properties tailored for biological imaging. Previously 
reported commercially available turn-ON dyes are shown in order of maximum absorbance (lmax) 
values (Figure 3.3).  Coumarins have absorption at 325 nm while fluorescein and rhodamine 
derivatives, including those that are silicon-substituted, span 500 nm to 657 nm, with excellent 
water solubility and cell permeability. Our quinoline probes have absorption at 415 nm, completing 
the palette of probes spanning the visible region, with the potential to benefit multi-color imaging 
applications. Here, we show a novel quinoline-based multi turn-ON probe that undergoes an 
increase in fluorescence quantum yield upon click ligation. In addition to chemical turn-ON, 
quinoline probes have a unique advantage in that they undergo a second environmental turn-ON to 
yield an unprecedented multi turn-ON sensor.  
 200 
 
Figure 3.3 Previously reported turn-ON probes (right) and new turn on probe with sensing domain 
(left) are shown and PeT donor moiety is highlighted with red. Under fluorogenic core name, 
absorbance (lmax) / emission (lem) is shown as (nm / nm).  
In order to design a PeT-based, internally quenched quinoline probe, we used the azide 
moiety as a PeT donor that acts as a simple ‘molecular switch’ to turn-ON and OFF the fluorescence 
of the parent fluorophore. The key challenge lies in the identification of the structure that will 
undergo dramatic fluorescence enhancement by virtue of the chemical transformation. One solution 
is to find the appropriate substitution position that has a strong impact on the core’s fluorescence 
properties.  For instance, azides installed on the C-3 position of 7-hydroxycoumarin and C-3 of the 
pendent 4,6-substituted benzene ring of fluorescein analogues showed good turn-ON signal upon 
triazole formation.33 For DMAQ, C-4 was envisioned to be a good position for PeT donation as it 
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had an impact on the fluorescence based on previous research with aryl C-4 substituents. 
Additionally, C-4 offered a sterically favored position, as the neighboring ring acts as ortho-
substituted aryl ring, which can further twist the triazole form to prevent PeT quenching.  Moreover, 
4-azido DMAQ is favored from a synthetic perspective, as we can generate the azide-functionalized 
DMAQ in three steps (Scheme 3.1).   
 
3.2.2. Synthesis of Multi Turn-ON DMAQ (MTOQ) 
 
Scheme 3.1 Three step synthesis of MTOQ probe 
 
 
 
Key synthetic efforts identified column-free synthetic conditions to install the azide in 
quantitative yields. Using silver as a Lewis acid catalyst,35 we observed displacement of chloride 
into azide in less than 24 hours where, without silver, the reaction often took over 2-3 days without 
full conversion. As is the case with other turn-ON dyes, azido-quinolines tend to degrade upon 
column purification due to exposure to acidic silica, oxygen and light. However, the silver catalyzed 
reaction condition results in quantitative yields and the product can be purified simply by water 
precipitation (or extraction, for water soluble compounds) (4e).  With this, we screened temperature, 
the presence of silver perchlorate, and reaction time to obtain high yields of azido compounds 
(Figure 3.4).  Interestingly, other silver catalysts or Lewis acids did not have same effect, and 
instead reduced the azide to an amine. It is important to note that these synthetic conditions involve 
explosive materials, and thus we encourage using our scale (<100 mg) and purification method, 
which does not involve potentially explosive conditions.  
NH2N
2.  POCl3 (5.0 equiv)
     105 oC, 2 h
1.  Diethylmalonate
     (1.1 equiv)
     Diphenyl Ether
     200 oC, 4 h
NN Cl
Cl
2 (1.0 equiv)
Ar-B(OH)2 (1.0 equiv)
Pd(PPh3)2Cl2 (5.0 mol %)
K2CO3 (3.0 equiv)
THF :H2O (4 :1) 0.1 M
65 °C, 24 h
NN Ar
Cl
3 (1.0 equiv)
NaN3 (5.0 equiv)
AgClO4 (3.0 equiv)
DMF or MeCN
80 °C, 3-24 h NN Ar
N3
41 (1.0 equiv)
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Figure 3.4 (Top) Table for optimized azide displacement reaction for each derivative. (Bottom) 
Ultra-performace liquid chromatography tandem mass spectrometry (UPLCMS) analysis of crude 
azidation reaction of 4a under four different conditions. The 4-chloro DMAQ starting material 
(yellow) and the 4-azido product (magenta) distributions after 18 h of reactions are shown.   
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3.2.3. In Vial Studies: Turn-ON DMAQ  
Previous studies and reported oxidation potential values suggested that the azide to triazole 
transition can enhance quantum yield via a relief of PeT quenching mechanism. This effect is 
clearly shown in the fluorescence spectra of azide-functionalized DMAQ (4a-4f) and triazole-
functionalized DMAQ resulting from reaction with either propargyl phenyl ether (PE) or 
bicyclononyne (BCN). Six different azido DMAQ (4a-4f) and PE clicked DMAQ (4a-PE - 4f-PE) 
were synthesized and characterized. PE was chosen as model alkyne as it represents the sidechain 
of unnatural amino acid (UAA) propargyl tyrosine (PpY) that can be genetically incorporated into 
a protein construct. BCN (purchased from Milipore Sigma, CAS number is 1263166-90-0) is a 
model cyclooctyne for BCN-polyethylene glycol maleimide (BCN-PEG3-Mal(exo) purchased 
from Conju-Probe, SCU: CP-6043), which can be labeled at a cysteine site in a protein (Scheme 
3.2). Because DMAQ is solvatochromic, we observed different enhancement depending on the 
solvent. To represent aprotic environments, dimethyl sulfoxide (DMSO) was chosen, and for polar 
protic environments, methanol (MeOH) was chosen. We observed up to 62-fold increase in 
fluorescence in DMSO and 30-fold increase in MeOH. The fold-increase values are obtained by 
dividing quantum yield of azido DMAQ over that of PE clicked DMAQ (Figure 3.5). Due to the 
possible chelating effect of quinoline nitrogen, we used Cu2SO4 (2.0 equiv), sodium ascorbate (20.0 
equiv), and tris-hydroxypropyltriazolylmethylamine (THPTA) ligand (12.0 equiv), and observed 
quantitative conversion to the triazole within 20 min based on the HPLC trace. further analyze the 
turn-ON effect in other solvents further, we performed copper-free click with BCN in a plate reader 
to observe up to 37-fold increase in quantum yield.  
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Scheme 3.2 List of pre- and post-clicked DMAQ 
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Figure 3.5 Fold-increase of quantum yield between MTOQ (4a-4f) and PE clicked MTOQ (4-
PE). 
 
 
3.2.4. Rational Design of pKa Tunable DMAQ  
Previously, we observed DMAQ derivatives having interesting pH sensitivity with 
bathochromic shifts and Stokes shifts of up to 300 nm (lex/lem = 405/700 nm) in cellular 
environments.24 Quinoline is a p-deficient heterocycle with a slightly lower pKa (4.9) than pyridine 
(pKa =5.2). Previous studies and recent work by Dempsey et al. report that the pKa values of the 
conjugate acids of quinoline derivatives were easily tuned by varying the substituent at the 2- and 
4-positions of the quinoline backbone.37 Demspey et al. have synthesized three 2,4-bis arylated 
DMAQ derivatives and determined pKa values ranging from 14.2 to 15.2 in acetonitrile. They 
observed that more electron-donating aryl substituents yielded higher pKa values of the conjugate 
acid. While their system substituted both the 2 and 4 positions with the same aryl groups, we used 
our regioselective chemistry to investigate the effect of the 2-position alone by synthesizing a series 
of DMAQ derivatives with a variety of electronegativities.  
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3.2.5. Plate Reader Fluorescence Analysis  
Plate reader fluorescence analysis was performed to visualize fluorescence changes of the 
compounds in different solvents (Figure 3.6). Overall, the effect of pH was more pronounced in 
the fluorescence spectra than in the absorption spectra. Hence, we show emission spectra of each 
species and highlight the multi turn-ON processes (Figure 3.6A-D). Interestingly, 4b-PE and 4c-
PE underwent bathochromic shifts up to 100 nm higher in DCM with 0.1% TFA relative to that of 
neutral DCM. However, 4e-PE did not show such red-shift upon protonation, indicating the 
substitution effect on the pKa of the compound. Figure 3.6E shows the water quenching effect: 4f-
PE derivatives exhibited about 60-fold increase in intensity in DMSO relative to that in aqueous 
solution. Additionally, it is important to note that azide-functionalized DMAQ derivatives (4a-f) 
do not exhibit any fluorescence change due to a quenched state. Collectively, the plate reader data 
demonstrated pH sensitivity and environmental sensitivity of the MTOQ.    
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Figure 3.6 Plate-reader fluorescence analysis of 4a-4f and 4a-PE – 4f-PE derivatives. R 
is para-substituted group of C-2 aryl ring and R’ is C-4 group. A) Schematic view of 4b 
and 4b-PE in MeOH and acidic MeOH. B-D) Emission of B) 4b-PE, C) 4e-PE, and D) 
4c-PE in various solvents highlighting the bathochromic shift in acidic DCM and MeOH. 
E) Fluorescence intensity difference between aqueous pH 7 vs DMSO. 4a-f spectra have 
low intensity, which are shown near the bottom of the grpah. DCM is dichoromethane, 
MeOH is methanol, and DMSO is dimethyl sulfoxide. H+ is from 0.1% trifluoroacetic acid.  
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We observed a substitution dependent shift in absorption and emission upon protonation. 
Under various organic solvents with 0.1% of trifluoroacetic acid, most of 4-PE (4a-PE – 4f-PE) 
underwent a significant bathochromic (red) shift in fluorescence. This photophysical change might 
be due to the lowering of the pH of the medium, which can be attributed to the protonation of the 
quinoline ring, which in turn promotes stronger charge transfer from the C-7 substituted 
dimethylamino group. It is known that the spectral properties of fluorophores are related to charge 
transfer interactions and in this case, PARCT. 25, 38-39 Due to this structural change, the excited 
resonance structures result in different photophysical properties than that of the ground state species. 
Such excited state geometry changes often result in large Stokes shifts (Figure 3.9).40  These 
theories can relate back to our probes, which display both protonation-induced bathochromic shifts 
and large Stokes shifts. The binding of a proton to 4-PE alters and expands p-conjugation, changing 
the electron-accepting nature of the aromatic moieties. Therefore, the spectral properties of 4-PE 
might be related to PARCT reactions, which result in multiple resonance structures in the excited 
state (Scheme 3.3). 
 
Figure 3.7 Jablonski diagram to show possible change of DMAQ upon protonation activated 
resonance charge transfer (PARCT) 
 209 
Scheme 3.3 Resonance process of protonated 4-PE 
 
 
 
3.2.6. X-ray Crystal Structure Analysis  
To analyze the bathchromic shift upon protonations further, we obtained X-ray crystal 
structures to investigate the protonation site. Based on the X-ray crystal structures, we observed 
that the acceptor moiety was the quinoline nitrogen (Figure 3.8).41 Though there are two sites that 
can accept a proton, the 7-dimethylamino and quinoline nitrogen, 7-dimethylamino is involved in 
a conjugated system, resulting in a C-N bond length of 1.35-1.37 Å.  Because the bond length of 
1.355 Å is for sp2 N, 1.395 Å is for sp3 N, and 1.465 Å is for ammonium salt in aniline, the bond 
length of C-N bonds (red) in crystal structures are due to nitrogen between sp2 and sp3. This 
indicates the nitrogen in 7-dimethylamino of MTOQ is more electron deficient than that of the 
quinoline nitrogen, and less likely to accept a proton. We also observed clear crystal structure with 
protonated DMAQ (5), showing the formation of a trifluoroacetic acid (TFA) salt.  
 
Figure 3.8 Crystal structure of 4a-PE, 4e, and 5 with TFA salt. Bond length for the C-N bond on 
7-dimethylamino substituent is shown to be shorter than the single bond. Based on reference, 1.355 
Å is for sp2 N, 1.395 Å is for sp3 N, and 1.465 Å is for ammonium salt in aniline. 
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3.2.7. Potential Aggregation-Induced Emissive (AIE) Property 
Solid state emission of a PE-clicked DMAQ (4a-PE) was observed (Figure 9).  The crystal 
structure of 4a-PE indicated the J-aggregated state upon crystallization.42-44 The packing analysis 
shows that neighboring quinoline units are almost coplanar with respect to each other, with an 
average distance of 3.3 Å. The library of compounds studied generally exhibited a large Stokes 
shift (Figure 3.9) and solvatochromic properties mainly due to the combined effect of increasing 
polarity of the medium and ICT by a strong electron donating group, N,N-dimethylamino attached 
to the 7-position of quinoline. These properties suggested the potential aggregation-induced 
emission (AIE) nature of our probes, which will allow advanced biological studies.42-44 
 
 
 
Figure 3.9 Fluorescence spectra (excitation and emission) of 4-PE compounds are shown 
(left). The family of 4-PE molecules generally have a larger Stokes shift that potentially 
reduces self-quenching and increases solid-state fluorescence. Crystal structure of 4a-PE 
with J-aggregated structure is shown. All 4-PE exhibited solid state emissive property.  
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To investigate the aggregation-induced emissive property of DMAQ dyes, we conducted a 
standard water-THF titration experiment (Figure 10).45 Due to the N,N-dimethylamino substituent 
being involved in conjugation, rotation of the dimethylamino group is restricted, giving 
fluorescence in organic solution (THF). However, upon addition of water, we see a red-shift in 
fluorescence. As the water percentage increases, we observe red-shifted emission, which is one of 
the features of J-aggregates. However, possibly due to poor water solubility or a potential twisted 
internal charge transfer (TICT) state, fluorescence was quenched with 90% of water. Excess water 
molecules might be involved in multiple hydrogen bonds and break down ICT by twisting of the 
C-N bond of the N,N-dimethylamino group. TICT can lead to rapid nonradiative decay of the 
excited state and result in no fluorescence or emission.46 This intermediate is also prone to 
irreversible bleaching reactions.  Similarly, the TICT system in rhodamine is energetically 
favorable due to the lower ionization potential of N,N-dialkylanilines versus less substituted 
anilines.12 Lavis and co-workers have addressed this issue by installing azetidine in place of a 
dialkylamino substituent.12 Hence, the water quenching effect of DMAQ may improve by installing 
an azetidine at the 7 position to avoid TICT, or making the compound more water soluble. 
Nonetheless, this feature of TICT can provide the benefit of an environmentally sensitive probe47 
that is quenched in water but undergoes turn-ON in non-polar environments in addition to the 
protonation effect. This can be a useful feature to detect the accessibility of biomolecules as it will 
have enhanced fluorescence in hydrophobic environments such as in membranes or folded protein 
regions and is quenched when exposed to water.  
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Figure 3.10 AIE test of three representative 4-PE compounds. Red-shift upon addition of water 
was observed. Change in absorption was also observed.    
3.2.8. Proof of Principle Studies of MTOQ  
Since MTOQ possesses the unique features of quinoline as well as multiple sites that can 
be modulated in an orthogonal manner, we found MTOQ to be an exciting probe for biological and 
biophysical studies. To test the multi turn-ON property of MTOQ, we applied our probe to a simple 
giant unilamellar vesicle (GUV) experiment. Using 20% alkyne-labeled GUVs, we performed no 
wash turn-ON labeling of vesicles. GUVs were generated with a 1:4 ratio of 1,2-distearoyl-sn-
glycero-3-phosphocholine (N-propynyl) (propargyl-PC) : 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) via a standard electroformation protocol. To ensure the presence of GUVs, 
we also added Texas Red (0.5% of total GUV content) to both the experimental and control GUV 
batch (Figure 3.11). Within 1 to 2 hours, we clearly observed enhanced fluorescence following 
addition of the copper catalyst. We observed this turn-ON effect with most of the DMAQ dyes, two 
of which (4d and 4f) are shown as an example (Figure 3.9). Upon addition of  a Cu(I) catalyst and 
one hour of incubation, brightness was enhanced in 405ex/FITC emission filter (500-550 nm). To 
study multi turn-ON, we introduced 25 µL of 1 M HCl to 250 µL imaging solution, resulting in 
100 mM HCl (pH 1.08) (Figure 3.12).36 Upon addition of acid, we observed an extremely large 
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bathochromic shift in emission, giving fluorescence in 561ex/Cy5(670-712 nm). Furthermore, we 
can utilize this feature for live cell imaging. Though MTOQ, like many synthetic probes, suffers 
from some water solubility issues,32, 48 we show that our probe is cell permeable and lights up in a 
live cell setting. (Figure 3.13) 
 
Figure 3.11 DMAQ is Cu-catalyzed clicked to GUVs without washing. GUV composition is 20% 
propargyl-PC+ 80% DOPC +0.5% Texas Red. Control has no copper catalyst 
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Figure 3.12 A-C) 4d was incubated with GUV (20% propargyl-PC + 80% DOPC) for 2 h without 
copper catalyst. D-F) 4d was incubated with GUV for 1.5 h with copper catalyst, followed by G-I) 
in-situ addition of HCl solution (final concentration 100 mM). 405ex/Cy5 means images taken at 
405 nm laser with Cy5 emission filter (604 -712 nm). Each channel was color-coded based on the 
wavelength of laser. 
 
 
 
Note. Contrast adjustments were made by each column. Images from 405 nm laser (A, D, and G) 
were normalized to the same contrast value. Images from 488 nm laser (B, E, and H) were 
normalized to the same contrast value. Images from 561 nm laser (C, F, and I) were normalized to 
the same contrast value.  
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Figure 3.13 Live HeLa cell imaging of selected DMAQ derivatives. Images taken for A) 
4a, B) 4e, C) 4f, D) 4a-PE, E) 4e-PE, and F) 4f-PE were processed under the same imaging 
condition including contrast value. White boxes in A-C) are images of 4a,4e, and 4f 
processed with higher contrast values to demonstrate their cell penetration properties. 
Imaging Condition: 5uM dye stock in DMSO in HeLa Cell, 3 h incubation, lex = 405 nm / 
lem = 485 nm – 550 nm, same gain value. 
 
 
3.3   Future Direction 
Because MTOQ possesses a large Stokes shift as well as AIE features, we found MTOQ to be an 
interesting probe for live cell and protein aggregation studies. First, simple live cell imaging 
experiment can be done by utilizing MTOQ to detect two intracellular organelles with different pH 
(e.g., mitochondria, lysosome) with a single probe (Figure 3.14).  
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Figure 3.14 Scheme for live cell imaging with MTOQ    
 
We also envision this probe to be useful for aggregating proteins like a-synuclein (aS), which 
undergoes lyso-endosomal uptake.49 Aggregates of αS are a hallmark of Parkinson’s disease. 
Although a role for cellular transmission of aggregates has now been clearly established in the 
spread of pathology, the mechanisms underlying endocytosis of aggregates, intracellular trafficking, 
or endosomal escape of aggregates in neurons remain largely unknown, partly due to the lack of 
appropriate probes. Hence, a small, non-perturbing probe with environmental sensitivity would be 
a powerful tool to study the dynamics of aS aggregates, particularly pre-formed fibrils (aS-pffs).  
Previously, the Petersson group has developed an efficient way to engineer and purify αS with a 
single cysteine (aS-SH) or with propargyl tyrosine (αS-PpY) incorporated through unnatural amino 
acid mutagenesis (Figure 3.15).50 Fluorescently labeled aS can be used to investigate the 
internalization and endo-lysosomal trafficking of αS, following protocols developed in the Lee 
laboratory. Currently, two dyes are being used: BODIPY for labeling aS-pff and pHrodo dye as a 
pH sensitive probe. An issue with pHrodo dye is that it only turns on in acidic environments, so 
other dyes with different pH profiles would be valuable.  With the MTOQ probe, due to the non-
self-quenching nature of quinoline, we might be able to address the fates of specific MTOQ-aS-
pffs in a quantitative manner and determine whether there is growth of aggregations or if certain 
vesicles are internalized within or escaped from endocytotic vesicles, which have pH of 4.5-6.5 
(Figure 3.16). 
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Figure 3.15 Engineered aS constructs with alkyne and cyclooctyne handle for click 
reaction.    
 
 
Figure 3.16 Summary of potential MTOQ mechanism and application in tracking aS. 
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3.4   Conclusion 
In summary, we have successfully designed and synthesized a novel quinoline-based 
fluorescent probe with a PeT-based click turn-ON sensor and tunable pKa involving ICT. We show 
that DMAQ can respond to pH variation with a large emission shift of ~100 nm. Through a series 
of studies, we were able to correlate each photophysical mechanism to a fluorescence signal to 
rationally design our probe with multiple turn-ON properties. Our experiments demonstrate the 
versatility of these optimized probes for labeling a variety of alkyne-functionalized lipids, proteins, 
or biomolecules for in vitro and in cellulo studies. Beyond developing PeT-based fluorogenic 
probes, DMAQ’s tunable sensitivity may allow us to further address the limitations of the current 
dye family.  Understanding the scaffold can also motivate further improvements in our PeT turn-
ON probes by installing different PeT donors or diversifying substitution, thereby generating a 
library for probe development. In addition, the incorporation of zwitterionic sulfobetaine tails or 
replacement of the dimethylamino moiety with azetidine may be general strategies for increasing 
the solubility of DMAQ probes for protein labeling and brightness in water, respectively. Future 
work will focus on demonstrating multi turn-ON properties, reversibility of photo-convertibility 
upon protonation and deprotonation, and detection of intracellular pH fluctuation. We believe that 
MTOQ can be a quantitative tracking tool for no-wash labeling of biomolecules based on the pH 
of the intracellular location. 
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3.7   Experimental Section  
3.7.1. General Information. 
Materials. All commercial reagents and solvents were used as received. trans-
dichlorobis(triphenylphosphine)palladium(II) was purchased from Strem Chemicals, Inc. 
(Newburyport, MA). Anhydrous silver perchlorate and 4-(Boc-aminomethyl)benzeneboronic acid 
was purchased from Alfa Aesar (Haverhill, MA). 4-methoxyphenylboronic acid were purchased 
from Acros (Waltham, MA). Phenylboronic acid was purchased from Fluka (Muskegon, Michigan). 
All other reagents and solvents were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise specified. Flash column chromatography was performed using Silicycle silica gel (40-63 
µm (230-400 mesh), 60 Å irregular pore diameter). Thin-layer chromatography was performed on 
TLC Silica gel 60G F254 plate from Millipore Sigma. Reagents were purchased at the highest 
commercial quality and used without further purification, unless otherwise stated. Dulbecco’s 
Modified Eagle Medium (DMEM) was purchased from Invitrogen (Carlsbad, CA). Fetal bovine 
serum (FBS) was purchased from Gibco, Life Technologies (Gaithersburg, MD). 
Penicillin/streptomycin were purchased from Corning Cellgro (Corning, NY).  
 
Instruments. Accurate mass measurement analyses were conducted on an LCT Premier XE, time-
of-flight, LCMS with electrospray ionization (ESI).  The signals were measured against an internal 
lock mass reference of leucine enkephalin. Waters software calibrates and reports by use of neutral 
atom mass. The mass of an electron is not included.  High-resolution mass spectra were obtained 
by Dr. Charles Ross III at the University of Pennsylvania’s Mass Spectrometry Service Center on 
a Micromass AutoSpec electrospray/chemical ionization spectrometer. X-ray diffraction data 
obtained and solved by Dr. Patrick Carroll at the University of Pennsylvania. Fluorescence spectra 
and UV-Vis measurement were acquired on a PTI Quantamaster40 fluorometer and a Hewlett-
Packard 8452A diode array spectrophotometer (currently Agilent Technologies; Santa Clara, CA, 
 224 
USA), respectively, using quartz cells with a 1 cm cell path length (Starna Cells, Inc 120ul UV 
cells) or disposable UV cuvettes.  Fluorescence spectra were acquired on a Tecan M1000 plate 
reader (Mannedorf, Switzerland). Nuclear magnetic resonance (NMR) spectra were obtained on a 
Neo 400, Bruker UNI-500 and AVII-500B instrument and are calibrated using deuterated solvent 
(CD2Cl2 at 53.84 ppm 13C NMR. The following abbreviations were used to explain multiplicities: 
s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad).  Analytical High-
performance liquid chromatography (HPLC) studies were done with a Agilent Technology Infinity 
II equipped with a Phenomenex Luna Omega 5μm PS C18(2) 100A; 250 x 4.60 mm column using 
aqueous (H2O + 0.1% CF3CO2H) and organic (CH3CN+ 0.1% CF3CO2H) phases. The infrared (IR) 
spectra were obtained with Perkin Elmer Spectrum Two FT-IR by dissolving a small amount of 
compound in dichloromethane to mount the sample. For certain experiments, anhydrous solvents 
are obtained from Meyer Solvent Dispensing System (Laguna Beach, CA). 
 
Cell Culture and Imaging. HeLa cells were maintained in a humidified incubator at 37 °C in 5% 
CO2. HeLa cells were cultured in DMEM supplemented with 10% fetal bovine serum (Gibco, Life 
Technologies) and penicillin and streptomycin (Corning Cellgro). For live cell imaging, cells were 
plated in glass-bottom 35-mm dishes (MatTEK) 48 h before experiments. 48 h after plating, 2 μL 
of compound (stock solution 5 mM) was added to 2 mL of media. Cells were incubated for 2-5 h 
with compounds at 37 °C, followed by washing with fresh media 2 times. During imaging, cells 
were maintained in DMEM without phenol red, supplemented with 10% FBS. A Leica TCS SP8 
confocal microscope equipped with a 40x and 63x/1.4 NA oil immersion objective lens was used.  
 
GUV and Imaging. Images were acquired on a Nikon spinning disk confocal microscope equipped 
with a 60x oil immersion objective lenses. Images were processed using Nikon Elements software. 
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3.7.2. Experimental Procedure 
Previous synthesis of compound 3 
 
Figure S 3.1 Previous synthesis of 4-chloro-N,N-dimethyl-2-arylquinolin-7-amine (3a-3f) 
 
Selected derivatives of compound 3 (3a-3f) were synthesized following the previously reported 
synthesis. Key precursor 2,4-dichloro-N,N-dimethylquinolin-7-amine (2) was synthesized by one-
pot two step cyclo-condensation and chlorination reaction with 96% over yield. 2 (400 mg, 1.67 
mmol, 1.0 equiv) was used to generate six derivatives (3a-3f) in good to high yield (76-94%).   
 
Optimized synthesis of compound 4 
 
Figure S 3.2 Synthesis of 4-azido-N,N-dimethyl-2-arylquinolin-7-amine (4a-4f) 
NH2N
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General Procedure A: Azidation Reaction 
  In a 20 mL scintillation vial with a magnetic stirrer, sodium azide (5.0 equiv), anhydrous 
silver perchlorate (3.0 equiv), and 4-chloro-N,N-dimethyl-2-arylquinolin-7-amine (3a-3f) were 
added. To the reaction vial charged with nitrogen gas, the premixed solution of 15-crown-5 ether 
(5.0 equiv) dissolved into dry dimethylformamide (DMF) were added to the reaction vial (0.05M) 
and capped tightly with Green Open Top SURE-Link™ Polypropylene Cap (Chemglass Life 
Sciences CG-4904-05).  The reaction vial was backfilled with an argon balloon. The reaction 
mixture was vigorously stirred and heated at 80 °C under the dark for 12-36 h until the reaction is 
completed. The change in color from bright yellow to darker yellow solution was observed. After 
complete conversion was confirmed by liquid-chromatography mass spectrometry (LCMS) and 
TLC, the reaction vial was cooled down to room temperature (Graphical guide A). To 500 mL 
round bottom flask full of cold MiliQ water, the DMF solution mixture was slowly filtered by 
syringe to remove any insoluble byproducts including silver salts (Graphical guide B). In order 
to avoid any explosion from dried silver azide complex, the filter was kept wetted by DMF 
(Graphical guide C-D). The desired product is crashed out as yellow solid precipitates leaving 
excess sodium azide and crown ether stay dissolved in the water layer (Graphical guide E-F). 
The aqueous mixture was then filtered quickly to avoid the contact with air followed by washing 
with water three times (Graphical guide G-H). It is also suggested to centrifuge down the crashed 
out solid to collect the yellow solid. Collected solids were then lyophilized or dried (Graphical 
guide I).   
For compound 4e, the aqueous solution after step E-F (Graphical guide) was extracted 
with EtOAc three times and washed with brine. Organic layers were combined, dried over Na2SO4 
and concentrated in vacuo to give a brownish solid.  
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Graphical guide  
 
Photos were taken to show work-up procedure for azidation reaction.  
 
 
Figure S 3.3 Graphical guide of purification following azidation reaction 
 
General Procedure B: Click Reaction 
Cu-catalyzed Click Reaction (Alkyne = propargyl phenyl ether; PE) Stock solutions of copper 
sulfate and Tris(benzyltriazolylmethyl)amine (THPTA), and alkyne were prepared and kept in the 
fridge. Fresh stock of sodium ascorbate (100 mM) is prepared. Copper catalyst cocktail was pre-
made by mixing Copper sulfate, THPTA and sodium ascorbate.  To a reaction vial with magnetic 
stirrer, MTOQ (4a-4f) and alkyne were added and mixed well prior to the addition of copper 
catalyst. Once the copper catalyst is added, the vial was stirred at room temperature for 20 min to 
5 hours.  
 
Cu-free Click Reaction (Alkyne = bicyclononyne; BCN or bicyclononyne-PEG-maleimide; 
BCN-Mal) Stock solutions of dye and alkyne were prepared. The reaction was stirred at room 
temperature for 9-15 hours.   
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3.7.3. Silver Additive and Temperature Screening for Azidation Reaction  
Crude UP-LCMS Analysis Method for experiments were carried out to screen the effect of silver 
and temperature for each derivative using 3.0 mg of compound 3. Each product is colored based 
on the retention time of previously synthesized standard and expected m/z. Background solvent 
(grey), desired product (magenta), starting material (yellow) and side product (green) are shown. 
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Figure S 3.4  Crude UP-LCMS of azidation reaction done at A) 60 °C with silver catalyst, B) 
60 °C without silver catalyst, C)80 °C with silver catalyst, B) 80 °C without silver catalyst for each 
derivative. The best condition is boxed and further optimized condition is written in red. 
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3.7.4. Turn-ON Analysis of MTOQs (4a-4f) via Plate Reader. 
I. MTOQs	(4a-4f)	and	BCN	
Experiments were set up using two types of 96 well plates with black flat bottoms. Organic solvents 
(polarity screening) were screened on Greiner Bio-One 96 well non-treated polypropylene 
microplates. A 5 mM DMSO stock solutions (4a-4f) were dosed to each well and diluted with 
corresponding solvents. BCN was added to “+” or “ON” row and blank miliQ was added to “-” or 
“OFF” rows (control). Regardless of their optimal maximum absorption, every compound was 
excited at 405 nm. Due to possible errors in pipetting and evaporation of solvents, the intensity is 
only treated as an estimate. By comparing the highest intensity of 4-PE and 4 in the selected solvent, 
a fold-increase value is obtained. 
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Figure S 3.5 A) Plate reader analysis of copper-free turn on efficiency of MTOQ and BCN under 
various solvents.  B) Best turn-ON in organic solvent condition for each derivative is shown. Fold-
increase value under emission (nm) is written. Dotted line is emission of azide-functionalized 
DMAQ (MTOQ) and solid-line is emission of MTOQ clicked with BCN (4-BCN). C) Best turn-
ON in aqueous solvent conditions. 
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II. MTOQs	(4a-4f)	and	PE	
Due to lack of solubility in purely aqueous solutions, the click reaction was done in 2:1 DMSO: 
Water (25mM). Prior to adding copper catalyst, 5 µL of reaction solution was diluted to 500 µL of 
0.1% TFA in acetonitrile, chloroform or dimethyl sulfoxide to give 250 µM (shown in photo). Fold 
increase in selected acid-sensitive compounds (4b and 4c) are shown at 488 nm excitation and 692 
nm emission.  
 
Figure S 3.6 MTOQ turn-ON in acidic solvent, non-polar organic and polar organic solvent.  
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III. MTOQs	(4a-4f)	and	BCN-Mal	
 
Best turn-on solvent condition for corresponding compounds are boxed in white. Generally, DMSO 
and DMF gave the best turn-ON for compound 4 except for 4b. 4e, 4c, 4d, and 4f showed good 
turn-ON at pH 11 (aqueous) and 4b and 4c at 0.1% TFA in acetonitrile.  
 
 
 
Figure S 3.7 MTOQ turn-ON with BCN-Mal in aqueous, non-polar organic and polar organic 
solvents. 
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IV. Multi	turn-ON	analysis	and	pH	sensitivity	of	MTOQs	(4a-4f)	via	plate	reader	
 
 
 
Figure S 3.8 Multi turn-ON analysis  
 
Figure S 3.9  pH sensitivity analysis  
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3.7.5. Spectroscopic Characterization 
 
Fluorescence Excitation and Emission Spectra. Prior to spectroscopic characterization, stocks of 
each MTOQ derivative were prepared in DMSO at a concentration of 5 mM. Absorbance and 
fluorescence measurements were taken at 50 uM and 5 uM dye in neutralized methanol. 
Absorbance measurements were acquired at concentrations of 50 uM and 1 uM for proper 
visualization of the ~400 nm region. Fluorescence measurements were acquired under identical 
conditions, at concentrations of 50 uM and 1 uM for all compounds on a PTI Quantamaster40 
fluorometer. Spectra were collected using the maximum absorbance wavelength for each derivative. 
The collection window started 10 nm from the excitation wavelength and extended to 800 nm. All 
slit widths were set to 2 nm and spectra were acquired with an integration time of 1 sec/nm.  
 
Coefficients were calculated from absorbance measurements collected on a Tecan M1000 plate 
reader (Mannedorf, Switzerland). Samples containing 100, 50, 25, 10 and 1 μM chromophore were 
prepared in neutralized methanol solution with a total sample volume of 200 μL.  Following brief 
vortexing and centrifugation, samples were loaded into a Corning CoStar black, clear bottom, 96-
well plate.  Absorbance and emission spectra are reported below. The sensitivity of the absorbance 
and emission to pH was assessed for each MTOQ derivative in both the pre-clicked (4a-4f) and 
PE-clicked state (4-PE)  in 1:1 CH3CN/buffer. The buffers were a titration of 0.1 mM citric acid 
and 0.1 M Bis-Tris propane, the pH 10, 11 and 14 were adjusted with varying amounts of 0.1 M of 
NaOH. The sensitivity of the emission to varying solvents was assessed for each DMAQ derivative 
in both the preclicked and PE-clicked state at 5 uM concentration in the following solvents DCM, 
IPA, MeCN, DMSO both neutralized and with 0.1% TFA. For Approximate quantum yield 
measurements, all derivatives were excited at 388 nM in MeOH and normalized to the emission at 
of Acrydonylalanine in MeOH.  
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Table S 3.1 Photophysical data of azide (4) and triazole (4-PE) functioanlized DMAQ 
 
 
R 4 / 4-PE λabs λex λem ε Φ
NMe2 4a 402 411 485 54,592 0.0324a-PE 414 423 502 62,720 0.078
OH 4b 387 387 489 14,457 0.0284b-PE 407 407 501 17,114 0.61
OCH3 4c 393 392 490 24,689 0.0384c-PE 407 407 503 14,548 0.771
CH2NHBo
c
4d 397 397 505 20,422 0.023
4d-PE 411 410 510 16,548 0.698
H 4e 393 390 508 26,056 0.0554e-PE 404 413 511 24,464 0.912
CF3 4f 404 408 518 16,318 0.0294f-PE 417 417 528 18,874 0.768
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Figure S 3.10 Spectroscopy data of 4a-c, 4a-PE, 4b-PE, and 4c-PE 
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Figure S 3.11 Spectroscopy data of 4d-f, 4d-PE, 4e-PE, and 4f-PE 
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3.7.6. Preliminary studies of other derivatives 
General procedure C. General reaction A with 2,4-dichloro dimethylamino quinoline (2) and 
hydrolyzed compound (2c). Silver perchlorate was not used. General reaction B with propargyl 
phenyl ether (PE) and phenylacetylene (PA) was done.   
 
 
Figure S 3.12 Synthetic scheme with turn ON effect on non-arylated dimethylamino quinolines 
(2b, 2d) 
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Figure S 3.13 A) Fluorescence spectra (dotted line: excitation, solid line: emission spectra) of 
azide-functionalized 2b and triazole-functionalized 2b-PA or 2b-PE. Spectra are not normalized. 
B) kinetics of click reaction with 2b upon formation of triazole 2b-PA or 2b-PE. C) Crystal 
structures of 2b-PA and 2b-PE to show twisted structure of triazole moieties. 
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General procedure D. Cross coupling reaction of compound 2b or 2d with para-substituted 
potassium phenyltrifluoroborates compounds. Resulting side products including dichlorination, 
hydrogenation, and hydrolysis products were purified by HPLC and confirmed by HRMS.   
Table S 3.2 HRMS analysis  
Cmpd Chemical formula [M] 
Calculated  
[M+H/Na]+ 
Observed 
[M+H/Na]+ ESI 
2a C11H10ClN5 270.0522 270.0520 [M+Na]+ 
2b C11H10ClN5 248.0703 248.0705 [M+H]+ 
2d C11H11N5O 230.1042 230.1042 [M+H]+ 
2b-PA C19H16ClN5 350.1172 350.1177 [M+H]+ 
2d-PA C19H17N5O 332.1511 332.1511 [M+H]+ 
H-PA C19H17N5 316.1562 316.1567 [M+H]+ 
4a-PA C27H26N6 435.2297 435.2295 [M+H]+ 
4e-PA C25H21N5 392.1875 392.1880 [M+H]+ 
4f-PA C26H20F3N5 460.1749 460.1750 [M+H]+ 
2b-PE C20H18ClN5O 380.1278 380.1288 [M+H]+ 
2d-PE C20H19N5O2 362.1617 362.1607 [M+H]+ 
H-PE C20H19N5O 346.1668 346.1673 [M+H]+ 
4e-PE C26H23N5O 422.1981 422.1996 [M+H]+ 
4f-PE  C27H22F3N5O 490.1855 490.1858 [M+H]+ 
 
 
Figure S 3.14 Fluorescence emission spectra of PA- or PE-functionalized derivatives. 
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Figure S 3.15 Selected live Hela cell imaging with PA- and PE-series from Figure S 3.14.  
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Figure S 3.16 Solid state emissive properties of PA-series from Figure S 3.14  
 
 
3.7.7. GUV imaging 
Synthesis: GUVs were prepared as previously described. Phospholipid stock of DOPC and 18:1 
propargyl PC (1.0 mM) were prepared in chloroform-methanol (2:1 v:v) and combined in a 1:1 or 
4:1 molar ratio. 40μL of lipid mixture in organic solvent was deposited on the microscope cover 
slide on the conductive face while heating at 30°C. Two slides per sample were prepared. After 
drying under vacuum overnight to remove residual solvent, the two slides were then combined with 
a silicone spacer (Grace Bio-Labs, Bend, OR) to enclose 450 μL 150 mM sucrose solution and 
electroformed using a function generator (AC field 2 V/mm, 5 Hz) for 2 h. Prepared GUV solutions 
were diluted 10-fold and imaged on MatTek (35 mm dish, #1.5 cover glass) dishes at room 
temperature. 
In-situ click condition: 25 μL of GUV solution (177 mM) were added to 214 μl 1:1 
sucrose/glucose solution (150 mM). Then 0.5 μL 5.0 mM azide solution (3.0 eq relative to 18:1 
propargyl PC) was added, followed by 10.6 μL of freshly prepared click solution or 1:1 
sucrose/glucose (control), giving a final GUV concentration of 17.7 mM. The solution was mixed 
well and added to the center of a MatTek dish for imaging. Click solution was prepared by first 
adding 25 μL 10 mM copper sulfate pentahydrate in 1:1 sucrose/glucose (to avoid rupturing GUVs) 
and 150 μL 10 mM THPTA in sucrose/glucose. Next, 125 μL freshly prepared 10 mM sodium 
ascorbate in 1:1 sucrose/glucose was added. 
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Figure S 3.17 In-situ turn on click with 50% alkyne functionalized GUV with 4c, 4d, 4e, and 4f.  
 
Figure S 3.18 In-situ turn on click with 20% alkyne functionalized GUV with 4b. Texas red (0.5% 
GUV composition) was added to ensure there are vesicles in the control images (no Cu(I)). 
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Figure S 3.19 In-situ turn on click with 20% alkyne functionalized GUV with 4d. Each 
experiment with Cu(I) and control experiment without Cu(I) images were taken and HCl solution 
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was added in situ for acid-red shifted images. Only post-clicked 4d had significant red-shift in 
emission while control (unclicked 4d) experiment with acid showed no significant change. 
 
 
Figure S 3.20 In-situ turn on click with 20% alkyne functionalized GUV with commercially 
available BODIPY (Lumiprobe, BDP FL azide).  Only post-clicked 4d had significant quench in 
emission upon addition of acid.   
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Characterization Data for 4-azido-2-(4-(dimethylamino)phenyl)-N,N-dimethylquinolin-7-
amine (4a) 
 
General procedure (163 mg scale, 98% yield) Following the General Procedure A, 4-chloro-2-
(4-(dimethylamino)phenyl)-N,N-dimethylquinolin-7-amine (3a) (163 mg, 0.50 mmol, 1.0 equiv) 
with silver perchlorate (311 mg, 1.50 mmol, 3.0 equiv) at 80 °C in dimethylformamide (DMF) for 
18 h afforded 163 mg of the title compound after precipitation method. 
 
Physical state: brown solid 
TLC: Rf = TBD 
1H NMR: (500 MHz, Methylene Chloride-d2)  δ 8.10 – 7.99 (m, 2H), 7.82 (d, J = 9.1 Hz, 1H), 7.30 
(s, 1H), 7.16 – 7.01 (m, 2H), 6.90 – 6.77 (m, 2H), 3.12 (s, 6H), 3.06 (s, 6H). 
13C NMR: (126 MHz, CD2Cl2) δ 157.67, 152.16, 151.58, 151.30, 145.69, 128.16, 127.13, 122.60, 
114.81, 112.27, 112.01, 106.66, 101.82, 40.35, 40.20 
HRMS (ESI-TOF): calc’d for C19H20N6 [M+H]+ 333.1828; found 333.1828. 
IR (neat): 2891.44, 2804.77, 2107.98, 1607.44, 1582.19, 1563.22, 1508.72, 1483.14, 1442.86, 
1419.12, 1406.47, 1356.22, 1356.22, 1288.81, 1256.74, 1224.02, 1191.04, 1168.3, 1126.67, 
1063.68, 1063.68 cm-1 
  
N
N3
N
N
 248 
Characterization Data for 4-(4-azido-7-(dimethylamino)248uinoline-2-yl)phenol (4b) 
 
General procedure (200 mg scale, 60% yield) Following the General Procedure A, 4-chloro-7-
(dimethylamino)248uinoline-2-yl)phenol (3b) (200 mg, 0.67 mmol, 1.0 equiv) at 60 °C without 
silver perchlorate for 18 h in dimethylformamide (DMF) afforded 120 mg (60 % isolated yield) of 
the title compound after precipitation method.  
 
Physical state: brown solid 
TLC: Rf = TBA 
1H NMR: (500 MHz, Acetone-d6) δ 8.21 – 8.12 (m, 2H), 7.81 (dd, J = 9.2, 1.5 Hz, 1H), 7.48 (d, J 
= 1.5 Hz, 1H), 7.19 (dd, J = 9.1, 2.6 Hz, 1H), 7.07 (d, J = 2.7 Hz, 1H), 6.99 – 6.94 (m, 2H), 2.83 
(s, 6H) 
13C NMR: (126 MHz, CDCl3) δ 205.24, 158.90, 156.98, 152.12, 151.11, 145.75, 130.94, 128.72, 
122.37, 115.32, 115.27, 112.10, 106.59, 101.85, 39.54, 29.09, 28.94, 28.79. 
HRMS (ESI-TOF): calc’d for C17H15N5O [M+H]+ 306.1355; found 306.1355. 
IR (neat): 2110.36, 1618.4, 1508.59 cm-1  
N
N3
N
OH
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Characterization Data for 4-azido-2-(4-methoxyphenyl)-N,N-dimethylquinolin-7-amine (4c) 
 
 
General procedure (157 mg scale, 85% yield) Following the General Procedure A, 4-chloro-2-
(4-methoxyphenyl)-N,N-dimethylquinolin-7-amine (3c) (157mg, 0.50 mmol, 1.0 equiv) without 
silver perchlorate 3h at 80 °C in dimethylformamide (DMF)  for 18 h afforded 136 mg of the title 
compound after precipitation method. 
 
Physical state: yellowish brown solid 
TLC: Rf = TBD 
1H NMR: (500 MHz, Methylene Chloride-d2) δ 8.11 (dd, J = 9.4, 2.8 Hz, 2H), 7.89 – 7.80 (m, 1H), 
7.30 (d, J = 3.8 Hz, 1H), 7.12 (dq, J = 5.5, 2.6 Hz, 2H), 7.04 (dd, J = 9.4, 2.7 Hz, 2H), 3.89 (s, 3H), 
3.13 (s, 6H). 
13C NMR:  (126 MHz, CD2Cl2) δ 161.00, 157.26, 152.22, 151.23, 146.04, 132.30, 128.64, 122.65, 
115.35, 114.09, 112.42, 106.65, 102.20, 55.47, 40.32. 
HRMS (ESI-TOF): calc’d for C18H17N5O [M+H]+ 320.1511; found 320.1524. 
IR (neat): 2108.41, 2005.44, 1607.17, 1576.06, 1576.06, 1505.99, 1456.29, 1429.31, 1406.59, 
1355.06, 1305.43, 1289.85, 1247.6, 1219.92, 1172.91, 1154.27, 1066.79, 1030.31, 837.58, 810.54, 
652.46 cm-1 
 
  
N
N3
N
OMe
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Characterization Data for tert-butyl (4-(4-azido-7-(dimethylamino)quinolin-2-
yl)benzyl)carbamate (4d) 
 
General procedure (190 mg scale, 90% yield) Following the General Procedure A, (4-(4-chloro-
7-(dimethylamino)quinolin-2-yl)benzyl)carbamate (3d) (190 mg, 0.46 mmol, 1.0 equiv) with silver 
perchlorate (287 mg, 1.38 mmol, 3.0 equiv) at 80 °C in dimethylformamide (DMF) for 18 h 
afforded 174mg of the title compound after precipitation method. 
 
Physical state: yellowish brown solid  
TLC: Rf = TBD 
1H NMR: (500 MHz, Methylene Chloride-d2) δ 8.09 (d, J = 7.9 Hz, 2H), 7.88 (d, J = 9.9 Hz, 1H), 
7.43 (d, J = 8.0 Hz, 2H), 7.33 (s, 1H), 7.15 (d, J = 8.0 Hz, 2H), 5.37 – 5.28 (m, 2H), 4.38 (d, J = 
6.1 Hz, 2H), 3.13 (s, 6H), 1.48 (s, 9H). 
13C NMR: (126 MHz, CD2Cl2) δ 157.32, 156.01, 152.32, 151.07, 146.36, 140.87, 138.61, 127.63, 
127.54, 122.72, 115.75, 112.63, 106.45, 102.66, 79.41, 44.35, 40.31, 28.24. 
HRMS (ESI-TOF): calc’d for C23H26N6O2 [M+H]+ 419.2195; found 419.2183. 
IR (neat): 2110.3, 2005.35, 1699.11, 1616.35, 1586.11, 1574.51, 1506.91, 1454.89, 1429.72, 
1406.7, 1390.4, 1354.31, 1320.28, 1252.59, 1165.22, 1065.73, 1048.92, 1022.17, 838.97, 810.36 
cm-1 
 
  
N
N3
N H
N
Boc
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Characterization Data for 4-azido-N,N-dimethyl-2-phenylquinolin-7-amine (4e) 
 
 
General procedure (100mg scale, 75% yield) Following the General Procedure A, 4-chloro-N,N-
dimethyl-2-phenylquinolin-7-amine (3e) (100 mg, 0.35 mmol, 1.0 equiv) with silver perchlorate 
(220 mg, 1.06 mmol, 3.0 equiv) at 70 °C in acetonitrile for 18 h afforded 77 mg of the title 
compound after extraction method. 
 
Physical state: brown solid 
TLC: Rf = TBD 
1H NMR: (500 MHz, Methylene Chloride-d2) δ 8.16 (s, 2H), 7.86 (d, J = 9.1 Hz, 1H), 7.59 – 7.52 
(m, 2H), 7.49 (d, J = 7.1 Hz, 1H), 7.33 (s, 1H), 7.26 – 7.06 (m, 2H), 3.13 (s, 6H). 
13C NMR: (126 MHz, Methylene Chloride-d2) δ 157.63, 152.21, 151.29, 146.13, 139.88, 128.77, 
127.38, 122.68, 115.70, 112.65, 106.78, 102.67, 53.58, 40.31. 
HRMS (ESI-TOF): calc’d for C17H15N5 [M+H]+ 290.1406; found 290.1394. 
IR (neat): 2105.69, 1613.09, 1587.84, 1576.33, 1552.25, 1514.17, 1494.77, 1484.88, 1455.61, 
1438.36, 1420.75, 1349.28, 1322.54, 1255.79, 1238.84, 1218.56, 1152.37, 810.22, 770.89, 693.4 
cm-1 
 
  
N
N3
N
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Characterization Data for 4-azido-N,N-dimethyl-2-(4-(trifluoromethyl)phenyl)quinolin-7-
amine (4f) 
 
General procedure (175mg scale, 95% yield) Following the General Procedure A, 4-chloro-N,N-
dimethyl-2-(4-(trifluoromethyl)phenyl)quinolin-7-amine (3f) (175 mg, 0.50 mmol, 1.0 equiv) with 
silver perchlorate (311mg, 1.50 mmol, 3.0 equiv) at 80 °C in dimethylformamide (DMF) for 18 h 
afforded 169 mg of the title compound after extraction method 
 
Physical state: yellow solid, brown crystal 
TLC: Rf = TBD 
1H NMR: (400 MHz, Methylene Chloride-d2) δ 8.18 (d, J = 8.1 Hz, 2H), 7.79 (d, J = 9.1 Hz, 1H), 
7.69 (d, J = 8.2 Hz, 2H), 7.25 (s, 1H), 7.13 – 7.02 (m, 2H), 3.04 (s, 6H). 
13C NMR: (101 MHz, CD2Cl2) δ 155.88, 152.21, 151.14, 146.37, 143.17, 130.83, 130.51, 127.59, 
127.56, 125.70, 125.58, 125.54, 125.50, 125.46, 123.00, 122.61, 116.08, 112.67, 106.47, 102.45, 
40.16. 
19F NMR: (376 MHz, CD2Cl2) δ -62.85. 
HRMS (ESI-TOF): calc’d for C18H14F3N5 [M+H]+ 358.1280; found 358.1300 
IR (neat): 2109.73, 1994.26, 1703.82, 1615.87, 1586.13, 1574.6, 1506.83, 1455.8, 1429.56, 
1406.59, 1390.58, 1353.32, 1319.87, 1252.41, 1167.96, 1047.43, 1021.89, 968.99, 838.33, 809.87 
cm-1 
 
 
N
N3
N
CF3
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Characterization Data for 2-(4-(dimethylamino)phenyl)-N,N-dimethyl-4-(4-
(phenoxymethyl)-1H-1,2,3-triazol-1-yl)quinolin-7-amine (4a-PE) 
 
  
General procedure B: Following the General Procedure B, 4-azido-dimethylquinoline (4a) with 
1.0 equiv of copper catalyst in 2:1 DMSO: water at room temperature for overnight.  
 
Physical state: orange solid (green solid state fluorescent or pink film fluorescent) 
TLC: Rf =TBD 
1H NMR: (400 MHz, Acetonitrile-d3) δ 8.34 (s, 1H), 8.03 (d, J = 8.8 Hz, 2H), 7.63 – 7.47 (m, 2H), 7.32 – 
7.18 (m, 3H), 7.15 – 7.07 (m, 1H), 7.02 (d, J = 8.1 Hz, 2H), 6.93 (s, 1H), 6.72 (d, J = 8.9 Hz, 2H), 5.24 (s, 
2H), 3.03 (s, 6H), 2.92 (s, 6H). 
13C NMR: (101 MHz, CD3CN) δ 158.96, 157.13, 152.78, 152.67, 150.77, 144.52, 142.33, 130.21, 129.12, 
126.46, 124.21, 121.81, 117.89, 117.05, 115.44, 112.92, 112.41, 109.35, 105.33, 61.88, 40.11, 39.99. 
HRMS (ESI-TOF): calc’d for C28H28N6O [M+H]+ 465.2403; found 465.2414. 
IR (neat): 1611.45, 1587.47, 1561.65, 1513.16, 1487, 1464.9, 1441.9, 1362.32, 1265.39, 1230.32, 
1191.93, 1169.65, 1127.82, 1107.16, 1031.08, 1015.8, 818.73, 753.86, 734.96, 691.58 cm-1 
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Characterization Data for 4-(7-(dimethylamino)-4-(4-(phenoxymethyl)-1H-1,2,3-triazol-1-
yl)quinolin-2-yl)phenol (4b-PE): 
 
 
 
 
General procedure B: Following the General Procedure B, 4-azido-dimethylquinoline (4b) with 
1.0 equiv of copper catalyst in 2:1 DMSO: water at room temperature for overnight.  
Physical state: red-orange solid (dim brown greenish solid state fluorescent) 
TLC: Rf = 0.35 (10% acetone in DCM) 
1H NMR (500 MHz, DMSO-d6) δ 8.95 (s, 1H), 8.24 – 8.05 (m, 2H), 7.86 (s, 1H), 7.64 (d, J = 9.4 
Hz, 1H), 7.37 – 7.31 (m, 2H), 7.28 (dd, J = 9.4, 2.6 Hz, 1H), 7.14 – 7.06 (m, 3H), 7.00 – 6.95 (m, 
1H), 6.91 – 6.84 (m, 2H), 5.30 (s, 2H), 3.09 (s, 6H). 
13C NMR: (101 MHz, DMSO-d6) δ 157.10, 152.01, 151.50, 143.70, 141.36, 130.07, 129.26, 129.23, 
127.18, 123.86, 121.49, 117.36, 116.10, 115.23, 112.54, 109.37, 106.55, 61.37. 
HRMS (ESI-TOF): calc’d for C26H23N5O2 [M+H]+ 438.1930; found 438.1922 
IR (neat): 2924.52, 2854.5, 1727.35, 1579.01, 1460.39, 1376.32, 1270.14, 1170.94, 1122.66, 
1072.82, 1037.55, 835.55, 754.46 cm-1 
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Characterization Data for 2-(4-methoxyphenyl)-N,N-dimethyl-4-(4-(phenoxymethyl)-1H-
1,2,3-triazol-1-yl)quinolin-7-amine (4c-PE): 
 
 
 
General procedure B: Following the General Procedure B, 4-azido-dimethylquinoline (4c) with 
1.0 equiv of copper catalyst in 2:1 DMSO: water at room temperature for overnight.  
 
Physical state: yellow solid (dim red film fluorescent) 
TLC: Rf = 0.35 (1% acetone in DCM) 
1H NMR: (500 MHz, Acetonitrile-d3) δ 8.41 (d, J = 1.7 Hz, 1H), 8.21 (dt, J = 8.3, 1.6 Hz, 2H), 7.75 (d, J = 
1.6 Hz, 1H), 7.67 (d, J = 9.3 Hz, 1H), 7.40 – 7.31 (m, 2H), 7.27 (ddd, J = 9.4, 2.7, 1.7 Hz, 1H), 7.21 (d, J = 
2.5 Hz, 1H), 7.10 (tt, J = 8.3, 1.3 Hz, 4H), 7.02 (s, 1H), 5.34 (d, J = 1.7 Hz, 2H), 3.88 (d, J = 1.6 Hz, 3H), 
3.14 (d, J = 1.7 Hz, 6H). 
13C NMR: (101 MHz, Methylene Chloride-d2) δ 129.59, 128.59, 124.82, 123.13, 121.32, 116.81, 
114.80, 114.12, 109.23, 106.78, 61.85, 55.38, 53.97, 53.70, 53.43, 53.16, 52.89, 40.13. 
HRMS (ESI-TOF): calc’d for C27H25N5O2 [M+H]+ 452.2087; found 452.2107. 
IR (neat): 2923.09, 1616.26, 1595.62, 1578.28, 1509.51, 1490.02, 1463.2, 1443.14, 1373.32, 
1304.01, 1285.71, 1247.55, 1172.91, 1110.63, 1029.78, 834.33, 809.42, 753.28, 735, 691.34 cm-1 
 
   
N
N
N
O
N
N
O
 256 
Characterization Data for tert-butyl (4-(7-(dimethylamino)-4-(4-(phenoxymethyl)-1H-1,2,3-
triazol-1-yl)quinolin-2-yl)benzyl)carbamate (4d-PE): 
 
 
 
General procedure B: Following the General Procedure B, 4-azido-dimethylquinoline (4d) with 
1.0 equiv of copper catalyst in 2:1 DMSO: water at room temperature for overnight.  
 
Physical state: yellow solid (green film fluorescent) 
TLC: Rf = 0.33 (3:2 hexane/ethyl acetate) 
1H NMR: (500 MHz, Acetonitrile-d3) 1H NMR (500 MHz, Acetonitrile-d3) δ 8.39 (s, 1H), 8.20 – 8.09 
(m, 2H), 7.73 (s, 1H), 7.67 (d, J = 9.1 Hz, 1H), 7.41 (d, J = 7.8 Hz, 2H), 7.37 – 7.32 (m, 2H), 7.25 (dt, J = 
9.6, 2.4 Hz, 1H), 7.20 (d, J = 2.7 Hz, 1H), 7.13 – 7.06 (m, 2H), 7.03 – 6.99 (m, 1H), 5.32 (s, 2H), 4.29 (d, J 
= 6.4 Hz, 2H), 3.11 (s, 6H), 1.44 (s, 9H). 
13C NMR: (101 MHz, Acetonitrile-d3) δ 130.23, 128.06, 127.85, 126.45, 123.97, 121.83, 117.90, 
115.48, 110.22, 106.94, 61.93, 44.13, 40.11, 28.22. 
HRMS (ESI-TOF): calc’d for C32H34N6O3 [M+H]
+ 551.2771; found 551.2756. 
IR (neat): 3348.44, 2925.17, 1704.14, 1617.83, 1598.16, 1510.12, 1494.76, 1374.2, 1239.98, 
1170.62, 1110.31, 1031.81, 1016.89, 844.11, 811.2, 754.31, 691.78, 496.06 cm-1 
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Characterization Data for N,N-dimethyl-4-(4-(phenoxymethyl)-1H-1,2,3-triazol-1-yl)-2-
phenylquinolin-7-amine (4e-PE) 
 
 
 
General procedure B: Following the General Procedure B, 4-azido-dimethylquinoline (4e) with 
1.0 equiv of copper catalyst in 2:1 DMSO: water at room temperature for overnight.  
 
Physical state: yellow solid (green solid state fluorescent/ red film fluorescent) 
TLC: Rf = 0.33 (5:2 hexane/ethyl acetate) 
1H NMR: (400 MHz, Methylene Chloride-d2) δ 8.32 – 8.08 (m, 4H), 7.87 (d, J = 9.6 Hz, 1H), 7.52 – 7.47 
(m, 4H), 7.28 – 7.23 (m, 2H), 7.20 (dd, J = 9.6, 2.6 Hz, 1H), 7.01 – 6.96 (m, 2H), 6.96 – 6.91 (m, 1H), 5.28 
(s, 2H). 
13C NMR: (101 MHz, CD3CN) δ 158.97, 157.74, 152.65, 152.22, 144.56, 142.12, 139.35, 130.34, 130.21, 
129.41, 127.77, 126.48, 123.99, 121.81, 115.45, 113.65, 110.34, 106.97, 68.31, 61.91, 40.11. 
HRMS (ESI-TOF): calc’d for C27H25N5O2 [M+H]
+ 422.1981; found 422.1987. 
IR (neat): 2923.27, 2853.53, 1615.5, 1597.46, 1553.04, 1518.97, 1488.74, 1464.31, 1440.22, 
1374.27, 1236.89, 1173.55, 1160.35, 1103.71, 1079.19, 1030.38, 1015.91, 811.52, 754.43, 692.13 
cm-1 
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Characterization Data for N,N-dimethyl-4-(4-(phenoxymethyl)-1H-1,2,3-triazol-1-yl)-2-(4-
(trifluoromethyl)phenyl)258uinoline-7-amine (4f-PE) 
 
 
 
 
General procedure B: Following the General Procedure B, 4-azido-dimethylquinoline (4f) with 
1.0 equiv of copper catalyst in 2:1 DMSO: water at room temperature for overnight.  
 
Physical state: greenish yellow crystal (bright green solid state fluorescent) 
TLC: Rf = TBD 
1H NMR: (400 MHz, Acetonitrile-d3) δ 8.42 (s, 1H), 8.39 (d, J = 8.1 Hz, 2H), 7.85 (d, J = 8.2 Hz, 2H), 7.79 
(s, 1H), 7.72 (d, J = 9.4 Hz, 1H), 7.41 – 7.26 (m, 3H), 7.22 (s, 1H), 7.18 – 7.08 (m, 2H), 7.04 (s, 1H), 5.35 
(s, 2H), 3.13 (s, 6H). 
13C NMR: (101 MHz, CD3CN) δ 158.95, 155.95, 152.61, 152.18, 152.15, 144.59, 142.92, 142.17, 131.26, 
130.93, 130.21, 130.14, 130.11, 128.30, 126.42, 126.36, 126.26, 126.22, 126.19, 126.15, 124.03, 123.67, 
121.81, 118.56, 118.24, 117.89, 115.52, 115.43, 115.34, 115.31, 113.75, 110.22, 108.11, 106.84, 66.96, 61.88, 
61.74, 40.05. 
HRMS (ESI-TOF): calc’d for C27H22F3N5O [M+H]+ 490.1855; found 490.1861. 
IR (neat): 2923.71, 2853.54, 1618.2, 1598.63, 1554.33, 1513.71, 1488.63, 1464.97, 1377.13, 
1322.16, 1238.72, 1164.57, 1123.95, 1111.18, 1071.41, 1032.12, 1015.68, 844.75, 813.62, 754.26 
cm-1 
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Figure S 3.21 Analytical HPLC of azide-functionalized DMAQ (4a-4f)) 
 260 
 
 
Figure S 3.22 Analytical HPLC of PE-functionalized DMAQ (4-PE) 
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3.8    Spectra and Supplemental Information 
 
 
 
 
Figure S 3.23 ORTEP drawing of the title compound 2a with 50% thermal ellipsoids. 
 
 
Table S 3.3 Summary of Structure Determination of Compound 2a 
 
 
  
Empirical formula  C22H20Cl2N10  
Formula weight  495.38  
Temperature/K  100  
Crystal system  triclinic  
Space group  P1
_
  
a  9.3567(4)Å  
b  11.1297(4)Å  
c  11.7042(4)Å  
α  63.202(2)°  
β  85.889(2)°  
γ  83.244(2)°  
Volume  1080.15(7)Å3  
Z  2  
dcalc  1.523 g/cm3  
μ  0.337 mm-1  
F(000)  512.0  
Crystal size, mm  0.32 × 0.25 × 0.03  
2θ range for data collection      3.9 - 55.168°  
Index ranges  -12 ≤ h ≤ 12, -14 ≤ k ≤ 14, -15 ≤ l ≤ 15  
Reflections collected  45944  
Independent reflections  4861[R(int) = 0.0270]  
Data/restraints/parameters  4861/0/311  
Goodness-of-fit on F2  1.040  
Final R indexes [I>=2σ (I)]  R1 = 0.0341, wR2 = 0.0899  
Final R indexes [all data]  R1 = 0.0406, wR2 = 0.0959  
Largest diff. peak/hole  0.44/-0.29 eÅ-3  
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Figure S 3.24 ORTEP drawing of the title compound 2b-PA with 50% thermal ellipsoids. 
 
 
Table S 3.4 Summary of Structure Determination of Compound 2b-PA 
 
 
  
Empirical formula  C19H16ClN5  
Formula weight  349.82  
Temperature/K  100  
Crystal system  triclinic  
Space group  P1
_
  
a  5.6982(3)Å  
b  11.9927(6)Å  
c  13.2774(7)Å  
α  65.293(3)°  
β  81.649(3)°  
γ  85.903(3)°  
Volume  815.48(8)Å3  
Z  2  
dcalc  1.425 g/cm3  
μ  0.246 mm-1  
F(000)  364.0  
Crystal size, mm  0.45 × 0.22 × 0.01  
2θ range for data collection      3.404 - 55°  
Index ranges  -7 ≤ h ≤ 7, -15 ≤ k ≤ 15, -17 ≤ l ≤ 17  
Reflections collected  25826  
Independent reflections  3723[R(int) = 0.0300]  
Data/restraints/parameters  3723/0/228  
Goodness-of-fit on F2  1.037  
Final R indexes [I>=2σ (I)]  R1 = 0.0345, wR2 = 0.0836  
Final R indexes [all data]  R1 = 0.0453, wR2 = 0.0945  
Largest diff. peak/hole  0.38/-0.23 eÅ-3  
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Figure S 3.25 ORTEP drawing of the title compound 2b-PE with 50% thermal ellipsoids. 
 
 
Table S 3.5 Summary of Structure Determination of Compound 2b-PE 
 
 
  
Empirical formula  C20H18ClN5O  
Formula weight  379.84  
Temperature/K  100  
Crystal system  orthorhombic  
Space group  Pbca  
a  13.8627(9)Å  
b  9.6029(5)Å  
c  26.7328(17)Å  
Volume  3558.7(4)Å3  
Z  8  
dcalc  1.418 g/cm3  
μ  0.236 mm-1  
F(000)  1584.0  
Crystal size, mm  0.28 × 0.18 × 0.06  
2θ range for data collection      3.046 - 57°  
Index ranges  -18 ≤ h ≤ 18, -12 ≤ k ≤ 12, -35 ≤ l ≤ 35  
Reflections collected  124698  
Independent reflections  4491[R(int) = 0.0376]  
Data/restraints/parameters  4491/0/246  
Goodness-of-fit on F2  1.040  
Final R indexes [I>=2σ (I)]  R1 = 0.0311, wR2 = 0.0842  
Final R indexes [all data]  R1 = 0.0362, wR2 = 0.0887  
Largest diff. peak/hole  0.35/-0.21 eÅ-3  
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Figure S 3.26 ORTEP drawing of the title compound 4e with 50% thermal ellipsoids. 
 
 
 
Table S 3.6 Summary of Structure Determination of Compound 4e 
 
 
 
 
  
Empirical formula  C17H15N5  
Formula weight  289.34  
Temperature/K  100  
Crystal system  triclinic  
Space group  P1
_
  
a  7.2537(3)Å  
b  8.4629(3)Å  
c  12.1732(5)Å  
α  71.7940(10)°  
β  76.9930(10)°  
γ  85.118(2)°  
Volume  691.57(5)Å3  
Z  2  
dcalc  1.389 g/cm3  
μ  0.088 mm-1  
F(000)  304.0  
Crystal size, mm  0.28 × 0.18 × 0.1  
2θ range for data collection      6.124 - 50.752°  
Index ranges  -8 ≤ h ≤ 8, -10 ≤ k ≤ 10, -14 ≤ l ≤ 14  
Reflections collected  14979  
Independent reflections  2524[R(int) = 0.0361]  
Data/restraints/parameters  2524/0/201  
Goodness-of-fit on F2  1.055  
Final R indexes [I>=2σ (I)]  R1 = 0.0479, wR2 = 0.1190  
Final R indexes [all data]  R1 = 0.0572, wR2 = 0.1259  
Largest diff. peak/hole  0.28/-0.44 eÅ-3  
 
 265 
 
Figure S 3.27 ORTEP drawing of the title compound 4a-PE with 50% thermal ellipsoids. 
 
 
Table S 3.7 Summary of Structure Determination of Compound 4a-PE 
 
 
  
Empirical formula  C28H28N6O  
Formula weight  464.56  
Temperature/K  100  
Crystal system  triclinic  
Space group  P1
_
   
a  8.7988(3)Å  
b  10.4477(4)Å  
c  12.9692(5)Å  
α  93.1590(10)°  
β  98.9890(10)°  
γ  92.3860(10)°  
Volume  1174.26(8)Å3  
Z  2  
dcalc  1.314 g/cm3  
μ  0.083 mm-1  
F(000)  492.0  
Crystal size, mm  0.1 × 0.08 × 0.08  
2θ range for data collection      6.078 - 50.812°  
Index ranges  -10 ≤ h ≤ 10, -12 ≤ k ≤ 12, -15 ≤ l ≤ 15  
Reflections collected  40453  
Independent reflections  4320[R(int) = 0.0537]  
Data/restraints/parameters  4320/0/320  
Goodness-of-fit on F2  1.049  
Final R indexes [I>=2σ (I)]  R1 = 0.0418, wR2 = 0.0993  
Final R indexes [all data]  R1 = 0.0546, wR2 = 0.1071  
Largest diff. peak/hole  0.25/-0.39 eÅ-3  
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Figure S 3.28 ORTEP drawing of the title compound 5 with 50% thermal ellipsoids. 
 
 
Table S 3.8  Summary of Structure Determination of Compound 5 
 
 
 
 
 
 
 
  
Empirical formula  C40H44F6N6O10  
Formula weight  882.81  
Temperature/K  100  
Crystal system  monoclinic  
Space group  P21  
a  12.9366(7)Å  
b  8.1811(4)Å  
c  19.8600(10)Å  
β  100.831(2)°  
Volume  2064.45(18)Å3  
Z  2  
dcalc  1.420 g/cm3  
μ  0.120 mm-1  
F(000)  920.0  
Crystal size, mm  0.48 × 0.08 × 0.01  
2θ range for data collection      5.922 - 50.824°  
Index ranges  -15 ≤ h ≤ 15, -9 ≤ k ≤ 9, -22 ≤ l ≤ 23  
Reflections collected  54667  
Independent reflections  7583[R(int) = 0.0763]  
Data/restraints/parameters  7583/1/609  
Goodness-of-fit on F2  1.077  
Final R indexes [I>=2σ (I)]  R1 = 0.0501, wR2 = 0.1143  
Final R indexes [all data]  R1 = 0.0645, wR2 = 0.1215  
Largest diff. peak/hole  0.34/-0.26 eÅ-3  
Flack parameter 0.3(3) 
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Figure S 3.29  1H NMR spectrum of 4a in CD2Cl2 (500 MHz).  
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Figure S 3.30  13C NMR spectrum of 4a in CD2Cl2 (126 MHz). 
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Figure S 3.31  1H NMR spectrum of 4b in Acetone-d6 (500 MHz). 
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Figure S 3.32  13C NMR spectrum of 4b in CDCl3 (126 MHz). 
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Figure S 3.33  1H NMR spectrum of 4c in CD2Cl2 (500 MHz).  
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Figure S 3.34  13C NMR spectrum of 4c in CD2Cl2 (126 MHz).  
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Figure S 3.35  1H NMR spectrum of 4d in CD2Cl2 (500 MHz).  
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Figure S 3.36  13C NMR spectrum of 4d in CD2Cl2 (126 MHz).  
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Figure S 3.37 1H NMR spectrum of 4e in CD2Cl2 (500 MHz).  
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Figure S 3.38 13C NMR spectrum of 4e in CD2Cl2 (126 MHz). 
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Figure S 3.39 1H NMR spectrum of 4f in CD2Cl2 (400 MHz) 
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Figure S 3.40 13C NMR spectrum of 4f in CD2Cl2 (101 MHz).  
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Figure S 3.41 19F NMR spectrum of 4f in CD2Cl2 (376 MHz). 
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Figure S 3.42  1H NMR spectrum of 4a-PE in CD3CN (400 MHz). 
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Figure S 3.43  13C NMR spectrum of 4a-PE in CD3CN (101 MHz).  
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Figure S 3.44  1H NMR spectrum of 4b-PE in DMSO-d6 (500 MHz).  
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Figure S 3.45 13C NMR spectrum of 4b-PE in DMSO-d6 (101 MHz). 
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Figure S 3.46  1H NMR spectrum of 4c-PE in CD3CN (500 MHz). 
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Figure S 3.47  13C NMR spectrum of 4c-PE in CD2Cl2 (101 MHz)  
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Figure S 3.48  1H NMR spectrum of 4d-PE in CD3CN (500 MHz). 
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Figure S 3.49  13C NMR spectrum of 4d-PE in CD3CN (101 MHz). 
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Figure S 3.50  1H NMR spectrum of 4e-PE in CD2Cl2 (400 MHz). 
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Figure S 3.51  13C NMR spectrum of 4e-PE in CD3CN (101 MHz).  
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Figure S 3.52  1H NMR spectrum of 4f-PE in CD3CN (400 MHz).  
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Figure S 3.53  13C NMR spectrum of 4f-PE in CD3CN (101 MHz).  
 
10
20
30
4
0
50
60
70
80
90
10
0
110
120
130
14
0
150
160
170
180
190
f1	(ppm
)
40.05
61.74
61.88
66.96
106.84
108.11
110.22
113.75
115.31
115.34
115.43
115.52
117.89
118.24
118.56
121.81
123.67
124.03
126.15
126.19
126.22
126.26
126.36
126.42
128.30
130.11
130.14
130.21
130.93
131.26
142.17
142.92
144.59
152.15
152.18
152.61
155.95
158.95
 292 
 
 
Chapter 4 
 
A “Clickable” Photoconvertible Small Fluorescent Molecule as a 
Minimalist Probe for Tracking Individual Biomolecule Complexes 
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Abstract 
  
Photoconvertible fluorophores can enable the visualization and tracking of specific biomolecules, 
complexes, and cellular compartments with precise spatiotemporal control. The field of 
photoconvertible probes is dominated by fluorescent protein variants, which can introduce 
perturbations to the target biomolecules due to their large size. Here, we present a photoconvertible 
small molecule, termed CPX, that can be conjugated to any target through azide-alkyne 
cycloaddition (“click” reaction). To demonstrate its utility, we have applied CPX to study 1) 
trafficking of biologically relevant synthetic vesicles and 2) intracellular processes involved in 
transmission of α-synuclein (αS) pathology. Our results demonstrate that CPX can serve as a 
minimally perturbing probe for tracking the dynamics of biomolecules. 
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4.1    Introduction 
Over the last several decades, there has been a remarkable growth in the number of 
fluorescence imaging techniques for studying biological systems.1 Functional fluorescent probes 
such as photoactivatable fluorophores can provide dynamic information concerning the localization 
and quantity of biomolecules in living cells.2-3 Though much progress has been made in recent 
years with genetically encoded photoactivatable fluorescent proteins (FPs), these are often larger 
than the target molecule, and can cause undesired aggregation or altered protein function.2,4-6 
Moreover, incorporation of those FPs is generally restricted to the C- or N-terminus, a constraint 
not optimal for studying dynamic proteins or small targets such as peptides. 
 
A small molecule photoactivatable probe has many potential advantages in terms of size and 
options for its installation. However, photoactivatable small molecules are still rare and generally 
depend on “photoactivation,” which refers to the conversion from an initial dark state into a 
fluorescent state.2-3,7-9 Recently, the Chenoweth group reported a new class of “photoconvertible” 
dye built upon a 1,1’-diazaxanthilidene scaffold, that utilizes an activation mechanism based on a 
photochemically allowed 6p electrocyclization/oxidation reaction leading to the conversion of one 
fluorescent state to another.8-10 Unlike other “photoactivation” mechanisms, such as 
photoisomerization,11 photouncaging,12 or photodecomposition of azides,13 this “photoconvertible” 
mechanism facilitates visualization of both the pre- and post-activation forms and without 
producing potentially harmful side products (e.g., nitrosoaromatics) or reactive intermediates (e.g., 
nitrene).  Herein, we present a Clickable and Photoconvertible diazaXanthilidene (CPX) probe 
made by introducing an orthogonal “clickable” linker to a diazaxanthilidene fluorophore (Figure 
4.1). We demonstrate the advantageous properties of this new CPX probe in two biologically 
relevant systems, one with phospholipid vesicles and a second with an amyloidogenic protein.  
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Figure 4.1 General structure of CPX probe with absorption (dashed line) and emission (solid line) 
spectra of pre- (green) and post-activated (red) forms shown. 
 
4.2    Results and Discussion 
4.2.1. Design and Synthesis of CPX Probe.  
Our clickable, photoconvertible small molecule fluorescent probe is well-suited for 
tracking or monitoring biomolecules. In an effort to develop a noninvasive tracking probe, we 
carefully designed the probe to meet four key criteria: 1) small molecular size (<500 Da) to preserve 
its non-invasive and minimally perturbing nature (i.e., noncytotoxic for lengthy analysis), 2) high 
sensitivity, to visualize biological compounds at physiological concentrations (<µM), 3) efficient 
photoconversion using mild activating conditions (i.e., visible light), and 4) applicability to 
versatile targets for widespread use in cell biology.  
 
Recently, we showed that N-methylation of compound 1 (Me-1) led to a highly water-
soluble, non-cytotoxic, cell-permeable, and readily photoconvertible mitochondria-specific 
imaging dye.14 To expand the application of 1, we designed the CPX probe to have a linker with a 
“clickable” handle that is capable of versatile covalent labeling.15 The linker was conveniently 
installed via alkylation of the diazaxanthilidene pyridine nitrogen, rendering the probe water-
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soluble.14 The alkane linker length was kept to greater than 3 carbons (3C) to avoid interactions 
between diazaxanthilidene and azide, which could change the photophysical properties of the 
fluorophore or reduce the reactivity of the azide. The linker was kept shorter than 7C to avoid 
generating lipid-like properties, which could decrease solubility as well as localization propensity 
of the CPX probe. Hence, we investigated CPX probes with linker lengths of 4 carbons and 6 
carbons.  
 
 
Figure 4.2 Schematic reaction for linker synthesis (top) and X-ray crystal structure of anti-folded 
(Z)-2a (bottom) are shown.  
 
Compound 1 was alkylated with diiodohexane or diiodobutane to afford the desired mono-
alkylated product 2a or 2b in 98% and 88% yields, respectively.14,16 The reaction was efficiently 
driven by adding an excess of alkylating agent under refluxing conditions at 90 °C, wherein product 
formation can be monitored via appearance of a purple color due to generated iodine and triiodide. 
Simple extraction with hexane and acetonitrile removes excess alkylating agent. The resulting 
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crude reaction can be carried forward directly to the azidation, providing 3a and 3b in 99% yield. 
(Figure 4.2).  
Single crystals of (Z)-2a were obtained by slow evaporation of acetonitrile to show that 
(Z)-2a adopts an anti-folded conformation even with the increased steric hindrance from the 6C 
linker (Figure 4.2). The anti-folded conformation and Z-isomer are important requirements for 
photochemical reaction through a preorganized structure for conrotatory cyclization.14 Therefore, 
the (Z)-2a crystal structure supported our hypothesis that CPX with a 4C or greater linker can 
preserve the structure allowing photoconvertibility and a flexible reactive handle.   
 
Photophysical properties, including photoconvertibility of 3a,3b, did not show any 
significant deviation from those of Me-1 (Figure S 4.16-4.17). These validations confirmed that 
the linker does not disrupt the core fluorophore structure.  We focused on probe 3a to demonstrate 
the utility of the CPX probe. To promote the photocyclization of 3a in an in vitro system, we 
irradiated 3a at 420 nm using a Rayonet photoreactor to yield photoconverted (PC) product 3a-PC 
in a 42% isolated yield. Gratifyingly, the azide remained intact and did not photodegrade during 
irradiation (Figure S 4.9). This allows one to vary the order of the click reaction and 
photoconversion for other applications. Photoactivation followed by tracking experiments in a 
confocal microscope were performed using three channels (Figure S 4.18). The pre-activated 3a 
was imaged with a 405 nm laser and FITC emission filter (525±18 nm), here referred to as the 
green channel (405ex/FITC). Photoactivation was achieved by digital-micromirror device (DMD) 
module, which allows freely customized shape and size for irradiating regions of interest, and a 
stimulation laser at 440 nm. The post-activated 3a-PC was excited with 488 nm and/or 561 nm 
lasers and observed with a Cy5 emission filter (700±36 nm), referred to here as the red channels 
(488ex/Cy5 and 561ex/Cy5). Merged images of green and red channels were used to investigate 
the photoconversion of 3a. The decrease in brightness of “green” and the increase in “red” allows 
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good signal detection of the photoactivated 3a-PC over background in a spatially defined manner. 
The remaining “green” serves as a reference background for un-activated regions. To investigate 
spatially selective photoactivation followed by tracking, regional photo-irradiation was carried out 
with a dense population of vesicles or live cells. 
 
4.2.2. Photoactivation of GUV.  
Giant unilamellar vesicles (GUVs) consisting of 3a functionalized phospholipids were 
utilized to represent a simple cell membrane system.17 GUVs were prepared by a standard 
electroformation method in sucrose solution.18-22 Each set of GUVs were formulated with 
commercially available lipids, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-dibenzocyclooctyl (16:0 DBCO-PE), and 3a 
labeled DBCO-PE (3a-PE), which was synthesized via a copper-free click reaction between 3a and 
dibenzocyclooctyne (Figure S 4.20-4.21). GUV1s (5:95 DBCO-PE/DOPC) were formulated and 
labeled in situ by incubating with an excess of 3a for 20 min prior to imaging. Under the green 
channel, five GUV1s were found (Figure 4.3A) and one of GUV1 was selectively photoconverted 
by irradiating with the 440 nm laser for 60 s (Figure 4.3B-D). To demonstrate trafficking, GUV2s 
(5:95 3a-PE/DOPC) were synthesized to ensure that every vesicle was homogeneously labeled with 
3a. Two free floating GUV2s were photoactivated (Figure 4.3E-F). After 2 min, non-
photoactivated neighboring vesicles appeared, and could be clearly distinguished from previously 
photoactivated vesicles (Figure 4.3G-H).  
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Figure 4.3 Photoactivation of 3a conjugated GUVs. White dotted squares indicate irradiated 
regions. Pre-activated (A, E) and post-activated (B-D, F-H) GUVs are shown. Images G and H 
were taken 2 min after photoactivation. 
 
4.2.3. Photoactivation and Tracking of α-Synuclein.  
Aggregates of α-synuclein (αS) are a hallmark of Parkinson’s disease.23 Although a role for 
cellular transmission of aggregates has now been clearly established in the spread of pathology, the 
mechanisms underlying endocytosis of aggregates, intracellular trafficking, and seeding of 
aggregation in healthy neurons remain largely unknown, partly due to the lack of appropriate 
probes.24 The kinetics of αS inclusion growth have been investigated by others using αS tagged 
with a FP such as mEOS2 (26 kDa)25 or PS-CFP2 (27 kDa),26 both approximately twice the size of 
αS (14kDa) itself. Specifically, FPs have significant limitations in studying αS pre-formed fibrils 
(pffs) endocytosis as they can disrupt aggregation when attached to the N-terminus and can be 
proteolyzed when attached to the C-terminus.27-28 Hence, a small, non-perturbing probe that can be 
placed at internal sites would be a powerful tool to study αS aggregate dynamics. Here, we show 
that our probe overcomes the limitations of FPs by incorporating CPX (488 Da) at three different 
positions in the αS protein. 
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Previously, the Petersson group has developed an efficient way to engineer and purify αS 
with propargyl tyrosine (PpY) incorporated site-specifically using unnatural amino acid 
mutagenesis in combination with a traceless C-terminal intein tag (Figure 4.4A).29-32 3a was 
conjugated to αS constructs with PpY (αS-PpY3a) at position 94, 114 or 136 (Figure S 4.26-4.29). 
Following purification, the three protein constructs of monomeric αS-PpY3a were tested for 
photoconversion and aggregated to demonstrate that these 3a-labeled fibrils can be photoconverted 
over 6 h of irradiation in vitro without degradation (Figure 4.4B-E and Figure S 4.30-4.36). As 
we previously found position 114 to be a non-perturbing location for the attachment of other 
fluorescent dyes (e.g., BODIPY), the 3a-labeled αS-Ppy114 pre-formed fibrils (3a-pffs) were used 
to investigate the internalization and endolysosomal trafficking of αS following protocols 
developed in the Lee laboratory (see Figure S 4.37-4.40 for fibril characterizations).24 
 
 
Figure 4.4 A) Schematic view of generating 3a-labeled αS-PpY114 pre-formed fibrils (3a-pffs) 
and photoconverted fibrils (3a-PC-pffs). B) MALDI-MS and C) SDS-PAGE analysis of wild-type 
(WT) and 3a-labeled αS-PpY114 (αS-PpY3a114) irradiated for 0 or 6 h. FITC (lex = 473nm, lem = 520 
nm) TMR (lex = 532 nm, lem = 580 nm) filters are used. D-E) Emission spectra upon 
photoirradiation to measure disappearance of 3a-pffs and appearance of 3a-PC-pffs. PpY is 
propargyl tyrosine and MW is molecular weight standards.  
 
   301 
 
 
Figure 4.5  1) Neuronal uptake and photoactivation of 3a-pffs. A) Internalized 3a-pffs (green) in 
neurons stained with Trypan Blue (blue). White dotted box is zoomed in to show B) pre- and C) 
post-activation of single endosome/lysosome containing 3a-pffs in white bracket. 2) Sequential 
activation of internalized 3a-pffs in white brackets. Pre-activation (D-G), first post-activation (H-
K), and second activation (L-O) are shown in merged, blue (561ex/Cy5), red (488ex/Cy5), and 
green (488ex/FITC) channels from left to right.  3) Merged images of differential interference 
contrast (DIC), green and red channels are shown. P) 3a-pffs under yellow triangle was irradiated 
and zoomed in (white dotted box) to Q-T) track 3a-pffs over 3 h. Scale bars are 10 µm. See 
Experimental Section 4.6 for details. 
 
The 3a-pffs were transduced into 7-10 days old mouse primary hippocampal neurons over a 
period of 20 h. Prior to imaging, trypan blue was added to stain the neuronal membrane to 
distinguish internalized 3a-pffs from extracellular material (Figure 4.5A). An individual 
endosome/lysosome with internalized 3a-pffs was then activated by laser irradiation to enable 
tracking of the pffs (Figure 4.5B-C). Sequential photoactivation was achieved with excellent 
spatial control over individual endosome/lysosome in crowded environments (Figure 4.5D-O). 
Trypan blue is false-colored to blue in the 561ex/Cy5 channel (Figure 4.5E,I,M). The appearance 
of red vesicles (Figure 4.5F,J,N) and corresponding disappearance of green vesicles (Figure 
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5G,K,O) indicated successful photoconversion. Lastly, the tracking of 3a-pffs for 3 h following 
photoconversion showed that we can indeed monitor the specific 3a-pffs (Figure 4.5P-T, Figure 
S 4.44-4.52). These new tools will enable future studies involving larger populations and specific 
challenges to endosome integrity (e.g., chloroquine treatment) to further explore αS internalization 
using 3a-pffs to determine unusual characteristics of certain vesicles that may lead to pathology. 
 
4.3    Conclusion 
In conclusion, we have developed a clickable and photoconvertible small molecule fluorescent 
probe that is based on an electrocyclization/oxidation mechanism.14 The probe is water-soluble, 
cell-permeable, non-cytotoxic, and small in size, allowing cellular protein localization and tracking 
studies with minimal perturbation. The applications demonstrated here show the ability to impart 
precise spatiotemporal control, even in living cells for lengthy experiments of up to 8 h.  
Furthermore, 2a,2b is not only a precursor to azides; other molecules ready for bioconjugation can 
be generated by nucleophilic displacement of the iodide. Another advantage of the technology that 
we wish to emphasize is that the photophysical properties of a small molecule can be drastically 
modulated by the inclusion of electron-withdrawing or electron-donating groups.33 Therefore, 
studies are underway to alter the CPX pre- and post-conversion spectra. Beyond the proof-of-
principle demonstrations here with αS, CPX will be a valuable probe for measuring and monitoring 
the movement of individual biomolecules or complexes, which are essential not only for basic 
biology research but also for the diagnosis and treatment of disease.  
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4.6    Experimental Section 
 
4.6.1. General Information for Synthesis. 
 
Materials. All commercial reagents and solvents were used as received. 1,6-diiodohexane was 
purchased Alfa Aesar (Haverhill, MA). Sodium azide was purchased from Acros (Waltham, MA). 
All other reagents and solvents were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise specified. Flash column chromatography was performed using Silicycle silica gel (40-63 
µm (230-400 mesh), 60 Å irregular pore diameter). Thin-layer chromatography was performed on 
TLC Silica gel 60G F254 plate from Millipore Sigma. Reagents were purchased at the highest 
commercial quality and used without further purification, unless otherwise stated.  
 
Instruments. Accurate mass measurement analyses were conducted on either a Waters GCT 
Premier, time-of-flight, GCMS with electron ionization (EI), or an LCT Premier XE, time-of-flight, 
LCMS with electrospray ionization (ESI).  The signals were measured against an internal lock mass 
reference of perfluorotributylamine (PFTBA) for EI-GCMS, and leucine enkephalin for ESI-
LCMS. Waters software calibrates and reports by use of neutral atom mass. The mass of an electron 
is not included.  High-resolution mass spectra were obtained by Joomyung Vicky Jun and Dr. 
Charles Ross III at the University of Pennsylvania’s Mass Spectrometry Service Center on a 
Micromass AutoSpec electrospray/chemical ionization spectrometer. X-ray diffraction data 
obtained and solved by Dr. Patrick Carroll at the University of Pennsylvania using a Bruker 
APEX2-DUO CCD X-ray Diffractometer. Photoreactions were carried out in a Rayonet 
Photochemical Reactor (model RPR-100). UV-Vis absorption spectra were acquired on a Hewlett-
Packard 8452A diode array spectrophotometer (currently Agilent Technologies; Santa Clara, CA, 
USA) using quartz cells with a 1 cm cell path length (Starna Cells, Inc 120ul UV cells) or disposable 
UV cuvettes.  Fluorescence spectra were acquired on a PTI QuantaMaster fluorometer equipped 
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with a Peltier temperature controller.  Nuclear magnetic resonance (NMR) spectra were obtained 
on a Bruker DMX 500 MHz and AV-II 500 MHz NMR instruments.  NMR spectra for 3a-PC was 
obtained on a Brucker AVIII 500 MHz (Cryo) NMR instrument. The following abbreviations were 
used to explain multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = 
broad. High-performance liquid chromatography (HPLC) chromatograms were recorded and 
compounds were purified on an JASCO SEMI-PREP equipped with a VyDAC HPLC Columns 
Grace Davison discovery SciencesTM Protein and Peptide Gemini C18 column (cat#218TP510). 
Labeled proteins were purified using a GE AKTA ® FPLC system and subsequently purified using 
a Varian ProStar HPLC equipped with a Vydac C4 218TP C4-semipreparative HPLC column. 
Analytical HPLC studies were done with a JASCO-FC-2088-30 HPLC or Agilent Technology 
Infinity II equipped with a Phenomenex Luna Omega 5μm PS C18(2) 100A; 250 x 4.60 mm column 
using aqueous (H2O + 0.1% CF3CO2H) and organic (CH3CN+ 0.1% CF3CO2H) phases. The 
infrared (IR) spectra were obtained with Perkin Elmer Spectrum Two FT-IR by dissolving a small 
amount of compound in dichloromethane to mount the sample. For certain experiments, anhydrous 
solvents are obtained from Meyer Solvent Dispensing System (Laguna Beach, CA). MALDI-TOF 
mass spectra were collected on a Bruker UltraFlex III MALDI-TOF/TOF instrument (Billerica, 
MA). 
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4.6.2. General Information for Cell Imaging 
Materials. Dulbecco’s Modified Eagle Medium (DMEM) was purchased from Invitrogen 
(Carlsbad, CA). Fetal bovine serum (FBS) was purchased from Gibco, Life Technologies 
(Gaithersburg, MD). Penicillin/streptomycin were purchased from Corning Cellgro (Corning, NY). 
For complete neuronal medium, Neurobasal without phenol red and 5% B27 supplement were 
purchased from Thermo Fisher. Trypan blue diphosphate was purchased from Sigma-Aldrich.  
 
Primary Neuronal Cell Culture and Photoactivation Experiment. Primary neuronal cultures 
were prepared from E15-E17 embryos of CD1 mice (Charles River) as previously described 
(Volpicelli-Daley 2011).1 All procedures were performed according to the NIH Guide for the Care 
and Use of Experimental Animals and were approved by the University of Pennsylvania 
Institutional Animal Care and Use Committee (IACUC). Dissociated hippocampal neurons were 
plated at a density of 100,000 cells in the glass center chamber of a MatTek dish (35 mm dish,14 
mm well, #1.5 coverglass) for live cell imaging, and were allowed to mature for 7-10 d in complete 
neuronal medium (Neurobasal without phenol red (Thermo Fisher), 5% B27 supplement (Thermo 
Fisher)).  Medium was partially exchanged every 3-4 days. Images were acquired on a Nikon 
spinning disk confocal microscope equipped with a 100x oil immersion objective lense. Images 
were processed using Nikon Elements software. See page S37-S54 for details. 
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4.6.3. Chemical Synthesis and Characterizations 
I.     Core Diazaxanthilidene Scaffold (1) and Methylated Compound (Me-1)2 
Diazaxanthilidene Core (1) 
 
Synthesis of (E/Z)-1:  Following previously published procedure,2 50 mg (25 % isolated yield) of 
the title compound.  
Physical Property: pale yellow solid 
TLC: Rf = 0.26 (50% EtOAc in Hexanes) 
1H NMR (500 MHz, CD2Cl2-d2) δ 8.17 (s, 1H), 8.09 (s, 1H), 7.66 – 7.51 (m, 2H), 7.39 – 7.18 (m, 
7H), 6.95 (m, 3H). 
HRMS (ESI-TOF): calc’d for C24H15N2O2 + [M]+ 363.1134; found 363.1128 
 
 
1N-Methylation of Compound 1 (Me-1)  
 
 
 
Full characterizations can be found on previously published paper.2 
O
N
O
N
N
O
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N
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II.     6C-linker CPX (3a)  
 
General Linker Synthesis.  
To a 4.0 mL scintillation vial, 7.5 mg (0.02 mmol, 1.0 equiv) of compound 1 and 66 μL of excess 
1,6-diiodohexane (135 mg, 0.4 mmol, 20 equiv), was added in 2.1 mL of dry acetonitrile (0.01M). 
The vial was taped with Teflon tape both interior and exterior of the cap, and the mixture was stirred 
for 48 h at 90 ˚ C. Upon completion of the reaction, the solution turned purple, which is an indication 
of released iodine compounds. After complete conversion was confirmed by LCMS and analytical 
HPLC, the reaction vial was cooled down.  1.0 mL of hexane was added to the reaction mixture 
and mini-extraction was done to remove excess diiodohexane in hexane layer. Once mini-extraction 
was repeated three times, collected hexane layer was discarded and remaining acetonitrile was 
removed in vacuo.  To the same 4.0 mL scintillation vial, excess sodium azide (10.4 mg, 0.16 mmol, 
8 equiv) was added in 2.0 mL of dry acetonitrile. The reaction mixture was capped and sealed with 
Teflon tape, and was stirred for 4 to 8 h at 90 ˚C. The crude reaction solution was then mixed with 
2.0 mL of MiliQ water and filtered prior to HPLC purification. Following the HPLC condition 
below, 11.6 mg (97 % isolated yield with TFA salt) of the title compound 3a was obtained.  
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HPLC-Semi PREP condition: 35 to 70% MeCN (0.1% TFA) in H2O (0.1% TFA) over 30 min 
Product Eluted condition: 55 to 65% MeCN (0.1% TFA) in H2O (0.1% TFA). 20-26 min 
 
Figure S 4.1 HPLC Semi-Prep gradient and HPLC trace for crude 3a.  
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III.     Characterization of iodo-intermediate (2a) and CPX (3a) 
 
Iodo-intermediate (2a) 
 
    
Physical Property: purple crystal (crystal structure shown in page S53-S54) 
HRMS (ESI-TOF): calc’d for C30H26IN2O2
+ [M]+ 573.1033; found 573.1057 
1H NMR (500 MHz, CD2Cl2-d2) 2a crude (Figure S6) 
TLC: Rf = 0.0 (50% EtOAc in Hexanes) 
IR (neat): 2981.91, 2929.20, 1715.97, 1452.23, 1388.93, 1367.84, 1272.88, 1251.78, 1167.38, 
951.11, 764.00, 743.00 cm-1 
 
Figure S 4.2 IR spectrum of iodo-intermediate 2a. 
 
Figure S 4.3 Visualization of 2a crystals under ambient light (left) and with light microscope 
(right) 
I3
N
N
O
O
 
         
I
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6C-linker CPX (3a) 
      
 
Physical Property: yellow solid as salt (yellow fluorescence under 365 nm handheld UV lamp) 
1H NMR (500 MHz, CD3CN-d3) δ 8.39 – 8.33 (m, 2H), 8.13 (dd, J = 4.4, 1.4 Hz, 1H), 7.92 (ddd, 
J = 7.7, 6.5, 1.2 Hz, 1H), 7.81 (dt, J = 8.3, 1.4 Hz, 1H), 7.58 – 7.44 (m, 5H), 7.46 – 7.40 (m, 1H), 
7.32 – 7.25 (m, 1H), 7.13 (dd, J = 8.1, 1.5 Hz, 1H), 7.00 (ddd, J = 8.2, 7.0, 1.3 Hz, 1H), 4.01 (dt, J 
= 13.5, 7.6 Hz, 1H), 3.51 (dt, J = 12.8, 6.2 Hz, 1H), 3.04 (m, 2H), 1.61 – 1.52 (m, 2H), 1.25 (m, 
2H), 1.09 – 1.02 (m, 2H), 1.02 – 0.91 (m, 1H), 0.87 – 0.79 (m, 1H). 
13C NMR (126 MHz, CD2Cl2-d2) δ156.70, 155.73, 154.97, 151.05, 147.08, 144.65, 140.68, 140.44, 
133.19, 133.11, 132.22, 130.74, 128.90, 128.73, 128.08, 127.66, 127.64, 127.43, 125.17, 124.15, 
120.86, 119.41, 119.29, 113.40, 60.04, 52.36, 32.30, 29.56, 27.09, 27.00. 
HRMS (ESI-TOF): calc’d for C30H26N5O2
+ [M]+ 488.2081; found 488.2062 
IR (neat): 3358.77, 2933.54, 2098.54, 1663.72, 1446.86, 1430.50, 1302.48, 1277.54, 1148.85, 
807.75, 762.06, 706.17, 608.34 cm-1 
 
Figure S 4.4 IR spectrum of 6C-linker CPX 3a. The terminal azide is identified by the N=N 
asymmetric stretching absorption3 at 2098.54 cm-1. 
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Figure S 4.5 Analytical HPLC (Agilent) of purified 3a 30-100% MeCN in H2O over 70 min (15-
85 min) 
 
1H NMR comparison of core (1), intermediate (2a), and CPX (3a) 
 
 
 
Figure S 4.6 1H NMR comparison of aromatic region of 1 vs. 2a vs. 3a in CD2Cl2. 
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Figure S 4.7  1H NMR comparison of Me-1 vs. 3a in aromatic region in D2O 
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IV.   Post-activated Product of 3a (3a-PC)  
 
 
  
 
 
 
General Photoconversion. To a 20.0 mL scintillation vial, 8.1 mg (13 µmol, 4.5 µM) of compound 
3a in 3.0 mL of 1:2 MeCN: H2O (0.1M of HCl). The vial was capped with syringe needles on the 
trifluoroethanol (TFE) septa to allow oxygen flow (see picture below). The vial was stirred and 
irradiated with four 420 nm (LZC-420) lamps using Rayonet Photoreactor for 4 days. The crude 
reaction was purified with Semi-Prep Varian HPLC. Following the HPLC condition below, 3.4 mg 
(5.7 µmol) of the title compound 3a-PC was obtained in 42 % isolated yield. Masses are calculated 
with trifluoroacetate as a counter ion. 
 
Important Notes. The rate of photoconversion will highly dependent on the power of the laser, 
experimental set up, and irradiation area. With a Rayonet Photoreactor (LZC-420 nm, 8 Watt), 
complete photoconversion to 3a-PC takes more than 4 d. With microscope stimulation laser 
(Spectra X, 440 nm), full photoconversion takes less than 60 s.  
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HPLC-Semi PREP condition: 45 to 75% MeCN (0.1% TFA) in H2O (0.1% TFA) over 27 min 
Product Eluted condition: 59 to 63% MeCN (0.1% TFA) in H2O (0.1% TFA). 20-24 min 
 
 
 
Figure S 4.8  HPLC-Semi Prep gradient and HPLC trace for crude 3a-PC.     
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Characterization of photoproduct 3a-PC  
 
      
 
Physical Property: red solid as salt (pink fluorescence under 365 nm handheld UV lamp) 
1H NMR (Cryo 500 MHz, CD3CN-d3) δ 8.42 (d, J = 5.8 Hz, 1H), 8.34 (ddd, J = 24.7, 8.5, 0.9 Hz, 
2H), 8.25 (dd, J = 4.4, 1.4 Hz, 1H), 8.19 (dd, J = 8.5, 1.2 Hz, 1H), 7.92 – 7.82 (m, 2H), 7.78 – 7.68 
(m, 2H), 7.54 (dd, J = 8.4, 4.4 Hz, 1H), 7.50 (dd, J = 8.1, 0.9 Hz, 1H), 7.40 (dd, J = 7.9, 0.8 Hz, 
1H), 4.44 (dt, J = 13.5, 7.7 Hz, 1H), 3.83 (dt, J = 13.0, 6.4 Hz, 1H), 2.89 (t, J = 6.9 Hz, 2H), 1.49 
(d, J = 5.4 Hz, 2H), 1.20 – 1.00 (m, 2H), 0.95 – 0.75 (m, 3H), 0.71 (d, J = 8.8 Hz, 1H). 
13C NMR (Cryo 126 MHz, CD3CN-d3) δ 154.29, 150.39, 149.07, 148.71, 145.82, 141.22, 140.21, 
137.47, 131.46, 131.38, 130.88, 130.03, 129.01, 127.88, 127.64, 126.45, 126.09, 123.26, 120.12, 
119.07, 117.88, 113.86, 112.89, 106.57, 59.49, 50.59, 31.37, 27.77, 25.16, 24.57. 
HRMS (ESI-TOF): calc’d for C30H24N5O2+ [M]+ 486.1930; found 486.1925 
IR (neat): = 3365.54, 2109.20, 1673.60, 1442.00, 1190.2, 1139.9, 802.48, 721.91 cm-1 
 
 
Figure S 4.9 Presence of terminal azide peak (2109.20 cm-1) even after irradiated with 
photoreactor (420 nm) over 4 days.3 
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Figure S 4.10 Analytical HPLC of purified 3a-PC 30-100% MeCN in H2O over 70 min (15-85 
min) 
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2.4 4C-linker	CPX	(3b)		
 
 
 
2.4.1   Synthesis of 3b. Following the general linker synthesis procedure in page S5, 5.0 mg (0.014 
mmol) of 1 gave 6.9 mg (87 % isolated overall yield) of the title compound was obtained after 
HPLC purification.  Formation of 2b (88% analytical HPLC yield) was confirmed by analytical 
HPLC, HRMS, and crude 1H NMR. Final product 3b was purified with Semi-Prep HPLC and eluted 
around 50-55% MeCN (0.1% TFA) in H2O (0.1% TFA).  
 
 
 
Monitoring Reaction with Analytical (Varian) HPLC  
30 to 80% MeCN (0.1% TFA) in H2O (0.1% TFA) over 10 min (10 min - 20 min retention time) 
  
 
Figure S 4.11 Analytical HPLC of each step with starting material standards in two UV channels 
(254 nm and 320 nm).  
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2.4.2   Characterization of Iodo-intermediate (2b) and CPX (3b) 
 
Iodo-intermediate (2b) 
 
 
HRMS of 2b (ESI-TOF): calc’d for C28H22IN2O2
+
 [M]+ 545.0726; found 545.0719 
 
4C-linker CPX (3a) 
 
 
 
 
Physical Property: yellow solid as salt 
1H NMR (500 MHz, CD3CN-d3) δ 8.38 (s, 2H), 8.13 (dd, J = 4.4, 1.4 Hz, 1H), 7.93 (dd, J = 8.5, 
6.1 Hz, 1H), 7.82 (dd, J = 8.4, 1.4 Hz, 1H), 7.56 (s, 2H), 7.49 (s, 3H), 7.44 (s, 1H), 7.30 (d, J = 0.7 
Hz, 1H), 7.14 (dd, J = 8.1, 1.6 Hz, 1H), 7.01 (ddd, J = 8.2, 7.0, 1.3 Hz, 1H), 4.05 (s, 1H), 3.53 (s, 
1H), 3.07 (t, J = 6.6 Hz, 2H), 1.64 (s, 2H), 1.28 (s, 1H), 1.14 (d, J = 6.8 Hz, 1H). 
13C NMR (126 MHz, CD3CN-d3) δ 155.06, 154.52, 153.54, 149.57, 145.71, 142.64, 139.90, 139.20, 
132.00, 131.42, 130.53, 128.99, 127.65, 127.54, 126.43, 126.33, 126.01, 125.72, 123.45, 123.11, 
119.92, 112.40, 57.65, 50.25, 28.15, 24.80. 
HRMS of 3b (ESI-TOF): calc’d for C28H22N5O2
+ [M]+ 460.1768; found 460.1749 
 
Figure S 4.12 Analytical HPLC of purified compound 3b 
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1H NMR comparison of intermediate (2b), and CPX (3b) 
 
 
 
 
 
Figure S 4.13  1H NMR (500 MHz, CD3CN-d3) analysis of crude 2b and purified 3b 
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3.   X-Ray Structure Comparison  
 
 
 
Figure S 4.14  X-Ray Analysis of A) compound 12, B) N-methylation of 1 (Me-1)2, and C) 2a 
 
 
 
 
Figure S 4.15 Side views of methylated compound (Me-1) and alkylated compounds (2a). 
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4.6.4. Photophysical Property of CPX (3a/3a-PC, 3b/3b-PC)  
 
Figure S 4.16    Fluorescence spectra of compound 3a and 3a-PC obtained in 1:1 MeCN:H2O 
(0.1% TFA) 
  
 
 
 
Figure S 4.17  Fluorescence spectra of compound 3b and 3b-PC obtained in H2O 
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4.6.5. General Experiment for Photoactivation 
Nikon Microscope Set Up  
Microscope:  Nikon Eclipse Ti2 Inverted Microscope with ANDOR iXon Ultra 897, 
CSU-X1 (Yokogawa), Tokai Hit Incubator (STX stage top; temp & CO2) 
Confocal Laser:  CSU BA Spinning Disc Emission (Bandpass Filter) Wheel  
Nikon LUNV Laser Launch: output power at the fiber end (20mW) 
405ex/FITC:   Excitation at 405 nm, FITC Em filter (525/36nm) a 
488ex/Cy5:      Excitation at 488 nm, Cy5 Em filter (700/72 nm) a 
561ex/Cy5:      Excitation at 561 nm, Cy5 Em filter (700/72nm) a 
a Filter center wavelength / full width at half maximum in nm 
Stimulation Laser:  440/20 nm (output power 256 mW) 100% laser power  
  (Mightex Polygon 400 DMD, Lumencor Spectra X LED Illuminator)  
Filter: 442 C-TIRF 97320 (dichroic only) 
Note. Exact laser power (Watt) will vary depending on the area (ROI) of 
stimulation  
Objectives:   CFI APO 100X Oil TIRF NA 1.49 WD 0.12MM  
Image processor:  NIS Elements Imaging Software (High Content Package) 
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4.6.6. Photoactivation Experiment Procedure 
Experiment is conducted by looking at two or three channels before (pre-activation) and after (post-
activation) irradiation with DMD/ Spectra X laser at the region of interests (ROIs). Green channel 
(405ex/FITC) reveals the initial state of CPX (3a), and thus is anticipated to show disappearance 
of 3a upon irradiation. Red channels (488ex/Cy5 or 561ex/Cy5) will reveal newly formed 
photoconverted product, 3a-PC. Merging these channels at pre- and post-activated states will show 
the successful photoconversion in ROIs. 561ex/Cy5 is used as a second channel for photoactivated 
species; 561ex/Cy5 shows less background signal (3a) but also weaker product signal (3a-PC) 
compare to that of 488ex/Cy5. 561ex/Cy5 is used as indicator for third dye (e.g., Trypan Blue) in 
neuronal uptake experiment. 
 
 
 
Figure S 4.18  Schematic view of general photoactivation (photoconversion) confocal imaging 
experiment.  
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4.6.7. Giant Unilamellar Vesicle (GUV) Experiment 
 
 
Figure S 4.19  Schematic view of 3a conjugated GUV and photoactivation 
 
Materials of GUVs.  Stock material was prepared by commercially available materials. 18:1 
(Delta9) Cis PC 1,2-dioleoyl-sn-glycero-3-phosphochline (DOPC) and 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-dibenzocyclooctyl (16:0 DBCO-PE) are purchased from 
Avanti polar lipids and used without further purification. 3a-PE was synthesized by mixing DBCO-
PE and 3a in chloroform/methanol (2:1v/v) overnight. ITO glass slides are from Delta 
Technologies (Stillwater, MN).  
 
Figure S 4.20  Chemical Structures of GUV materials. 
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Synthesis of GUV for Imaging 
 
 
I.    General Synthesis of GUVs 
GUVs were prepared as previously described.4-5 3a dye stock (1.0 mM) and phospholipids stock 
solutions of DOPC, DBCO-PE, and 3a-PE (1.0 mM) were prepared in chloroform-methanol (2:1 
v:v). The following mixtures were used: DOPC/DBCO-PE (95/5, mol ratios); DOPC/3a-PE (95/5, 
mol ratios), DOPC/DBCO-PE (99/1, mol ratios); DOPC/3a-PE (99/1, mol ratios). 40µl of each 
lipid mixture in organic solvent was deposited on the microscope cover slide on the conductive 
face while heating at 60°C. Two slides per sample were prepared. After drying under vacuum 
overnight to remove the residual solvent, two slides were then combined with a silicone spacer 
(Grace Bio-Labs, Bend, OR) to enclose 148mM sucrose solution, and incubated at 60°C in the 
Function generator (AC field 2 V/mm, 5 Hz) for 3 h.5 Prepared GUV solutions were diluted in 10-
fold and imaged on the MatTek dish (35 mm dish, #1.5 cover glass) at room temperature. 
 
Lipid Mixtures 
• GUV 1 : 190µL DOPC + 10µL DBCO-PE ; then add 3a dye later (5 mol% in situ labeling) 
• GUV 2: 190µL DOPC + 10µL 3a-PE (5 mol%) 
• GUV	3:	198µL	DOPC	+	2µL	DBCO-PE	;	then	add	3a	dye	later	(1	mol%	in	situ	labeling)	
• GUV 4: 198µL DOPC + 2µL 3a-PE (1 mol%) 
 
In-situ Click Condition: 2 µL of 3a stock solution (1.0 mM) were added to 2.0 mL of sucrose 
solution in MatTek Dish. (Final 1.0 µM of 3a).  
  
   329 
II.    Synthesis of 3a-PE  
 
1.0 mL of DBCO-PE (1.0 mM) and 1.0 mL of 3a (1.0 mM) in chloroform: methanol (2:1 v/v) was 
mixed in room temperature and let it sit overnight. The product, 3a-PE, formation was confirmed 
by LCMS and HRMS. (Note: Since reaction mixture of 3a-PE was used without further purification, 
there might be small amount of unreacted DBCO-PE or 3a present.) 
 HRMS of 3a-PE: calc’d for C86H113N7O12P [M+H]+ 1466.8185; found 1466.8190 
 
 
 
 
Figure S 4.21   LCMS analysis (loop injection) to see the mass composition of the crude reaction 
of 3a-PE. Mass of 3a-PE is found as the strongest signal and no mass for free 3a is found. 
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4.6.8. Imaging GUV with Nikon Microscope.  
Green channel is used for imaging pre-activated 3a. Upon photo-stimulation, intensity of 3a will 
decrease under green channel.  Sequentially, red channel is used for imaging post-activated 3a-PC. 
Initially, when none of 3a is activated, 3a will not be visible or will have low background 
fluorescence under red channel. After photo-stimulation (photoactivation), fluorescence of post-
activated product 3a-PC will appear under red channel.  
 
Green channel:405ex/FITC 100% (excitation laser 405 nm with FITC emission filter) 
Red channel:    488ex/Cy5 50% or 561ex/Cy5 100%  
(excitation laser 488 nm or 561 nm with Cy5 emission)        
Merge:             Relative intensity between green and red channel indicates photoactivated regions. 
Stimulation:  440 nm DMD 100% on ROIs (region of interest) 
Note. Imaging under 405ex 100% laser can also activate 3a probe. Hence capture image under 
lower laser power (<25%) with 405 nm. Or, find the dark area under 488ex or 561ex laser where 
no photoactivated 3a-PC background fluorescence is detected.  
Dotted white square: ROIs where Spectra X laser was irradiated 
 
Types of Experiment 
 
A. Tracking experiment: Find the vesicles under 405ex/FITC and activate the whole field of view 
with the 440 nm 100% DMD stimulation laser for 1-2 min.  Wait and see if other new (not-
photoactivated) vesicle comes. Then capture at 405ex/FITC (green channel) and 488ex/Cy5 or 
561ex/Cy5 (red channel)  
 
B. Selective Turn-On Experiment:  Find the dark region under 488ex/Cy5, and activate the ROIs 
with 440 nm 100% Spectra X laser. In order to photoconvert the whole vesicle, make a ROIs (i.e. 
dotted square) within the vesicle. 
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4.6.9. Additional Photoactivation Imaging with 1 mol% 3a-GUV 
 
 
Figure S 4.22  Photo-activation of GUV 3 (1:99 DBCO-PE/ DOPC; then in-situ click with 3a) 
in ROI. 
 
 
 
Figure S 4.23   GUV3 sample from Figure S22. Merged images of 405ex/FITC, 488ex/Cy5, and 
561ex/Cy5 channels over 7 different Z-positions (Z1-Z7) in increasing stimulation time point over 
2 min (t1=0 s, t2=30 s, t3=60 s, t4=90 s, t5=120 s).  
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Figure S 4.24   Photoactivation of GUV4 (1:99 3a-PE/ DOPC) in ROI.  
 
 
 
 
 
 
Figure S 4.25   Sequential photoactivation of GUV4 (1:99 3a-PE/ DOPC) in ROI.   
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4.6.10. a-Synuclein (aS) Protein Experiment  
 
General Experimental Workflow 
 
 
Figure S 4.26   General experimental workflow to study CPX (3a) labeled a-Syunclein (aS). In 
order to study the neuronal uptake of CPX(3a)-labeled aS, pre-formed fibrils consisting of 3a-
labeled aS (3a-pffs) were systematically synthesized and validated in following order. 
 
 
 
 
 
 
 
Figure S 4.27  aS sequence with labeling positions highlighted for locations chosen for CPX (3a) 
labeling. 3a is indicated with green circles at position 94, 114, and 136 of aS. Residues 1-60 (green 
region) are required for vesicle interactions and contain several key sites of point mutations 
associated with familial Parkinson’s Disease. Residues 61-100 (yellow region) are the non-amyloid 
component (NAC) region, which is necessary for β-sheet fibril formation. Residues 101-140 (red 
region) comprise the highly acidic and unstructured C-terminal tail.6  
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Expression of Engineered a-Synuclein with Alkyne Handle (aS-PpYX) 
 
 
 
 
Proteins containing propargyl tyrosine (PpY) at residues 94, 114, and 136 have been previously 
described.7-9 A plasmid encoding for aS-TAGX-MxeHis6 was generated via site-directed 
mutagenesis as previously described using primers with sequences provided below.  
 
Forward: 5'-CCCACAGGAAGGAATTCTGTAGGATATGCCTGTGGATCCTG-3' 
Reverse: 5'-CAGGATCCACAGGCATATCCTACAGAATTCCTTCCTGTGGC-3' 
 
Mutagenesis was confirmed by DNA sequencing. Briefly, plasmids containing DNA sequences 
encoding for aS-TAGX-MxeHis6 were transformed into BL21(DE3) E. coli cells bearing the 
pDULE-pXF expression plasmid encoding for a modified M. janaschii tyrosyl synthetase capable 
of charging a suppressor tRNACUA with proparyl tyrosine (PpY). Cells (40 µL) were incubated with 
aS-encoding plasmid (1 µL) for 20-30 minutes on ice. Following incubation, cells were heat 
shocked at 42 °C for 1 minute, then cooled on ice for 2 minutes. After this time, 450 mL of SOC 
media was added and cells were incubated at 37 °C for 1 hour with 250 rpm shaking. Following 
this time, cells were plated on LB-agar plates supplemented with ampicillin and streptomycin and 
incubated at 37 °C overnight. Single colonies were then selected and grown in 5 mL LB media 
supplemented with 100 μg/mL ampicillin and 50 μg/mL streptomycin until visibly cloudy. After 
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this time, cultures were transferred into 1 L of M9 minimal media supplemented with streptomycin 
(50 mg/L) and ampicillin (100 mg/L) and incubated at 37 °C, 250 rpm shaking for 4-6 hours until 
OD600 = 0.7-1.0. The incubator temperature was then decreased to 18 °C and propargyltyrosine 
(218 mg/L, 1 mM final concentration) solubilized in water with a few drops of 5 M NaOH was 
added. After incubation for 10 minutes, isopropyl-β-D-1-thiogalactopyranoside (IPTG) was added 
to 1 mM final concentration. The culture was then incubated at 18 °C, 250 rpm shaking overnight 
(15-18 hours). Following incubation, cells were harvested by centrifugation (4000 rpm, 4 °C, 20 
minutes) in a Sorvall RC5B centrifuge using a GS3 rotor. The supernatant was then decanted and 
the resulting cell pellet resuspended in 40 mM Tris pH 8.3 supplemented with one Roche cOmplete 
Mini protease inhibitor cocktail pill (catalogue #04693159001) and phenymethanesulfonylfloride 
(PMSF, 1 mM final concentration from a 1 M stock in isopropanol). The resuspended cells were 
lysed by probe sonication (amplitude 50, 1 second on/off cycles for a total of 5 minutes on), then 
centrifuged in a Sorvall RC5 centrifuge equipped with an SS34 rotor operated at 14000 rpm for 25 
min at 4 °C. Following this time, the supernatant was decanted and incubated with a 3 mL bed 
volume of Ni-NTA resin (Gold Bio, catalogue #H-350-50) for 1 hour on ice. The liquid was then 
allowed to flow through, and the resin was washed with 15 mL 50 mM HEPES pH 7.5, then with 
20 mL 50 mM HEPES, 5 mM imidazole pH 7.5. Following these wash steps, protein was eluted 
by three washes consisting of 4 mL each of 50 mM HEPES, 300 mM imidazole pH 7.5. The 
fractions were combined and treated with β-mercaptoethanol (200 mM final concentration) 
overnight at room temperature.10 Following this treatment, the protein was dialyzed into 20 mM 
Tris pH 8 at 4 °C for 6-8 hours. After dialysis, the protein solution was incubated with a 3 mL bed 
volume of Ni-NTA resin for 1 hour on ice, then the flow through collected and dialyzed overnight 
at 4 °C into 20 mM Tris pH 8. The protein was subsequently labelled as described below. Typical 
protein yields following this procedure were approximately 5-8 mg of semi-crude protein per 
culture.   
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Click-Labeling of a-Synuclein (aS-PpY3a) 
 
 
 
 
 
Labeling of propargyltyrosine (PpY) containing aS proteins with fluorophore azide has been 
previously described.8-9, 11-12 A similar procedure was followed for labeling with CPX (3a) dye as 
described below. Protein concentrations from stocks purified as described above were determined 
using a Thermo Fisher Scientific Pierce BCA protein assay kit using bovine serum albumin (BSA) 
standards at 2, 1, 0.5, 0.25 and 0.125 mg/mL protein. Following incubation and determination of 
absorbance at 562 nm, a standard calibration curve was generated and used to estimate the 
concentration of aS-PpYX containing protein (X indicating PpY at position 94, 114, or 136). 
Following concentration determination, the following labeling procedure was followed. A catalyst 
mixture for copper(I) azide-alkyne cycloaddition (CuAAC) was generated by mixing 10 
equivalents (relative to protein) CuSO4 (80 mM stock in water) with 15 equivalents (relative to 
protein) tris(3-hydroxypropyltriazolylmethyl)amine (THPTA, 50 mM stock in water) and briefly 
vortexing. Sodium ascorbate (30 equivalents relative to protein) was then added from a freshly 
prepared 100 mM stock in water and the resulting catalyst solution incubated at room temperature 
for 5-10 minutes. Following this time, CPX (3a) dye (5 equiv relative to protein) was added to the 
protein containing solution from a 25 mM stock in H2O:MeCN (1:2). Following addition of the 
dye, the catalyst mixture was added to the protein containing solution and the resulting mixture 
vortexed briefly, then incubated at 37 °C until complete consumption of the starting (unlabeled) 
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protein was observed by MALDI-TOF MS (typically 3-4 hours). Labeling reactions were then 
transferred to pre-wetted 3.5 kDa cutoff regenerated cellulose dialysis tubing (Fisher Scientific 
catalogue # 21-152-10) and dialyzed at 4 °C overnight in 20 mM Tris pH 8. Following dialysis, 
labelled proteins were purified by FPLC using an AKTA FPLC system and GE HiTrap Q HP 
column (catalogue #17-1154-01) and gradients between 20 mM Tris pH 8 and 20 mM Tris, 1 M 
NaCl pH 8. Fractions containing the desired protein were identified by MALDI-TOF MS, pooled, 
and concentrated using Amicon Ultra 3 kDa cutoff filters (EMD catalogue #UFC900324) to a final 
volume of ~1 mL. This material was further purified by RP-HPLC on a Varian ProStar system 
equipped with a Vydac C4 semi-preparative column using gradients between 0.1% TFA in water 
and 0.1% TFA in acetonitrile. Fractions containing the desired protein were pooled, diluted ~5-fold 
with aS buffer (20 mM Tris, 100 mM NaCl pH 7.5) and concentrated using Amicon Ultra 3 kDa 
cutoff filters; following the first concentration, protein was re-diluted and concentrated twice more 
to remove residual acetonitrile. Following concentration to ~0.5 mL total volume, proteins were 
stored at -80 °C and thawed only once per assay. 
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Figure S 4.28    MALDI-MS of Labeling Reactions. Click labeling reactions of aS-PpY94, aS-
PpY136 and aS-PpY114 with 3a show > 90% labeling after 4 to 6 h. to Click condition: protein (1.0 
equiv.), CuSO4 (10 equiv.), THPTA (15 equiv.) sodium ascorbate (30 equiv.), and CPX (3a) dye 
(5 equiv.). 
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4.6.11. Possible Copper binding between triazole and pyridine moiety of CPX probe13 
 
 
 
 
 
 
Excess of copper catalyst (10 equiv) was used for efficient labeling as we observed possible copper 
binding to pyridine moiety of CPX probe. Crude labeling reactions through HPLC showed distinct 
peaks approximating [M+H]+ as well as [M+H+64]+ and [M+H+128]+ Da.  These adducts are 
hypothesized as Cu+ or Cu2+ chelated mass. These adducts were removed following exchange of 
HPLC fractions into buffer containing 100 uM EDTA, but MALDI ionization was poor. It should 
be noted that copper can cause broadening of MALDI-MS. 
 
 
 
Figure S 4.29   MALDI-MS analysis after and before EDTA buffer exchanged aS-PpY3a94 and 
aS-PpY3a136. 
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4.6.12. Photoconversion of Monomer 
 
Photoconversion of aS-PpY3a 114 with Rayonet Photoreactor 
 
 
 
 
Solutions of aS-PpY3a 114 at 0.5 μM protein concentration were transferred to a LCMS vial (Thermo 
Scientific™ 9mm Wide Opening Clear Vial Convenience kits) and irradiated under Rayonet 
Photochemical Reactor (model RPR-100). Emission spectra were collected using λex = 410 nm, λem 
= 420 – 700 nm or λex = 505 nm, λem = 515 – 700 nm. Excitation spectra were collected using λem 
= 545 nm, λex = 350 – 530 nm; λem = 615 nm, λem = 350 – 600 nm. Following collection of data 
prior to irradiation, solutions were kept in the vial and irradiated with 420 nm (LZC-420) light bulb 
using Rayonet Photoreactor for successive periods of 2 hours. After each irradiation time (0, 2, 4 
and 6 hours in the vial), spectra were collected using the parameters above. Proteins in pH 7.5 
(20mM Tris 100mM NaCl) and pH 4.5 (50 mM citrate buffer) were analyzed and compared. 
Triplicate samples were measured and irradiation time and averaged in the plots on the next page. 
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Figure S 4.30    A-B) Emission spectra and C-D) Excitation spectra of aS-PpY3a 114 monomer. 
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Photoconversion of monomer aS-PpY3a 94  and aS-PpY3a 136 with Fluorometer 
  
 
 
 
Solutions of aS-PpY3a 94 or aS-PpY3a 136 at 4 μM protein concentration were transferred to a 1 cm 
path length fluorometer cuvette. Emission spectra were collected using λex = 410 nm, λem = 420 – 
700 nm and λex = 505 nm, λem = 515 – 700 nm. Excitation spectra were collected using λem = 543 
nm, λex = 350 – 530 nm; λem = 612 nm, λem = 350 – 600 nm. Following collection of data prior to 
irradiation, solutions were kept in the cuvette and irradiated with 410 nm light using the fluorometer 
light source (deuterium lamp) for successive periods of 2 hours. After each irradiation time (0, 2, 4 
and 6 hours in the cuvette), spectra were collected using the parameters above.  
 
 
 
Figure S 4.31     Excitation (solid) and emission(dotted) spectra of ⍺S-PpY3a 94 and ⍺S-PpY3a 136 
over 0, 2, 4, 6h of irradiation with fluorometer. 
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4.6.13. Photo-degradation Analysis of Monomer aS-PpY3a 114 
Test for photodegradation of aS: 40 μL of aS-PpY3a 114 at 70 μM protein (monomer) were 
transferred to a LCMS vial as described in page S27 and irradiated up to 11 hours. First 10 μL of 
aS-PpY3a 114 was stopped after 6 h and rest of protein was diluted to 20 μM for additional 5 h of 
irradiation (total of 11 h). Emission spectra were collected using λex = 410 nm, λem = 420 – 700 nm 
for disappearance of 3a (pre-activated) and λex = 505 nm, λem = 515 – 700 nm for appearance of 
3a-PC (post-activated) probe on protein (Figure S32 Top).   Following the confirmation of 
photoconversion, MALDI-MS (Figure S32 bottom) and SDS-PAGE (Figure S33) analysis were 
done to determine presence of severe degradation.  
 
 
 
Figure S 4.32     Fluorescence measurement to confirm the photoconversion (top). MALDI-MS 
analysis for photodegrdation of aS-PpY3a 114. Post-irradiated proteins (bottom) did not show any 
significant fragmentations. Water adduct masses ([M+18]+) were observed (bottom). 
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Figure S 4.33 SDS-PAGE of wild-type aS (WT) and aS-PpY3a 114 after 0, 6, and 11h of 
irradiation (20 μM protein). Coomassie stain of gel was done to show any fragmentation or photo-
crosslinked high molecular weight protein. Fluorescence gel images were acquired on a Typhoon 
FLA7000 (FITC filter: λex = 473 nm, λem = 520 nm) for presence of pre-activated 3a (aS-PpY3a 114) 
and TAMRA filter (λex = 532 nm, λem = 580 nm) for presence of post-activated 3a-PC (aS-PpY3a-
PC 114). No significant aggregation or photo-crosslinked proteins of higher molecular weight 
observed. 
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4.6.14. Photoconversion of fibril in photoreactor 
 
 
 
Protein concentrations were determined using UV-Vis spectroscopy on a Hewlett-Packard 8452A 
diode array spectrophotometer (currently Agilent Technologies). Wild-type aS was quantified 
using ε280 = 5120 M-1 cm-1 based on amino acid sequence.14 aS-PpY3aX proteins (X = 94, 114, 136) 
were quantified using ε408 = 11040 M-1 cm-1 based on previously reported extinction coefficient for 
dye in water.2 Labeled proteins were used to generate fibrils under the following conditions: 100 
µM protein in 20 mM Tris, 100 mM NaCl pH 7.5 in a 1.7 mL Eppendorf tube. For aS-PpY3a94 and 
aS-PpY3a136, 5 µM labeled protein and 95 µM mixture is used. For aS-PpY3a114, 50 µM labeled 
protein and 50 µM WT protein mixture is used. Fibrils were formed by agitation at 37 °C, 1500 
rpm for 48 hours in an IKA MS3 orbital shaker. Following fibril formation, aggregated protein was 
pelleted (13,200 rpm, 4 °C, 90 min) in a benchtop fixed-rotor Eppendorf centrifuge. Following 
centrifugation, the supernatant was carefully decanted and the resulting pellet resuspended by 
addition of an equivalent volume of the buffer above and repeated vortexing. Resuspended fibrils 
were then diluted (10x) into 50 mM citrate buffer, pH 4.5 for irradiation & fluorescence acquisition 
(~10 μM total protein).  Irradiation was performed using a Rayonet Photochemical Reactor (model 
RPR-100) at room temperature 0, 2, 4, 6 hours & ~200 µL aliquot removed at given time point, 
stored shielded from light until fluorescence data acquired. Steady state fluorescence spectra were 
collected using a PTI QuantaMaster fluorometer equipped with a Peltier temperature controller. All 
spectra were collected at 20 °C using a 1 nm step size, 0.25 second integration time, and 5 nm 
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excitation and emission slit widths. Triplicate samples were measured for each labeling and 
irradiation time and averaged in the plots below. Steady-state emission spectra were collected using 
λex = 410 nm, λem = 420 – 700 nm or λex = 505 nm, λem = 515 – 700 nm. Steady state excitation 
spectra were collected using λem = 545 nm, λex = 350 – 530 nm or λem = 615 nm, λem = 350 – 600 
nm. 
 
 
 
Figure S 4.34 Visualization of change in emissive color of   aS-PpY3a Proteins Incorporated into 
Fibrils. Hand held UV lamp 365 nm to visualize 5% aS-PpY3a 94 , 5% aS-PpY3a 114, and 50 %  aS-
PpY3a 136 in WT fibrils from left to right.  Hours indicate irradiation hours with photoreactor. 
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Figure S 4.35   Emission spectra of aS-PpY3a Proteins Incorporated into Fibrils. Fluorescence 
emission spectra from excitation at 410 nm (left) or 505 nm (right) for A) 5% aS-PpY3a 94 fibrils, 
B) 5% aS-PpY3a 136 fibrils, and C) 50% aS-PpY3a 114 fibrils at pH 4.5.  
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Figure S 4.36  Excitation spectra of aS-PpY3a Proteins Incorporated into Fibrils. Fluorescence 
excitation spectra from emission at 545 nm (left) or 615 nm (right) for A) 5% aS-PpY 3a 94 fibrils, 
B) 5% aS-PpY3a 136 fibrils, and C) 50%  aS-PpY3a 114 fibrils at pH 4.5.  
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4.6.15. SDS-PAGE Analysis of Labeled Protein Incorporation 
 
 A 30 µL aliquot was removed and stored at -20 °C prior to aggregation from the protein mixtures 
described above to use as a quantification standard. Following fibril formation, insoluble material 
was pelleted and resuspended as described above. The resuspended pellet (10 µL aliquot) was 
combined with SDS (2 µL from a 150 mM stock in water; 25 mM final concentration) and boiled 
for 15-20 minutes. The samples were then cooled on ice for 10-15 minutes, then 3 µL 4X loading 
dye added. Monomeric samples for calibration were prepared by serial 2-fold dilution of 10 µL 
with water (standard lanes correspond to 100, 50, 25, and 12.5 µM total protein from left to right 
with 5% aS-PpY3aX); 2 µL water was then added to each standard sample, followed by 3 µL loading 
dye. Standard and pellet samples were then analyzed by SDS-PAGE (15% acrylamide gel run at 
150 V for 1.5hours). Fluorescence images were acquired using a Typhoon FLA7000, and each gel 
stained with Coomassie Brilliant Blue then destained at room temperature and imaged (Figure S37-
38). Gel quantification was performed using ImageJ software. The area of each fluorescent band or 
total protein by Coomassie staining was determined, and the monomeric standards used to generate 
a linear calibration; the protein present in the pellet samples was determined relative to the 
calibration curve, and the fraction relative to the first standard band calculated. The three samples 
were averaged and plotted as mean and standard deviation. 
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Figure S 4.37  SDS-PAGE Incorporation of 5% aS-PpY3a 94 and 5% aS-PpY3a 94 Proteins into 
Fibrils. The identity of each protein is indicated above the plots corresponding to Coomassie-
stained gels (left) or fluorescence gel images (middle). Standards refers to monomeric samples, 
serially diluted. Pellets correspond to triplicate samples of fibrils generated under identical 
conditions. Fibrils made with A) 5% aS-PpY3a 94 B) 5% aS-PpY3a 136 in WT. C) Quantification of 
protein in aggregated samples relative to monomer as determined by gel densitometry. Bars 
represent mean with error bars representing standard deviation. 
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Figure S 4.38  SDS-PAGE Incorporation of 50% aS-PpY3a 114 Proteins into Fibrils. A) 
Coomassie-stained gels (left) or fluorescence gel images (middle). Standards refers to monomeric 
samples, serially diluted. Pellets correspond to triplicate samples of fibrils generated under identical 
conditions. Fibrils made with 50% aS-PpY3a114 in WT.  C) Quantification of protein in aggregated 
samples relative to monomer as determined by gel densitometry. Bars represent mean with error 
bars representing standard deviation. 
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4.6.16. Live Neuronal Uptake Experiment  
 
Synthesis and Validation of 3a-pffs (50% WT and 50% aS-PpY3a 114)  
 
 
Figure S 4.39   3a-pffs were prepared by mixing 50% WT-aS and 50% aS-PpY3a 114. 
 
Synthesis of 3a-pffs. 3a-pffs were prepared by mixing 50% WT-aS with 50% aS-PpY3a 114 at a 
total concentration of 2 mg/mL in Dulbecco’s Phosphate Buffered Saline (DPBS).  The resulting 
solution was sterile filtered and incubated at 37°C with constant agitation at 1,000 rpm for 7 days.    
 
Circular Dichroism Spectroscopy (Figure S40A). The concentration of purified WT (ε280 = 5120 
M-1 cm-1) and aS-PpY3a 114 (ε408 = 11040 M-1 cm-1) were determined by UV-Vis absorbance. CD 
spectra were acquired on an Aviv model 410 circular dichroism spectrophotometer in 1 mM path 
length quartz cuvettes at 25 °C. Spectra were acquired as previously described.15-16 aS-PpY3a114 
exhibited spectra indicative of an a-helical conformation; the intensity of the helical signal at 208 
and 222 nm were similar to wild-type (WT).  
 
In Vitro Aggregation Kinetics (Figure S40B). The aggregation reaction was carried out for 3a-
pffs generated with 50% aS-PpY3a 114 in WT as previously described.15-16  Aggregation kinetics of 
3a-pffs were slower than that of WT,16 but such delayed aggregation has been observed previously, 
and no deleterious effects were observed for cellular uptake.15  
   353 
 
SDS-PAGE (Figure S40C). Fibrillization was confirmed by sedimentation analysis as previously 
described for WT aS.17 Briefly, samples were spun on an ultracentrifuge (Beckamn-Coulter) at 
100,000x g for 30 min at rt.  The supernatant (S) was collected, and the insoluble pellet (P) was 
resuspended in an equal volume of DPBS.  Samples were diluted in 5X Laemmli buffer, boiled, 
and separated by SDS-PAGE.  The gel was stained by Coomassie Brilliant Blue, and bands were 
quantified using ImageJ (NIH).  It was found that 95.7 ± 1.6 % of the total protein for each sample 
was found in the pellet fraction (mean ± SD, n = 2, each measured in duplicate).   
 
Transmission Electron Microscopy or TEM (Figure S40D) For TEM, a 4 µL drop of sample 
was applied to a carbon Formvar coated 300-mesh Cu grid.  Samples were allowed to rest for 5 
min at room temperature. Excess solution was wicked off and the grid was washed 2 x 5 min by 
inversion over a water droplet. The grids were then stained for 5 min with freshly-prepared and 
sonicated 0.4-2% w/v uranyl acetate in water. Excess uranyl acetate solution was wicked from the 
grids with a kimwipe.  TEM was carried out on a JEOL-1010 instrument with an accelerating 
voltage of 80 kV.  Images were collected at magnification of 100,000x. 
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Figure S 4.40  A) Circular dichroism spectra of aS-WT (gray) and 100% aS-PpY3a 114 (green); 
B) in vitro aggregation kinetic data of 3a-pffs (50% aS-PpY3a 114 in WT); C) SDS-PAGE of 3a-
pffs, and D) TEM imaging of 5% aS-PpY3a 94 in WT, 3a-pffs (50% aS-PpY3a 114 in WT), and 5% 
aS-PpY3a 136 in WT 
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4.6.17. Experimental Set Up for Neuronal Uptake  
 
Cell Culture.  Primary neuronal cultures were prepared from E15-E17 embryos of CD1 mice 
(Charles River) as previously described.1 All procedures were performed according to the NIH 
Guide for the Care and Use of Experimental Animals and were approved by the University of 
Pennsylvania Institutional Animal Care and Use Committee (IACUC). Dissociated hippocampal 
neurons were plated at a density of 100,000 cells in the glass center chamber of a MatTek dish (35 
mm dish,14 mm well, #1.5 coverglass) for live cell imaging, and were allowed to mature for 7-10 
d in complete neuronal medium (Neurobasal without phenol red (Thermo Fisher), 5% B27 
supplement (Thermo Fisher)).  Medium was partially exchanged every 3-4 days. 
Sample Preparation.  Images were acquired as previously described.15  Trypan blue diphosphate 
(Sigma-Aldrich) solutions were freshly prepared on the day of experiment as a 2x solution (1 mM 
in DPBS without Ca2+, Mg2+, Gibco) and sterilized by filtration.  Trypan blue, complete neuronal 
medium, and neurobasal without phenol red, B27, or antibiotic supplementation were equilibrated 
at 37°C, 5% CO2. 3a-pffs (50% aS-PpY3a114 & 50% WT) were diluted in DPBS to 100 µg/mL for 
and sonicated (Diagenode Biorupter™ UCD-300 bath sonicator set to high, 30s sonication followed 
by a delay period of 30s, 10 min total). Sonicated pffs were then diluted in neurobasal to 10 µg/mL. 
All neuronal medium was collected from the dish and 100 µL of the transduction suspension was 
directly added to the center chamber.  Transduced cultures were incubated for 3-4h before filtered 
conditioned medium was returned to the dish. Transductions were allowed to proceed for 4 h to 1 
d. For trypan blue experiments, immediately before imaging the neuronal culture dish was washed 
gently with 1 mL equilibrated neurobasal to remove B27. Trypan blue solution (1 mL, 1 mM in 
DBPS) was added dropwise to the dish and mixed by gentle pipetting for a final concentration of 
500 µM trypan blue.  For longer-term imaging experiments without trypan blue, neurons were 
maintained in conditioned neuronal medium. Images were acquired on a Nikon spinning disk 
confocal microscope. 
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Imaging Conditions.  Green channel (405ex/FITC) was used to image pre-activated 3a. Upon 
activation, fluorescence intensity from 3a decreases under the green channel.  Sequentially, red 
channel (488ex/Cy5) was used to image post-activated 3a-PC upon stimulation. Initially, when 
none of the probe is activated, 3a is not detected or displays very low background fluorescence 
under the red channel. After photo-stimulation (photoactivation) with the Spectra X laser, 
fluorescence of post-activated 3a-PC will appear under the red channel.  The false-colored blue 
channel (561ex/Cy5) is used to image trypan blue, which fluoresces when bound to extracellular 
proteins on the cell membrane, enabling the visualization of intact cell membranes.  Only 
fluorescence of internalized 3a-pffs is detected, as fluorescence of extracellular 3a-pffs in contact 
with trypan blue is quenched.  
 
Green channel:  405ex/FITC 100% (excitation laser 405 nm with FITC emission filter); 3a   
Red channel:     488ex/Cy5 50% (excitation laser 488 nm with Cy5 emission filter); 3a-PC 
Blue channel:    561ex/Cy5 100% (excitation laser 561 nm with Cy5 emission); Trypan blue   
Merge:              Green, Red, and Blue channels are merged. 
Stimulation:   440 nm Spectra X 100% on ROIs (DMD) for 40 – 60 sec 
Incubator:         37°C, 5% CO2 
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Guideline for Imaging Analysis.  Red Channel (488ex/Cy5) shows fluorescence from both 3a-
PC and Trypan blue. Hence, the merged purple region between channels (488ex/Cy5) and 
(561ex/Cy5) indicate the cell membrane. Merged images between the green (405ex/FITC) and red 
(488ex/Cy5) channels indicate the population of pre- (3a-pffs; appearing as green puncta) and post-
activated 3a-pffs (3a-PC-pffs; appearing as red puncta).  
 
Note. 405ex 100% laser can also activate 3a probe. It is best to identify the cell of interest and focus 
using the blue channel (561ex/Cy5). For fine focus to identify specific vesicles, use laser power 
(<25%) with 405ex for green channel(405ex/FITC). The dotted white square below indicates a 
representative ROI (region of interest) where DMD/Spectra X laser stimulation would be applied.  
 
 
 
 
Figure S 4.41 Schematic view of three channels pre- and post-activation of a single neuron. The 
white dotted square indicates a representative region of irradiation with the stimulation laser (440 
nm, DMD).   
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4.6.18. Photoactivation and Tracking Protocols 
 
Photoactivation of a single endosome/lysosome experiment (Exp A) 
 
 
 
 
Figure S 4.42  Schematic view of Exp A 
 
 
The neuronal culture dish (transduced with 3a-pffs overnight) was carefully washed with 1.0 mL 
of neurobasal medium. 1.0 mL of neurobasal medium was added to the culture dish, which was 
placed on the stage-top incubator and allowed to equilibrate for 3-5 min.  Neurons were identified 
under Differential Interference Contrast (DIC) before addition of 1.0 mL of trypan blue solution as 
described above.  The correct focal place was identified low power 561ex/Cy5. “Pre-activated” 
images were captured using three channels: green, red, and blue with three z-planes. For stimulation, 
vesicles of interest in the center of the collected z-stack were identified, and ROIs were drawn to 
contain these vesicles. Exposure times for imaging were minimized (i.e., images were not collected 
simultaneously while stimulating the ROI). ROIs were photoactivated with 440 nm Spectra X laser 
at 100% for 60 s. Images of “post-activated” puncta were captured under three channels: green, red, 
and blue. Depending on the size of vesicles or focused point of laser, stimulation time required for 
full conversion may vary.  
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Tracking photoactivated endosome/lysosome experiment (Exp B) 
 
 
 
 
 
Figure S 4.43  Schematic view of Exp B 
 
 
 
The neuronal culture dish (transduced with 3a-pffs 12 to 48 h) was carefully washed with 1ml of 
complete neuronal medium. 2.0 mL of complete neuronal medium was then added to the culture 
dish. Neurons were identified under DIC. Cells with optimal uptake of 3a-pffs were identified 
under the green channel at low power (405/FITC, 25%) . “Pre-activated” images were captured 
under two channels: green (25%) and red (50%) with 3 z-planes. ROIs were photoactivated with 
the 440 nm Spectra X laser at 100% for 60 s. “Post-activated” images were collected under two 
channels: green (25%) and red (50%), with 3 z-planes, every 20-30 min over periods of 3 to 8 h as 
indicated.   
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4.6.19. Additional Imaging Data 
Data for Exp A: Photoactivation of a single endosome/lysosome  
 
 
 
Figure S 4.44   Schematic view of endosomes/lysosomes containing 3a-pffs (green puncta).  
 
 
 
Figure S 4.45  Photoactivation of internalized 3a-pffs. Merged images of blue, green, and red 
channels are shown 
.  
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Simultaneous Activation of Multiple ROIs 
 
A) Sample 1 
  
 
 
 
 
B) Sample 2 
  
 
 
 
Figure S 4.46 Photoactivation of multiple ROIs with internalized 3a-pffs in endosomes  or 
lysosomes. Merged, blue, red, and green channels are shown from left to right. 
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Single Vesicle Activation 
 
 
 
Figure S 4.47 Photoactivation of a single endosome/lysosome containing 3a-pffs is shown. 
Merged, blue, red, and green channels are shown from left to right 
 
. 
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Sequential Activation  
 
A) Sample	1	(Main	text	Figure	5D-O)	
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B) Sample	2	
 
 
 
 
Figure S 4.48  Sequential photoactivation of individual endosomes/lysosomes containing 
internalized 3a-pffs. Merged, blue, red, and green channels are shown from left to right.  
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Data for Exp B:  Time course Tracking Experiment without Trypan Blue 
 
 
Sample 1. Neurons were transduced with 3a-pffs for 48 h prior to photoactivation 
 
 
 
Figure S 4.49  Large population of neurons are shown in A) differential interference contrast 
(DIC) image, and B) 405ex/FITC channel. C) Pre-activated image before tracking.  The majority 
of signal corresponds to extracellular 3a-pffs, although endocytosed 3a-pffs were identified by 
spherical, somatic, perinuclear morphology prior to photoactivation. 
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Figure S 4.50  Time point imaging in three z-planes after photoactivation of a single 
endosome/lysosome containing 3a-pffs. Internalized 3a-pffs were quite static, moving only slightly 
over 8 h. (t1 = 2 h, t2 = 4 h, t3 = 6 h, t4 = 8 h). 
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Figure S 4.51  A) Movement of single photoactivated endosome/lysosome containing 3a-pffs 
over 8 h. B) White line indicates the recorded distance moved by the punctum. 
 
 
 
 
  
   368 
Sample 2. Neurons were transduced with 3a-pffs for 20 h prior to photoactivation. 
 
1) Region	1:	Photoactivation	of	multiple	regions	of	interests	(ROIs)	
        
 
 
2) Region	2:	Photoactivation	of	multiple	regions	of	interests	(ROIs)	
 
 
 
3) Combined	view	of	photoactivated	regions	1	and	2.	Scale	bar	corresponds	to	10	µm.	
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4) Tracking	of	photoconverted	ROIs	up	to	3	h		
 
Figure S 4.52  Tracking of individual 3a-pff puncta 1 and 2. “Tracking A” images are 
representative of the appearance of  a non-photoconvertible probe. “Tracking B” images represent 
when a CPX probe is used to mark (via photoconversion) a subset of 3a-pffs to assist the trafficking 
of subpopulations of fibrils over 3 h.  
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4.6.20. X-ray Structure Determination of Compound 2a 
     
 
Compound 2a,  C30H26I4.86N2O2, crystallizes in the triclinic space group P1
_
 with a=10.5582(6)Å, 
b=12.7047(8)Å, c=14.4180(9)Å, α=64.250(2)°, β=86.988(2)°, γ=66.557(2)°, V=1581.15(17)Å3, 
Z=2, and dcalc=2.233 g/cm3 . X-ray intensity data were collected on a Bruker D8QUEST [1] CMOS 
area detector employing graphite-monochromated Mo-Kα radiation (λ=0.71073Å) at a temperature 
of 100K. Preliminary indexing was performed from a series of twenty-four 0.5° rotation frames 
with exposures of 10 seconds. A total of 2960 frames were collected with a crystal to detector 
distance of 33.0 mm, rotation widths of 0.5° and exposures of 5 seconds.Rotation frames were 
integrated using SAINT [2], producing a listing of unaveraged F2 and σ(F2) values. A total of 39909 
reflections were measured over the ranges 6.05 ≤ 2θ ≤ 55.118°, -13 ≤ h ≤ 13, -15 ≤ k ≤ 16, -18 ≤ l 
≤ 18 yielding 7127 unique reflections (Rint = 0.0425). The intensity data were corrected for Lorentz 
and polarization effects and for absorption using SADABS [3] (minimum and maximum 
transmission 0.5704, 0.7456). The structure was solved by direct methods - ShelXT [4]. There are 
two tri-iodide ions that lie on crystallographic centers of symmetry (at ½, ½, ½ and 1, 1, 0). The 
tri-iodide ion at 1, 1, 0 is disordered in two different orientations with relative occupancies of 86/14. 
There is also an I2 molecule that is not fully occupied, but has an ocuppancy of 0.86. The hexyl 
chain is also disordered by a twisting of the 5th and 6th carbons as shown below (the relative 
occupancies of the two sets of disordered carbons is 50/50: 
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Refinement was by full-matrix least squares based on F2 using SHELXL-2017 [5]. All reflections 
were used during refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ 74.0705P] where P 
= (Fo2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically and hydrogen atoms were 
refined using a riding model. Refinement converged to R1=0.0895 and wR2=0.1641 for 5480 
observed reflections for which F > 4σ(F) and R1=0.1189 and wR2=0.1834 and GOF =1.270 for all 
7127 unique, non-zero reflections and 370 variables. The maximum Δ/σ in the final cycle of least 
squares was 0.000 and the two most prominent peaks in the final difference Fourier were +3.44 and 
-2.84 e/Å3. 
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Table S 4.1 Summary of Structure Determination of Compound 9869 
 
 
 
Empirical formula  C30H26I4.86N2O2  
Formula weight  1063.26  
Temperature/K  100  
Crystal system  triclinic  
Space group  P1
_
  
a  10.5582(6)Å  
b  12.7047(8)Å  
c  14.4180(9)Å  
α  64.250(2)°  
β  86.988(2)°  
γ  66.557(2)°  
Volume  1581.15(17)Å
3
  
Z  2  
dcalc  2.233 g/cm
3
  
μ  4.811 mm
-1
  
F(000)  987.0  
Crystal size, mm  0.22 × 0.2 × 0.08  
2θ range for data collection      6.05 - 55.118°  
Index ranges  -13 ≤ h ≤ 13, -15 ≤ k ≤ 16, -18 ≤ l ≤ 18  
Reflections collected  39909  
Independent reflections  7127[R(int) = 0.0425]  
Data/restraints/parameters  7127/343/370  
Goodness-of-fit on F
2
  1.270  
Final R indexes [I>=2σ (I)]  R1 = 0.0895, wR2 = 0.1641  
Final R indexes [all data]  R1 = 0.1189, wR2 = 0.1834  
Largest diff. peak/hole  3.44/-2.84 eÅ
-3
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Figure S 4.53  1H NMR spectrum of 1 in CD2Cl2 (500 MHz). 
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Figure S 4.54   1H NMR spectrum of 3a in CD3CN (500 MHz). 
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Figure S 4.55  13C NMR spectrum of 3a in CD2Cl2 (126 MHz). 
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Figure S 4.56    19F NMR spectrum of 3a-Trifluoroacetate (TFA)  in CD2Cl2 (500 MHz).  
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Figure S 4.57 1H NMR spectrum of 3b in CD3CN (Cryo 500 MHz). 
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Figure S 4.58  13C NMR spectrum of 3a-PC in CD3CN (Cryo 126 MHz).  
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Figure S 4.59  1H NMR spectrum of 3b in CD3CN (500 MHz).  
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Figure S 4.60  13C NMR spectrum of 3b in CD3CN (126 MHz). 
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Chapter 5 
Diazaxanthilidene-Based	Neuronal	Fluorescent	“NeuroX”	Probes	
	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The text of this chapter was taken in part from a manuscript in preparation. The work is mainly 
from Sung-Eun Suh and collaborators including Elen Hernandez, Mai N. Tran, J. Nicholas Betley, 
David M. Chenoweth at the University of Pennsylvania.  
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Abstract  
Fluorescent probes are an important tool in cellular imaging. However, many readily available 
small-molecule imaging probes are either cytotoxic or easily photobleached and thus not 
compatible with lengthy live cell or tissue imaging experiments. One particularly limited field of 
application is neuroscience, where small molecule probes for neuronal labeling at the tissue level 
are highly valuable for studying the structure and function of the nervous system. Here, we describe 
a series of nuclear stains that we refer to as NeuroX (Nuclear-specific Neuronal diazaXanthilidene 
dyes). These probes were generated through a simple two-step synthesis of the reported structure 
of xylopyridine A and possess several properties that enable experiments with live cells (i.e., water 
solubility, cell-permeability, high photostability, and most importantly negligible cytotoxicity). We 
demonstrate that NeuroX probes can be utilized for ex vivo and in vivo nuclear labeling in neuronal 
systems. These probes also demonstrate retrograde transport properties, suggesting the potential 
for use in labeling and tracing of neuronal populations. 
  
   384 
5.1    Introduction 
Fluorescent probes have emerged as an essential tool for advanced imaging techniques to 
understand biochemical and biological phenomena.1 In particular, fluorescent small molecules are 
advantageous due to their small size and structural diversification, allowing a minimally perturbed 
system as well as the ability to tune photophysical properties2 or install conjugatable handles3 to 
visualize living systems. Thus, a vast number of synthetic fluorophores were developed over 
several decades and successfully employed for live cell imaging.  
However, many small organic fluorophores still have issues related to cytotoxicity,4 insufficient 
brightness,5 and photobleaching,6 limiting their application in long-term live cell imaging or thick-
tissue imaging experiments. Addressing these limitations is critical for expanding the ability to 
apply small molecule probes for neuroscientists. Current imaging tools in neuroscience primarily 
require the use of viral delivery of genetically encoded markers and sensors.7 Nuclear staining dyes 
are an important class of probes that could be utilized for imaging neuronal populations in ex vivo 
and in vivo studies.8 Here, we introduce a new nuclear-specific fluorogenic dye scaffold based on 
the reported structure of xylopyridine A (or diazaxanthilidene).9 These dyes exhibit cellular 
localization, cell permeability, water solubility, high quantum yield, non-cytotoxic, and high 
photostability (Figure S 5.1).10  This new family of Nuclear-specific Neuronal diazaXanthilidene 
dyes are referred to as NeuroX probes.  
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5.2    Results and Discussion 
5.2.1. Two-Step Synthesis of the Reported Structure of Xylopyridine A  
Recently, we reported a novel fluorescent dye scaffold based on the reported structure of a natural 
product xylopyridine A (E/Z)-1.9b We discovered that the diazaxanthilidene scaffold exhibits 
advantageous potential for application in organelle-specific staining and development of 
photoconvertible probes for live cell imaging and tracking applications.3, 9a, 10 Previously, we 
synthesized (E/Z)-1 in five steps from 4-cyanopyridine.9b Herein, we developed a shorter and more 
efficient two-step synthesis of (E/Z)-1 via pyridyne insertion followed by direct reductive coupling. 
The synthesized (E/Z)-1 was photoelectrocyclized and methylated to generate the NeuroX probes 
(Figure 5.1). 
 
 
Figure 5.1 Two-step synthesis of (E/Z)-1 from pyridine precursor (top) and the synthesis of 
NeuroX (5-7a/7b). 
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5.2.2. Pyridyne Insertion and Dimerization Reaction 
In the first step of the synthesis, in situ-generated pyridyne, which was obtained from the 
reaction of 3,4-pyridyne precursor 2 and CsF, was inserted into the C-O bond of 2-fluorobenzoic 
acid 8 to afford azaxanthones 9 and 10 (Scheme 5.1, Figure S 5.1). To optimize the pyridyne 
insertion reaction, we studied the effects of the halobenzoic acid, fluoride source, base, solvent, and 
temperature. The reaction of 2 and 8 with CsF in Ph2O at 220 oC for 4 hours resulted in the best 
yield of 9 (12% yield) and 10 (25% yield). Despite the modest yield, our work provides the first 
example of utilizing a pyridyne precursor to generate 2-azaxanthone (10)11  and 3-azaxanthone (9). 
Next, we focused on optimizing the dimerization reaction to yield (E/Z)-1. To minimize the 
reaction steps and handling, we attempted to homodimerize 9 directly using Woollins’ reagent 
(Scheme 5.1).12 After optimization, the reaction in Ph2O at 140 oC for 12 hours afforded (E/Z)-1 
in 88% yield in one step.  Using this approach, we successfully developed a facile two-step 
synthetic route to obtain (E/Z)-1 via pyridine insertion and tandem selenation/reductive coupling, 
providing rapid access to the key precursor for the development of NeuroX probes. 
Scheme 5.1  Two Step Synthesis of (E/Z)-1. 
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5.2.3. Synthesis of NeuroX 
Adopting Katz’s photocyclization/oxidation conditions, we converted diazaxanthilidene 1 to 
photoproducts 3 and 4 (2:1 ratio, 74% yield, Figure S 5.6).  Further methylation of the two isomers 
(3 and 4) improved the water solubility and successfully enabled diversification into four candidate 
molecules (5, 6, 7a/7b, and 11) for use as nuclear staining dyes (Figure 5.2A). The synthesized N-
methylated photoproducts efficiently stained the nuclei of live cells (Figures S 5.2-5.5). This 
property may be due to the well-balanced lipophilic and cationic nature of the dyes, allowing cell 
permeability, water solubility and electrostatic attraction with nucleic acids. 
 
Figure 5.2  Synthesis of N-methylated diazaxanthilidene compounds (top). Absorption (dotted 
line) and emission (solid line) spectra of NeuroX compounds are shown in orange (5), red (6), and 
yellow (7a/7b). 
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The nuclear staining properties of compounds 5, 6, and 7a/7b, a family of NeuroX probes, were 
evaluated in neurons. Compound 11 exhibited a relatively high cytotoxicity, which may be due to 
the redox active cross-conjugated N-methylpyridinium moiety similar to pyridinocyanine dyes 
(Figure S 5.8).13 All absorption and emission wavelengths of compounds 5,6, and 7a/7b are located 
in the same visible light spectrum range with large Stokes shifts of 80-100 nm, allowing these dyes 
to be compatible for simultaneous imaging with green fluorescent protein (GFP) or DAPI co-labels 
(Figure 5.2B). 
 
Figure 5.3  Time-lapse imaging of NeuroX 5 over 4 h. Scale bar is 10 μm (p = prophase, pm = 
prometaphase, m = metaphase, a = anaphase, t = telophase, c = cytokinesis). 
 
5.2.4. Live Cell Imaging of NeuroX 
Nuclear staining is an important tool to reveal the natural location of cells in tissues and provide 
a means to follow nuclear changes throughout cell cycles. To demonstrate the non-cytotoxic and 
photostable nature of NeuroX probes, we conducted cell viability and photostability experiments 
(Figure S 5.2). All three NeuroX probes (5-7a/7b) exhibited more than 80% cell viability after 48 
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hours and retained more than 80% of their fluorescent intensity after 200 seconds of continuous 
irradiation with either a 488 nm (5 and 7a/7b) or 552 nm laser (6 and 11), indicating significant 
resistance to photobleaching (Figure S 5.2). For initial cellular localization studies, we compared 
the localization of pre-methylated (3 and 4) and methylated compounds (5, 6, 7a/7b, and 11). Pre-
methylated compounds were not water soluble but localized primarily in tubular networks in the 
cytoplasm of live HeLa cells, consistent with mitochondrial localization (Figure S 5.6). All 
methylated products (5, 6, and 7a/7b) were water soluble, cell permeable, and primarily localized 
in the nuclei. Compound 5 was selected for time-lapse experiments in Neuro2a cells over 4 hours, 
and no cell death or distinctive photobleaching was observed (Figure 5.3). 
5.2.5. NeuroX Probes Label Brain Tissue 
We explored the utility of NeuroX probes 5-7a/7b as in situ nuclei labels in mouse brain tissue. 
First, the paraformaldehyde fixed tissues were incubated with 1.0 µM of NeuroX probes 5, 6, or 
7a/7b (Figures 5.4A-J, Figure S 5.10) to stain various regions of brain slices. Dense and intense 
nuclear labeling was observed throughout the brain, as demonstrated by labeling of nuclei in the 
Islands of Calleja (IC)14 and dentate gyrus (DG) regions of the hippocampus15 (Figures 5.4A-J). 
Nearly all neurons in these brain regions were labeled, but the intensity of labeling was more 
heterogeneous, demonstrating the possible differential ability of NeuroX probes to label various 
neuronal types (Figure S 5.10). To demonstrate that NeuroX can penetrate nuclei in living tissue, 
we incubated live coronal sections with 1.0 μM NeuroX 5 for 2 hours (Figures 5.4K-P, Figure S 
5.11). We observed bright staining in both IC and DG regions similar to that in fixed tissue, 
demonstrating that NeuroX probes can efficiently label neurons in living tissue. 
To demonstrate the utility of NeuroX dyes in diverse histochemical applications, we performed 
co-labeling experiments in fixed tissues with other fluorescent markers. Both DAPI (λex= 405 nm, 
λem = 465 nm) and NeuroX 5 (λex= 488 nm, λem = 600 nm) were co-labeled in the DG region of the 
brain using two excitation lasers (Figures 5.5A-D). Because both are nuclei specific dyes, we 
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observed co-localization of DAPI and 5, as shown in the merged image (Figure 5.5D). In addition, 
NeuroX 6 and 7a/7b were imaged in brain slices containing GFP driven from the Neuropeptide Y 
promoter (NPY-GFP), demonstrating that fluorescent protein emission remains intact following 
incubation with the NeuorX probe (Figure S 5.12). Due to the large stoke shifts of NeuroX probes, 
both NeuroX (λ,ex= 488 nm, λem = 600 nm) and NPY-GFP (λex= 488 nm, λem = 520 nm) were 
imaged with a single excitation laser at 488 nm, demonstrating the possibility to detect multiple 
different fluorophores with a single excitation wavelength. 
We observed labeling of NeuroX in a set of diverse brain regions including DG, arcuate nucleus 
(ARC), and anterior olfactory nucleus (AON) regions (Figure 5.5E-P). We found that NeuroX 
labels a much larger population of neurons than the NPY-GFP. Taken together, these observations 
in live and fixed tissue demonstrate that NeuroX dyes can serve efficiently as a tool to label and 
image neuronal nuclei in many different neural subtypes throughout the brain. 
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Figure 5.4  General protocol for tissue imaging (top). Fixed tissue imaging of NeuroX 5-7a/7b 
after overnight incubation (A-J, a-j). Live tissue imaging of NeuroX 5 after 2 h incubation (K-P, k-
p). Scale bar is 100 µm for A-P and 50 µm for a-p. Images are taken at λex= 488 nm, λem = 600 nm. 
Bright field (D, I, K, N) and merged (E, J, M, P) images are shown. 
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5.2.6. Retrograde Transport of NeuroX 
Successful labeling of NeuroX in living tissue suggested that these probes could be useful in 
anatomical studies to label neurons. We explored the possibility that small molecule NeuroX dyes 
could be used in neural tracing experiments as a dye that undergoes axonal uptake and retrograde 
transport.  Currently, the ability to identify upstream target neurons through retrograde transport is 
limited to tools that are either large viral reagents such as retrograde AAV16 cytotoxic viruses such 
as rabies virus,17 and large fluorescently labeled latex beads called RetroBeads.18 Additional tools 
that could be used to label upstream neural circuits efficiently without concomitant changes in 
molecular profiling that occur following viral transduction, would be useful for mapping, 
monitoring and manipulating neural circuits in vivo. Thus, to test the ability of NeuroX probes to 
undergo retrograde labeling, mice were injected unilaterally with 150 nL of 5 (3.0 µM) or 6 or 
7a/7b (30 µM) to the bed nucleus stria terminalis (BNST). After recovering for 2 weeks, brains 
were then harvested and imaged to identify known presynaptic regions. We compared NeuroX 
labeling with both retro-AAV and RetroBead labeling, in the AON and the Central nucleus of the 
Amygdyla (CEA), regions that send dense projections to the BNST,19 to determine if NeuroX 
provides a comparable, nontoxic label that can be used to identify presynaptic inputs to a given 
brain region. We find dense and intense NeuroX labeling in both regions, suggesting that retrograde 
transport of NeuroX is comparable with Retro-AAV and RetroBeads (Figure 5.6). Overall, NeuroX 
dyes provide a non-viral, nuclear specific small molecule probe to label neurons with a specific 
anatomical projection pattern. The utility of such a tool can be applied as a counter-label in ex vivo 
physiology, in vivo neural activity measures such as calcium imaging, and molecular profiling 
experiments using neurons sorted for fluorescent label following dissociation.13 The essentially 
limitless options to couple anatomical with physiological and molecular experiments are enhanced 
by the availability of a nontoxic dye with retrograde transport capability. 
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Figure 5.5 Co-labeling of NeuroX either DAPI or NPY-GFP. Co-labeling of 5 and DAPI on DG 
region (A-D), 6 and NPY-GFP on DG region (E-H), and 7a/7b and NPY-GFP on ARC (I-L) or 
AON regions (M-P). Scale bar for E-P is 100 µm. 
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Figure 5.6 Retrograde labeling of NeuroX 7a/7b (A), NeuroX 6 (D), Retro-AAV (B,E), and 
RetroBeads (C,F). AON region (A-C) and central nucleus of the amygdala (CEA) region (D-F) are 
traced from BNST region as shown in general scheme (G). Scale bar is 100 µm. 
5.3    Conclusion 
In conclusion, the rapid two-step synthesis of (E/Z)-1, a universal precursor for NeuroX dyes, 
was developed by employing a pyridyne insertion reaction followed by Woollin’s reductive 
coupling reaction. NeuroX displayed bright, non-cytotoxic, cell-permeable, and photostable 
properties both in vitro and in vivo studies. We successfully demonstrated the utility of NeuroX 
from simple live cell imaging experiments through retrograde labeling of the murine brain. 
Postmortem analysis revealed these dyes are stable and tolerate co-labeling protocols, allowing for 
diverse application in neuronal studies. Overall, NeuroX dyes are powerful new nuclear stains for 
imaging neuronal tissues, especially for non-genetic species. In conjunction with our recent studies 
of clickable diazaxanthilidene dyes,3 NeuroX dyes have the potential for further modification with 
targeting domains to enhance selective detection of neuronal sub-populations in various brain 
regions, a highly desirable property that currently lacks an experimental tool. 
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5.6    Supplementary Information 
5.6.1. General Information for Imaging  
 
Cell imaging  
For fixed and live cell imaging in Figure 3, S4-S8, S10, or S11, HeLa cells and neuro-2a cells 
(purchased from ATCC) were used. Cells were cultured in a 60 mm culture dish or a 75 cm2 culture 
flask using Life Technologies Dulbecco’s Modified Eagle Medium (DMEM) media with phenol 
red, 10% Fetal Bovine Serum and 1% penicillin-streptomycin at 37 °C in a humidified atmosphere 
with 5% CO2. The cells were detached with 0.05% trypsin-EDTA and transferred to a 35 mm glass 
bottom poly-D-lysine coated dish 2 days before imaging with about 2 mL of the above-mentioned 
media. One microliter of a 5 mM solution of 3, 4, 5, 6, 7a/7b, or 11 in MiliQ water was mixed with 
2 mL new media and added to the cells after the old media was removed. After incubation (1 hour 
to overnight for 3, 4; and 3 hours to overnight for 5, 6, 7a/7b, and 11), the excess dyes were washed 
twice with non-phenol red DMEM before imaging (optional for 5 and 6). The cells were kept in 1 
mL non-phenol red DMEM during imaging. A Leica DMI 6000B inverted microscope equipped 
with a 100x oil immersion HCX PL APO (1.46 NA; correction collar), 63x oil immersion HCX PL 
APO CS (1.40-0.60 NA; variable iris), and 20x dry HC PLAN APO (0.70 NA) was used to record 
the images shown in Figure S4A, S5, S6, S7, S10, and S11. A Leica TCS SP5 II confocal 
microscope equipped with a 100x oil immersion HCX PL APO (1.46 NA; correction collar), 63x 
oil immersion HCX PL APO CS (1.40-0.60 NA; variable iris), and 20x dry HC PLAN APO (0.70 
NA) was used to record the images shown in Figure 3 or S8C. For time-lapse experiment in Figure 
3, cells on microscope stage incubator was kept in humidified atmosphere of 5% CO2 at 37 °C and 
“Mark and find” was used for eight different regions on a cell dish. 25% of argon laser intensity 
with 488 nm filter (12%) was used as power source and each image was scanned in 400 Hz for 62 
iterations including start (0 minute) and end (240 minute) time points for 4 hours; 1 scan/4 minutes. 
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All image and video processing were performed by using Fiji software. Imaging condition is noted 
as “488/600” if excitation laser is 488 nm and emission filter is 600±25 nm.  
 
Cytotoxicity and photostability studies.  
 In a 96-well plate, HeLa cells were plated at 5,000 cells/well in the previously mentioned culture 
media (50 μL/well) and incubated at 37 °C in a humidified atmosphere with 5% CO2. After 24 
hours, the cells were treated with 3, 4, 5, 6, 7a/7b, or 11 (final concentration of 5 μM) as well as 
MitoTracker Red FM (final concentration 1 μM) and DMSO (vehicle control for MitoTracker). For 
wells treated with MitoTracker and DMSO, the DMSO concentration was maintained at 1%. 
Untreated cells were used as a vehicle control for 3, 4, 5, 6, 7a/7b, or 11. The final volumes were 
100 μL/well. The cells were incubated at 37 °C in 5% CO2 for 24 or 48 hours. Alamar Blue (10 μL) 
was added 2 hours prior to the fluorescence measurement. Fluorescence was measured at an 
excitation wavelength of 560 nm and an emission wavelength of 590 nm. The vehicle control was 
taken as 100% cell viability. Normalized plot of the average intensity of 3, 4, 5, 6, 7a/7b, or 11, as 
well as Mitotracker Red FM over 100 laser pulses (300 ms/scan, 0.8 mW intensity). To assess the 
photostability of NeuroX1-X3, time-lapse experiments were performed with a 444/525 channel for 
3 and 4, a 488/600 channel for 5, 7a/7b, a 552/600 channel for 6, 11, and a 594/632 channel for 
MitoTracker Red FM. 
  
Formaldehyde fixation. 
 After achieving the desired cell confluency (70-90%), media was removed and the cells were 
washed once with prewarmed PBS buffer and once with a prewarmed 4% formaldehyde solution. 
The cells were kept in 4% formaldehyde at room temperature for 20 minutes before the 
formaldehyde solution was removed and the dish was washed twice with PBS buffer. The sample 
can be kept in PBS buffer at 2-8 °C until needed. 
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Ethanol fixation.  
After achieving the desired cell confluency, media was removed and the cells were washed with 
PBS buffer, cold ethanol (-20 °C), then kept in ethanol at -20 °C. After 10 minutes, ethanol was 
removed, and the dish was washed twice with PBS buffer and stored in PBS buffer at 2-8 °C until 
needed. 
 
Statistical Analysis.  
Values are reported as means and linear fitting was conducted using excel and SigmaPlot. 
Correlations and R values were obtained using SigmaPlot software. 
5.6.2. Summary of Development of Diazaxanthilidene-Based Small Molecule Fluorescent Probes 
 
Figure S 5.1 Development of new synthetic strategy toward the reported structure of xylopyridine 
A (1) and derivatization of 1 to diazaxanthilidene-based small molecule fluorescent probes 
localized in lysosome, cytoplasm, or nucleus. Confocal microscopy images of live HeLa cells 
stained with S2 was copied from our previous literature.S1 
 
S1.   M. N. Tran, D. M. Chenoweth, Chem. Sci. 2015, 6, 4508–4512. 
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5.6.3. Cell Imaging of 5, 6, and 7a/7b (NeuroX) 
 
 
 
Figure S 5.2 (A-N) Confocal images of live HeLa cells, formaldehyde-fixed HeLa cells, ethanol-
fixed HeLa cells, and live Neuro-2a cells stained with NeuroX 5, 6, and 7a/7b. A 488/600 channel 
(488 nm for excitation and 600 nm for detection of fluorescence) was used to observe NeuroX 5 
and NeuroX 7a/7b, while a 552/600 channel was used for NeuroX 6, scale bar = 10 μm. (B) 
Viability assays of HeLa cells incubated with NeuroX 5, 6, and 7a/7b (5 μM) at 37 °C in a 
humidified atmosphere with 5% CO2 over 24 and 48 hours. (C) A normalized plot of the average 
intensity of 5, 6, and 7a/7b over 200 seconds of continuous irradiation.  
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Figure S 5.3 Confocal microscopy images of fixed and live cells incubated with NeuroX 5. The 
fluorescence image was observed using the 488/600 channel (488 nm for excitation and 600 nm 
for detection of fluorescence). Scale bar = 10 µm. (A) Live Neuro-2a cells. (B) Ethanol-fixed HeLa 
cells. (C) Paraformaldehyde-fixed HeLa cells. (D) Time-lapse experiment of HeLa cells during 200 
seconds of continuous irradiation. 
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Figure S 5.4 Confocal microscopy images of fixed and live cells incubated with NeuroX 6. The 
fluorescence image was observed using the 552/600 channel (552 nm for excitation and 600 nm 
for detection of fluorescence). Scale bar = 10 µm. (A) Live Neuro-2a cells. (B) Ethanol-fixed HeLa 
cells. (C) Paraformaldehyde-fixed HeLa cells. (D) Time-lapse experiment of HeLa cells during 200 
seconds of continuous irradiation. 
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Figure S 5.5 Confocal microscopy images of fixed and live cells incubated with NeuroX 7a/7b. 
The fluorescence image was observed using the 488/600 channel (488 nm for excitation and 600 
nm for detection of fluorescence). Scale bar = 10 µm. (A) Live Neuro-2a cells. (B) Ethanol-fixed 
HeLa cells. (C) Paraformaldehyde-fixed HeLa cells. (D) Time-lapse experiment of HeLa cells 
during 200 seconds of continuous irradiation. 
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 5.6.4. Cell Imaging of 3 and 4 
 
 
Figure S 5.6 Photocyclization/oxidation of (E/Z)-1 affording the photoproducts 3 and 4 (top). (A) 
Observed absorption and emission spectra of (E/Z)-1S2 (upper) as well as 3 and 4 (lower). (B) 
Photophysical properties of (E/Z)-1, 3, and 4. (C) Fluorescence images of live HeLa cells stained 
with 3 (upper panels) and 4 (lower panels). A 458/500 channel (458 nm for excitation and 495 nm 
for detection of fluorescence) was used to observed 3 or 4 in live HeLa cells. Scale bar = 25 μm. 
(D) Normalized plot of the average fluorescence intensity of 3, 4, or Mitotracker Red FM over 100 
laser pulses (300 ms/scan). The 444/525 channel was used to observe 3 and 4, and the 594/632 
channel was used to observe MitoTracker Red FM. (E) Viability assays of HeLa cells incubated 
with 3 (5 μM), 4 (5 μM), and MitoTracker Red FM (1.0 μM) at 37 °C in a humidified atmosphere 
with 5% CO2 over 24 and 48 hours. 
 
 
 
S2.   R. F. Rarig, M. N. Tran, D. M. Chenoweth, J. Am. Chem. Soc. 2013, 24, 9213–9219. 
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Figure S 5.7 Time-lapse experiment for HeLa cells incubated with 3, 4, or MitoTracker Red FM 
during 30 seconds of continuous irradiation using the 444/495 channel for 3 or 4 (444 nm for 
excitation and 495 nm for detection of fluorescence) and 594/632 channel for MitoTracker Red 
FM. Scale bar = 10 µm. HeLa cells were incubated with (A) 3. (B) 4. (C) MitoTracker Red FM. 
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5.6.5. Cell Imaging of 11 
 
                
Figure S 5.8 Confocal microscopy images of fixed and live cells incubated with 11. The 
fluorescence image was observed using the 552/600 channel (552 nm for excitation and 600 nm 
for detection of fluorescence). Scale bar = 10 µm. (A) Live Neuro-2a cells. (B) Ethanol-fixed HeLa 
cells. (C) Paraformaldehyde-fixed HeLa cells. (D) Time-lapse experiment of HeLa cells during 200 
seconds of continuous irradiation. 
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5.6.6. Time-Lapse Live Cell Imaging of NeuroX (Compound 5) 
A Leica TCS SP5 II confocal microscope equipped with a 100x oil immersion HCX PL APO (1.46 
NA; correction collar), 63x oil immersion HCX PL APO CS (1.40-0.60 NA; variable iris), and 20x 
dry HC PLAN APO (0.70 NA) was used to record the images shown below. For time-lapse 
experiment, cells on microscope stage incubator was kept in humidified atmosphere of 5% CO2 at 
37 °C and “Mark and find” was used for eight different regions on a cell dish. 25% of argon laser 
intensity with 488 nm filter (12%) was used as power source and each image was scanned in 400 
Hz for 62 iterations including start (0 minute) and end (240 minute) time points for 4 hours; 1 
scan/4 minutes. All image and video processing were performed by using Fiji software.S3 
 
 
Figure S 5.9 Neuro-2a Live Cell Imaging of NeuroX 5 
 
 
S3.    Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, S. Preibisch, C.       
Rueden, S. Saalfeld, B. Schmid, J.-Y. Tinevez, D. J. White, V. Hartenstein, K. Eliceiri, P. 
Tomancak, Nat. Methods, 2012, 9, 676–682. 
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5.6.7.  Mouse Brain Tissue Imaging of NeuroX  
Fixed Tissue ImagingS4 
 
Mice were deeply anesthetized and then euthanized by perfusion with phosphate buffered saline 
(PBS) followed by 4% paraformaldehyde in PBS. Brains were dissected and fixed overnight in 4% 
paraformaldehyde and transferred to PBS. Brain slices (50 μm) were cut by vibratome sectioning 
(Leica) and incubated overnight with 1.0 μM of NeuroX 5 or 2.0 μM of NeuroX 6 or 7a/7b diluted 
in PBS. Slices were mounted on glass slides in a VECTASHIELD® mounting medium and cover-
slipped for imaging. Tissue images were obtained using a Leica TCS SP8 confocal microscope 
equipped with a 20x/0.75 NA dry or a 63x/1.4 NA oil immersion objective lens. A 488/600 channel 
(488 nm for excitation and 600 nm for detection of fluorescence) was used to observe NeuroX 5, 
6, or 7a/7b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S4.   J. N. Betley, Z. F. Cao, K. D. Ritola, S. M. Sternson, Cell, 2013, 155, 1337–1350.  
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Figure S 5.10  Additional confocal images of fixed tissue sectioned at 50 μm of thickness and 
incubated overnight with 2 μM of either NeuroX 5, 6, or 7a/7b diluted in PBS focused in the regions 
Dentate Gyrus (DG), or DG-molecular layer (DG-mo), Inferior Colliculus (IC), and Paraventricular 
nucleus of the Thalamus (PVT). Images were obtained using brightfield and channel 488/600 at 
63x oil immersion. Scale bar, 50 μm. 
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5.6.8. Live Tissue ImagingS5  
 
Mice were deeply anesthetized and euthanized by live decapitation. Brains were dissected and 
immediately sectioned at 200μm using vibratome (Campden Instruments) submerged in iced 95 % 
O2 / 5% CO2 bubbled Artifical Cerebral Spinal Fluid (ACSF) bath. Coronal slices were incubated 
for no more than 2 hours with final concentration of 1.0 μM of NeuroX 5 in bubbled ACSF. Slices 
were mounted on glass slides in a VECTASHIELD® mounting medium and cover-slipped for 
imaging. Tissue images were obtained using a Leica TCS SP8 confocal microscope equipped with 
a20x/0.75NAdryor a63x/1.4 NA oil immersion objective lens. A 488/600 channel (488 nm for 
excitation and 600 nm for detection of fluorescence) was used to observe 1.0 μM of NeuroX 5. 
 
 
 
 
 
 
 
 
 
 
 
S5.   C. M. Hempel, K. Sugino, S. B. Nelson, Nat. Protoc., 2007, 2, 2924–2929. 
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Figure S 5.11  Additional confocal images of live tissue sectioned at 50 μm of thickness and 
incubated overnight with 2 μM of NeuroX 5 diluted in PBS focused in the regions Anterior 
Olfactory Nucleus (AON) and Claustrum (CLA). Images were obtained using brightfield and 
channel 488/600 at both 20x objective without oil and 63x objective with oil immersion. 
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5.6.9. Co-Labeling Experiment 
1) Protocol for Co-Labeling of NeuroX 5 with DAPI 
Mice were deeply anesthetized and then euthanized by perfusion with phosphate buffered saline 
(PBS) followed by 4% paraformaldehyde in PBS. Brains were dissected and fixed overnight in 4% 
paraformaldehyde and transferred to PBS. Brain slices (100 μm) were cut by vibratome sectioning 
(Leica) and incubated overnight with final concentration of 2.0 μM of NeuroX 5 in PBS. Slices 
were mounted on glass slides in a VECTASHIELD® mounting medium with 1.0 μM of DAPI and 
cover-slipped for imaging. Tissue images were obtained using a Leica TCS SP8 confocal 
microscope equipped with a 20x/0.75NA dry or a 63x/1.4 NA oil immersion objective lens. A 
488/600 channel (488 nm for excitation and 600 nm for detection of fluorescence) was used to 
observe NeuroX5 while a 405/465 channel (405 nm for excitation and 465 nm for detection of 
fluorescence) was used for DAPI. 
 
2) Protocol for Co-Labeling of NeuroX with NPY-GFP 
 
Neuropeptide Y Green Fluorescent Protein (NPY-GFP) transgenic mice were deeply anesthized 
using isoflurane and perfused with PBS followed by 4% paraformaldehyde in PBS.  Brains were 
dissected and incubated overnight in 4% paraformaldehyde and then transferred to PBS. Brains 
were sectioned at 50 μm of thickness and incubated for 1 hour with either NeuroX 5, 6 or 7a/7b 
(final concentration of NeuroX 5 is 1.0 μM and that of NeuroX 6 and 7a/7b were 2.0 μM) diluted 
in PBS. Tissue images were obtained using a Leica TCS SP8 confocal microscope equipped with 
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a 20x/0.75 NA dry or a 63x/1.4 NA oil immersion objective lens. A 488/600 channel was used to 
observe NeuroX 5, 6 or 7a/7b while a 405/465 channel was used for NPY-GFP. 
 
3) Protocol for Co-Labeling of NeuroX and compound 3 
NPY-GFP transgenic mice were deeply anesthetized and then euthanized by perfusion with 
phosphate buffered saline followed by 4% paraformaldehyde in PBS. Brains were dissected and 
fixed overnight in 4% paraformaldehyde and transferred to PBS. Brain slices (100μm) were cut by 
vibratome sectioning (Leica) and incubated overnight with 100 μM of 3 and 1.0 μM of NeuroX 5. 
Slices were mounted on glass slides in a VECTASHIELD® mounting medium and cover slipped 
for imaging. Tissue images were obtained using a Leica TCS SP8 confocal microscope equipped 
with a 20x/0.75 NA dry or a 63x/1.4 NA oil immersion objective lens. A 488/600 channel (488 nm 
for excitation and 600 nm for detection of fluorescence) was used to observe NeuroX 5 while a 
405/465 channel was used for 3. 
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Figure S 5.12    Confocal images of NPY-GFP fixed tissue imaging with incubation 2.0 uM of 
either NeuroX 5, 6, or 7a/7b diluted in PBS. Images observed using 20x brightfield, 488/600 for 
Neuro X compounds, and 405/465 for NPY-GFP. Fluorescence co-labeling was observed in 
regions Bed nuclei of the stria terminalis (BST), Arcuate (ARC), IC, DG, and AON 
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Figure S 5.13   Additional confocal images of fixed tissue imaging with incubation 100 uM of 
compound 3 and 1.0 uM of NeuroX 5 diluted in PBS. Images observed using 20x brightfield and 
63x oil immersion, 488/600 for Neuro X 5, and 405/465 for compound 3. Fluorescence co-labeling 
was observed in regions DG and Lateral hypothalamus (LH).  
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5.6.10. Retrograde Transport Experiment  
 
C57blk/6 wild type mice were anesthetized with 2% isoflurane and were placed into a stereotaxic 
apparatus (Stoelting Instruments). The skull was exposed through a small incision and a small hole 
was drilled for injection. Mice were injected with wither 3.0 μM of NeuroX 6 or 30 μM of Neurox 
7a/7b unilaterally in the BNST. A pulled glass pipette with 40–60-μm tip diameter was inserted 
into the brain and a unilateral injection (150 nl) of the probe was performed at coordinates around 
the BNST (bregma, +1.0 mm; midline, -0.83 mm; dorsal surface, –4.25 mm). A micromanipulator 
(1ul) was used to control the injection speed (10 nl min–1) and the pipette was withdrawn 2 minutes 
after injection of a probe. The incision was closed using sutures (Ethicon) and mice were returned 
to their home cage for a recovery period of two weeks. 
 Retrograde Transport Experiment via Viral Injection.  Mice were anesthetized with 2% 
isoflurane and placed into stereotaxic apparatus (Stoelting Instruments). A small incision of 3mm 
was made to expose the skull and a holee was drilled for injection site at indicated coordinates. 
C57blk/6 wild type mice were injected with either AAV retro tdTomato (AAV.rg-CAG-tdTomato) 
virusS6 or Red RetroBeads (LumaFluor Inc.). Mice were injected bilaterally with 120 nl volume of 
either compound using the BNST coordinates (bregma, +1.0mm; midline, -0.83mm; dorsal surface, 
-4.25mm). The incision was closed using Ethicon sutures (4-5) and mice were recovered for 2 
weeks before performing NeuroX incubation experiments. 
 
S6.   D. G. R. Tervo, B.-Y. Hwang, S. Viswanathan, T. Gaj, M. Lavzin, K. D. Ritola, S. Lindo, S. 
Michael, E. Kuleshova, D. Ojala, C.-C. Huang, C. R. Gerfen, J. Schiller, J. T. Dudman, A. W. 
Hantman, L. L. Looger, Neuron 2016, 92, 372–382. 
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Chapter 6 
 
Improving the Fluorescent Probe Acridonylalanine Through a 
Combination of Theory and Experiment 
 
 
 
 
 
 
 
 
 
 
 
 
The content of this chapter was originally published in the Journal of Physical Organic Chemistry. 
It is adapted here with permission from the publisher: I. Sungwienwong; J. J. Ferrie; J. V. Jun; C. 
Liu; T. M. Barrett; Z. M. Hostetler, Naoya Ieda; A. Hendricks; A. K. Muthusamy; R. M. Kohli; D. 
M. Chenoweth; G. A. Petersson,* and E. J. Petersson* J. Phys. Org. Chem. 2018 31 e3813.  
Copyright © 2018 John Wiley & Sons, Ltd. The full text is available on the publisher’s website 
at: https://onlinelibrary.wiley.com/doi/full/10.1002/poc.3813 DOI:10.1002/poc.3813 
† These authors contributed equally to this work. 
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Abstract 
Acridonylalanine (Acd) is a useful fluorophore for studying proteins by fluorescence spectroscopy, 
but improvement can be achieved by designing brighter analogues or those exhibiting a longer 
wavelength.  Here, we report the synthesis of Acd core derivatives and their photophysical 
characterization.  The amino acid aminoacridonylalanine (Aad) was synthesized in forms 
appropriate for genetic incorporation and peptide synthesis.  We show that Aad is a superior FRET 
acceptor to Acd in a peptide cleavage assay, and that Aad can be activated by an aminoacyl tRNA 
synthetase for genetic incorporation.  Together, these results show that we can use computation to 
design enhanced Acd derivatives that can be used in peptides and proteins. 
 
 
Figure 6.1 Top) Fluorescent amino acids based on 7-methoxycoumarin and acridone cores. 
Bottom) Aad is a Superior FRET Acceptor for Mcm.  Bottom) Absorbance (solid lines) and 
fluorescence emission (dashed lines) of Mcm (purple), Acd (blue), and Aad (orange) with spectral 
overlap shaded.  Both Acd and Aad have low absorbance at the excitation maximum of Mcm (325 
nm) and comparable spectral overlap (shaded areas), but Aad emission can more easily be 
distinguished from Mcm emission.   
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6.1    Introduction 
 Fluorescence spectroscopy can be a valuable tool for studying the structural dynamics of 
proteins and protein/protein interactions.1  The Petersson laboratory has developed a 
methoxycoumarinylalanine (Mcm, 1)/ acridonylalanine (Acd, 2) FRET pair for monitoring 
distances in the 15 to 40 Å range, and thioamide/Mcm or thioamide/Acd eT quenching pairs for 
short distance (<15 Å) measurements.2 In addition to being better suited to short distance ranges 
than Fam or Tmr, Acd is small enough to be directly genetically incorporated, rather than post-
translationally attached, and is less likely to disrupt protein folding.3  We have developed an 
engineered aminoacyl tRNA synthetase (RS)/ orthogonal tRNA pair for selective Acd 
incorporation by unnatural mutagenesis.4  Although many aspects of the Mcm/Acd FRET pair are 
optimal, such as significant spectral overlap and a high Mcm extinction coefficient at 325 nm where 
Acd has a minimum, one disadvantage is the small Acd Stokes shift, which leads to significant 
overlap of their emission spectra (Figure 6.1).  This overlap necessitates a challenging 
deconvolution of the Mcm/Acd spectra  to determine FRET efficiencies and distance measurements.  
Thus, an Acd derivative with a larger Stokes shift would be desirable for Mcm FRET. Finally, we 
synthesize Aad and perform initial trials toward its genetic incorporation. 
 
6.2    Results and Discussion  
6.2.1. Acridone derivative syntheses 
 To synthesize acridone cores that were not commercially available, we used two general 
strategies, functionalization of acridone and cross-coupling of pre-functionalized aryl units.  
Nitration of acridin-9(10H)-one 5 was performed with HNO3 in CH3COOH at 50 oC, giving a 
mixture 2-nitroacridin-9(10H)-one (6) and 4-nitroacridin-9(10H)-one (7) (variations in reaction 
conditions produced a 74% yield of 6 or 38% yield of 7, Experimental Section 6.6 for details).5  
Reduction of 6 and 7 using Na2S and NaOH in refluxing EtOH/water gave 2-aminoacridin-9(10H)-
   422 
one (8) and 2-aminoacridin-9(10H)-one (9), respectively, in quantitative yields (Na2S used for 
small scale, Pd/C also used to reduce 7, see Experimental Section 6.6 for details).5 (Scheme 6.1) 
 
Acd (2) was synthesized as we have previously reported.  Nitration of Acd was carried out 
similarly to nitration of acridone, affording a single nitro isomer in 39% isolated yield (>90% 
conversion based on integration of the chromatogram).  The nitration reaction mixture was basified 
and sodium sulfide added to perform the reduction to give Aad (4) in 86% yield. (see Experimental 
Section 6.6)   
 
Scheme 6.1 Synthesis of nitroacridones (6 and 7) and aminoacridones (8 and 9). 
 
6.3    Conclusions 
Aad appears to be superior to Acd for several fluorescence applications.  As demonstrated here, the 
red-shifted emission of Aad provides superior dynamic range in ratiometric FRET measurements 
with an Mcm donor.   
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6.6    Experimental Section 
6.6.1. General Information 
Materials. L-Tyrosine, thionyl chloride, di-tert-butyl dicarbonate (Boc2O), methyl 2-amino 
benzoate, and phenylsepharose CL-4B resin were purchased from Sigma-Aldrich (St. Louis, MO, 
USA).  N-Phenyl-bis(trifluoromethane sulfonimide) was purchased from Oakwood Chemical 
(West Columbia, SC, USA). Acridin-9(10H)-one, 2-aminoacridin-9(10H)-one, 2-methoxyacridin-
9(10H)-one, and 3-Methyl-2-aminonaphthoic acid were purchased from Sigma-Aldrich. Nα-Fmoc-
7-methoxycoumarin-4-yl-alanine (Mcm) was purchased from Bachem (Torrence, CA, USA).  All 
other Fmoc protected amino acids and peptide coupling reagents, as well as Rink amide resin, were 
purchased from EMD Millipore (Billerica, MA, USA).  Piperidine was purchased from American 
Bioanalytical (Natick, MA, USA).  Milli-Q filtered (18 MΩ) water was used for all solutions 
(Millipore; Billerica, MA, USA).  All other reagents and solvents were purchased from Fisher 
Scientific or Sigma-Aldrich unless otherwise specified. 
Instruments.  Low resolution electrospray ionization mass spectra (ESI-LRMS) were obtained on 
a Waters Acquity Ultra Performance LC connected to a single quadrupole detector (SQD) mass 
spectrometer (Milford, MA, USA). Accurate mass measurement analyses were conducted on either 
a Waters GCT Premier, time-of-flight, GCMS with electron ionization (EI), or an LCT Premier XE, 
time-of-flight, LCMS with electrospray ionization (ESI).  The signals were measured against an 
internal lock mass reference of perfluorotributylamine (PFTBA) for EI-GCMS, and leucine 
enkephalin for ESI-LCMS.  Nuclear magnetic resonance (NMR) spectra were obtained on a Bruker 
DRX 500 MHz instrument (Billerica, MA, USA).  Analytical HPLC was performed on an Agilent 
1100 Series HPLC system.  Preparative HPLC was performed on a Varian Prostar HPLC system 
(currently Agilent Technologies).  HPLC columns were purchased from W. R. Grace & Company 
(Columbia, MD, USA).   
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6.6.2. Chemical Synthesis 
2-Nitroacridin-9(10H)-one (6) and 4-nitroacridin-9(10H)-one (7) S1 
 
Acridone (5, 50 mg, 0.25 mmol) in 36% acetic acid (250 µL) was stirred vigorously at 50 °C.  Then 
glacial acetic acid (500 µL) and 70 % nitric acid (250 µL) were added (Table S1, entry 2). The 
reaction mixture was stirred for 1 h at 50 °C.  The mixture was then poured into ice-water (10 mL), 
neutralized with K2CO3, and extracted with EtOAc three times, resulting in a yellow precipitate in 
the aqueous layer.  The yellow solid in the aqueous layer was filtered off, washed thoroughly with 
water and EtOAc, and dried overnight.  Dried solid was then recrystallized in boiling ethanol to 
give 6 (30 mg, 49% isolated yield).  The organic layer was extracted, dried with anhydrous Na2SO4, 
and concentrated in vacuo.  The crude mixture was purified by flash column chromatography to 
give 7 (6 mg, 10% isolated yield). 
Characterization of 2-Nitroacridin-9(10H)-one (6)  
HRMS (ESI) calculated for C13H9N2O3+ is 241.0613, [M+H]+ found  241.0627.  
1H NMR (500 MHz, DMSO-d6) δH: 12.34 (s, 1H), 8.98 (d, 1H, J = 2.6 Hz), 8.42 (dd, 1H, J = 9.5, 
2.7 Hz), 8.23 (d, 1H, J = 8.2 Hz), 7.79 (t, 1H, J = 7.5 Hz), 7.60 (dd, 2H, J = 25.3, 9.0 Hz), 7.34 (t, 
1H, J = 7.3 Hz)    
 13C NMR (100 MHz, DMSO-d6) δC: 177.1, 145.7, 141.8, 141.1, 135.0, 127.8, 126.7, 123.7, 123.4, 
121.5, 120.0, 119.8, 119.2 
 
Characterization of 4-Nitroacridin-9(10H)-one (7)  
HRMS (ESI) calculated for C13H9N2O3+ is 241.0613 [M+H]+ found 241.0625.  
1H NMR (500 MHz, DMSO-d6) δH:  11.47 (s, 1H), 8.69 – 8.66 (m, 2H), 8.22 (dd, 1H, J = 8.1, 1.5 
Hz), 8.07 (dt, 1H, J = 8.4, 0.7 Hz), 7.81 (ddd, 1H, J = 8.5, 7.0, 1.6 Hz), 7.44 – 7.37 (m, 2H). 
13C NMR (500 MHz, DMSO-d6) δC: 176.5, 140.8, 136.0, 135.5, 135.3, 135.1, 132.2, 126.4, 123.9, 
123.7, 121.3, 120.6, 119.9 
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Table S 6.1 Screening of Acridone Nitration Conditions 
 
 
Each reaction was performed on 50 mg (0.25 mmol) 5 following the general experimental 
procedure described above. Yields calculated based on the area of corresponding HPLC 
chromatogram peak (100% = area of 5 + 6 + 7). 
 
 
Figure S 6.1 Screening of Acridone Nitration Conditions. 
  
Entry AcOH (%) HNO3 (%) 5 (%) 6 (%) 7 (%) 
1 75 17.5 5 74 21 
2 59 17.5 10 61 29 
3 43 17.5 7 68 25 
4 27 17.5 98 2 0 
5 75 12.5 11 50 38 
6 59 12.5 10 55 35 
7 43 12.5 87 10 3 
8 27 12.5 98 1.5 0.5 
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2-Aminoacridin-9(10H)-one (8) and 4-aminoacridin-9(10H)-one (9) 
 
Reduction of 2-nitroacridone (6) to form 2-aminoacridone (8) was preformed to test conditions for 
the reduction of nitroacridonylalanine (S7) to form aminoacridonylalanine (4). 
 
Condition 1 (without NaOH)S1 : To a stirred suspension of 2-nitroacridin-9(10H)-one (6, 4.0 mg, 
0.016 mmol) in ethanol (1.3 mL), a solution of sodium sulfide nonahydrate (110 mg, 0.46 mmol) 
in water (2.0 mL) was added. The reaction was refluxed for 20 h. Resulting analytical HPLC data 
of the crude, showed that there was no reaction. 
Condition 2 (with NaOH)S2  : Subsequent reduction to 2-aminoacridin-9(10H)-one (8) was tried  
under alkaline condition (condition 2). To a stirred suspension of 2-aminoacridin-9(10H)-one (8), 
a premixed solution of sodium sulfide nanhydrate (110 mg, 0.46 mmol) and sodium hydroxide (26 
mg, 0.65 mmol) in water (2.0 mL) was added. After refluxing the reaction mixture for 20 h, 2-
nitroacridone (6) was almost completely reduced to 2-aminoacridone (8, 84% HPLC yield) with a 
trace amount of starting material. 
 
4-nitroacridin-9(10H)-one (7, 4.0 mg, 0.016 mmol) was also reduced under basic solution 
(condition 2) to give 4-aminoacridin-9(10H)-one (9, 80% HPLC yield). HPLC yields were obtained 
by using 2-aminoacridone or 4-aminoacridone as a standard. 
 
S1. Gao, C.; Liu, F.; Luan, X.; Tan, C.; Liu, H.; Xie, Y.; Jin, Y.; Jiang, Y., Novel synthetic 2-amino-10-
(3,5-dimethoxy)benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents. 
Bioorg. Med. Chem. 2010, 18 (21), 7507-7514. 
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S2. Montalvo-Quirós, S.; Taladriz-Sender, A.; Kaiser, M.; Dardonville, C., Antiprotozoal Activity and 
DNA Binding of Dicationic Acridones. J. Med. Chem. 2015, 58 (4), 1940-1949. 
 
 
Figure S 6.2 Screening of 2- and 4-Nitroacridone Reduction Conditions. 
 
(S)-2-amino-3-(7-amino-9-oxo-9,10-dihydroacridin-2-yl)propanoic acid (4) 
 
To 180 mg (0.64 mmol) of Acd (2) in a 40 mL scintillation vial, glacial acetic acid (3 mL) and 70% 
nitric acid (1 mL) were added.  The reaction mixture was stirred for 2 h at 50 °C.  The mixture was 
cooled to room temperature and cold brine (20 mL) was added to precipitate (S)-2-amino-3-(7-
nitro-9-oxo-9,10-dihydroacridin-2-yl)propanoic acid (S7).  The crude yellow precipitate (81 mg, 
39% isolated yield; >90% conversion based on integration of the HPLC chromatogram, but 
6
Reduction	of	6	(condition	1)
Reduction	of	6	(condition	2)
8	(standard)
Reduction	of	7	(condition	2)
7	
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isolation of pure material was limiting) was reduced without further purification.  81 mg S7 (0.247 
mmol, 1 equiv) was dissolved in 2 mL ethanol and 1 mL water in a 20 mL scintillation vial.  In a 
separate vial, NaOH (333 mg, 8.3 mmol, 33 equiv) and sodium sulfide nonahydrate (500 mg, 2.08 
mmol, 8.4 equiv) were mixed in 2 mL of water.  The premixed solution of NaOH and sodium 
sulfide was added to the reaction vial and stirred overnight at 80 oC.  After the reaction was 
complete, the crude solution was purified by ion-exchanged resin and lyophilized to give (S)-2-
amino-3-(7-amino-9-oxo-9,10-dihydroacridin-2-yl)propanoic acid (S)-2-amino-3-(7-amino-9-
oxo-9,10-dihydroacridin-2-yl) propanoic acid (Aad, 4) (63 mg, 86 % yield).   
 
HRMS (ESI) calculated for C16H16N3O3+ is  298.1192,  found 298.1191.  
1H NMR (500 MHz, D2O) δH: 7.31 (1 H, d, J 2.1), 6.99 (1 H, dd, J 8.5, 2.0), 6.84 – 6.75 (2 H, m), 
6.61 (2 H, dd, J 19.7, 8.6), 4.72 (1 H, d, J 1.1), 3.65 (1 H, dd, J 7.6, 5.6), 2.84 (1 H, dd, J 14.5, 5.6), 
2.72 (1 H, dd, J 14.5, 7.6).  
13C NMR (126 MHz, D2O) δC: 176.34, 160.89, 140.29, 137.79, 133.85, 133.49, 128.21, 125.25, 
124.46, 119.41, 117.96, 117.55, 117.43, 107.71, 56.19, 37.25. 
 
(S)-2-((tert-butoxycarbonyl)amino)-3-(7-((tert-butoxycarbonyl)amino)-9-oxo-9,10-dihydro 
acridin-2-yl)propanoic acid (Boc2-Aad, S8) 
 
To 90 mg (0.32 mmol, 1 equiv) Acd (2) in a 40 mL scintillation vial, glacial acetic acid (1.5 mL) 
and 70% nitric acid (0.5 mL) were added.  The reaction mixture was stirred for 2 h at 50 °C.  The 
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mixture was cooled down room temperature and cold water (5 mL) was added to quench the 
nitration reaction.  For reduction, ethanol (5 mL) was added to the crude material followed by 
addition of premixed NaOH (512 mg, 12.8 mmol, 40 equiv) and sodium sulfide nonahydrate (769 
mg, 3.2 mmol, 10 equiv) in water (2 mL).  The reaction vial was stirred overnight at 80 oC.  After 
the reaction was judged complete by chromatography analysis, the crude solution was cooled to 
room temperature and quenched by adding saturated NaHCO3 (5 mL).  The crude mixture was 
transferred to a 100 mL round bottom flask.  NaHCO3 (900 mg) was added to the reaction mixture 
and it was stirred at room temperature.  Once the pH of the reaction mixture reached pH 8-9, Boc2O 
(2.1 g, 9.6 mmol, 30 equiv) was added, and the reaction stirred at room temperature overnight.  The 
mixture was then slightly acidified with a saturated NH4Cl solution.  The aqueous mixture was 
extracted with ethyl acetate three times, then the organic layer was collected and dried with Na2SO4.  
The organic layer was concentrated in vacuo and purified via silica column chromatography (0%-
20% MeOH in CH2Cl2) to remove excess t-butanol.  The product was obtained and lyophilized to 
give Boc2-Aad (S8, 79 mg, 50% yield over three steps).   
 
Characterization of Boc2-Aad, S8  
HRMS (ESI) calculated for C26H32N3O7+ is 498.2240, found 498.2230.    
1H NMR (500 MHz, MeOD) δH: 8.28 (1 H, s), 8.16 (1 H, s), 7.83 (1 H, d, J 8.4 Hz), 7.61 (1 H, d, 
J 9.1 Hz), 7.45-7.41 (2 H, m), 4.39 (1 H, br. s), 3.28 (1 H, m), 3.04 (1 H, br. s), 1.55 (9 H, s), 1.33 
(9 H, s), 1.40 (tBuOH residual peak), 3.35 (MeOH solvent residual peak)  
13C NMR (126 MHz, MeOD) δC: 179.94, 158.19, 155.92, 141.52, 138.92, 136.86, 135.30, 132.84, 
128.37, 122.33, 127.87, 122.33, 121.49, 119.38, 118.82, 115.67, 80.91, 58.07, 39.33, 29.25 (31.22 
residual tBuOH).   
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Figure S 6.3 1H NMR of Boc2-Aad (S8) in MeOD 
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Figure S 6.4 13C NMR of Boc2-Aad (S8) in MeOD 
 
